Natura &Co Holding (NTCOY) 20-F 13 May 24 2023 FY Annual report (foreign) Financial data

Cover page

Cover page	12 Months Ended
	Dec. 31, 2023 shares
Document Information [Line Items]
Document Type	20-F
Amendment Flag	false
Entity Registrant Name	Natura &Co Holding S.A.
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Central Index Key	0001776967
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2023
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-39169
Entity Incorporation, State or Country Code	D5
Entity Address, Address Line One	Avenida Alexandre Colares
Entity Address, Address Line Two	No. 1188, Sala A17-Bloco A
Entity Address, Address Line Three	Parque Anhanguera
Entity Address, City or Town	São Paulo
Entity Address, Postal Zip Code	05106-000
Entity Address, Country	BR
Entity Common Stock, Shares Outstanding	1,386,848,066
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Accounting Standard	International Financial Reporting Standards
Entity Shell Company	false
Auditor Name	PricewaterhouseCoopers
Auditor Firm ID	1351
Auditor Location	São Paulo, Brazil
Document Financial Statement Error Correction [Flag]	false
Business Contact [Member]
Document Information [Line Items]
Contact Personnel Name	Guilherme Strano Castellan
Entity Address, Address Line One	Avenida Alexandre Colares
Entity Address, Address Line Two	No. 1188, Sala A17-Bloco A
Entity Address, Address Line Three	Parque Anhanguera
Entity Address, City or Town	São Paulo
Entity Address, Postal Zip Code	05106-000
Entity Address, Country	BR
City Area Code	+55 (11)
Local Phone Number	4389-7881
Common Shares [Member]
Document Information [Line Items]
No Trading Symbol Flag	true
Title of 12(b) Security	Common shares, no par value (the “Natura &Co Holding Shares”)
American Depositary Shares [Member]
Document Information [Line Items]
No Trading Symbol Flag	true
Title of 12(b) Security	American Depositary Shares (the “ADSs”) (as evidenced by American Depositary Receipts), each representing two Natura &Co Holding Shares

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
CURRENT
Cash and cash equivalents		R$ 3750944	R$ 4195713
Short-term investments		4,024,056	1,800,439
Trade accounts receivable		3,524,395	3,502,399
Accounts receivable - sale of subsidiary		22,915
Inventories		3,087,395	4,516,874
Recoverable taxes		608,530	911,410
Income tax and social contribution		175,563	196,143
Derivative financial instruments		188,997	235,114
Other current assets		604,427	763,384
Current assets other than assets held for sale		15,987,222	16,121,476
Assets held for sale			51
Total current assets		15,987,222	16,121,527
NON-CURRENT
Accounts receivable - sale of subsidiary		806,582
Recoverable taxes		1,112,407	1,356,868
Deferred income tax and social contribution	[1]	2,200,695	3,519,515
Judicial deposits		408,030	457,550
Derivative financial instruments		89,453	773,251
Long-term investments		36,698	35,235
Other non-current assets		1,027,679	1,252,437
Total noncurrent assets		5,681,544	7,394,856
Property, plant and equipment		3,457,574	4,966,150
Intangible		16,569,866	23,260,970
Right of use		1,050,809	2,941,887
Total non-current assets		26,759,793	38,563,863
TOTAL ASSETS		42,747,015	54,685,390
CURRENT
Borrowings, financing and debentures		163,844	331,151
Lease		298,600	878,448
Trade accounts payable and reverse factoring operations		5,302,478	6,375,930
Dividends and interest on shareholders' equity payable		294,231	260
Payroll, profit sharing and social charges		1,019,688	1,276,977
Tax liabilities		634,760	828,125
Income tax and social contribution		908,442	70,294
Derivative financial instruments		329,676	1,613,968
Provision for tax, civil and labor risks		491,301	463,655
Other current liabilities		970,479	1,499,060
Total current liabilities		10,413,499	13,337,868
NON-CURRENT
Borrowings, financing and debentures		5,947,858	13,261,135
Lease		851,840	2,392,289
Payroll, profit sharing and social charges		16,069	26,152
Tax liabilities		127,194	117,358
Deferred income tax and social contribution	[1]	328,090	934,414
Income tax and social contribution		380,176	448,532
Derivative financial instruments			191,274
Provision for tax, civil and labor risks		875,291	873,618
Other non-current liabilities		686,533	751,566
Total non-current liabilities		9,213,051	18,996,338
TOTAL LIABILITIES		19,626,550	32,334,206
SHAREHOLDERS' EQUITY
Capital stock		12,484,515	12,484,424
Treasury shares		(164,236)	(262,360)
Capital reserves		10,466,501	10,540,885
Legal Profit Reserve		780,308
Retained earnings (losses)			(1,994,555)
Other comprehensive income (loss)		(463,849)	1,564,340
Shareholders' equity attributed to the Company's shareholders		23,103,239	22,332,734
Non-controlling interest in shareholders' equity of subsidiaries		17,226	18,450
Total shareholders' equity		23,120,465	22,351,184
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY		R$ 42747015	R$ 54685390
[1] Balance presented in the balance sheet including the effects of the jurisdictional offset of deferred tax assets and liabilities of the same nature, originating from the same taxpayer and tax authority.

STATEMENT OF PROFIT OR LOSS

STATEMENT OF PROFIT OR LOSS - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
STATEMENT OF PROFIT OR LOSS
NET REVENUE FROM CONTINUING OPERATIONS	R$ 26737277		R$ 29223656	R$ 31742726
Cost of Sales	(9,675,435)		(11,770,762)	(12,531,303)
GROSS PROFIT	17,061,842		17,452,894	19,211,423
OPERATING (EXPENSES) INCOME
Selling, marketing and logistics expenses	(11,015,940)		(11,558,866)	(12,386,193)
Administrative, R&D, IT and project expenses	(4,225,027)		(5,023,626)	(5,217,633)
Impairment loss on trade receivables	(605,874)		(604,847)	(839,357)
Other operating income (expenses), net	(1,369,849)		(649,192)	(207,431)
OPERATING PROFIT (LOSS) BEFORE FINANCIAL RESULT	(154,848)		(383,637)	560,809
Financial results	(2,513,499)		(1,784,981)	(908,090)
PROFIT (LOSS) BEFORE INCOME TAX AND SOCIAL CONTRIBUTION	(2,668,347)		(2,168,618)	(347,281)
Income tax and social contribution	86,400		(92,353)	1,297,237
PROFIT (LOSS) FOR THE PERIODS FROM CONTINUING OPERATIONS	(2,581,947)		(2,260,971)	949,956
DISCONTINUED OPERATIONS
PROFIT (LOSS) FROM DISCONTINUED OPERATIONS	5,556,457	[1]	(597,655)	90,733
NET INCOME (LOSS) FOR THE YEAR	2,974,510		(2,858,626)	1,040,689
ATTRIBUTABLE TO
The Company's shareholders	2,973,731		(2,859,629)	1,047,960
Non-controlling shareholders	R$ 779		R$ 1003	R$ 7271
NET INCOME (LOSS) PER SHARE FOR THE YEAR FROM CONTINUING OPERATION-R$
Basic	R$ 1.8739		R$ 1.648	R$ 0.6898
Diluted	(1.8633)		(1.6365)	0.6894
NET INCOME (LOSS) PER SHARE FOR THE YEAR -R$
Basic	2.1582		(2.0843)	0.761
Diluted	R$ 2.1482		R$ 2.0843	R$ 0.7503
[1]The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023..

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
STATEMENT OF COMPREHENSIVE INCOME
PROFIT (LOSS) FOR THE PERIOD	R$ 2974510	R$ 2858626	R$ 1040689
Other comprehensive income to be reclassified to income statement in subsequent years:
Conversion of financial statements of controlled companies abroad	(2,738,295)	(2,962,142)	(148,696)
Exchange rate effect on the conversion from hyperinflationary economy	227,027	24,956	218,227
Earnings (losses) from cash flow hedge operations	746,648	(790,479)	(210,150)
Tax effects on earnings (losses) from cash flow hedge operations	(251,950)	270,035	72,939
Other comprehensive income (loss) not reclassified for the income (loss) of the periods in subsequent periods:
Actuarial gain (loss)	(23,204)	21,764	459,875
Tax effects on (losses) earnings from actuarial	9,582	(61,965)	(106,979)
Comprehensive income (loss) for the periods, net of tax effects	944,318	(6,356,457)	1,325,905
ATTRIBUTABLE TO
The Company's shareholders	945,541	(6,353,752)	1,327,531
Noncontrolling shareholders	(1,223)	(2,705)	(1,626)
Comprehensive income (loss) for the periods, net of tax effects	R$ 944318	R$ 6356457	R$ 1325905

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - BRL (R$) R$ in Thousands	Total	Sharesholders' equity attributed to controlling shareholders [member]	Capital stock [member]	Treasury shares [member]	Share premium [member]	Special reserve [member]	Additional paid-in capital [member]	Income froIncome (loss) from transactions with non-controlling shareholders [member]	Tax Incentives [member]	Retained earnings [member]	Retained earnings (losses) [member]	Other comprehensive income (loss) [member]	Non-Controlling Shareholders [member]
Beginning balance at Dec. 31, 2020	R$ 27387108	R$ 27364327	R$ 12377999	R$ 11667	R$ 10671605	R$ 362059	R$ 110537	R$ 92066	R$ 113302	R$ 6864	R$ 759937	R$ 4585631	R$ 22781
Profit (loss) for the year	1,040,689	1,047,960									1,047,960		(7,271)
Exchange rate effect on the conversion from hyperinflationary economy	218,227	218,227										218,227
Other comprehensive income (loss)	66,989	61,344										61,344	5,645
Comprehensive income (loss) for the periods, net of tax effects	1,325,905	1,327,531									1,047,960	279,571	(1,626)
Share repurchase	(174,113)	(174,113)		(174,113)
Transactions in stock and restricted shares option plans:
Provision for stock and restricted shares option plans	237,655	237,655					275,632			(37,977)
Exercise of stock and restricted shares option plans	(29,058)	(29,058)	103,684	34,438			(198,767)			31,587
Reclassification of grant reserve - Natura Cosméticos									(113,302)		113,302
Dividends	(180,772)	(180,772)									(180,772)
Constitution of tax incentive reserve										870,749	(870,749)
Losses absorption					(650,196)						650,196
Ending balance at Dec. 31, 2021	28,566,725	28,545,570	12,481,683	(151,342)	10,021,409	362,059	187,402	(92,066)		871,223		4,865,202	21,155
Profit (loss) for the year	(2,858,626)	(2,859,629)									(2,859,629)		1,003
Exchange rate effect on the conversion from hyperinflationary economy	24,956	24,956										24,956
Other comprehensive income (loss)	(3,522,787)	(3,519,079)										(3,519,079)	(3,708)
Comprehensive income (loss) for the periods, net of tax effects	(6,356,457)	(6,353,752)									(2,859,629)	(3,494,123)	(2,705)
Share repurchase	(120,300)	(120,300)		(120,300)
Transactions in stock and restricted shares option plans:
Provision for stock and restricted shares option plans	255,756	255,756					255,756
Exercise of stock and restricted shares option plans	5,460	5,460	2,741	9,282			(8,708)			2,145
Reclassification of grant reserve - Natura Cosméticos					(126,473)		(58,494)			(8,294)		193,261
Losses absorption										(865,074)	865,074
Ending balance at Dec. 31, 2022	22,351,184	22,332,734	12,484,424	(262,360)	9,894,936	362,059	375,956	(92,066)			(1,994,555)	1,564,340	18,450
Profit (loss) for the year	2,974,510	2,973,731									2,973,731		779
Exchange rate effect on the conversion from hyperinflationary economy	227,027	227,027										227,027
Other comprehensive income (loss)	(2,257,219)	(2,255,216)										(2,255,216)	(2,003)
Comprehensive income (loss) for the periods, net of tax effects	944,318	945,542									2,973,731	(2,028,189)	(1,224)
Transactions in stock and restricted shares option plans:
Provision for stock and restricted shares option plans	122,589	122,589					122,589
Exercise of stock and restricted shares option plans	(3,640)	(3,640)	91	98,124			(196,973)			95,118
Dividends	(293,986)	(293,986)									(293,986)
Legal profit reserve										685,190	R$ 685190
Ending balance at Dec. 31, 2023	R$ 23120465	R$ 23103239	R$ 12484515	R$ 164236	R$ 9894936	R$ 362059	R$ 301572	R$ 92066		R$ 780308		R$ 463849	R$ 17226

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
CASH FLOW FROM OPERATING ACTIVITIES
Profit (loss) for the year	R$ 2974510		R$ 2858626		R$ 1040689
Adjustments to reconciliate profit (loss) for the periods with net cash genereted by (used in) operating activities:
Depreciation and amortization	1,587,995		1,596,317		1,766,872
Interest and exchange variation on short-term investments	(977,203)		(537,289)		(264,764)
Loss from swap and forward derivative contracts	1,791,905		992,813		(441,554)
Increse (reversion) of provision for tax, civil and labor risks	71,166		28,844		(56,177)
Monetary adjustment of judicial deposits	(28,460)		(35,508)		(15,246)
Monetary adjustment of provision for tax, civil and labor risks	73,011		79,280		25,731
Income tax and social contribution	(86,400)		119,568		(1,250,013)
Income from sale and write-off of property, plant and equipment and intagible	174,227		55,701		174,993
Interest and exchange rate variation on leases	187,410		115,938		202,093
Interest and exchange rate variation on borrowings, financing and debentures, net of acquisition costs	517,531		348,742		898,467
Adjustment and exchange rate variation on other assets and liabilities	2,777		2,757		2,198
Provision (reversal) for losses on property, plant and equipment, intangible assets and leases	22,040		34,198		89
Impairment of goodwill	663,892		282,921
Increase (reversion) of provision for stock option plans	118,858		258,475		275,632
Trade accounts receivables losses, net of reversals	605,874		605,995		837,298
Inventory losses, net of reversals	422,498		305,705		400,019
Reversion of carbon credits provision	(12,459)		(17,948)		(13,618)
Effect from hyperinflationary economy	117,553		349,859		165,826
Gain on Borrowing and financing prepayment	(206,228)		12,510		(70)
Cash flows from (used in) operations before changes in working capital	8,020,497		1,740,252		3,748,466
DECREASE (INCREASE) IN ASSETS
Trade accounts receivable and related parties receivable	(1,137,677)		(686,691)		(645,157)
Inventories	(140,418)		485,787		(1,117,671)
Recoverable taxes	490,981		106,221		(315,458)
Other assets	(406,665)		197,023		(1,223,245)
Subtotal	(1,193,779)		102,340		(3,301,531)
INCREASE (DECREASE) IN LIABILITIES
Domestic and foreign trade accounts payable and related parties payable	(110,615)		39,730		467,538
Payroll, profit sharing and social charges, net	41,524		(19,783)		(42,274)
Tax liabilities	(8,843)		46,730		(13,232)
Other liabilities	(5,488)		(370,854)		(165,386)
Subtotal	(83,422)		(304,176)		246,646
OTHER CASH FLOWS FROM OPERATING ACTIVITIES
Payment of income tax and social contribution	(381,489)		(434,688)		(976,542)
Release of judicial deposits net of withdrawals	21,734		40,054		(3,893)
Payments related to tax, civil and labor lawsuits	(59,875)		(125,569)		(132,784)
Payments due to settlement of derivative transactions	(1,487,092)		(594,225)		(9,040)
Payment of interest on lease	(124,516)		(148,342)		(181,271)
Payment of interest on borrowings, financing and debentures	(1,067,731)		(789,592)		(764,883)
Operating Activities - discontinued operations	(5,992,000)		1,185,485		1,260,662
CASH (USED IN) GENERATED BY OPERATING ACTIVITIES	(2,347,673)		671,539		(114,170)
CASH FLOW FROM INVESTING ACTIVITIES
Additions of property, plant and equipment and intangible	(947,106)		(765,867)		(986,019)
Proceeds from sale of property, plant and equipment and intangible	524,381		14,794		114,473
Short-term investments acquisition	(18,867,618)		(12,763,990)		(11,739,911)
Redemption of short-term investments	16,744,695		12,927,831		12,325,210
Redemption of interest on short-term investments	211,979		152,398		127,416
Investing activities - discontinued operations	12,287,226		(336,953)		(493,208)
CASH (USED IN) GENERATED BY INVESTING ACTIVITIES	9,953,557		(771,787)		(652,039)
CASH FLOW FROM FINANCING ACTIVITIES
Repayment of lease - principal	(303,313)		(277,086)		(865,503)
Repayment of borrowings, financing and debentures – principal	(8,057,650)		(6,379,559)		(7,247,551)
New borrowings, financing, and debentures	1,494,101	[1]	8,557,507	[2]	5,683,509
Acquisition of treasury shares, net of receipt of option strike price			(120,300)		(174,113)
Payment of dividends and interest on equity			(180,512)
Receipt (payment) of funds due to settlement of derivative transactions	(310,870)		118,707		1,570,584
Capital Increase	91		2,741
Financing activities - discontinued operations	(584,118)		(1,123,031)		(212,108)
CASH (USED IN) GENERATED BY FINANCING ACTIVITIES	(7,761,759)		598,467		(1,245,182)
Effect of exchange rate variation on cash and cash equivalents	(288,894)		(309,763)		196,976
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(444,769)		188,456		(1,814,415)
Opening balance of cash and cash equivalents	4,195,713		4,007,257		5,821,672
Closing balance of cash and cash equivalents	3,750,944		4,195,713		4,007,257
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	R$ 444769		R$ 188456		R$ 1814415
[1] The movement that occurred in 2023 is mainly due to the revolving credit line obtained by the subsidiary &Co Luxembourg during the year, which was fully settled during the third quarter with resources from the sale of the former subsidiary Aesop. Funding carried out in the year ended December 31, 2022 basically refers to: (i) use of a revolving credit line in the principal amount of up to US$ million by the subsidiary &Co Luxembourg; (ii) issuance of debt securities by the subsidiary &Co Luxembourg maturing on April 19, 2029 in the total principal amount of US$ million (approximately R$ million), subject to interest of % per year, which are guaranteed by &Co Holding and the subsidiary S.A. (iii) issuance of the 11 th series of debentures in the amount of R$ million maturing in 2025 and issuance of the 12 th series of debentures in the amount of R$ million, maturing between 2025 and 2032 by the subsidiary S.A. (iv) issuance of commercial notes by the subsidiary in the amount of R$ million maturing in 2025 and (v) new credit line in the total principal amount of US$ million by the subsidiary &Co Luxembourg.

GENERAL INFORMATION

GENERAL INFORMATION	12 Months Ended
	Dec. 31, 2023
GENERAL INFORMATION
GENERAL INFORMATION	1. GENERAL INFORMATION Natura &Co Holding S.A. (“Natura &Co ” ) was incorporated on January 21, 2019, and has the purpose of holding interests in other companies, as partner or shareholder, whose main business is in the cosmetics, fragrance and personal hygiene segments, through the manufacturing, distribution, and sale of their products in Brazil, in the city of São Paulo, State of São Paulo, at Avenida Alexandre Colares, No. 1188 05106 000 used to trade American Depositary Receipts (“ADRs”) on the New York Stock Exchange (“NYSE”), under the ticker “NTCO” , however, on January 18, 2024, the Company's Management approved the delisting from the NYSE, which is in line with its long-term strategy of simplifying its operations. The effective date of termination of the deposit agreement for our ADS program and of the ADS program will be August 7, 2024. Brands managed by the Company include “Natura” and “Avon”. In addition to using the retail market, e-commerce, business-to-business (B 2 1.1 Sale of subsidiary Aes op On August 30, 2023, the Company concluded the sale of the subsidiary Natura Brazil Pty Ltd. (hereinafter referred to as “Aesop”) to L’Oréal for a total amount of R$12,429,175, after obtaining all regulatory approvals. The total gain obtained on the derecognition of the subsidiary’s assets and liabilities and recognized as discontinued operations net of income tax and social contribution was R$7,377,768, which includes the reclassification of accumulated balance sheet conversion gains recognized in other comprehensive income amounting to R$115,168 and the write-off of goodwill in the amount of R$124,315. Further details about this transaction, as well as the results of discontinued operations for the years ended December 31, 2023, and 2022 35 1.2 Sale of subsidiary The Body Shop On December 29, 2023, the Company concluded the sale of the subsidiary The Body Shop to Aurelius Investment Advisory Limited (“Aurelius”) for a total amount of R$829,496, after obtaining all regulatory approvals. When the sale became probable in October 2023, a loss was recognized due to the impairment of the recoverable amount of net assets held for sale in the amount of R$4,007,744, due to the measurement to the lower of fair value less selling costs (recognized in the discontinued operations). The total loss incurred in the derecognition of assets and liabilities of the subsidiary, recognized as discontinued operations, net of income tax and social contribution, amounted to R$1,081,340. This includes the reclassification of balance sheet conversion gains accumulated and recognized in other comprehensive income in the amount of R$1,622,436 and the impairment loss upon reclassification of the respective operations to assets held for sale, amounting to R$4,007,744. The total consideration recognized as a result of discontinued operations considered: i) a fixed installment received on January 2, 2024, in the amount of R$22,915; ii) a fixed installment whose receipt is scheduled for December 29, 2028, in the amount of R$320,153; and iii) the fair value of two variable installments of contingent consideration ('earn-out'), in 2025 2026 5 Further details about this transaction, including the breakdown of contingent considerations to be received and the results of discontinued operations for the years ended December 31, 2023, and 2022 35

MANAGEMENT STATEMENT AND BASIS

MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2023
MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS
MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS	2. MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS The consolidated financial statements (herein referred to as “financial statements”) have been prepared and are being presented in accordance with the International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS Accounting Standards”). The financial statements show all the relevant information specific to the financial statements, and only them which are consistent with those used by the Management in its activities. The Company’s financial statements were approved by the Board of Directors and authorized for issuance at the meeting held on May 9, 2024. The financial statements were prepared on a historical cost basis, except for items measured at fair value through profit or loss, which include (i) derivative instruments; (ii) contingent considerations arising from the disposal of the former subsidiary The Body Shop; (iii) other financial assets referred to in explanatory note no. 3.6.1 3.6.2 The financial statements are expressed in thousands of Reais (“R$”), rounded to the nearest thousand, and the disclosures of amounts in other currencies, when necessary, were also made in thousands. The items disclosed in other currencies are duly identified, whenever applicable.

SUMMARY OF MATERIAL ACCOUNTING

SUMMARY OF MATERIAL ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2023
SUMMARY OF MATERIAL ACCOUNTING POLICIES
SUMMARY OF MATERIAL ACCOUNTING POLICIES	3 SUMMARY OF MATERIAL ACCOUNTING POLICIES The material accounting policies applied in the preparation of these financial statements are defined below. These practices have been applied consistently in all the years presented, except for the accounting policies adopted for the first time in 2023 3.28 3.1 Current versus non-current classification The Company presents assets and liabilities in the balance sheet based on the classification of current and non-current, according to the expectation for realization and/or expected consumption during the ordinary course of the operating cycle, as defined in CPC 26 2 1 Deferred tax assets and liabilities are classified as non-current assets and liabilities, as disclosed in note no. 3.17 3.2 Foreign currency translation Functional currency The items included in the financial statements of the Company and each of the companies included in the consolidated financial statements are measured using the currency of the main economic environment in which each of the companies operates (“functional currency”). The financial statements are presented in the Company’s functional and presentation currency, the Brazilian Real. 3.2.1 Transactions and balances in a currency other than the functional currency Transactions in foreign currency, that is, any currency other than the functional currency, are translated into the functional currency of the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions. Balance sheet account balances are translated using the exchange rates prevailing on the dates of the reporting period. Gains and losses from exchange rate variation arising from the settlement of such transactions and the translation of monetary assets and monetary liabilities denominated in foreign currency are recognized in the statement of profit or loss as “finance income” and “finance expenses”. 3.2.2 Subsidiaries with different functional currency In preparing the consolidated financial statements, the statement of profit or loss and cash flow statement and all other changes of assets and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions. The balance sheet is translated into Brazilian Reais at the exchange rate prevailing at each reporting date. The effects of exchange rate variations resulting from these translations are presented under the item Other Comprehensive Income (“OCI”) in the statement of comprehensive income in shareholders’ equity. The translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”), Cosmeticos Avon Sociedad Anonima Comercial e Industrial (“Avon Argentina") and Avon Kozmetik Urunleri Sanayi ve Ticaret Anonim Siketi (“Avon Turkey”), which became hyperinflationary economies as of July 1, 2018 for Argentina and June 1, 2022 for Turkey, in which other than the balance sheet, the revenue and expenses are also translated into Reais at the exchange rates prevailing at each reporting date (note no. 3.2.4 3.2.3 Hyperinflationary economy On July 1, 2018 and June 1, 2022, Argentina and Turkey were considered hyperinflationary economies, respectively considering the rise in the official price indices of the respective countries accumulated on those dates (Consumer Price Index, or “IPC” for the Argentina and the Internal Wholesale Price Index, or “IPIM” for Turkey). Accordingly, non-monetary assets and liabilities recorded at historical cost in these subsidiaries were restated based on the respective indices mentioned above, with the effects resulting from changes in general purchasing power being presented in the statement of income. The net effect of the inflation adjustment for the years ended December 31, 2023 and 2022 28 For the purpose of converting the accounting balances of the respective subsidiaries into the presentation currency (reais R$) used in the Company's individual and consolidated financial statements, the following procedures were adopted: ➢ Assets and liabilities were translated at the exchange rate prevailing at the reporting date (0.0059 and 0.02955 Argentine peso for each Brazilian Real and 0.1639 and 0.2786 Turkish lira for each Brazilian Real on December 31, 2023 and 2022 ➢ Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date (the same as indicated above), instead of the average exchange rate of the year, which is used to translate currencies in non- economies. The accumulated inflation for the year ended December 31, 2023 was 211.4% in Argentina and 64.8% in Turkey (94.8% in Argentina and 64.3% in Turkey as of December 31, 2022), as per IPC and IPIM 3.3 Consolidation The following procedures are applied in the preparation of the financial statements: a) Investments in subsidiaries The Company controls an entity when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date when the Company obtains control until the date when the control ceases to exist. Below is a list of the Company’s direct subsidiaries as of December 31, 2023 and 2022 Interest - % 2023 2022 Direct interest: Avon Products, Inc. 100.00 100.00 Natura Cosméticos S.A. 100.00 100.00 Natura &Co International S.à r.l. 100.00 100.00 The activities of the direct subsidiaries are described below: ➢ Avon Products, Inc . (“Avon Products”): a global manufacturer and marketer of beauty and related products, with operations started in 1886 one ➢ Natura S.A. (“ ”): is a privately held corporation, established in accordance with the laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term and the main focus of which is the commercialization of cosmetics and fragrances in general. It also operates through e-commerce and has an expanded network of its own physical stores. The former subsidiaries The Body Shop International Limited (The Body Shop) and Holding Pty Ltd. (Aesop) were fully sold during the year ended December 31, 2023 (see explanatory notes no. 1.1 1.2 35 ➢ Natura &Co International S.à r.l. (“ &Co International”): a company established in Luxembourg on February 14, 2020 with the main purpose of operating as the finance arm of the Company (a “ ”), centralizing the fundraising activities with external entities and providing funding for the other entities of the economic group on behalf of the parent company. Furthermore, the entity has also the purpose of managing and holding stakes in national and foreign companies. As of December 31, 2023 and 2022 3.4 Goodwill Goodwill arising from a business combination is initially measured at cost, with the exceeding aggregate amount of: (i) the consideration transferred, measured at fair value; (ii) the amount of any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s previously held equity interest in the acquiree at the acquisition date; over the net assets acquired (identifiable net assets acquired and assumed liabilities). When this aggregate amount is lower than the net amount of the identifiable assets acquired and the assumed liabilities, a gain on a bargain purchase is immediately recognized in the statement of profit or loss. Subsequently, goodwill is measured at cost less any accumulated impairment losses. For impairment testing purposes, goodwill acquired in a business combination is, from the acquisition date, allocated to each of the group of Cash-Generating Units (“CGU”) that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to those units and annually tested, and whenever circumstances indicate that the carrying amount may present impairment losses. 3.5 Cash and cash equivalents Cash and cash equivalents are maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents include cash, demand deposits and short-term investments realizable within 90 days of the original date of the security or considered to be highly liquid granted by the issuer or convertible into a known amount of cash and which are subject to an insignificant risk of changes in value. Instruments that are not eligible for the classification of cash and cash equivalents, due to their liquidity, maturity or even the risk of changes in value, are classified as short-term investments. 3.6 Financial instruments 3.6.1 Financial assets Initial recognition and measurement Upon initial recognition, a financial asset not measured at fair value through profit or loss, is measured at fair value plus or minus transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability. Subsequently, financial assets are measured at amortized cost, at fair value through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”). The classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial asset and the business model of the Company for the management of these financial assets. The business model of the Company for managing financial assets refers to how the Company manages its financial assets to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are “non-derivative” financial assets held within a business model with the objective to hold financial assets to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are held within a business model with the objective of holding financial assets to collect contractual cash flows and selling them. Subsequent measurement Financial assets at amortized cost Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains or losses are recognized in the statement of profit or loss when the asset is written off, modified, or impaired. The main financial assets of the Company classified as amortized cost include balances of trade accounts receivable, other current assets and non-current assets balances (see note 5.5 Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are presented in the balance sheet at fair value with net changes in fair value recognized in the statement of profit or loss. This category includes derivative instruments and short-term investments which the Company had not irrevocably elected to classify according to the fair value through OCI. The financial assets measured at fair value through profit or loss are investment funds, government securities, restricted cash, treasury bills, investment fund Dynamo Beauty Ventures Ltd. fund (“DBV Fund”), Certificate of Bank Deposits (“CDB”), repurchase operations, derivatives financial and operational instruments and contingent considerations arising from the disposal of the former subsidiary The Body Shop, as presented in note no. 5.5 Derecognition (write-off) of financial instruments A financial asset (or, where applicable, part of a financial asset or part of a group of similar financial assets) is written off when the rights to receive cash flows from the asset have expired, when the Company transfers its rights or risk to receive cash flows from the asset or when the Company has assumed an obligation to pay the full amount of received cash flows, without significant delay, to a third party under an on-lending agreement and either (i) the Company has transferred substantially all risks and benefits of the asset, or (ii) the Company has neither transferred nor retained substantially all risks and benefits of the asset, but transferred the asset control. When the Company transfers its rights to receive cash flows of an asset or executes an on-lending agreement, it assesses whether, and at which extent, it has retained the risks and benefits of ownership. When the Company has neither transferred nor retained substantially all risks and benefits of the asset, nor transferred control over the asset, the Company continues to recognize the asset transferred to the extent of its continued involvement. In this case, the Company also recognizes an associated liability. The transferred assets and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained. Impairment of financial assets The Company recognizes an allowance for expected credit losses (“ECL”) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive, discounted by an approximation of the original effective interest rate. ECLs are recognized in two stages: (i) for credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provisioned for credit losses that result from default events that are possible within the next 12 months 12 For trade accounts receivable, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for losses based on the ECL at each reporting date. The Company has recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment. Further details are disclosed in note no. 4.6 The Company considers a financial asset in default when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. 3.6.2 Financial liabilities Initial recognition and measurement All financial liabilities are recognized initially at fair value and, in the case of borrowing, financing and debentures, net of directly attributable transaction costs. The Company’s main financial liabilities include borrowing in local and foreign currency, financing and debentures (note no. 18 5 19 31 17 22 23 Subsequent measurement For purposes of subsequent measurement, financial liabilities are classified in two categories: (i) financial liabilities at fair value through profit or loss; or (ii) financial liabilities at amortized cost. Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition at fair value through profit or loss. Due to the fair value hedge established to protect against interest rate variability associated with the issuance of real estate receivable certificates (“CRI”), the respective liabilities presented in borrowing, financing and debentures were designated at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the short term. This category also includes derivative instruments entered into by the Company that are not classified as hedging instruments in the hedge relationships defined by CPC 48 9 Gains or losses on liabilities held for trading are recognized in the statement of profit or loss. Financial liabilities designated on initial recognition at fair value through profit or loss are designated on the initial recognition date and only if the criteria of CPC 48 9 Financial liabilities at amortized cost This is the most relevant category for the Company. After initial recognition, interest-bearing borrowings, financing and debentures are subsequently measured (except issuance of the aforementioned real estate receivables certificates) at amortized cost using the effective interest rate method. Gains and losses are recognized in profit or loss when the liabilities are written off as well as through the effective interest rate amortization process. Any difference between raised and settled amounts is recognized in the statement of profit or loss, using the effective interest rate method during the year in which the borrowings, financing and debentures are outstanding. Amortized cost is calculated by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest rate method. The effective interest rate amortization is included as finance expenses in the statement of profit or loss. This category generally applies to trade accounts payable and reverse factoring operations (see note no. 19 18 17 Derecognition Financial liability is written off when the obligation under the liability is discharged, canceled, or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as derecognition of the original liability and recognition of a new liability. The difference in the respective carrying amounts is recognized in the statement of profit or loss. Offsetting of financial instruments Financial assets and financial liabilities are offset, and the net amount is reported in the balance sheet if there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously. The offsetting of financial instruments is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with the financial institution, in which the current account positions of the Company (including overdraft balances) are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions on a net basis. 3.6.3 Derivative financial instruments Derivative financial instruments transactions contracted by the Company consist of swaps and non-deliverable forwards (“NDF”) intended exclusively to hedge against foreign exchange risks related to (i) exchange rate risks associated to balance sheet position, purchase of goods and property, plant and equipment, forecast exports in addition to and foreign-denominated cash flows for capital contributions in foreign subsidiaries; and (ii) variability in interest rates associated with contracted debt. The derivative instruments are measured at fair value, and changes are recognized through profit or loss, except when they are designated as cash flow hedge accounting, in which changes in fair value are recorded in OCI. The fair value of derivative instruments is measured by the treasury department of the Company based on information on each contracted transaction and related market inputs as of the reporting date of the financial statements, such as interest and exchange rates. For the purpose of hedge accounting, hedges are classified as: (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction or the foreign currency risk in an unrecognized firm commitment; and that may affect the result. The Company does not have a hedge At the inception of a hedge relationship, the Company formally designates and documents the hedge relationship to which it wishes to apply hedge accounting, the risk management goal and strategy for hedging. The documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed on an ongoing and future basis to determine that they actually have been highly effective throughout the financial reporting periods for which they were designated. Any imbalance between the hedge index of the object and the hedge instrument that is not in compliance with the hedge purpose is adjusted so that the index returns to the standards established in the protection strategy. Fair value and cash flow hedges that meet all the qualifying criteria for hedge accounting are accounted for as described below. Fair value Hedge It consists in providing protection against variation at fair value of assets or liabilities recognized or firm commitments not recognized, or a component of any such items, that is attributed to a specific risk and that may affect the result. Any gain or loss arising from variations at fair value of the derivative instruments designated as hedge instruments and the hedged assets or liabilities are recognized in the financial result. In the years ending on December 31, 2023 and 2022 5.3 Cash flow hedges It consists in providing a hedge against variation in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast transaction and that may affect statement of profit or loss. The effective portion of changes in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated in the “gains (losses) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly in OCI, in shareholders’ equity, while the ineffective portion of hedge is immediately recognized as finance income (expense). For the years ended December 31, 2023 and 2022 5.3 Discontinuing hedge accounting Hedge accounting is discontinued when the Company terminates the hedge relationship, the hedge instrument matures or is sold, revoked, or executed, or no longer qualifies to hedge accounting. Any gains or losses recognized in OCI and accumulated in shareholders’ equity up to that date remain in shareholders’ equity related to cash flow hedge and are recognized when the forecast transaction is eventually recognized in the statement of profit or loss. If a forecast transaction results in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss. For example, when the non-financial asset is depreciated or sold. On the other hand, if a forecast transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit or loss. For example, when financial income or expense is recognized. When the forecast transaction is no longer expected, cumulative gains or losses and deferred in the statement of changes in shareholders' equity are immediately recognized in the statement of profit or loss. The Company assesses, on a prospective basis, throughout the hedge term, the effectiveness of its derivative instruments, as well as changes in their fair value. The fair values of derivative instruments are disclosed in note no. 5.5 3.7 Trade accounts receivable Trade accounts receivable correspond to amounts receivable for the sale of goods and services in the ordinary course of the activities of the Company and are recognized to the extent that the consideration, which is unconditional, is due by the customer (that is, only the passage of time is required before payment of the consideration is due) and are measured on initial recognition at cost for the consideration to which the Company expects to be entitled in exchange for the products promised to the client. Subsequently, trade accounts receivables are measured at amortized cost by using the interest rate method and they are subject to an impairment test. 3.8 Inventories Inventories are valued at their average cost and the net realizable value, whichever is lower. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale. The Company considers the following items when determining its allowance for inventory losses: discontinued products, products with slow turnover, expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “cost of sales”. 3.9 Carbon credits – carbon neutral program In 2007 This commitment, which presently refers to the operations of all Company and does not reflect a legal obligation to the extent in which the specific regulations still have not been promulgated by the legislative branch. Thus, considering the practices historically applied by the Company and the specificity of the commitments assumed and disclosed to the market and society, this commitment is considered a non-formalized obligation, according to CPC 25 37 The liability is estimated through carbon emission inventories carried out annually and valued based on the best estimate of the cash disbursement that will be required to settle the current obligation at the reporting date, considering the history of similar transactions carried out by the Company for such end. As of December 31, 2023 and 2022 2015 2023 The Company elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market. Thus, the costs incurred will generate carbon credits after completion or maturation of these projects. Such expenses are recorded in the line item “other current assets” (see note 14 Upon effective delivery of the related carbon neutral certificates to the Company, and duly filed, the obligation of being carbon neutral is effectively fulfilled; therefore, the asset balances are offset against those of the liabilities. 3.10 Property, plant and equipment Property, plant and equipment is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if applicable. Land is not depreciated. Depreciation of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values using the straight-line method over their useful lives and is recognized in the statement of profit or loss. The estimated useful lives of the assets are mentioned in note no. 15 Gains and losses on disposals are calculated by comparing the proceeds from the sale with the carrying residual amount and are recognized in the statement of profit or loss as “other operating income (expenses), net”. Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company. 3.11 Intangible assets Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are reported at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangible assets, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the year in which the expenditure is incurred. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the method for an intangible asset with a finite useful life are reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense regarding intangible assets with finite lives is recognized in the statement of profit or loss in the expense category that is consistent with the function of the intangible assets. Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, and when circumstances indicate that the carrying amount may be impaired, either individually or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether indefinite life continues to be supportable. If not, the useful life is changed from indefinite to finite on a prospective basis. An intangible asset is written off upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon write-offs of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of profit or loss in item “other operating income (expenses), net”. The main classes of intangible assets and useful life are detailed below and described in note no. 16 3.11.1 Software Licenses of software and enterprise management systems acquired are capitalized and amortized according to the useful lives, and maintenance costs are recognized as expenses when incurred. Business management system acquisition and implementation costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will be generated and when the asset is controlled by the Company, taking into consideration its economic and technological viability. Contracts involving hosting and/or processing of information in the cloud (“cloud computing arrangements”) generate intangible assets to the extent that on the contract start date, the Company obtains control of the software. Contracts which only provide the right of access to the supplier's software during the term of the contract are treated as a service contract and, consequently, recognized as an expense in the statement of profit or loss as the service is provided (since the right of receiving access to the supplier's software does not give the Company, at the commencement date of the contract, the power to obtain the future economic benefits arising from the software itself and to restrict third parties' access to those benefits). The amounts incurred on software development recognized as assets are amortized under the straight-line method over its estimated useful life. The expenditures related to software maintenance are recognized in profit or loss of the year when incurred. 3.11.2 Trademarks and patents Separately acquired trademarks and patents are stated at their historical cost. Trademarks and patents acquired in a business combination are recognized at fair value on the date of acquisition. For trademarks and patents with a defined useful life, amortization is calculated using the straight-line method. 3.11.3 Relationship with agents Relationships with agents acquired in business combinations are recognized at fair value on the date of acquisition and amortization is calculated using the straight-line method. 3.11.4 Technologies developed Technologies developed include technology for product development (including formulas, labeling data, manufactur

CRITICAL ACCOUNTING ESTIMATES A

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS	12 Months Ended
	Dec. 31, 2023
CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS
CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS	4 CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS The preparation of the consolidated financial statements requires management to make certain judgments and use assumptions and estimates based on experience and other factors considered relevant, which affect the values of assets and liabilities, and which may present results that differ from actual results. The areas that require a higher level of judgment and have greater complexity, as well as the areas in which assumptions and estimates are material for the financial statements, are disclosed below. 4.1 Income tax, social contribution, and other taxes Deferred tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits, together with future tax planning strategies and other sources of income. The Company has R$ 12,254,435 of reportable unrecognized tax losses as of December 31, 202 3 (R$ 12,735,337 on December 31, 202 2 ). These losses relate to subsidiaries that have a history of losses, do not expire, and may not be used to offset taxable income in other subsidiaries. The subsidiaries neither have any taxable temporary difference nor any tax planning opportunities available that could partly support the recognition of these losses as deferred tax assets. Based on this, the Company determined that it cannot recognize deferred tax assets on these tax losses carried forward. 4.2 Provision for tax, civil and labor risks The Company is party to several legal and administrative procedures as described in note no. 2 1 . Provisions are recorded for processes related to tax, civil and labor risks related to lawsuits that represent probable, except for those related to business combinations, and are estimated with a certain degree of certainty. The assessment of the likelihood of loss includes the assessment of the available evidence, the hierarchy of laws, the available jurisprudence, the most recent court decisions, and their relevance in the legal system, as well as the assessment of legal advisors. 4.3 Post-employment health care plan The cost of the post-employment health care plan is determined using actuarial valuations. An actuarial valuation involves making various assumptions that may differ from actual developments in the future. These are based on a series of financial and demographic assumptions, such as the discount rate, medical inflation, and percentage of adhesion to the plan, which are disclosed in note no. 2 2 . Due to the complexities involved in the valuation and its long-term nature, a defined benefit obligation is highly sensitive to changes in these assumptions. All assumptions are reviewed at each reporting date. 4.4 Stock option plan, restricted share plan, strategy-acceleration program and performance share program Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about it. The stock option plan, restricted share plan, strategy-acceleration program and performance share program are measured at fair value at the grant date and the expense is recognized in profit or loss during the vesting period and in “Additional paid-in capital” in shareholders’ equity. On the balance sheet dates, Management reviews the estimates as to the number of purchase options/restricted shares and, where applicable, recognizes the effect arising from this review in profit or loss for period against shareholders’ equity. The assumptions and models used to estimate the fair value of the stock option plan, restricted share plan and strategy-acceleration program are disclosed in note no. 2 7 . 1 4.5 Impairment of non-financial assets An impairment loss exists when the carrying amount of an asset or CGU exceeds its recoverable amount, which is the higher of fair value less cost of disposal and value in use. Fair value less costs of disposal is calculated based on information available about similar assets sold or market prices less additional costs to dispose of the asset. Value in use is calculated based on the discounted cash flow model. Cash flow derives from financial budgets approved by the Board of Directors for period of three years and complemented for a discretionary period of ten years estimated by Management, with a terminal value projected for the end of the period. The ten . The value in use is sensitive to the discount rate used under the discounted cash flow method, as well as the operating margins considered, the growth rate and perpetuity used for extrapolation purposes. 4.6 Allowance for trade accounts receivables expected losses The allowance for expected losses on trade accounts receivable from customers is estimated based on the loss risk in an aging list model. The characteristics of the Company’s trade accounts receivable are (i) immaterial financial component; (ii) non-complex receivables portfolio; and (iii) low credit risk. For trade accounts receivable, the Company applies the simplified approach in calculating expected credit losses (“ECL”) based on expected credit losses at each reporting date. The allowance determined based on (i) each of the subsidiaries credit losses historical experience, observed in each group of the trade accounts receivable aging list, and (ii) adjustments for specific forward-looking factors for defaulters and the economic environment. An estimated range is used based on the weighted average of the losses for the last 12 4.7 Allowance for inventory losses The allowance for inventory losses is estimated using a methodology to contemplate discontinued products, materials with slow turnover, materials with an expired expiration date or close to the expiration date, and materials outside the quality parameters. 4.8 Leases - Incremental borrowing rate The Company cannot readily determine the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (“IBR”) to measure lease liabilities. The IBR is the interest rate that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Company “would have to pay”, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary’s functional currency). The Company estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates. 4.9 As disclosed in explanatory notes 5.5 3 5 , part of the agreed consideration , from the former subsidiary The Body Shope sale, involved in the future collection of installments are contingent on meeting performance targets : of the operation of The Body Shop. The eventual achievement of these goals is assessed based on like ly hood studies associated with the specific results of The Body Shop as of the balance sheet date, applying the discounted cash flow method. Further details about premises and measurement basis are included in explanatory note 5.5

FINANCIAL RISK MANAGEMENT

FINANCIAL RISK MANAGEMENT	12 Months Ended
	Dec. 31, 2023
FINANCIAL RISK MANAGEMENT
FINANCIAL RISK MANAGEMENT	5 FINANCIAL RISK MANAGEMENT 5.1 General considerations and policies Risks and financial instruments are managed through policies, the definition of strategies and implementation of control systems, defined by the risk management committees of the entities of the group, and approved by the Company’s Board of Directors. The compliance of treasury financial instruments positions, including derivatives, in relation to these policies, is presented and assessed on a monthly basis by the Company’s Treasury Committee and subsequently submitted to the analysis of the Audit and Risk Management and Finance Committees, the Executive Committee and, if necessary, the Board of Directors. Risk management of the Company’s operations is performed by the Company’s Corporate Treasury, which is also responsible for approving short-term investments and borrowings transactions. Risk management of the subsidiaries Aesop, The Body Shop, Avon and Natura Cosméticos is conducted by local treasury teams, subject to monitoring and approval of the Company’s Corporate Treasury. 5.2 Risks associated with the conflict between Russia and Ukraine The Company's Management is continuously monitoring developments to assess any possible future impacts that may arise as a result of the ongoing crisis, including the impairment of financial and non-financial assets, which the Company’s Management assesses based on the best information available. So far, the conflict resulted in the suspension of the operations of exports from the Russian manufacturing unit to other countries in the region, including Ukraine, which are now supplied by our unit in Poland. Avon, however, continues to provide a basic earning opportunity to its representatives through a simplified operating model. As of the date of these financial statements, the Company confirms that the facilities, as well as the goods and stocks held therein, have not been damaged and are in a suitable condition to be operated. Regarding operations of the subsidiary Avon in Russia, as of the date of these financial statements, no significant impacts were identified that affect the business model for managing financial assets or the classification of these assets. Additionally, there are no indications of a significant increase in the expected credit loss associated with operations, considering the maintenance of receivables collection levels and the increase in cash transactions (considering the reduction in credit operations as a result of restrictions imposed locally and of credit card processing companies in the country). Considering the maintenance of collection levels and sales operations for the local market in Russia, as well as the inexistence of significant restrictions that affect the Company's ability to carry out the management and cash changes necessary to maintain its operations, there is no significant risk of liquidity related to these events that affect this financial statement. Similarly, market risks associated with the transaction, including interest rate, currency and other price risks, including raw materials, did not significantly affect the Company's financial assets, considering the expectation of recoverability of the amounts in the ordinary course of business. Regarding the operations in Ukraine, the impacts arising from the lower economic activity under the new simplified operating model are not relevant to the individual and consolidated financial statements. As a result of the developments of the conflict in the year ended December 31, 2023, there were still no impacts resulting from possible breaches of covenants or losses related to derecognition and/or modification of financial instruments or reclassification of cash flow hedge reserve amounts as a result of loss of effectiveness of derivatives recognized by hedge accounting or by the loss of expectation that transactions evaluated as highly probable will actually occur. 5.3 F inancial risk factors The Company’s activities expose them to several financial risks: market risks (including foreign currency and interest rate risks), credit risk and liquidity risk. The Company’s overall risk management program is focused on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance, using financial instruments to hedge certain risk exposures. The Company does not operate derivative instruments with the purpose of speculation. 5.3.1 Market risks Market risks reflect the risks that the fair value or future cash flows of a financial instrument will fluctuate as a result of changes in market prices, including foreign exchange risk, interest rate risk and other price risks. The Company is exposed to market risks arising from their business activities. These market risks mainly comprise possible fluctuations in exchange and interest rates. Other price risks include, among others, exposures to financial instruments due to changes in commodity and raw material prices. Climatic aspects, such as the availability of natural raw material used in the products and/or significant changes in the cost of these items may expose the Company to additional market risks that affect the entity's operations as well as the measurement and/or recoverability of financial instruments. As of December 31, 2023, the Company’s Management assessed these risks and concluded that they are not material. 5.3.1.1 Derivative financial instruments used to manage market risks The Company classifies derivative financial instruments as financial derivatives and operational derivatives. Financial derivatives include swaps or forwards used to hedge exchange rate or interest rate risks related to loans, financing, debt securities and loans between related parties. Operational derivatives include forward contracts used to hedge the exchange rate risk of the Company's operational activities (such as import and export transactions). As of December 31, 2023 and 2022 As of December 31, 2023 and 2022 Consolidated Fair value Gains (losses) of fair value adjustment Description 2023 2022 2021 2023 2022 2021 Swap agreements: (a) Asset portion: Dollar long position 876,664 6,108,505 6,881,981 19,457 34,867 978,350 Liability portion: Post-fixed CDI Rate: Short position in CDI (824,344 ) (6,874,285 ) (6,348,442 ) - (697,678 ) (823,887 ) Forward contracts and NDF: Liability portion: Post-fixed CDI Rate: Natura Cosméticos (5,878 ) (521 ) (48 ) (2,090 ) (521 ) (48 ) Natura Indústria (28,856 ) (6,633 ) - (28,856 ) (6,633 ) - Natura Mexico (Latam) 320 - - 151 - - The Body Shop - 16,789 (2,554 ) - (1,180 ) 12 Aesop - (1,350 ) - - 90 - Avon Brasil (3,702 ) (1,183 ) - (3,702 ) (1,183 ) - Avon Internacional (43,248 ) (19,203 ) (14,462 ) (28,633 ) (6,925 ) 106 Natura Luxembourg (22,182 ) (18,996 ) (89 ) 180 2,293 (89 ) Total derivative instruments, net: (51,226 ) (796,877 ) 516,386 (43,493 ) (676,870 ) 154,420 a) Swap transactions consist of swapping the exchange rate variation for a correction related to a percentage of the fluctuation of the Certificate of bank deposits (post-fixed CDI), in the case of Brazil Below are the changes in net derivatives balances for the years ended on December 31, 2023 and 2022 Consolidated Balance as of December 31, 2021 516,637 Losses from swap and forward derivative contracts for the year (unrealized) (992,813 ) Payment of funds due to settlement of derivative transactions - operational activity 594,225 Receipt of funds due to settlements of derivative instruments - financing activity (118,707 ) Losses in cash flow hedge operations (other comprehensive income) (790,479 ) Other movements (5,740 ) Balance as of December 31, 2022 (796,877 ) Losses from swap and forward derivative contracts for the year (unrealized) (1,791,905 ) Payment of funds due to settlement of derivative transactions - operational activity 1,487,092 Payment of funds due to settlements of derivative instruments - financing activity 310,870 Losses in cash flow hedge operations (other comprehensive income) 746,648 Other movements (7,054 ) Balance as of December 31, 2023 ( 51,226 ) Foreign currency risk The Company is exposed to foreign exchange risk resulting from financial instruments and operations in currencies other than their functional currencies, as well as to operating cash flows in foreign currencies. To reduce this exposure, policies were implemented to hedge the Company from foreign exchange risk, which establish exposure levels related to these risks. Pursuant to the Foreign Exchange Hedging Policy, the derivatives entered into by the Company should eliminate the foreign exchange risk of financial instruments in currencies other than their functional currencies and should also limit losses due to exchange rate variation on future cash flows. The treasury procedures defined by the current policies include quarterly projection and assessment of the consolidated foreign exchange rate exposure of the Company, on which Management’s decision-making is based. The Company’s foreign exchange hedging policy considers the amounts of foreign currency of receivables and payables balances from commitments already assumed and recorded in the financial statements, as well as future cash flows associated with transactions predicted to be highly probable with an average term of up to twelve months. During 2023 19 The debt denominated in US dollars was included in a hedge accounting structure, aiming to protect the variability of payments arising from exchange rate and interest rate risks. Considering the transfer made to the subsidiary Natura &Co Luxembourg, whose functional currency is the US dollar, the protected risk was no longer eligible within the hedge accounting structure and, consequently, the Company proceeded with the derecognition of this structure. As a result, the amount of R$4,958,286, previously recognized in the liabilities of the subsidiary Natura Cosméticos S.A., was derecognized and recognized in the subsidiary Natura &Co Luxembourg. Losses recognized in other comprehensive income of R$700,810, before tax effects, were reclassified to the statement of profit and loss for the nine Sensitivity analysis For the foreign exchange risk sensitivity analysis, the Company’s Management believes that it is important to consider, in addition to the assets and liabilities with exposure to fluctuations in exchange rates recorded in the balance sheet, the fair value of the financial instruments entered into by the Company to hedge certain exposures as of December 31, 2023 and 2022 Consolidated 2023 2022 Borrowing and financing in foreign currency in Brazil (a) - (5,252,376 ) Trade accounts receivable in foreign currency in Brazil 328,346 521,427 Trade accounts payable in foreign currencies in Brazil (158,500 ) (15,214 ) Fair value of financial derivatives (38,436 ) 6,101,350 Net asset exposure 131,410 1,355,187 a) Excluding transaction costs. This analysis considers only financial assets and liabilities recorded in Brazil in foreign currency, since exposure to the foreign exchange rate variation in other countries is close to zero Consolidated Parity - R$ vs US$ 4.8413 3.6715 2.4477 Scenario Scenario I Scenario II Operation/Instrument Brazilian Real Depreciation 25 Depreciation 50 Assets denominated in US$ Fair value of “financial” derivatives (38,436 ) (29,149 ) (19,432 ) Trade accounts receivable in foreign currency in Brazil 328,346 249,007 166,005 Liabilities denominated in US$ Trade accounts payable in foreign currencies in Brazil (158,500 ) (120,201 ) (80,134 ) Impact on net income and shareholders’ equity 131,410 (31,753 ) (64,971 ) The probable scenario considers future US dollar rates for a 90 days-term. According to quotations obtained at the Brazilian Stock Exchange (“B 3 1.00 1.00 1.00 a) Interest rate risk The interest rate risk arises from short and long-term investments, borrowing, financing and debentures. Financial instruments issued at variable rates expose the Company to cash flow risk associated with interest rate. Financial instruments issued at fixed rates expose the Company to the fair value risk associated with the interest rate. The Company’s cash flow risk associated with interest rate arises from short-term and long-term investments, borrowing and financing issued at floating rates. The Company’s Management holds, for the most part, the indexes of its exposures to deposit and lending interest rates tied to floating rates. Short-term investments are adjusted by the Certificate interbank deposits (“CDI”) whereas borrowing and financing are adjusted by the CDI and fixed rates, according to the contracts entered into with financial institutions and through the negotiation of securities with investors in that market. Additionally, the Company considered potential aspects related to sustainability and climate change commitments as part of the risks to which it is exposed in relation to the interest rate on financial instruments, except for the risks associated with the ESG notes (disclosed in item (f) below), there is no exposure to material risks which should be subject to specific disclosure. Sensitivity analysis As of December 31, 2023, there are borrowing, financing and debentures contracts denominated in foreign currency that are linked to interest swap agreements, changing the liability index rate to the CDI variation. Accordingly, the risk of the Company becomes the exposure to the variation of the CDI. The following table presents the exposure to interest rate risks of transactions related to CDI, including derivative transactions (borrowing, financing and debentures in Brazil were considered in full, given that 99.4% of the amount is related to the CDI): Consolidated Total borrowing, financing and debentures - in local currency (note 19 (6,111,702 ) Operations in foreign currency with derivatives related to CDI (a) 52,319 Short-term investments (notes 6 7 5,661,434 Net exposure (397,949 ) (a) Refers to transactions involving derivatives related to CDI to hedge the borrowing, financing and debentures arrangements raised in foreign currency in Brazil. The sensitivity analysis considers the exposure of borrowing, financing and debentures, net of short-term investments, linked to CDI (notes no. 6 7 The following tables show the projection of incremental loss that would have been recognized in profit or loss for the following year, assuming that the current net liability exposure is static and the following scenarios: Description Company Risk Probable scenario Scenario II Scenario III Consolidated Net liability Rate increases (5,683 ) 40,184 86,050 The probable scenario considers future interest rates for 90 days-term, according to B 3 5.3.1.2 Derivative instruments designated for hedge accounting a) Cashflow h edge The Company formally designated its operations subject to hedge accounting for derivative instruments to hedge borrowings, financing and debentures denominated in foreign currency and other expenses of Company, for derivative instruments contracted to hedge the purchase of nationalized materials of indirect subsidiaries Avon Industrial and Natura Industria and for derivative instruments contracted to hedge the operating cash flows from subsidiary The Body Shop’s foreign currency purchase and sales transactions. There is an economic relationship between the hedged items and the hedging instruments, as the terms of the contracts correspond to (i) the terms of anticipated and highly probable transactions (for example, the notional amount and expected payment date) to the case of derivative instruments contracted to protect highly probable purchases; and (ii) terms associated with debts contracted in foreign currency which are hedged by derivatives that aim to eliminate the variability of cash flows associated with dollar-denominated debt. The Company established a hedge ratio of 1:1 for the hedge relationships, as the underlying risks of the contracts are identical to the protected risk components. To test the effectiveness of the hedge, the Company uses the hypothetical derivative method and compares the changes in the fair value of the hedging instruments with the changes in the fair value of the hedged items attributable to the hedged risks. The sources of ineffectiveness, historically immaterial, may come from: (i) differences in the timing of cash flows from hedged items and hedging instruments; (ii) different indices (and, consequently, different curves) associated with the hedged risk of hedged items and hedging instruments; (iii) counterparty credit risk having a different impact on fair value movements of hedging instruments and hedged items; and (iv) changes in the expected amount of cash flows from hedged items and hedging instruments. For years ending on December 31, 2023 and 2022 As of December 31, 2023, the net position of derivative instruments designated as cash flow hedges consists exclusively of operational derivatives and is detailed: Other comprehensive income Hedged item Notional currency Fair value Gain (loss) in the year Gain (loss) in the year Currency swap – US$/R$ - Natura Cosméticos Currency and interest rate BRL (5,878 ) (2,090 ) 763,197 Forward agreements (Avon Industria) Currency BRL (3,702 ) (3,702 ) 5,452 Forward agreements (Natura Dist. Mexico) Currency BRL 320 151 151 Forward agreements (Natura Industria) Currency BRL (21,497 ) (21,497 ) ( 22,637 ) Forward agreements (Natura Holding) Currency BRL 1,731 486 485 Total (29,026 ) (26,652 ) 746,648 The changes in cash flow hedge reserve recorded in OCI are shown below: Consolidated Cash flow hedge balance as of December 31, 2020 159,077 Change in the fair value of hedge instrument recognized in OCI (210,150 ) Tax effects on fair value of hedge instrument 72,939 Cash flow hedge balance as of December 31, 2021 21,866 Change in the fair value of hedge instrument recognized in OCI (790,479 ) Tax effects on fair value of hedge instrument 270,035 Cash flow hedge balance as of December 31, 2022 (498,578 ) Change in the fair value of hedge instrument recognized in OCI 746,648 Tax effects on fair value of hedge instrument (251,950 ) Cash flow hedge balance as of December 31, 2023 (3,880 ) b) Fair value hedge For the years ending December 31, 2023 and 2022 2 3 12 The type of hedge relationship applied to such instruments is fair value hedge, which is used to offset variations arising from changes in the fair value of the liability attributable to the specific risk. There is an economic relationship between protected items and hedging instruments, as the terms of the contracts correspond to terms associated with the contracted debt. The Company established a hedge ratio of 1:1 To test the effectiveness of the hedge, the Company uses the sensitivity test, measuring the variation using the offset method in US dollars. Sources of ineffectiveness, historically immaterial, may arise from: (i) reductions or modifications of the protected item (debt payment); (ii) changes in the credit risk of the Company or the counterparty to the contracts; (iii) changes in the spread over IPCA in the swap. As of December 31, 2023, the net position of derivative instruments designated as fair value hedges consists exclusively of financial derivatives and is detailed below: Protection object Reference currency (Notional) Fair value Fair value Interest Rate BRL 52,319 Total 52,319 5.3.2 Credit risk Credit risk refers to the risk of a counterparty not fulfilling its contractual obligations, causing the Company to incur financial losses. The Company's sales are made to a large number of Natura and Avon Consultants and this risk is managed through a credit granting process. The result of this management is reflected in the item “provision for expected credit losses” in “accounts receivable from customers”, as shown in explanatory note no. 8 The Company is also subject to credit risks related to financial instruments contracted in the management of its business, mainly represented by cash and cash equivalents, financial investments and derivative financial instruments. The Company considers the credit risk of the operations it maintains in financial institutions with which it operates to be low, which are considered by Management to be first line. The financial investment policy established by the Company's Management elects the financial institutions with which contracts can be concluded, in addition to defining limits regarding the percentages of resource allocation and absolute values to be applied to each of them. 5.3.3 Liquidity risk Prudent liquidity risk management implies maintaining sufficient cash, short-term investments, funds available through credit facilities and the ability to settle market positions. Management monitors the Company’s liquidity level considering the expected cash flows in exchange for unused credit facilities, as shown in the following table: Consolidated 2023 2022 Total current assets 15,987,222 16,121,527 Total current liabilities (10,413,499 ) (13,337,868 ) Total net working capital 5,573,723 2,783,659 As of December 31, 2023 and 2022 2023 Less than a year One five More than five Total expected contractual cash flow Interest to be accrued Carrying amount Borrowing, financing and debentures 357,568 4,194,476 4,078,504 8,630,548 (2,518,846 ) 6,111,702 Derivatives 140,679 71,134 (160,587 ) 51,226 - 51,226 Lease liability 401,217 912,529 135,207 1,448,953 (298,513 ) 1,150,440 Trade accounts payables, related parties and reverse factoring operations 5,302,478 - - 5,302,478 - 5,302,478 Dividends payable 294,231 - - 294,231 - 294,231 2022 Less than a year One five More than five Total expected contractual cash flow Interest to be accrued Carrying amount Borrowing, financing and debentures 722,146 3,228,866 13,140,599 17,091,611 (3,499,325) 13,592,286 Derivatives 640,257 1,504,007 (1,347,387) 796,877 - 796,877 Lease liability 1,070,253 2,019,723 856,402 3,946,378 (675,641) 3,270,737 Trade accounts payables, related parties and reverse factoring operations 6,375,930 - - 6,375,930 - 6,375,930 Dividends payable 260 - - 260 - 260 New borrowing and financing in the year ended December 31, 2023 are disclosed on note no 19 Matters related to climatic factors and other sustainability commitments assumed may expose the Company to possible risks related to its financial instruments, especially related to the potential variability of cash flows required to settle obligations with third parties on financing that involve such commitments. On May 4, 2021, subsidiary Natura Cosméticos concluded the offer of the notes linked to the sustainability goals subject to interest of 4.125% p.a. and with maturity date on May 3, 2028 (“ESG Notes”) subject to foreign exchange risk, in the total principal amount of US$1,000,000, and these are guaranteed by the Company. The targets, to be met by 2026 5.4 Capital management The Company's objectives when managing its capital are to safeguard the Company's ability to continue to provide returns to shareholders and benefits to other interested parties, in addition to maintaining an ideal capital structure to reduce this cost. The Company monitors capital based on financial leverage ratios. This index corresponds to net debt divided by EBITDA (earnings before interest, taxes, depreciation and amortization - EBITDA). Net debt, in turn, corresponds to total loans and financing (including short- and long-term loans and financing, as shown in the consolidated balance sheet) subtracted from the amount of cash and cash equivalents and marketable securities (except resources of “Crer Para Ver” and the investment fund Dynamo Beauty Ventures Ltd (“DBV”). 5.5 Fair value measurement Financial instruments that are measured at fair value on the balance sheet dates as determined by CPC 46 13 ➢ Level 1 : Valuation based on quoted (unadjusted) prices in active markets for identical assets and liabilities at balance sheet dates. A market is viewed as active if quoted prices are readily and regularly available from a securities exchange, broker, industry group, pricing service or regulatory agency and those prices represent actual market transactions that occur regularly on a purely commercial basis; ➢ Level 2 : Used for financial instruments that are not traded in active markets (for example, over-the-counter derivatives), whose evaluation is based on techniques that, in addition to the quoted prices included in Level 1 , use other information adopted by the market for the asset or passive directly (i.e. as prices) or indirectly (i.e. derived from prices); and ➢ Level 3 : Valuation techniques for which the lowest level of input that is significant for measuring fair value is not observable. Below, we present the carrying amount and fair values of the Company's financial instruments as of December 31, 2023 and 2022 Carrying amount Fair value Consolidated Nota Classification by category Fair value hierarchy 2023 2022 2023 2022 Financial assets Cash and cash equivalent 6 Cash and banks Amortized cost Level 2 2,113,566 2,904,808 2,113,566 2,904,808 Certificate of bank deposits Fair value through profit or loss Level 2 203,561 46,864 203,561 46,864 Repurchase operations Fair value through profit or loss Level 2 1,433,817 1,244,041 1,433,817 1,244,041 3,750,944 4,195,713 3,750,944 4,195,713 Short-term investments 7 Government securities Fair value through profit or loss Level 2 1,272,445 31,415 1,272,445 31,415 Restricted cash Fair value through profit or loss Level 2 30,240 1,481 30,240 1,481 Financial treasury bills Fair value through profit or loss Level 2 392,253 539,450 392,253 539,450 Loan investment fund Fair value through profit or loss Level 2 2,329,118 1,228,093 2,329,118 1,228,093 DBV fund Fair value through profit or loss Level 3 36,698 35,235 36,698 35,235 4,060,754 1,835,674 4,060,754 1,835,674 Trade accounts receivables - related parties 8 32.1 Amortized cost Level 2 3,524,395 3,502,399 3,524,395 3,502,399 Judicial deposits 12 Amortized cost Level 2 408,030 457,550 408,030 457,550 Sublease receivables 14 Amortized cost Level 2 180,440 262,108 180,440 262,108 Receivables from service providers 14 Amortized cost Level 2 109,639 110,214 109,639 110,214 Accounts receivable - sale of subsidiary Amortized cost Fixed consideration 34 Amortized cost Level 2 343,068 - 343,068 - Contingent consideration 34 Fair value through profit or loss Level 3 486,429 - 486,429 - 5,052,001 4,332,271 5,052,001 4,332,271 Financial derivatives (hedge instrument) Fair value through profit or loss Level 2 23,293 - 23,293 - Financial derivative instruments Fair value through profit or loss Level 2 255,157 1,008,365 255,157 1,008,365 278,450 1,008,365 278,450 1,008,365 Financial liabilities Borrowing, financing and debentures 19 Borrowing in local currency Amortized cost Level 2 (6,111,702 ) (8,419,320 ) (6,111,702 ) (8,419,320 ) Foreign currency borrowings Amortized cost Level 2 - (5,172,966 ) - (5,172,966 ) (6,111,702 ) (13,592,286 ) (6,111,702 ) (13,592,286 ) Financial and operating derivative instruments Fair value through profit or loss Level 2 (329,676 ) (1,805,242 ) (329,676 ) (1,805,242 ) Lease liability 18 Amortized cost Level 2 (1,150,440 ) (3,270,737 ) (1,150,440 ) (3,270,737 ) Prepaid insurance Amortized cost Level 2 14,013 - 14,013 - Trade accounts payables, related-parties’ and reverse factoring 20 32.1 Amortized cost Level 2 (5,302,478 ) (6,375,930 ) (5,302,478 ) (6,375,930 ) Insurance payables 23 Amortized cost Level 2 (1,239 ) (69,364 ) (1,239 ) (69,364 ) Dividends payable 24 Amortized cost Level 2 (294,231 ) (260 ) (294,231 ) (260 ) When measuring, the carrying value represents a reasonable approximation of the fair value, as described below: (i) the balances of cash and cash equivalents, trade accounts receivables, accounts payable to suppliers and other current liabilities are equivalent to their carrying amounts, mainly due to the short-term maturities of these instruments; (ii) the balances of the short-term investments: a) measured at amortized cost approximate their fair values as a result of the transactions to be conducted at floating interest rates; and b) measured at fair value through profit or loss based on the rates agreed with the financial institutions considering the agreed rates among the parties, including market information that allows for such calculation; (iii) except for the real estate receivables certificates the carrying amounts of borrowing, financing and debentures are measured at their amortized cost and disclosed at fair value, which does not differ materially from the carrying amounts as interest rates are consistent with current market rates; and (iv) the fair value of exchange rate derivatives (swap and forwards) is determined based on the future exchange rates at the dates of the balance sheets, with the resulting amount being discounted at present value. The fair value of the investment in the Fundo Dynamo Beauty Ventures Ltda. (“DBV Fund”), classified at level 3 2022 As part of the sales agreement with the acquirer of the former subsidiary The Body Shop (as disclosed in explanatory note no. 35 2025 2026 There were no transfers between measurement levels in the fair value hierarchy in the year ended December 31, 2023 and 2022 Additionally, in the year ended December 31, 2023, there were no material effects on the fair value of financial assets and liabilities as a result of an increase in price volatility in markets affected by the conflict between Russia and Ukraine, counterparty risk in financial assets or market inactivity considered in the evaluation.

CASH AND CASH EQUIVALENT

CASH AND CASH EQUIVALENT	12 Months Ended
	Dec. 31, 2023
CASH AND CASH EQUIVALENT
CASH AND CASH EQUIVALENT	6. C ASH AND CASH EQUIVALENT Consolidated 2023 2022 Cash and banks 2,113,566 2,904,808 Certificate of bank deposits 203,561 46,864 Repurchase operations (a) 1,433,817 1,244,041 3,750,944 4,195,713 (a) Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”), these investments offer high liquidity with a redemption period of up to 90 2022

SHORT-TERM INVESTMENTS

SHORT-TERM INVESTMENTS	12 Months Ended
	Dec. 31, 2023
Short Term Investments [Abstract]
SHORT-TERM INVESTMENTS	7. SHORT-TERM INVESTMENTS Consolidated 2023 2022 Loan investment funds (a) 2,329,118 1,228,093 Treasury bills (b) 392,253 539,450 Government securities (LFT) (c) 1,272,445 31,415 DBV fund 36,698 35,235 Restricted cash 30,240 1,481 4,060,754 1,835,674 Current 4,024,056 1,800,439 Non-current 36,698 35,235 (a) Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the entities of Argentina, Chile, Colombia and Mexico. (b) As of December 31, 2023, investments in treasury bills are remunerated at an average rate of 108.15% of the CDI (109.69% as of December 31, 2022). (c) As of December 31, 2023, investments in Government securities (LFT) are remunerated at an average rate of 100.75% of the CDI (100.02% of the CDI as of December 31, 2022). The breakdown of securities constituting the Essential Investment Fund portfolio, regarding which the Company holds 100 2022 Consolidated 2023 2022 Certificate of bank deposits (CDB) 644 2,012 Repurchase operations (cash and cash equivalents) 1,433,487 937,645 Treasury bills 392,253 539,450 Government securities (LFT) 1,272,445 46,071 3,098,829 1,525,178 These amounts are presented together with the other investments of the same nature of the Company in the consolidated.

TRADE ACCOUNTS RECEIVABLE

TRADE ACCOUNTS RECEIVABLE	12 Months Ended
	Dec. 31, 2023
TRADE ACCOUNTS RECEIVABLE	8 TRADE ACCOUNTS RECEIVABLE Consolidated 2023 2022 Trade accounts receivable 3,893,880 3,933,550 (-) Allowance for expected credit losses (369,485 ) (431,151 ) 3,524,395 3,502,399 Maximum exposure to credit risk on the date of the financial statements is the carrying amount of each maturity date range, net of the allowance for expected credit losses. The following table shows trade accounts receivables by exposure to allowance for expected credit losses as of December 31, 2023 and 2022 Consolidated 2023 2022 Trade accounts receivable Allowance for expected credit losses Trade accounts receivable Allowance for expected credit losses Current 3,150,046 (111,784 ) 2,814,843 (94,148 ) Past due: Up to 30 348,851 (48,397 ) 621,711 (59,764 ) 31 60 89,271 (32,502 ) 142,507 (53,609 ) 61 90 66,496 (31,128 ) 106,124 (48,851 ) 91 180 239,194 (145,656 ) 248,365 (174,779 ) Over 180 22 (18 ) - - 3,893,880 (369,485 ) 3,933,550 (431,151 ) The changes in the allowance for expected credit losses for the year ended December 31, 2023 and 2022 Consolidated Balance as of December 31, 2020 (432,108 ) Additions, net of reversals (837,822 ) Write-offs (a) 817,446 Translation adjustment (1,497 ) Balance as of December 31, 2021 (453,981 ) Additions, net of reversals (605,995 ) Write-offs (a) 592,857 Translation adjustment 35,968 Balance as of December 31, 2022 (431,151 ) Write-off from sale of subsidiaries 7,107 Additions, net of reversals (605,874 ) Write-offs (a) 634,657 Translation adjustment 25,776 Balance as of December 31, 2023 (369,485 ) (a) Refers to accounts overdue for more than 180

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2023
INVENTORIES
INVENTORIES	9 INVENTORIES Consolidated 2023 2022 Finished products 2,390,999 3,634,068 Raw materials and packaging 882,514 1,159,507 Auxiliary materials 224,370 146,409 Products in progress 41,604 68,849 (-) Provision for inventory losses (452,092 ) (491,959 ) 3,087,395 4,516,874 The changes in the allowance for inventory losses for the years ended December 31, 2023 and 2022 are as follows: Consolidated Balance as of December 31, 2020 (594,071 ) Additions, net of reversals (a) (837,822 ) Write- off (b) 817,446 Translation adjustment (1,497 ) Balance as of December 31, 2021 (615,944 ) Additions, net of reversals (a) (305,705 ) Write- off (b) 366,198 Translation adjustment 63,492 Balance as of December 31, 2022 (491,959 ) Write-off from sale of subsidiaries 63,971 Additions, net of reversals (a) (422,498 ) Write-o ffs (b) 352,519 Translation adjustment 45,875 Balance as of December 31, 2023 (452,092 ) a) This refers to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company. b) It consists of write-offs of products for which there already had an allowance for losses, where the Company has no expectation of sales/realization.

RECOVERABLE TAXES

RECOVERABLE TAXES	12 Months Ended
	Dec. 31, 2023
RECOVERABLE TAXES
RECOVERABLE TAXES	10. RECOVERABLE TAXES Consolidated 2023 2022 ICMS on purchase of go ods (a) 561,224 704,018 Taxes on purchase of goods – foreign subsidiaries 214,699 245,955 ICMS on purchases of property, plant and equipment and purchase of goods 15,912 14,365 PIS and COFINS on purchase of property, plant and equipment and purchase of g oods (b) 620,631 950,307 Withholding PIS, COFINS and CSLL 1,671 1,671 Tax on Manufactured Goods - IPI (c) 127,127 152,686 Other 179,673 199,276 1,720,937 2,268,278 Current 608,530 911,410 Non-current 1,112,407 1,356,868 a) Tax credits related to the tax on the circulation of goods, interstate and inter-municipal transport and communication services (ICMS) were generated mainly by purchases, whose tax rate is higher than the average of sales. The Company expects to realize these credits during the ordinary course of business through offsetting with sales operations in the domestic market. b) The accumulated tax credits of PIS and COFINS basically arise from credits on purchases of raw materials used in the production and from purchase of property, plant and equipment, as well as credits arising out of the exclusion of ICMS from the calculation basis of the PIS/COFINS. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. c) The balance will be used to offset IPI (Taxes over industrialized products) payable in future operations of the Company.

INCOME TAX AND SOCIAL CONTRIBUT

INCOME TAX AND SOCIAL CONTRIBUTION	12 Months Ended
	Dec. 31, 2023
INCOME TAX AND SOCIAL CONTRIBUTION
INCOME TAX AND SOCIAL CONTRIBUTION	1 1 I NCOME TAX AND SOCIAL CONTRIBUTION 11.1 D eferred The deferred Corporate Income Tax - IRPJ and Social Contribution on Net Income - CSLL amounts arise from temporary differences in the subsidiaries. For certain subsidiaries and the Company, deferred tax balances on tax losses were also recognized. The Company’s Management assesses the possibility of offsetting deferred income tax assets and deferred income tax liabilities according to each jurisdiction. The amounts are as follows: i) Breakdown of deferred income taxes and social contribution Consolidated 2023 2022 Tax loss carryforwards 1,778,203 2,465,805 Receivables 141,595 192,260 Inventory 141,650 219,367 Fixed and intangible assets 31,991 160,716 Lease liabilities 262,175 444,444 Accruals, reserves and provision for tax, civil and labor risks (b) 358,108 649,768 Employee benefits 340,807 373,817 Non-functional currency positions, including derivatives and hedge accounting transactions (c) 9,811 307,732 Foreign t ax c redit c arryforwards (a) 10,003 363,493 Other temporary differences 145,151 124,689 Total deferred tax assets 3,219,494 5,302,091 Non-functional currency positions, including derivatives and hedge accounting transactions (c) (16,500 ) - Fixed and intangible assets (213,266 ) (339,627 ) Employee benefits (145,149 ) (132,609 ) Right to use assets (195,814 ) (359,072 ) Contingent consideration (157,966 ) - Fair value of identifiable net assets in business combination (d) (281,436 ) (1,561,946 ) Other temporary differences (336,758 ) (323,736 ) Total deferred tax liabilities (1,346,889 ) (2,716,990 ) Total of deferred income tax and social contribution, net 1,872,605 2,585,101 Deferred income taxes and social contribution assets, net (e) 2,200,695 3,519,515 Deferred income taxes and social contribution liabilities, net (e) (328,090 ) (934,414 ) a) Primarily relates to foreign tax credit in Brazil that had historically been reported as prepaid income taxes rather than deferred tax assets. b) Includes (i) expenses under the accrual basis, reflecting deductible expenses incurred in the year, (ii) deferred revenue, (iii) accrued and unpaid compensation and (iv) other reserves not currently deductible for tax. c) Due to underlying changes in non-functional currencies relative to the Brazilian Real, the balance at 2023 year-end primarily reflects a loss on a hedge instrument that can only be deducted when the hedge instrument is settled; as of 2022 year-end, the balance primarily reflected a gain on a hedge which could be deferred until settlement. d) The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of the subsidiaries Avon, The Body Shop and Aesop. e) Balance presented in the balance sheet including the effects of the jurisdictional offset of deferred tax assets and liabilities of the same nature, originating from the same taxpayer and tax authority. See Footnote 3 As of December 31, 2023, there are deferred tax assets recognized in the current and previous periods arising from tax losses and negative CSLL base in the total amount of R$ billion (R$ billion as of December 31, 2022) , of which approximately R$ billion is associated with operational entities, including our financial operation in the subsidiary Natura &Co Luxembourg, which currently generate taxable profits or have other sources of income. Additionally, there are deferred tax assets recognized in the current and previous periods for tax losses and/or other deferred tax assets arising from operations of the indirect subsidiary Avon México, which is currently in deficit, totaling R$376 million (R$293 million as of December 31, 2022). In relation to the indirect subsidiary Avon México, the Company's Management assessed the recoverability of these deferred tax assets based on all available information, including future taxable profits projected and incorporated into the projections, as well as the monitoring of initiatives (which also involve the restructuring of operations in the Latin America) that were approved at the highest levels of governance, and concluded that the realization of the assets is probable. The projections are also consistent with those prepared and used internally for business planning and impairment testing purposes. Based on these projections and the underlying facts and circumstances, it was determined that there would be sufficient taxable income to realize the benefit of the recognized deferred tax assets. The changes in deferred asset and liability income tax and social contribution for the years ended December 31, 2023 and 2022 Consolidated Asset Liability Balance as of December 31, 2021 3,100,515 (994,041 ) Effect on statement of profit or loss 599,136 (1,071 ) Reserve for grant of options and restricted shares 28,750 (1,617 ) Other comprehensive income impact 270,035 - Translation adjustment (478,921 ) 62,315 Balance as of December 31, 2022 3,519,515 (934,414 ) Effect on income statement (894,732 ) (167,668 ) Transfer between deferred income tax and social contribution liabilities and assets (18,502 ) 18,502 Reclass of UTP to Deferred Tax Liability - (46,760 ) Transfer of Prepaid to Deferred Tax 20,213 Discontinued operations (374,090 ) 788,977 Reserve for grant of options and restricted shares (31,772 ) 2,486 Other comprehensive income impact 8,195 - Translation adjustment (28,132 ) 10,787 Balance as of December 31, 2023 2,200,695 (328,090 ) As of December 31, 2023, the Company had the following unrecognized deferred tax assets: Item Amount Indefinite Expiration Definite Expiration Net operating loss (a) 9,513,303 8,715,748 797,555 Credits (b) 584,474 - 584,474 Other future deductible Items 2,156,658 2,156,658 Total 12,254,435 10,872,406 1,382,029 a) During , no significant expirations are expected; the majority of expirations are expected to occur in and successive years. b) During 2024 2027 . Unrecognized deferred tax assets are substantially associated with the acquisition of Avon’s operations, especially from operations in Luxembourg, United Kingdom and United States. As of December 31, 2023, there are no events or circumstances that could allow for further recognition of unrecognized deferred tax assets. This situation could change in the future as events and/or relevant facts and circumstances allow. 11.2 Reconcilia tion of income tax and social contribution reflected in continuing operations : Consolidated 2023 2022 Loss before income tax and social contribution (2,668,347 ) (2,168,618 ) Income tax and social contribution at the rate of 34% 907,238 737,330 Brazil Investment subsidies 427,897 207,608 Share of profit of equity investees - - Effect from differences of tax rates of entities abroad (147,265 ) (103,447 ) Taxation of profits of foreign subsidiaries (a) (49,264 ) 56,126 Unrecognized Deferred income tax ( b ) (642,608 ) (762,362 ) Exercise of purchase options and restricted share plans 52 Non-Deductible donation and contribution (27,136 ) (35,616 ) Interest on Net Equity - - Withholding and Sub-national taxes not recognized (42,763 ) (60,121 ) Goodwill impairment (b) (225,723 ) (70,730 ) Other permanent differences (113,976 ) (61,193 ) Income tax and social contribution benefit (expenses) 86,400 (92,353 ) Income tax and social contribution - current (976,000 ) (690,418 ) Income tax and social contribution - deferred 1,062,400 598,065 Effective tax rate - % 4.3% (4.3% ) a) Certain earnings of foreign subsidiaries may be subjected to income taxation net of applicable credits, if any, by their parent holding companies in addition to the local taxing jurisdictions in which they conduct operations. Within the Natura Group, these types of taxation regimes exist in various jurisdictions including but not limited to Brazil, Australia, United Kingdom, United States. b) During 2022 and 2023 , the Company recognizes an impairment of the g oodwill associated with Avon International CGU. The Avon International g oodwill resulting from its acquisition is non-deductible for income tax purposes. 11.3 Income tax and social contribution included in discontinued operations During the year ended December 31, 2023, a pre-tax profit of R$7,772 million was reflected in discontinued operations primarily associated with the former subsidiaries Aesop and The Body Shop. The pre-tax profit was generated by the net gain resulting from the divestiture of these business units partially offset with the net loss from operations of these business units and other discontinued operational losses associated with the Avon business unit. As of December 31, 2023, income tax expense was reflected in the results of discontinued operations in the amount of R$2,214 million resulting in an effective tax rate of 28.5%. The difference of 5.5% between the effective tax rate and the statutory tax rate of 34% is primarily attributable to the exclusion of income associated with currency translation effects included in book income that is excluded from taxable income partially offset with the effect of losses that cannot be benefitted. During the year ended December 31, 2022, a pre-tax loss of R$380 million was generated and no income tax benefit See section 11.1

JUDICIAL DEPOSITS

JUDICIAL DEPOSITS	12 Months Ended
	Dec. 31, 2023
JUDICIAL DEPOSITS
JUDICIAL DEPOSITS	12 JUDICIAL DEPOSITS Judicial deposits represent restricted assets of the Company and are related to the amounts deposited and held in court until the resolution of the disputes to which they are related. The judicial deposits held by the Company as of December 31, 2023 and 2022 Consolidated 2023 2022 Unaccrued tax proc eedings (a) 228,331 274,273 Accrued tax proc eeding (b) 154,077 150,929 Unaccrued civil proceedings 5,462 5,783 Accrued civil proceedings 1,453 1,470 Unaccrued labor proceedings 10,018 11,014 Accrued labor proceedings 8,689 14,081 Total judicial deposits 408,030 457,550 a) The tax proceedings related to these judicial deposits refer mainly to the ICMS-ST. b) The tax proceedings related to these judicial deposits refer, substantially, to the sum of the amounts highlighted in note no. 21 20 Changes in judicial deposits balances for the year ended December 31, 2023 and 2022 Consolidated Balance as of December 31, 2021 585,284 New deposits 27,479 Redemptions in favor of the Company (67,533 ) Monetary adjustment 35,508 Application in the liquidation of proceedings (121,025 ) Transfers 25 Translation adjustment (2,188 ) Balance as of December 31, 2022 457,550 Consolidated Balance as of December 31, 2022 457,550 New deposits 13,493 Redemptions in favor of the Company (35,227 ) Monetary adjustment 28,460 Application in the liquidation of proceedings (55,494 ) Translation adjustment (752 ) Balance as of December 31, 2023 408,030 In addition to judicial deposits, the Company has contracted insurance policies for certain lawsuits.

NON-CURRENT ASSETS HELD FOR SAL

NON-CURRENT ASSETS HELD FOR SALE	12 Months Ended
	Dec. 31, 2023
NON-CURRENT ASSETS HELD FOR SALE
NON-CURRENT ASSETS HELD FOR SALE	13 NON-CURRENT ASSETS HELD FOR SALE The changes in the balance for the years ended December 31, 2023 and 2022 are as follows: Consolidated Balance as of December 31, 2021 52,921 Transfers from property, plant and equipment, other assets and liabilities 13,235 Impairment (12,510 ) Sal e (55,034 ) Translation adjustment 1,439 Balance as of December 31, 2022 51 Balance as of December 31, 2022 51 Transfers from the former subsidiary Aeso p (a) 2,492,471 Other transf ers (b) 555,013 Impairment (c) (53,117 ) Write off due to ale (d) (2,988,713 ) Translation adjustment (5,705 ) Balance as of December 31, 2023 - a) These transfers include the assets of the former subsidiary Aesop, and whose sale was assessed as highly probable in the quarter ended March 31, 2023. The sales impacts are presented in note no. 36 b) The other transfers include certain properties of the subsidiary Avon, located in the United States, Chile and Brazil. c) Reflect the recognition of loss due to impairment of properties of the subsidiary Avon, located in the United States, Chile and Brazil, transferred to non-current assets held for sale and being tested for impairment purposes upon transfer and consequent measurement to the lower of fair value less selling costs and previous book value. d) The write-offs due to disposal presented in the movement include the value of the assets of the former subsidiary Aesop. Also among the write-offs are the sale of an asset of the subsidiary Avon in Chile, amounting to R$37,484.

OTHER CURRENT AND NONCURRENT AS

OTHER CURRENT AND NONCURRENT ASSETS	12 Months Ended
	Dec. 31, 2022
OTHER CURRENT AND NONCURRENT ASSETS
OTHER CURRENT AND NONCURRENT ASSETS	14. O THER CURRENT AND NON-CURRENT ASSETS Consolidated 2023 2022 Marketing and advertising advances 43,150 43,509 Supplier advances 203,193 290,205 Employee advances 19,297 20,267 Rent advances and guarantee deposit (a) 20,284 160,437 Advance insurance expenses 110,355 124,293 Overfunded pension plan (b) 723,130 694,527 Customs broker advances - Import taxes 43,316 38,398 Sublease receivables (c) 180,440 262,108 Carbon credits 13,970 14,297 Receivables from service providers (d) 109,639 110,214 Other 165,332 257,566 1,632,106 2,015,821 Current 604,427 763,384 Non-current 1,027,679 1,252,437 a) Mainly related to: (i) advances for lease agreements that were not included in the initial measurement of lease liabilities / right-of-use of the former subsidiary Avon, in accordance with the exemptions of IFRS 16 06 2 2022 b) Pension plan arising from the acquisition of subsidiary Avon. The variance in the balance refers to the revision in mortality tables offset by the impact of exchange rate variation due to the appreciation of the real. c) Refers to the sublease receivable from the New York office owned by the subsidiary Avon. d) Refers to receivables mainly arising from damage that occurred with carriers and insurance companies

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Dec. 31, 2023
PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT	15 PROPERTY, PLANT AND EQUIPMENT Consolidated Useful life range (in years) 2022 Additions Write-offs Transfers Transfer to asset held for sale Write-off due to sale of subsidiary Translation adjustment 2023 Cost: Vehicles 2 to 5 74,362 9,285 (5,629 ) 11 - - (30,292 ) 47,737 Tooling 3 204,177 72 (135 ) 6,700 - - 212 211,026 Tools and accessories 3 to 20 175,452 13,676 (16,033 ) 4,360 - - 4,275 181,730 Facilities 3 to 60 307,448 984 (1,338 ) 25,016 (166 ) - 7,491 339,435 Machinery and accessories 3 to 15 2,272,136 37,809 (75,340 ) 180,157 (25,065 ) (62,120 ) (127,358 ) 2,200,219 Leasehold improvements 2 to 20 1,128,086 47,444 (93,243 ) 4,514 (696,954 ) (223,379 ) (28,035 ) 138,433 Buildings 14 to 60 1,916,939 15,966 (56,721 ) (2,617 ) (582,033 ) (28,653 ) (132,441 ) 1,130,440 Furniture and fixtures 2 to 25 674,062 57,609 (89,422 ) 672 (93,440 ) (359,311 ) (31,344 ) 158,826 Land - 645,657 30,313 (631 ) - (267,425 ) (4,934 ) (13,106 ) 389,874 IT equipment 3 to 15 627,770 23,286 (108,116 ) 9,268 (52,223 ) (66,626 ) (39,004 ) 394,355 Other assets - 26,230 - (12 ) - - - (758 ) 25,460 Projects in progress - 580,627 376,452 (35,425 ) (318,663 ) (38,743 ) (11,016 ) (54,937 ) 498,295 Total cost 8,632,946 612,896 (482,045 ) (90,582 ) (1,756,049 ) (756,039 ) (445,297 ) 5,715,830 Accumulated depreciation: Vehicles (38,070 ) (5,812 ) 4,912 - (24) - 16,107 (22,887 ) Tooling (179,485 ) (8,920 ) 135 (13 ) - - (117 ) (188,400 ) Tools and accessories (135,440 ) (17,766 ) 15,872 (1,260 ) - - 76,188 (62,406 ) Facilities (201,307 ) (14,395 ) 2,554 (390 ) 166 - 6,033 (207,339 ) Machinery and accessories (1,118,339 ) (203,294 ) 62,508 (126 ) 17,185 37,722 15,722 (1,188,622 ) Leasehold improvements (626,431 ) (65,843 ) 89,857 - 464,551 120,073 23,647 5,854 Buildings (455,402 ) (105,083 ) 27,612 6 301,177 10,480 60,398 (160,812 ) Furniture and fixtures (408,832 ) (79,210 ) 71,758 1,620 62,651 248,773 22,245 (80,995 ) IT equipment (475,668 ) (64,163 ) 105,080 14 31,284 44,521 (13,775 ) (372,707 ) Other assets (27,822 ) (549 ) - - - - 48,429 20,058 Total depreciation (3,666,796 ) (565,035 ) 380,288 (149 ) 876,990 461,569 254,877 (2,258,256 ) Net total 4,966,150 47,861 (101,757 ) (90,731 ) (879,059 ) (294,470 ) (190,420 ) 3,457,574 Consolidated Useful life range (in years) 2021 Additions Write-offs Impairment Transfers Translation adjustment 2022 Cost: Vehicles 2 to 5 38,902 8 (6,559 ) - 49,285 (7,274 ) 74,362 Tooling 3 191,840 - (2,310 ) - 14,976 (329 ) 204,177 Tools and accessories 3 to 20 110,998 17,261 (8,177 ) - (43,369 ) 98,739 175,452 Facilities 3 to 60 303,452 181 (564 ) - 13,147 (8,768 ) 307,448 Machinery and accessories 3 to 15 1,959,943 23,188 (63,473 ) - 520,561 (168,083 ) 2,272,136 Leasehold improvements 2 to 20 1,128,504 68,980 (54,148 ) (1,665 ) 106,151 (119,736 ) 1,128,086 Buildings 14 to 60 1,982,245 7,174 (19,104 ) - 120,512 (173,888 ) 1,916,939 Furniture and fixtures 2 to 25 660,126 71,960 (41,095 ) (7,629 ) 53,632 (62,932 ) 674,062 Land - 628,373 - - - 10,043 7,241 645,657 IT equipment 3 to 15 634,580 26,602 (34,279 ) (191 ) 84,452 (83,394 ) 627,770 Other assets - 31,636 - (4,227 ) - - (1,179 ) 26,230 Projects in progress - 561,488 495,771 (1,739 ) - (429,391 ) (45,502 ) 580,627 Total cost 8,232,087 711,125 (235,675 ) (9,485 ) 499,999 (565,105 ) 8,632,946 Accumulated depreciation: Vehicles (9,457 ) (6,057 ) 5,508 - (40,920 ) 12,856 (38,070 ) Tooling (174,164 ) (7,841 ) 2,310 - - 210 (179,485 ) Tools and accessories (65,740 ) (16,385 ) 1,823 - 46,967 (102,105 ) (135,440 ) Facilities (183,420 ) (17,051 ) 192 - (8,804 ) 7,776 (201,307 ) Machinery and accessories (728,408 ) (172,480 ) 56,142 - (397,740 ) 124,147 (1,118,339 ) Leasehold improvements (602,622 ) (133,533 ) 50,379 - (12,257 ) 71,602 (626,431 ) Buildings (298,327 ) (103,822 ) 14,111 - (136,601 ) 69,237 (455,402 ) Furniture and fixtures (369,610 ) (90,731 ) 31,606 - (18,576 ) 38,479 (408,832 ) IT equipment (392,095 ) (119,870 ) 36,065 - (71,041 ) 71,273 (475,668 ) Other assets (30,836 ) (2,287 ) 3,868 - - 1,433 (27,822 ) Total depreciation (2,854,679 ) (670,057 ) 202,004 - (638,972 ) 294,908 (3,666,796 ) Net total 5,377,408 41,068 (33,671 ) (9,485 ) (138,973 ) (270,197 ) 4,966,150

INTANGIBLES

INTANGIBLES	12 Months Ended
	Dec. 31, 2023
INTANGIBLES
INTANGIBLES	16 INTAN GIBLES Consolidated Useful life range (in years) 2022 Additions Write-offs Impairment Transfers Transfer to asset held for sale Write-off due to sale of subsidiary Translation adjustment 2023 Cost: Software 2.5 to 10 2,949,813 391,102 (621,831 ) - 96,351 (96,956 ) (469,184 ) (150,242 ) 2,099,053 Trademarks and patents (defined useful life) 20 to 25 813,204 - - - - (139,869 ) (4,443 ) (49,005 ) 619,887 Trademarks and patents (indefinite useful life) - 4,818,030 - - - - - (2,503,964 ) 36,281 2,350,347 Goodwill Avon (a) - 12,307,865 - - (663,892 ) - - - (390,514 ) 11,253,459 Goodwill Emeis Brazil Pty Ltd. (b) - 124,315 - - - - (124,315 ) - - - Goodwill The Body Shop (c) - 1,645,527 - - - - - (1,701,981 ) 56,454 - Goodwill acquisition of The Body Shop stores - 1,456 - - - - - (1,456 ) - - Goodwill aquisition of Singu - - 52,049 - - - - - - 52,049 Relationship with retail clients 10 2,583 - (2,856 ) - - (2,255 ) (4,021 ) 6,752 203 Key money (indefinite useful life) (d) - 22,313 - (14,601 ) - - - (7,719 ) 7 - Key money (defined useful life) (e) 3 to 18 7,828 1,329 (3,519 ) - - - (5,279 ) (359 ) - Relationship with franchisees and sub franchisees and sales representative (f) 14 to 15 2,676,563 - - - - - (686,701 ) (57,787 ) 1,932,075 Technology developed (by acquired subsidiary) - 1,457,039 - - - - - - (105,109 ) 1,351,930 Other intangible assets and intangible under development - 133,403 3,779 (18,995 ) - (8,115 ) (9,797 ) (83,397 ) (10,149 ) 6,729 Total cost 26,959,939 448,259 (661,802 ) (663,892 ) 88,236 (373,192 ) (5,468,145 ) (663,671 ) 19,665,732 Accumulated amortization: Software (1,720,169 ) (439,031 ) 584,109 - 1,875 75,818 387,808 96,495 (1,013,094 ) Trademarks and patents (169,620 ) (31,901 ) - - - 45,298 12,127 18,919 (125,177 ) Key money (10,103 ) - - - - - 10,103 - - Relationship with retail clients (2,968 ) (1,668 ) 2,719 - - 2,255 - (540 ) (202 ) Relationship with franchisees and sub franchisees (918,994 ) (260,104 ) - - - - 279,726 30,248 (869,124 ) Technology developed (874,225 ) (278,969 ) - - - - - 71,649 (1,081,545 ) Other intangible assets (2,890 ) (4,136 ) 16,757 - 619 9,797 - (26,871 ) (6,724 ) Total accrued amortization (3,698,969 ) (1,015,809 ) 603,585 - 2,495 133,168 689,764 189,900 (3,095,866 ) Net total 23,260,970 (567,550 ) (58,217 ) (663,892 ) 90,731 (240,024 ) (4,778,381 ) (473,771 ) 16,569,866 Consolidated Useful life range (in years) 2021 Additions Write-offs Impairment Transfers Translation adjustment 2022 Cost: Software 2.5 to 10 2,492,616 155,044 (43,333 ) (21,381 ) 640,903 (274,036 ) 2,949,813 Trademarks and patents (defined useful life) 20 to 25 889,834 - - - - (76,630 ) 813,204 Trademarks and patents (indefinite useful life) - 5,888,623 - (43 ) - - (1,070,550 ) 4,818,030 Goodwill Avon (a) - 13,381,191 - - (282,921 ) - (790,405 ) 12,307,865 Goodwill Emeis Brazil Pty Ltd. (b) - 143,180 - - - - (18,865 ) 124,315 Goodwill The Body Shop (c) - 2,063,672 - - (2,599 ) - (415,546 ) 1,645,527 Goodwill acquisition of The Body Shop stores - 1,456 - - - - - 1,456 Relationship with retail clients 10 2,880 - - - - (297 ) 2,583 Key money (indefinite useful life) (d) - 24,985 268 (152 ) (623 ) - (2,165 ) 22,313 Key money (defined useful life) (e) 3 to 18 14,363 - (3,618 ) (940 ) - (1,977 ) 7,828 Relationship with franchisees and sub franchisees and sales representative (f) 14 to 15 2,990,558 - - - - (313,995 ) 2,676,563 Technology developed (by acquired subsidiary) - 1,580,808 - - - - (123,769 ) 1,457,039 Other intangible assets and intangible under development - 277,776 207,911 (21 ) - (336,346 ) (15,917 ) 133,403 Total cost 29,751,942 363,223 (47,167 ) (308,464 ) 304,557 (3,104,152 ) 26,959,939 Accumulated amortization: Software (1,369,767 ) (417,253 ) 42,462 - (179,645 ) 204,034 (1,720,169 ) Trademarks and patents (143,186 ) (36,791 ) - - - 10,357 (169,620 ) Key money (16,517 ) - 4,505 - - 1,909 (10,103 ) Relationship with retail clients (3,218 ) (42 ) - - - 292 (2,968 ) Relationship with franchisees and sub franchisees (729,049 ) (264,320 ) - - - 74,375 (918,994 ) Technology developed (632,326 ) (272,297 ) - - - 30,398 (874,225 ) Other intangible assets (296 ) (3,228 ) - - (48 ) 682 (2,890 ) Total accrued amortization (2,894,359 ) (993,931 ) 46,967 - (179,693 ) 322,047 (3,698,969 ) Net total 26,857,583 (630,708 ) (200 ) (308,464 ) 124,864 (2,782,105 ) 23,260,970 a) Goodwill related to the acquisition of subsidiary Avon. It does not have defined useful life and it is subject to annual impairment tests. b) Goodwill related to the acquisition of subsidiary Holdings Pty Ltd. acquisition. It does not have defined useful life and it is subject to annual impairment tests. c) Goodwill related to the acquisition of subsidiary The Body Shop, classified as future economic benefits. It does not have defined useful life and it is subject to annual impairment tests. d) Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. e) Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. f) The balance refers to identifiable intangible assets from relationship with the subsidiary The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years. a) Impairment test of intangible assets with indefinite useful lives Goodwill balances arising from business combinations, as well as intangible assets with indefinite useful lives were allocated to the CGU groups which expect to benefit from the synergy of the business combinations. In accordance with CPC 01 1 36 With the sale of the stake in the former subsidiaries The Body Shop and Aesop, the respective balances of intangible assets with an indefinite useful life were derecognized in 2023 The carrying amount of intangible assets with undetermined useful life and goodwill allocated to each CGU group are presented below: Groups of CGUs Trademarks and patents Goodwill Total 2023 2022 2023 2022 2023 2022 Natura &Co Latam - - 9,527,619 9,765,077 9,527,619 9,765,077 Avon International 2,350,347 2,396,290 1,777,889 2,542,788 4,128,236 4,939,078 TBS International - 2,421,740 - 1,645,527 - 4,067,267 Aesop International (*) - - - 124,315 - 124,315 Total 2,350,347 4,818,030 11,305,508 14,077,707 13,655,855 18,895,737 (*) The trademarks and patents recognized as part of the acquisition of Aesop were assessed as having a determined useful life and, therefore, are not presented in the table above as of December 31, 2022. The main assumptions used to calculate the value in use as of December 31, 2023 are presented below: Avon International Natura &C o Latam Impairment estimate (value in use) Discounted cash flow based on financial budgets approved by the Board of Directors for a period of three years and complemented for a discretionary period of ten years estimated by Management, with a terminal value projected for the end of the period. The ten-year period was considered for better aligning and smoothing the effects projected between the discretionary period and the effects calculated in perpetuity. Operating margin Operating margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next ten years. These margins are increased over the budget period to improve the expected efficiency. Estimated cost Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share. Revenue growth rates Growth rates are initially based on published industry research and adjusted by the expected performance for each CGUs group (which, considering the level of goodwill monitoring by the Company, reflects the operating segments), given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by governance leadership bodies (including the Board of Directors). Perpetuity growth rate (*) Constant growth of 4.66% Constant growth of 6.48 Discount rate Discount rates represent the risk assessment in the current market, specific to each group of CGUs, taking into account the value of overtime and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. Such cash flows were discounted at the discount rate calculated before tax on the currency with the one (*) The rates are based on published market analyzes and projections regarding the reporting segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable. Such rates are also calculated in a currency consistent with those used for the projects and the discount rates. The Company considers the correlation between its market capitalization and its book value, among other factors, such as the decline in the performance of certain operations and macroeconomic indicators that involve the sector in which it operates, when evaluating potential indications of impairment. On December 31, 2023, the Company's market capitalization was lower than the book equity value. In addition, inflationary pressures, and uncertainty in the markets, impacting the economic recovery in the retail and cosmetics sectors, as well as the generalized effects of the conflict between Russia and Ukraine, negatively affected the results and prospects of some of the Company’s operations, in particular for the Group of CGUs comprising Avon International operations. Such factors led to continuous monitoring of this indicator during the year. On December 31, 2023, a loss due to reduction in recoverable value was recorded in the amount of R$ 663,892 (loss of R$ 282,921 as of December 31, 2022) on the Avon International CGU goodwill balance (also recorded on the same segment on note 30) and there is no further loss to be recorded on the other CGUs where there is goodwill recorded. The recoverable value of Avon International's CGUs totaled R$6,511,243 and was determined based on its value in use, considering the above assumptions and based on a weighted assessment of possible scenarios based on these projections, which reflect Management's best estimates. The loss due to impairment was recognized in other operating expenses in the statement of income. Effects that would be observed from reasonably possible changes in significant assumptions applied to the projections would lead to the following effects on the amount of loss due to reduction to recognized recoverable value: Significant assumption affected by possible deterioration 1 Reduction of 1 Reduction of 1 Additional impairment that would be recognized in profit or loss for the year 762,709 401,389 651,156 Total impairment that would be recognized in profit or loss for the year 1,426,604 1,065,284 1,315,051 In relation to the groups of CGUs that comprise the operations of Natura &Co Latam, the results of the procedures did not indicate the need to recognize a loss due to impairment. The Company performed a sensitivity analysis considering any deterioration in: (i) discount rate; (ii) growth rate in perpetuity; and (iii) estimated future operating margin, given its potential impacts on cash flows. An increase of 1 1 1

RIGHT OF USE AND LEASE LIABILIT

RIGHT OF USE AND LEASE LIABILITIES	12 Months Ended
	Dec. 31, 2023
RIGHT OF USE AND LEASE LIABILITIES
RIGHT OF USE AND LEASE LIABILITIES	17 RIGHT OF USE AND LEASE LIABILITIES a) Right of use asset Consolidated Useful life range (in years) (a) 2022 Additions Write-offs Transfer to asset held for sale Write-off due to sale of subsidiary Translation adjustments 2023 Cost: Vehicles 3 164,661 73,708 (68,871 ) - (1,883 ) (8,446 ) 159,169 Machinery and equipment 3 to 10 31,216 19,850 (2,155 ) - (7,515 ) (3,515 ) 37,881 Buildings 3 to 10 1,570,088 224,800 (80,185 ) - (160,049 ) (79,839 ) 1,500,669 IT equipment 10 29,052 3,891 (6,299 ) - (1,702 ) 146 25,088 Retail stores 3 to 10 3,361,432 344,870 (299,934 ) (1,388,973 ) (1,790,631 ) (79,770 ) 146,994 Software 3 to 4 13,527 5,566 - - - 37 19,130 Tools and accessories 3 498 - (415 ) - (76 ) (7 ) - Total cost 5,170,474 672,685 (457,859 ) (1,388,973 ) (1,961,856 ) (171,394 ) 1,888,931 Depreciation value: Vehicles (105,457 ) (45,378 ) 66,122 - 1,109 7,117 (76,487 ) Machinery and equipment (13,787 ) (11,535 ) 1,996 - 6,120 3,762 (13,444 ) Buildings (556,655 ) (235,874 ) 61,748 - 54,968 48,061 (627,752 ) IT equipment (23,957 ) (5,645 ) 6,299 - 1,028 3,672 (18,603 ) Retail stores (1,525,308 ) (390,499 ) 235,125 563,908 994,062 31,908 (90,804 ) Software (3,121 ) (5,772 ) - - - (61 ) (8,954 ) Tools and accessories (302 ) (132 ) 300 - - (1,944 ) (2,078 ) Total accrued depreciation (2,228,587 ) (694,835 ) 371,590 563,908 1,057,287 92,515 (838,122 ) Net total 2,941,887 (22,150 ) (86,269 ) (825,065 ) (904,569 ) (78,879 ) 1,050,809 Consolidated Useful life in Years (a) 2021 Additions Write-offs Impairment Transfers (c) Translation adjustment 2022 Cost: Vehicles 3 168,062 38,241 (25,734 ) - - (15,908 ) 164,661 Machinery and equipment 3 a 10 33,629 13,455 (11,166 ) - - (4,702 ) 31,216 Buildings 3 a 10 1,543,018 296,161 (185,967 ) - (35,484 ) (47,640 ) 1,570,088 IT equipment 10 31,803 2,618 (4,151 ) - - (1,218 ) 29,052 Retail stores 3 a 10 3,417,595 712,979 (373,830 ) (30,785 ) 36,401 (400,928 ) 3,361,432 Software - 13,527 - - - - 13,527 Tools and accessories 3 1,053 - (394 ) - - (161 ) 498 Total cost 5,195,160 1,076,981 (601,242 ) (30,785 ) 917 (470,557 ) 5,170,474 Depreciation value: Vehicles (91,509 ) (46,287 ) 24,354 - - 7,985 (105,457 ) Machinery and equipment (17,133 ) (9,986 ) 11,166 - - 2,166 (13,787 ) Buildings (507,045 ) (249,796 ) 137,349 - 31,917 30,920 (556,655 ) IT equipment (24,410 ) (6,608 ) 4,345 - - 2,716 (23,957 ) Retail stores (1,458,512 ) (611,862 ) 367,247 - (31,960 ) 209,779 (1,525,308 ) Software - (3,121 ) - - - - (3,121 ) Tools and accessories (582 ) (206 ) 394 - - 92 (302 ) Total accrued depreciation (2,099,191 ) (927,866 ) 544,855 - (43 ) 253,658 (2,228,587 ) Net total 3,095,969 149,115 (56,387 ) (30,785 ) 874 (216,899 ) 2,941,887 a) Consolidated 2023 2022 Amounts recognized in the statement of income and losses: Financial expense on lease 110,356 112,456 Amortization of right of use 287,568 302,144 Appropriation in the result of variable lease installments not included in the measurement of lease liabilities 7,382 1,855 Sublease revenue (17,210 ) (20,724 ) Short-term lease expenses and low-value assets 6,444 21,556 Benefits granted by lessor related to Covid- 19 (111 ) (1,366 ) Adjustment to recoverable value of right-of-use assets - impairment 1,321 - Amounts recognized in the financing activities in the cash flow statement: Lease payments (principal) 309,328 277,086 Amounts recognized in the operating activities in the cash flow statement: Lease payments (interest) 100,442 113,655 Variable lease payments, not included in the measurement of lease liabilities 7,382 1,855 Short-term and low-value assets lease payments 1,906 6,510 a) Lease liability Consolidated 2023 2022 Current 298,600 878,448 Non-current 851,840 2,392,289 Total 1,150,440 3,270,737 Below are the changes in lease liability balances for the year ended December 31, 2023 and 2022 Consolidated Balance as of December 31, 2021 3,547,863 New agreements and modifications 1,065,794 Payments (principal amount) (953,048 ) Payments (interest) (199,769 ) Appropriation of financial charges 200,246 Write-off (a) (19,763 ) Translation adjustment (370,585 ) Balance as of December 31, 2022 3,270,737 Transfer to held for sale (891,098 ) New agreements and modifications 779,049 Payments (principal amount) (828,538 ) Payments (interest) (183,409 ) Appropriation of financial charges 187,410 Write-offs (a) (43,877 ) Write-off due to sale of subsidiary (b) (1,025,898 ) Translation adjustment (113,936 ) Balance as of December 31, 2023 1,150,440 a) Mainly related to termination of agreements related to lease of stores. b) Refers to the write-off of lease liabilities associated with the sale of the former subsidiaries Aesop and The Body Shop. The amount of lease liability payments, considering the interests payments, and corresponding maturities, are disclosed in note no. 5.3.3 The table below set forth the rates applied, according to the lease terms: As described in note no. 3.13 02 19 Contractual payments - consolidated Maturity Average discount rate 2023 2024 2025 2026 2027 Onwards 2028 2023 2024 5.5% to 16.3% 25,982 135,841 - - - - 2025 2027 5.4% to 18.7% 102,094 107,651 85,311 74,275 19,394 - 2028 2030 7.3% to 20.5% 8,119 9,092 10,200 11,450 12,850 12,442 2031 2036 7.7% to 21.9% 3,465 10,513 10,728 10,980 11,259 41,990 Total 139,660 263,097 106,239 96,705 43,503 54,432 Projected inflation 1 4% 3% 3% 3% 3% 3 % 1 Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3 Consolidated 2023 2022 Less than 1 401,217 1,070,253 From 1 5 912,529 2,019,723 More than 5 s 135,207 856,402 Total expected cashflows 1,448,953 3,946,378 Interests to incur (298,513 ) (675,641 ) Total 1,150,440 3,270,737 17.1. Sale and Leaseback transaction Interlagos Manufacturing Unit In December 2023, the subsidiary Natura Cosméticos sold and leased back the Interlagos manufacturing unit in Brazil, for receiving approximately R$272,000. As part of the lease terms, the Company recognized the right of use in the amount of R$62,197. The lease liability, initially recognized at the present value of non-cancelable considerations for the contractual term of 3 years, totaled R$62,197. Since the sale was made in an amount equal to the carrying amount of the asset, the transaction did not generate gains in profit or loss (the respective asset was already measured at fair value deducted from sales costs, as part of its reclassification to assets held for sale in 2023

BORROWING, FINANCING AND DEBENT

BORROWING, FINANCING AND DEBENTURES	12 Months Ended
	Dec. 31, 2023
BORROWING, FINANCING AND DEBENTURES
BORROWING, FINANCING AND DEBENTURES	18 BORROWING, FINANCING AND DEBENTURES Ref. Consolidated 2023 2022 Local currency Financing Agency for Studies and Projects - 3,546 16,979 Debentures A 1,962,188 1,913,204 Business notes B 517,534 519,044 Working capital – Avon operation 1,832 113,664 Working capital - C - 1,304,425 Notes – Avon D 129,535 1,421,272 Notes – Lux E, F 3,497,067 3,130,732 Total in local currency 6,111,702 8,419,320 Foreign currency: Notes F - 5,172,966 Total in foreign currency - 5,172,966 Grand total 6,111,702 13,592,286 Current 163,844 331,151 Non-current 5,947,858 13,261,135 Debentures Current 68,189 77,601 Non-current 1,852,699 1,835,603 Ref. Currency Maturity Charges Effective interest rate Guarantees A Brazilian Real July 2027 to September 2032 CDI + 1.65%; CDI + 0.8%; IPCA + 6.8% and IPCA + 6.9% with bi-annual payments CDI+1.65%, CDI+0.8%, CDI+1.34% e CDI+1.60% Guarantee of Natura &Co Holding S.A. B Brazilian Real September 2025 CDI interest + 1.55% with bi-annual payments CDI+1.55% Guarantee of Natura &Co Holding S.A. C US Dollar November 2025 SOFR + 2.47% p.a. with bi-annual payments SOFR + 2.47% p.a. Guarantee of Natura &Co Holding S.A. and Natura Cosmeticos S.A. D US Dollar March 2043 Interest of 8.45% of p.a. with bi-annual payments 8.45% p.a None E US Dollar April 2029 Interest of 6.00% p.a. with bi-annual payments 6.125% p.a Guarantee of Natura &Co Holding S.A. and Natura Cosmeticos S.A. F US Dollar May 2028 Interest of 4.125% p.a. with bi-annual payments 4.125% Guarantee of Natura &Co Holding S.A. Changes in the balances of borrowing, financing and debentures for the years ended December 31, 2023 and 2022 Consolidated Balance as of December 31, 2021 12,716,832 New borrowing and financing (a) 8,557,507 Repayment ( b ) (6,826,628 ) Appropriation of financial charges, net of costs of new borrowing and financing 762,703 Financial charges payment (808,976 ) Exchange rate variation (394,389 ) Translation effects (OCI) (414,763 ) Balance as of December 31, 2022 13,592,286 New borrowing and financing (c) 1,494,101 Repayment (d) (8,057,650 ) Gain on Borrowing and financing prepayment (206,228 ) Appropriation of financial charges, net of costs of new borrowing and financing (e) 839,580 Financial charges payment (842,719 ) Exchange rate variation (322,049 ) Translation effects (OCI) (385,619 ) Balance as of December 31, 2023 6,111,702 a) Funding carried out in the year ended December 31, 2022 basically refers to: (i) use of a revolving credit line in the principal amount of up to US$ million by the subsidiary &Co Luxembourg; (ii) issuance of debt securities by the subsidiary &Co Luxembourg maturing on April 19, 2029 in the total principal amount of US$ million (approximately R$ million), subject to interest of % per year, which are guaranteed by &Co Holding and the subsidiary S.A. (iii) issuance of the 11 th series of debentures in the amount of R$ million maturing in 2025 and issuance of the 12 th series of debentures in the amount of R$ million, maturing between 2025 and 2032 by the subsidiary S.A. (iv) issuance of commercial notes by the subsidiary in the amount of R$ million maturing in 2025 and (v) new credit line in the total principal amount of US$ million by the subsidiary &Co Luxembourg. b) The repayments carried out in the year ended December 31, 2022 mainly refer to (i) early redemption of debt securities of the subsidiary Avon; (ii) the early redemption of the 9 th and 10 th series of debentures issued by the subsidiary (iii) the early redemption of the credit line in the amount of £ million from the former indirect subsidiary The Body Shop and (iv) the refinancing of the credit line credit under Resolution No. 4131 / 62 of the subsidiary . c) The movement that occurred in 2023 is mainly due to the revolving credit line obtained by the subsidiary &Co Luxembourg during the year, which was fully settled during the third quarter with resources from the sale of the former subsidiary Aesop. d) The movement in amortizations in 2023 is substantially due to the debt rebalancing process initiated in the third quarter, where the Company carried out and settled (i) an offer to the holders of securities representing Avon's debt to repurchase approximately % of securities issued for R$ (comprising R$ of principal, R$ of premium and R$ of accrued interest); and (ii) offer to holders of debt securities of &Co Luxembourg (maturing in 2028 and 2029 ) to repurchase approximately % of the securities issued for R$ (comprising R$ of principal, R$ premium and R$ accrued interest). Other amortizations in the period also include the payment of working capital debt amounts at &Co Luxembourg of R$ (of which R$ refer to the settlement of the open position in the credit line revolving loan and R$ of working capital debt (“Club Loan”), in abovementioned item c). e) Amounts are net of funding costs in the total amount of R$ 15,361. The maturities of non-current portion of borrowing, financing and debentures recorded as non-current liabilities are as follows: Consolidated 2023 2022 2025 101,577 1,763,902 2026 - 11,497,233 2027 5,846,281 - Total 5,947,858 13,261,135 i) Deb e ntures On July 25, 2022, carried out the 11 476 476 eight twenty-six thirty one The funds arising from the 11 3 9 1 10 2 10 3 10 4 10 On October 6, 2022, the subsidiary Natura Cosmeticos made the twelfth ( 12 three Debentures of the 12 Title Contractual fee Maturity Total Amount Number of Debentures 1 100% DI + 0.8% 09/14/2027 R$ 255,889 255,889 2 IPCA + 6.8% 09/14/2029 R$ 487,214 487,214 3 IPCA + 6.9% 09/14/2032 R$ 306,897 306,897 The net proceeds obtained by the subsidiary Natura Cosmeticos with the issue of the Debentures will be used to pay rents not yet incurred and to reimburse expenses with rents already incurred in the 24 twenty-four On December 6, 2022, the subsidiary Natura Cosmeticos fully repaid the 4 10 The appropriation of costs related to the issue of debentures in the year ended December 31, 2023 was R$4,987 (R$7,704 as of December 31, 2022), recorded monthly under finance expenses, in accordance with the effective interest rate method. As of December 31, 2023, the balance of issue costs to be appropriated is R$27,072 (R$32,059 as of December 31, 2022). ii) ESG Notes On May 4, 2021, the subsidiary Natura Cosmeticos concluded the offer of the notes linked to the sustainability goals subject to annual interest of 4.125% and with maturity date on May 3, 2028 (“ESG Notes”) in the total principal amount of US$1 billion (approximately R$5.6 billion) and these are guaranteed by the Company. For this offer of notes, derivative instruments were contracted for foreign exchange hedging purposes. The targets, to be met by 2026 On August 28, 2023, Natura &Co Luxembourg Holdings S.a.r.l, a subsidiary of the Company, assumed the position of debtor of the ESG Notes, replacing the subsidiary Natura Cosmeticos as issuer of the debt securities. With the replacement, the ESG Notes are now guaranteed by the Company and Natura Cosmeticos S.A. The appropriation of costs related to the issuance of ESG Notes in August 2023 was R$ . There are no issuance costs to be recognized on December 31, 2023. iii) Notes - Avon As of December 31, 2023 the subsidiary Avon has the following note issued: Notes - Avon Main US$ Main R$ Annual percentage interest rate Maturity Unguaranteed 21,609 104,613 8.45% March 15, 2043 i v) Commercial notes On September 19, 2022, the 1 476 2009 The appropriation of costs related to the issue of commercial notes in the year ended December 31, 2023 was R$465 (R$126 in 2022 18. 1 C ovenants As of December 31, 2023, and 2022 12 9 10 The Company also has covenants related to non-financial indicators according to each contract. The Company is in compliance with such covenants as of December 31, 2023, and 2022

TRADE ACCOUNTS PAYABLE AND REVE

TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS	12 Months Ended
	Dec. 31, 2023
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS	19. TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS Consolidated 2023 2022 Domestic trade accounts payable 4,058,832 4,644,534 Foreign trade accounts payable (a) 588,685 877,496 Subtotal 4,647,517 5,522,030 Reverse factoring operations (b) 654,961 853,900 Total 5,302,478 6,375,930 a) Refers to imports mainly denominated in US dollars, Euros and British pounds. b) The Company has contracts signed with first-line financial institutions, mainly Banco S.A. to directly structure a reverse factoring operation with the Company’s main suppliers. Further details on these operations are included in note no. 3.15

TAX LIABILITIES

TAX LIABILITIES	12 Months Ended
	Dec. 31, 2023
TAX LIABILITIES
TAX LIABILITIES	20 TAX LIABILITIES Consolidated 2023 2022 ICMS (ordinary) (a) 216,882 180,708 ICMS-ST provision (b) 63,722 60,945 Taxes on invoicing abroad 150,706 346,407 Withholding tax 118,133 138,293 Other taxes payable - foreign subsidiaries 102,537 147,056 Income tax 23,084 18,170 PIS and COFINS payable (c) 60,678 140 INSS and service tax (ISS) payable 5,603 31,895 Other 20,609 21,869 Total 761,954 945,483 Current 634,760 828,125 Non-current 127,194 117,358 a) Refers to ICMS on the Company's sales of goods in Brazil. b) The Company has discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company, and in some cases, the amounts are deposited in court, as mentioned in note no. 12 c) Refers to the value of PIS and COFINS levied on interest on equity received from the subsidiary S.A.

PROVISION FOR TAX, CIVIL AND LA

PROVISION FOR TAX, CIVIL AND LABOR RISKS	12 Months Ended
	Dec. 31, 2023
PROVISION FOR TAX, CIVIL AND LABOR RISKS
PROVISION FOR TAX, CIVIL AND LABOR RISKS	21 PROVIS ION FOR TAX, CIVIL AND LABOR RISKS 21.1 Contingencies assessed as probable risk of loss The changes in the provision for tax, civil and labor risks and contingent liabilities are presented below: Consolidated Tax Civil Labor Contingent liabilities (business combination) (3) Total 2023 ( 4 2022 2023 2022 2023 2022 2023 ( 2 2022 2023 2022 Balance at the beginning of the years 187,052 181,694 557,675 305,690 186,118 233,472 406,428 597,585 1,337,273 1,318,441 Additions 42,055 78,410 446,554 425,398 122,846 91,694 4,204 - 615,659 595,502 Reversal (2) (18,136 ) (45,902 ) (10,172 ) (12,791 ) (57,530 ) (51,649 ) (29,971 ) (196,925 ) (115,809 ) (307,267 ) Payments / utilization of judicial deposits (1) (53,143 ) (31,354 ) (357,633 ) (162,953 ) (47,512 ) (67,424 ) - - (458,288 ) (261,731 ) Inflation adjustment 12,852 36,155 29,439 16,477 5,884 5,093 24,836 21,555 73,011 79,280 Exchange rate variation (OCI) (3,958 ) (31,951 ) (38,836 ) (14,146 ) (21,799 ) (25,068 ) (19,516 ) (15,787 ) (84,109 ) (86,952 ) Disposal of The Body Shop - - (445 ) - (700 ) - - - (1,145 ) - Balance at the end of the years 166,722 187,052 626,582 557,675 187,307 186,118 385,981 406,428 1,366,592 1,337,273 Current 491,301 463,655 Non-current 875,291 873,618 (1) Tax payments refer mainly to the completion of the administrative procedure with the State of Amazonas for the effective settlement of tax amnesties, using judicial deposits. (2) Reversals of contingent liabilities (business combination) with Avon refer mainly to the change in estimates for tax, civil and labor lawsuits. (3) The business combination amounts as of December 31, 2023, arising from the business combination with Avon are segregated between tax (R$ ) and labor (R$ ) lawsuits. (4) In December 2023, the subsidiary recognized a provision for estimated costs in relation to litigation involving discussion about the collection of ICMS Tax Rate Differential (“DIFAL”) with several states in Brazil, in the amount of R$ . The recognition of the provision occurs as a result of an unfavorable decision to the taxpayer in judgment at the Federal Supreme Court (STF), leading to a change in the prognosis from loss to probable. a) Disputes related to talc (Civil) The subsidiary Avon Products, Inc (“Avon”) has been named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the company sold in the past were contaminated with asbestos. Many of these actions involve several co-defendants, including manufacturers of cosmetics and manufacturers of other products that, unlike the subsidiary Avon’s Products, were designed to contain asbestos. As of December 31, 2023, there were 372 individual cases pending against the subsidiary Avon (during the year ended December 31, 2023, 234 new cases were started and 90 were dismissed, settled, or otherwise resolved). In December 2022, a case, titled Chapman, et al, v, Avon Products, Inc. et al., No, 22 05968 21. 2 Contingent liabilities assessed as possible risk of loss The Company maintains administrative and judicial discussions related to certain tax positions adopted in the calculation of IRPJ and CSLL, whose current prognosis analysis, based on Management's assessment, is that they will probably be accepted in decisions of higher courts of last instance, in in line with the provisions of ICPC 22 23 Consolidated 2023 2022 Tax 10,375,764 8,480,614 Civil 246,500 161,859 Labor 169,463 164,462 Total contingent liabilities 10,791,727 8,806,935 21.2 .1 Below are the most relevant tax contingencies related to the following matters: a) Lawsuits in which the industrial establishment equivalence is discussed, as provided for in the Decree No. 8,393 / 2015 , which now requires IPI taxation of products listed in the referred legal provision in outbound transactions carried out by interdependent wholesalers. On December 31, 2023, the amount under discussion is R$ (R$ on December 31, 2022). b) Administrative and judicial processes that discuss the illegality of changes in Federal State laws regarding the collection of ICMS and ICMS-ST. As of December 31, 2023, the total amount under discussion is R$ (R$ as of December 31, 2022). c) Infraction notices in which the Brazilian Federal Revenue Office requires IRPJ and CSLL tax debts to challenge the tax deductibility of the amortization of goodwill generated in the context of a corporate reorganization between related parties. Currently, the legality of the administrative decisions that rejected the motions for clarification presented to challenge the special appeals dismissed is being discussed in the courts. As of December 31, 2023, the total amount under discussion classified as possible loss is R$ (R$ as of December 31, 2022). d) Infraction notices in which the Finance Department of the Paulo Federal State requires the collection of ICMS-ST, which was fully collected by the recipient of the goods, the distributor. Currently, the process is pending judgment at the administrative court level. As of December 31, 2023, the total amount under discussion classified as possible loss is R$682,263 (R$ as of December 31, 2022). e) Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts for disagreeing with the tax classification adopted by the Company for some products. The tax assessment notices are awaiting judgment at the administrative court level. As of December 31, 2023, the total amount under discussion is R$ and includes the amount of R$ x’ (R$ as of December 31, 2022).

OTHER LIABILITIES

OTHER LIABILITIES	12 Months Ended
	Dec. 31, 2023
OTHER LIABILITIES
OTHER LIABILITIES	22. O THER LIABILITIES Consolidated 2023 2022 Pension and post-employment health care plans (a) 515,901 463,948 Deferred revenue from performance obligations with customers (b) 131,113 313,204 Provision for incentives to consultants 153,692 217,349 Provision for operating expenses (marketing / technology, etc.) (c) 482,287 604,064 Provision for store renovation - 116,137 Crer Para Ver (d) 47,571 87,420 Provision for restructuring (e) 113,440 175,809 Insurance payables 84,032 69,364 Other liabilities (f) 87,518 203,331 Total 1,657,012 2,250,626 Current 970,479 1,499,060 Non-current 686,533 751,566 a) As of December 31, 2023, there is R$253,606 (R$282,295 as of December 31, 2022) referring to pension plans, and R$567 referring to post-employment plans (R$28,456 as of December 31, 2022) of subsidiary Avon International, and R$209,288 (R$129,697 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary and R$52,441 (R$51,956 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary &Co International. b) Refers to the deferral of revenue from performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct sales consultants, of which R$88,017 (R$190,790 as of December 31, 2022) is referring to subsidiary Avon, R$31,089 (R$93,761 as of December 31, 2022) referring to the consolidated subsidiary and R$12,007 (R$28,653 as of December 31, 2022) referring to subsidiary &Co International. c) Refers to the Company's operating provisions arising mainly from expenses with the provision of technology, marketing, and advertising services. d) Contribution of the social program to the development of the quality of education. e) Provision for costs directly related to the integration plan and changes in the organizational structure of the subsidiary Avon and Group corporate structure review. f) Refers to miscellaneous provisions such as indemnities and non-current contractual obligations. Post-employment health care and Pension plan a) Defined benefit pension (Avon) The subsidiary Avon has contributory and noncontributory defined benefit retirement plans for substantially all of its employees. Benefits under these plans are generally based on an employee’s length of service and average compensation near retirement, and certain plans have vesting requirements. The plans are funded based on legal requirements and cash flow. The largest defined benefit pension plan of the subsidiary Avon outside the United States (“US”) is in the United Kingdom (“UK”). The UK defined benefit pension plan was frozen for future accruals as of April 1, 2013. The US defined benefit pension plan, the Avon Products, Inc. Personal Retirement Account Plan (the “PRA”), is closed to employees hired on or after January 1, 2015. Qualified retirement benefits for US-based employees hired on or after January 1, 2015 will be provided exclusively through Avon Personal Savings Account Plan (the “PSA”), as described in note no. 2 7 . 2 The most recent actuarial valuation of plan assets and the present value of the defined benefit obligation was carried out on December 31, 202 3 . The present value of the defined benefit obligation and the respective cost of current services and cost of past services were measured at projected unit credit method. The change in actuarial liabilities for the years ended December 31, 2023 and 2022 Pension plan 2023 2022 Balance at the beginning of the year 334,251 445,804 Cost of services – current 21,871 19,707 Interest cost – recognized in the statement of profit or loss 21,542 15,568 Administrative costs 4,046 2,698 Company contributions (6,004 ) (4,299 ) Benefits paid (30,896 ) (22,262 ) Actuarial loss in OCI (a) (2,096 ) (254,913 ) Reclassifications 832 24,956 Other 7,082 88,474 Translation adjustment (26,266 ) 18,518 Balance at end of year 324,362 334,251 (a) The actuarial loss recorded throughout 2022 19 The significant actuarial assumptions for the determination of the actuarial liability are discount rate and rate of compensation increase. The details of the assumptions are as follows: 2023 2022 Discount rate 1.20 % to 11.60 % 1.30 % to 12.00 % Rate of compensation increase 2.15 % to 5.50 % 2.55 % to 7.40 % The fair values of each major class of pension plan assets are presented below: Consolidated 2023 2022 Cash and cash equivalent 46,957 7,330 Equity instruments of other entities 486,511 520,799 Government bonds 1,481,317 1,013,584 Corporate bonds 1,219,908 1,317,122 Real estate 8,714 10,957 Other (525,722 ) (121,574 ) Total 2,717,685 2,748,218 b) Post-employment health care plan (Natura Cosmeticos) Post-employment health care plan as detailed in note no. 3.1 9 . 4 23 and 202 2 , the obligation weighted average duration is around 21.9 and 20.0 years, respectively, and its actuarial calculation base is as follows ➢ 2022 ➢ 2022 The actuarial liability was calculated, as of December 31, 202 3 and 202 2 , considering the following main assumptions: 2023 2022 Discount rate 9.69% 10.43% Initial growth rate of medical cost 4.25% 4.25% Inflation rate 4.00% 4.00% Final growth rate of medical cost 8.42% 8.42% Growth rate of medical costs due to aging - costs Per age range 1.25% a 4.75% a.a. Per age range 1.25% a 4.75% a.a. Growth rate of medical costs by aging - contributions 0.00% 0.00% Percentage of adherence to the plan in retirement Bradesco Plan 58.00% / Unimed Plan 85.00% Bradesco Plan 58.00% / Unimed Plan 85.00% Schedule of disabled mortality Mercer Disability Mercer Disability Schedule of mortality AT-2000 AT-2000 Schedule of turnover Proportional calculation at the time of service Proportional calculation at the time of service The reduction in the annual discount rate from 10.43% to 9.69% generated R$51,566 in gains in other comprehensive income. The table below sets forth the medical inflation rate and the discount rate sensitivity analysis, and their respective effect on the balance (present value of the obligation, or “PVO”) accounted as on the actuarial liabilities (maintaining the other assumptions): Rate Chance PVO Discount rate 9.69% 1% increase 229,052 Discount rate 9.69% 1% decrease 173,673 Rate of compensation 8.42% 1% increase 174,202 Rate of compensation 8.42% 1% decrease 227,843 The changes of actuarial liabilities for the years ended December 31, 2023 and 2022 Consolidated 2023 2022 Balance at the beginning of the year 129,697 124,649 Cost of the current service of subsidiary Natura Cosmeticos 983 812 Cost of interest 13,314 11,078 Expenses paid (4,021 ) (3,398 ) Actuarial gains in OCI 51,566 (3,444 ) Balance as of the end of the year 191,539 129,697

SHAREHOLDER'S EQUITY

SHAREHOLDER'S EQUITY	12 Months Ended
	Dec. 31, 2023
SHAREHOLDER'S EQUITY
SHAREHOLDER'S EQUITY	23. SHAREHOLDER’S EQUITY 23.1 Share capital On December 31, 2023, the share capital of the Company is of R$ 12,484,515, composed of 1,386,848,066 registered common shares without par value (R$ 12,484,424 composed of 1,383,206,405 registered common shares without par value on December 31, 2022). 23.2 Dividends payment policy The shareholders are entitled to receive every year a mandatory minimum dividend of 30% of net income, considering principally the following adjustments:  Increase in the amounts resulting from the reversal, in the period, of previously recognized reserves for contingencies.  Decrease in the amounts intended for the recognition, in the period, of the legal reserve and reserve for contingencies.  Whenever the amount of the minimum mandatory dividend exceeds the realized portion of net income for the year, management may propose, and the General Meeting approves, allocate the excess to the constitution of the unrealized profit reserve (article 197 6404 76 189 6.404 76 Based on the profit for the year 2023 2024 The Board of Directors may pay or credit interest on equity, in accordance with applicable legislation 23.3 Treasury shares As of December 31, 2023 and 2022 Number of shares R$ (in thousands) Average price per share - R$ Balance as of December 31, 2020 316,701 11,667 38.04 Used (754,719) (34,438) 45.63 Acquired 5,337,558 174,113 32.62 Balance as of December 31, 2021 4,899,540 151,342 30.89 Used (377,585 ) (9,282 ) 24.58 Acquired 5,391,900 120,300 22.31 Balance as of December 31, 2022 9,913,855 262,360 26.46 Used (3,709,807 ) (98,124 ) 26.45 Balance as of December 31, 2023 6,204,048 164,236 26.47 There was no aquisitions of treasury shares during 2023, therefore, no December 31, 2023. 23.4 Capital reserve In the year ended 31 December 2021, there was a reduction in the capital in the amount of R$650,196 to compensate losses for the year ended December 31, 2020. In the year ended December 31, 2022, there was an increase of R$247,048 related to change of stock option plans and restricted shares. During the year ended 31 December 2022, the amounts related to cumulative translation adjustment of subsidiaries in hyperinflationary economies presented in capital reserves and retained earnings was reclassified to other comprehensive income, as well component of the Company's shareholders' equity, for better presentation. In the year ended December 31, 2023, there was an increase of R$634,156 related to changes in stock option plans and restricted shares. The capital reserve as of December 31, 2023 amounted to R$11,175,041 (R$10,540,885 as of December 31, 2022). 23.5 Cumulative translation adjustment – O ther comprehensive income The Company recognizes in this equity item the exchange rate variation effect from investments in foreign subsidiaries, including exchange rate variations in a hyperinflationary economy, actuarial gains and losses arising from the employee benefit plan, and the effect from cash flow hedge operations. For exchange rate variation, the accumulated effect will be reversed to statement of profit or loss as a gain or loss only in the event of disposal or write-off of the investment. For actuarial losses and gains, the amounts will be recognized when the actuarial liability is remeasured. The cash flow hedge transactions are transferred to the statement of profit or loss in case an ineffective portion is identified or when the hedge relationship is terminated.

INFORMATION ON SEGMENTS

INFORMATION ON SEGMENTS	12 Months Ended
	Dec. 31, 2023
INFORMATION ON SEGMENTS
INFORMATION ON SEGMENTS	24 IN FORMATION ON SEGMENTS Operating segments and information by geographic area presents no changes in relation to disclosed in the financial statements for the year ended December 31, 2022, other than the sale of the former subsidiaries Aesop and The Body Shop, where information relating to these segments was presented as discontinued operations. Net revenue by segment is as follows for the year ended December 31, 2023:   The accounting policies for each segment are applied uniformly as described in note no. 3 The following tables provide summarized financial information related to the segments and geographic distribution of the Company’s commercial operations for December 31, 2023 and 2022 24.1 2023 Reconciliation to net income for the year Net Revenue Performance assessed by the company Depreciation and amortization Discontinued operations (1) Financial results Income tax Net income (loss) for the year Natura &Co Latam 20,440,834 2,239,663 (921,510 ) 6,286,298 (2,249,167 ) 624,892 5,980,176 Avon Internationa 1 6,286,771 (493,462 ) (665,753 ) (434,852 ) (855,283 ) (320,889 ) (2,770,239 ) The Body Shop 1 - - - (302,529 ) - - (302,529 ) Aesop 1 - - - (3,576 ) - - (3,576 ) Corporate expenses 9,672 (313,055 ) (731 ) 11,116 590,951 (217,603 ) 70,678 Consolidated 26,737,277 1,433,146 (1,587,994 ) 5,556,457 (2,513,499 ) 86,400 2,974,510 (1) The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023. 3 2022 Reconciliation to net loss for the year Net Revenue Performance assessed by the company Depreciation and amortization Discontinued operations Financial results Income tax Net loss for the year Natura&CoLatam 22,027,337 1,912,651 (912,412 ) - (1,412,369 ) 98,712 (313,418 ) Avon International 1 7,195,984 (74,655 ) (683,845 ) (380,416 ) (665,653 ) (200,474 ) (2,005,043 ) The Body Shop 2 - - - (349,448 ) - - (349,448 ) Aesop 2 - - - 132,677 - - 132,677 Corporative expenses 335 (615,103 ) (10,273 ) (468 ) 293,041 9,409 (323,394 ) Consolidated 29,223,656 1,222,893 (1,606,530 ) (597,655 ) (1,784,981 ) (92,353 ) (2,858,626 ) 2021 Reconciliation to net loss for the year Net Revenue Performance assessed by the company Depreciation and amortization Discontinued operations Financial results Income tax Net loss for the year Natura &Co Latam 22,413,401 2,595,653 (871,973 ) - (700,181 ) 165,137 1,188,636 Avon International 1 9,329,325 272,655 (830,931 ) (98,550 ) (473,195 ) 210,705 (919,316 ) The Body Shop 2 - - - (4,900 ) - - (4,900 ) Aesop 2 - - - 194,183 - - 194,183 Corporative expenses - ( 604,594) - - 265,286 921,394 582,086 Consolidated 31,742,726 2,263,714 (1,702,904 ) 90,733 (908,090 ) 1,297,236 1,040,689 2023 2022 Non-current assets Total assets Current liabilities Non-current liabilities Non-current assets Total assets Current liabilities Non-current liabilities Natura &Co Latam 18,240,916 23,253,227 6,914,476 4,324,263 18,256,204 29,762,132 8,363,130 10,164,706 Avon International 1 8,008,108 10,608,234 2,792,255 977,003 11,197,014 14,259,571 1,894,856 1,838,328 The Body Shop 2 - - - - 6,565,913 7,928,270 1,292,903 1,669,625 Aesop 2 - - - - 1,621,126 2,735,417 731,018 776,512 Corporate expenses 510,769 8,885,554 706,768 3,911,785 923,606 - 1,055,961 4,547,167 Consolidated 26,759,793 42,747,015 10,413,499 9,213,051 38,563,863 54,685,390 13,337,868 18,996,338 1 The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment. 2 The balances are at zero 2023 24.2 Net revenue Non-current asset 2023 2022 2021 2023 2022 Asia 1,326,431 1,555,054 1,758,912 572,168 1,284,783 North America 3,919,414 4,472,169 4,931,608 3,956,986 6,261,545 Mexico 3,284,608 3,570,990 3,079,033 3,883,804 3,631,768 Other 634,806 901,180 1,052,575 73,182 2,629,777 South America 16,481,018 17,513,597 17,476,158 14,015,695 14,508,816 Brazil 12,004,994 11,280,690 10,521,780 10,933,917 12,656,298 Argentina 1,711,783 3,003,214 2,973,638 261,155 694,172 Other 2,764,241 3,229,693 3,980,740 2,820,623 1,158,346 Europe, Middle East and Africa (EMEA) 5,010,413 5,682,836 7,445,713 8,214,944 15,271,251 United Kingdom 257,944 577,544 896,945 5,132,107 10,894,799 Other 4,752,469 5,105,292 6,548,768 3,082,837 4,376,452 Oceania - - 130,335 - 1,237,468 Consolidated 26,737,277 29,223,656 31,742,726 26,759,793 38,563,863 No individual or aggregate customer (economic group) represents more than 10% of the Company’s net revenue.

REVENUE

REVENUE	12 Months Ended
	Dec. 31, 2023
REVENUE
REVENUE	25 REVENUE Consolidated Gross revenue: 2023 2022 2021 Direct Selling 31,399,069 34,011,306 36,297,680 Retail 549,749 431,848 1,367,517 Online 1,461,888 1,737,356 1,491,696 Other sales 1,307,844 1,705,890 1,641,032 Subtotal 34,718,550 37,886,400 40,797,925 Returns and cancellations (442,676 ) (588,579 ) (590,911 ) Commercial discounts and rebates (11,610 ) (29 ) (1,771 ) Taxes on sales (7,526,987 ) (8,074,136 ) (8,462,517 ) Subtotal (7,981,273 ) (8,662,744 ) (9,055,199 ) Total net revenue 26,737,277 29,223,656 31,742,726

OPERATING EXPENSES AND COST OF

OPERATING EXPENSES AND COST OF SALES	12 Months Ended
	Dec. 31, 2023
OPERATING EXPENSES AND COST OF SALES
OPERATING EXPENSES AND COST OF SALES	26 OPERATING EXPENSES AND COST OF SALES Consolidated Classified by function 2023 2022 2021 Cost of sales 9,675,435 11,770,762 12,531,303 Selling, marketing and logistics expenses 11,015,940 11,558,866 12,386,193 Administrative, R&D, IT and project expenses 4,225,027 5,023,626 5,217,633 Total 24,916,402 28,353,254 30,135,129 Classified by nature Cost of sales 9,675,435 11,770,762 12,531,303 Raw material/packaging material/resale 8,541,488 10,587,972 10,703,627 Employee benefits expense (note 28 516,046 565,431 554,999 Depreciation and amortization 170,288 168,713 246,091 Other 447,613 448,646 1,026,586 Selling, marketing and logistics expenses 11,015,940 11,558,866 12,386,193 Logistics costs 1,523,083 1,941,593 2,161,844 Personnel expenses (note 28 2,804,788 2,734,895 3,101,951 Marketing, sales force and other selling expenses 6,224,588 6,357,494 6,371,933 Depreciation and amortization 463,481 484,614 745,419 Impairment - 40,270 5,046 Administrative, R&D, IT and project expenses 4,225,027 5,023,626 5,217,633 Innovation expenses 161,477 262,646 210,170 Personnel expenses (note 28 1,754,650 2,073,680 2,008,106 Restructuring expenses 730 125,804 - Other administrative expenses 1,354,083 1,619,949 2,030,979 Depreciation and amortization 954,087 941,547 968,378 Total 24,916,402 28,353,254 30,135,129

EMPLOYEE BENEFITS

EMPLOYEE BENEFITS	12 Months Ended
	Dec. 31, 2023
EMPLOYEE BENEFITS
EMPLOYEE BENEFITS	27. EMPLOYEE BENEFITS Consolidated 2023 2022 2021 Payroll, profit sharing and bonuses 3,553,374 3,848,557 3,975,494 Pension Plan 100,498 90,392 106,303 Share-based payments, net of charges 126,987 90,796 183,815 Health care, food and other benefits 579,116 704,449 661,445 Charges, taxes and social contributions 473,382 588,538 534,375 INSS 242,127 51,274 203,624 Total 5,075,484 5,374,006 5,665,056 27.1 Natura &Co offers long-term incentives to senior executives and employees responsible for implementing its long-term strategy. Overview of plans The share-based payment programs granted before the corporate restructuring, on December 18, 2019, were originally granted considering the shares of Natura Cosmeticos that were traded on B 3 3 Awards outstanding as of December 31, 2023 relate to various share-based plans, the terms of which are summarized in the tables below. In 2023 Under the “Co-Investment Plan”, eligible employees may invest part of their payout from the Profit Share Program in the purchase of Company’s shares. Company will grant awards ("Matching Awards”) to match such purchased shares on a 1: 1 three years In the “Long-Term Incentive Plan”, Company shares are granted to eligible employees. Certain “Long-Term Incentive Plan” awards are only subject to a requirement to remain in employment at the Company over the vesting period. While the awards referred to as “Performance Shares” are subject to both a requirement to remain employed at the Company over the vesting period and meeting certain performance conditions. For the outstanding awards presented in this note, there are generally no cash settlement alternatives (awards are settled with shares). Changes in the number of awards based on shares outstanding are shown below: Stock option plan and Strategy Acceleration Plan Weighted average strike price per option – R$ Options (thousands) Balance as of December 31, 2021 21.05 20,137 Granted 16.45 1,710 Changes from options to restricted shares 48.98 (1,100 ) Expired/Cancelled 27.22 (861 ) Exercised 11.98 (226 ) Balance as of December 31, 2022 18.92 19,660 Granted 16.45 30 Expired/Cancelled 22.92 (758 ) Exercised 13.02 (568 ) TBS Awards – equity to cash settlement conversion 21.43 (1,334 ) Balance as of December 31, 2023 18.74 17,030 Restricted shares (thousands) Performance shares (thousands) Balance as of December 31, 2021 5,494 8,045 Granted 2,359 6,485 Changes from options to restricted shares 1,100 - Expired/Cancelled (442 ) (1,902 ) Released (2,453 ) (573 ) Balance as of December 31, 2022 6,058 12,055 Granted 3,966 8,736 Expired/Cancelled (360 ) (2,921 ) Stock adjustment based on acquisition performance - (990 ) Released (3,033 ) (2,686 ) Adjustments related to vesting in the sale of Aesop - (964 ) Awards related to the sale of Aesop (182 ) (875 ) Adjustments related to the acquisition of rights in the sale of TBS (18 ) (1,476 ) TBS Awards – equity to cash settlement conversion (129 ) (383 ) Balance as of December 31, 2023 6,302 10,496 The number of shares above and throughout this disclosure: (I) The plans are presented using B 3 equivalents for awards that are to be exercised in ADRs to ensure consistency; and (II) The number of performance shares is disclosed considering achievement of the performance conditions target, whereas the expense recognized reflects the latest reassessment of the number of awards expected to vest. The share-based payment expense recognized in the year ended December 31, 2023 was R$13,304 in the parent company and R$126,987 in the consolidated (R$8,249 and R$123,931 and R$74,734 and R$228,133, respectively for the years ended December 31, 2022 and 2021), net of social charges. The outstanding stock options, restricted shares and performance shares as of the end of the period have the following maturity dates, fair values and strike prices: As of December 31, 2023 – Stock options Grant date Conditions for acquisition of right as of the grant date Strike Price (R$) Fair value at grant date (R$) Existing shares (thousands) Maximum remaining contractual life (years) Exercisable options (thousands) March 16,2015 2 to 4 years of service 12.71 7.16 to 7.43 85 0.2 85 July 11, 2016 (acceleration strategy) 4 to 5 years of service 11.28 6.84 to 6.89 1,540 0.5 1,540 March 10, 2017 2 to 4 years of service 12.46 6.65 to 6.68 350 1.2 350 March 10, 2017 (acceleration strategy) 4 to 5 years of service 12.46 6.87 to 6.89 1,890 1.5 1,890 March 12, 2018 2 to 4 years of service 16.83 7.96 to 8.21 1,501 2.2 1,501 March 12, 2018 (acceleration strategy) 3 to 5 years of service 12.04 to 16.83 8.21 to 9.67 3,800 2.2 3,800 April 12, 2019 2 to 4 years of service 23.41 11.71 to 11.82 1,421 3.2 1,421 April 12, 2019 (acceleration strategy) 4 to 5 years of service 23.41 11.51 to 11.71 1,900 3.2 950 December 17, 2021 3 to 4 years of service 27.28 13.85 to 18.16 3,703 8.0 - September 14, 2022 3 to 4 years of service 16.45 8.39 to 10.32 840 8.7 600 17,030 12,137 As of December 31, 202 3 – Restricted shares Grant date Conditions for acquisition of right as of the grant date Existing shares (thousands) Fair value at grant date (R$) Maximum remaining contractual life (years) March 31, 2021 1 to 3 years of service 737 48.13 0.3 April 14, 2022 1 to 3 years of service 1,138 24.91 to 24.99 1.3 March 31, 2021 (as modified in September 2022)* 4 to 5 years of service 1,100 7.41 to 24.77 2.3 May 5, 2023 1 to 3 years of service 3,327 11.2 2.3 6,302 *The original grant of March 31, 2021 was stock options, but became a restricted share award as a result of the September 2022 amendment. As of December 31, 2023 – Performed shares Grant date Conditions for acquisition of right as of the grant date Existing shares (thousands) Fair value at grant date (R$) Maximum remaining contractual life (years) March 31, 2021 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards 1,859 46.57 to 50.98 0.3 to 1.3 April 14, 2022 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards. 3,545 18.66 a 24.99 1.3 to 2.3 May 5, 2023 Achievement of performance conditions, 3 years of service 5,092 11.20 a 11.55 2.3 a 3.3 10,496 Assumptions Ranges of valuation assumptions for the new granting of restricted and performance shares in May 2023 are set out below. The valuation models used were Black-Scholes, Stochastic and Finnerty, depending on the type of award. Assumptions B 3 ADRs Share price (also used as strike price on Finnerty) R$ 11.21 USD 4.49 Strike price R$ 0.01 USD 0.00403 Expected volatility 48.64% to 57.70% 55.20% to 63.11% Expected term 1 to 3 years 1 to 3 years Expected dividend yield 0.00% 0.00% Risk-free interest rate 11.69% to 12.93% 3.68% to 4.82% Volatility was calculated over the period consistent with the expected grant term (or over the remainder of the performance period, where applicable) immediately prior to the grant date. In the model, volatility is calculated over the period proportional to the holding period immediately prior to the grant date. As of December 31, 2023, the market price was R$16.89 (R$11.61 as of December 31, 2022) per share. 27.1 The Company and some of its subsidiaries grant defined contribution retirement plans to eligible employees and, through some of their foreign subsidiaries, grant defined benefit plans to employees that are eligible. Defined contribution plans The Company, through its subsidiary Avon, offers a defined contribution plan for Avon employees in the United Kingdom (“UK”), which allows eligible participants to contribute eligible compensation through payroll deductions. The Company double employee contributions up to the first 5% of eligible compensation and therefore the maximum level provided by Avon is 10% of eligible compensation. In the year ended December 31, 2023, the subsidiary Avon made matching contributions to the contribution plan defined in the UK in the total amount of R$28,080 (R$33,915 in the year ended December 31, 2022), which follow the same investment allocation that the participant has selected for his or her own contributions. The Company offers a qualified defined contribution plan for U.S.-based employees, the Avon Personal Savings Account Plan (the “PSA”), which allows eligible participants to contribute up to 25% of eligible compensation through payroll deductions. The Company matches contributions dollar for dollar up to the first 3% of eligible compensation and covers 50 2023 2022 For U.S.-based employees hired on or after January 1, 2015, the Company made additional contributions to a Retirement Savings Account (“RSA”) within the PSA. Such contributions will range from 3% to 6% of a participant’s eligible compensation depending on the sum of the participant’s age and length of service (as of December 31 of the prior year). Investment of such contributions will follow the same investment allocation that the participant has selected for his or her own contributions to the PSA. A participant will be vested in the RSA generally after three Defined and post-retirement benefit plans The Company, through its subsidiary Avon and certain subsidiaries, have contributory and noncontributory defined benefit retirement plans for substantially all employees of those subsidiaries. Benefits under these plans are generally based on an employee’s length of service and average compensation near retirement, and certain plans have vesting requirements. The actuarial liability for the health care plan of the Company refers to a post-employment benefit plan for employees and former employees who made fixed contributions to the cost of the health plan until April 30, 2010, date when the design of the health plan was changed, and the employees’ fixed contributions were eliminated. For those who have contributed to the medical plan for ten years ten years one year Avon’s largest defined benefit pension plan outside the United States (“US”) is in the UK, which has been frozen for future accruals as of April 1 2013 st, 2015 2015

FINANCIAL RESULTS

FINANCIAL RESULTS	12 Months Ended
	Dec. 31, 2023
FINANCIAL RESULTS
FINANCIAL RESULTS	28 FINANCIAL RESULTS The breakdown set forth below is intended to provide a summarized view of the net of financial expense based on the nature of the related transactions. Consolidated 2023 2022 2021 Finance expesnes (debt interest) (868,614 ) (721,083 ) (610,913 ) Financial short-term investments and others income 977,203 535,587 251,542 Exchange variations on financial activities, net 322,049 323,496 (287,329 ) Losses with derivatives on exchange rate variations on financial activities, net (342,005 ) (383,178 ) 257,964 Losses on derivatives on interest payments and other financial activities, net (1,449,900 ) (553,253 ) 71,616 Monetary adjustment of provision for tax, civil and labor risks, and tax liabilities (73,011 ) (79,280 ) (25,731 ) Leases interest expenses (110,356 ) (112,456 ) (116,381 ) Other finance expenses (522,748 ) (327,588 ) (380,152 ) Hyperinflationary economy adjustment (117,553 ) (187,612 ) (26,528 ) Other gains (losses) from exchange rate variation on operating activities (328,564 ) (279,614 ) (42,178 ) Financial results (2,513,499 ) (1,784,981 ) (908,090 )

OTHER OPERATING EXPENSES, NET

OTHER OPERATING EXPENSES, NET	12 Months Ended
	Dec. 31, 2023
OTHER OPERATING EXPENSES, NET
OTHER OPERATING EXPENSES, NET	29 O THER OPERATING EXPENSES, NET Consolidated 2023 2022 2021 Other operating income, net Result on write-off of property, plant and equipment - (8,443 ) - Tax credits (a) 195,780 71,720 215,085 Tax benefit from amnesty program (b) - 126,272 82,140 Reversal for impairment provision - - - Revenue with sale of the customer portfolio 16,471 11,874 16,113 Royalty income (c) - 119,438 - Other operating income 23,924 (25,359 ) 30,214 Total other operating income 236,175 295,502 343,552 Other operating expenses, net Result on write-off of property, plant and equipment (32,704 ) 5,273 ( 9,122 ) Crer para Ver (d) (20,115 ) (54,062 ) (47,523 ) Goodwill Impairment (663,892 ) (282,921 ) - Provision for losses on fixed assets. intangible assets and leases (22,040 ) (34,198 ) - Expenses with sale of customer portfolio (8,168 ) - - Transformation and integration plan (e) (769,404 ) (423,232 ) ( 511,048 ) Restructuring expenses (f) (52,641 ) (50,903 ) ( 3,079 ) Increased provision for tax, labor and civil contingencies (32,383 ) - - Tax benefit for joining the amnesty program - (23,803 ) - Other operating expenses (4,677 ) (80,848 ) 19,789 Total other operating expenses (1,606,024 ) (944,694 ) ( 550,983 ) Other operating expenses, net (1,369,849 ) (649,192 ) ( 207,431 ) a) Refers to tax credits from PIS and COFINS. b) Refers to tax benefits in Brazil arising from the adhesion to state tax amnesty programs by the subsidiaries Natura Cosmeticos S.A. and Avon Cosmeticos Ltda. c) Refers to revenue from royalties received by subsidiary Avon from its representative in Japan, after a legal dispute. d) Refers to appropriation of operating resultsobtained on the sales of the non-cosmetic product line called "Crer Para Ver" to the Natura Institute, specifically earmarked for social projects aimed at developing the quality of education. e) Expenses related to the execution of the integration plan between the Natura and Avon brands, which is mainly supported by operational and logistical workflows, structure reorganization, credit and collection review and commercial model optimizations. f) Refers to expenses related to the closure of the operations of the subsidiary The Body Shop in Russia, the main expenses being related to employee remuneration and fines for terminating the store rental contract.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2023
EARNINGS PER SHARE
EARNINGS PER SHARE	30 EARNINGS PER SHARE The basic earnings per share are calculated by dividing the profit (loss) attributable to the Company’s shareholders by the weighted average number of outstanding common shares, excluding common shares purchased by the Company and held as treasury shares. Consolidated 2023 2022 2021 Profit (loss) attributable to the Company’s controlling shareholders 2,973,731 (2,859,629 ) 1,047,960 Weighted average of the number of issued common shares 1,385,675,623 1,381,594,182 1,377,932,809 Weighted average treasury shares (7,806,697 ) (9,613,311 ) ( 788,866 ) Weighted average of the number of outstanding common shares issued, net of treasured shares 1,377,868,926 1,371,980,871 1,377,143,943 Basic gain (loss) earnings per share - R$ 2.1582 (2.0843 ) 0.7610 Diluted earnings per share are calculated by adjusting the weighted average number of outstanding common shares, assuming the conversion of all potential common shares that would cause dilution. The Company has stock options, restricted shares and strategy acceleration that would have a dilutive effect on any earnings per share. On December 31, 2022 The Company incurred loss for the year ended, therefore any adjustment would have an anti-dilutive effect and, for this reason, the diluted result is equivalent to Basic earnings per share. The diluted earnings per share for the result for the year ended December 31, 2023 and 2021 Consolidated 2023 2021 Profit attributable to the Company’s controlling shareholders 2,973,731 1,047,960 Weighted average of the number of issued common shares issued, net of treasured shares 1,377,868,926 1,377,143,943 Adjustment for stock options and restricted shares 6,401,920 19,531,951 Weighted average of the number of ordinary shares for diluted earnings calculation 1,384,270,846 1,396,675,894 Diluted earnings per share – R$ 2.1482 0.7503 Net income (loss) per share for results from discontinued operations for the years ended December 31, 2023 and 2022 is presented below: Consolidated 2023 2022 2021 Profit (loss) attributable to the Company’s controlling shareholders 5,556,457 (597,655 ) 90,733 Weighted average of the number of issued common shares 1,385,675,623 1,381,594,182 1,377,932,809 Adjustment for stock options and restricted shares (7,806,697 ) (9,613,311 ) (788,866 ) Weighted average number of common shares issued, net of treasured shares 1,377,868,926 1,371,980,871 1,377,143,943 Basic profit (loss) per share – R$ 4.0326 (0.4365 ) 0.0659 The diluted earnings per share for the results of discontinued operations for the year ended December 31, 2023 and 2021 Consolidated 2023 2021 Profit attributable to the Company’s controlling shareholders 5,556,457 90,733 Weighted average of the number of issued common shares issued, net of treasured shares 1,377,868,926 1,377,143,943 Weighted average number of treasury shares 6,401,920 19,531,951 Weighted average number of common shares considered to diluted earnings per share 1,384,270,846 1,396,675,894 Diluted earnings per share - R$ 4.0139 0.0650

TRANSACTIONS WITH RELATED PARTI

TRANSACTIONS WITH RELATED PARTIES	12 Months Ended
	Dec. 31, 2023
TRANSACTIONS WITH RELATED PARTIES
TRANSACTIONS WITH RELATED PARTIES	31 T RANSACTIONS WITH RELATED PARTIES In the course of the Company’s operations, rights and obligations are generated between related parties, arising from administrative expenses and provision of services. 31 1 Uncontrolled and unconsolidated transactions with related parties Instituto Natura holds shares in the Essential Investment Fund, As of December 31, 2023, the balance is R$6,994 (R$6,805 as of December 31, 2022). On June 5, 2012, an agreement was signed between Indústria e Comércio de Cosmeticos Natura Ltda. and Bres Itupeva Empreendimentos Imobiliários Ltda., (“Bres Itupeva”), for the construction and rental of a goods processing, storage, and distribution center (HUB), in Itupeva, São Paulo. In 2019 On January 8, 2021, a related-party transaction was carried out between the Company, as lessee and owner, the subsidiary Indústria e Comércio de Cosmeticos Natura Ltda. and Natura &Co Holding S.A., as guarantors, and a special purpose company (Bresco IX) indirectly held by Messrs. Antônio Luiz da Cunha Seabra, Guilherme Peirão Leal and Pedro Luiz Barreiros Passos, as lessor and surface-right owner (Co-Chairmen of the Board of Directors of the Company and shareholders members of the controlling group of Natura &Co Holding S.A., Company's parent company). This transaction was entered into with the purpose of expanding the Company’s distribution network and increasing its logistical efficiency through the installation of a new distribution hub in the State of Alagoas. The amount involved in the transaction is recorded under item “Right of Use” of “Buildings” in the amount of R$47,445 and in the year ended December 31, 202 2 , the total amount paid as rent was R$ 8,786 ( On May 12, 2021, a transaction was entered between the Company, as lessee, and Bresco Logística Fundo de Investimento Imobiliário, as lessor, indirectly held by Messrs. Antônio Luiz da Cunha Seabra, Guilherme Peirão Leal and Pedro Luiz Barreiros Passos. (Co-Chairmen of the Board of Directors of Natura &Co Holding S.A. and shareholders members of the controlling group of Natura &Co Holding S.A). This transaction had the purpose of keeping the Company’s distribution hub activities in the city of Canoas, State of Rio Grande do Sul. The amount involved in the transaction is recorded under item “Right of Use” of “Buildings” in the amount of R$3,634 (R$4,996 in the year ended December 31, 2022) and in the year ended December 31, 2023, the total amount paid as rent was R$2,258 (R$2,152 in the year ended December 31, 2022). In the year ended December 31, 2023, the Company and its subsidiaries transferred to Instituto Natura as a donation associated with the net income from sales of the Natura Crer Para Ver product line in the amount of R$49,800 (R$55,000 on December 31, 2022). The Company has a policy for transactions with related parties, in addition to an internal control structure to support the identification, monitoring and approvals of transactions between related parties. 31.3 Key management personnel compensation The total compensation of the Company's key Management personnel is as follows: 2023 2022 2021 Compensation Compensation Compensation Fixed Variable Total Fixed Variable Total Fixed Variable Total Board of Directors 8,212 11,660 19,872 13,252 146,603 159,855 15,043 72,187 87,230 Executive Directors 27,991 200,529 228,520 34,403 50,423 84,826 51,576 71,162 122,738 36,203 212,189 248,392 47,655 197,026 244,681 66,619 143,349 209,968 The totals in the table above include the employer's social security charges. The amounts include increases and / or reversals of the cumulative expense recognized in the previous years due to reassessments of the number of awards expected to vest and re-estimation of the social security charges expected to be payable by the Company on vesting. Amounts in the variable category for the twelve

COMMITMENTS

COMMITMENTS	12 Months Ended
	Dec. 31, 2023
COMMITMENTS
COMMITMENTS	32. COM MITMENTS In the ordinary course of its business, the Company enters into long-term agreements for provision of manufacturing, transportation, information technology services and electric power supply (with physical delivery, for its manufacturing activities). The agreements have termination clauses for noncompliance with essential obligations. In general, the minimum agreed upon is acquired and therefore there are no liabilities recorded in addition to the amount recognized on the accrual basis. Total minimum supply payments, measured at nominal value, according to the contract, are: Consolidated 2023 2022 Less than one 273,548 614,075 One five 486,961 659,626 Above five 799 49,331 Total 761,308 1,323,032

INSURANCE

INSURANCE	12 Months Ended
	Dec. 31, 2023
INSURANCE
INSURANCE	33. INSURANCE The Company adopted an insurance policy that mainly considers risk concentration and its materiality, considering the nature of their activities and the guidance of their insurance advisors. As of December 31, 2023 and 2022, insurance coverage is as follows: Item Type of coverage Amount insured 2023 2022 Industrial complex and administrative sites Any damages to buildings, facilities, inventories, and machinery and equipment 4,694,455 4,924,868 Vehicles Fire, theft and collision for the vehicles insured by the Company 24,907 221,523 Loss of profits No loss of profits due to material damages to facilities buildings and production machinery and equipment - 2,056,000 Transport Damages to products in transit 81,328 97,308 Civil liability Protection against error or complaints in the exercise of professional activity that affect third parties 886,720 1,991,888 Environmental liability Protection against environmental accidents that may result in environmental lawsuits 30,000 30,000

ADDITIONAL INFORMATION RELATING

ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS	12 Months Ended
	Dec. 31, 2023
ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS	34 ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOW The following table presents additional information on transactions related to the cash flow statement: Consolidated 2023 2022 2021 Non-cash items Hedge accounting, net of tax effects 494,698 (520,444 ) (137,211 ) Dividends declared and not yet paid 294,231 - 180,772 Net effect of acquisition of property, plant and equipment and intangible assets not yet paid 27,900 28,472 172,104 Application of judicial deposits in the settlement of legal proceedings 55,494 121,025 -

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2023
Disclosure of analysis of single amount of discontinued operations [abstract]
DISCONTINUED OPERATIONS	35 DISCONTINUED OPERATIONS 3 5 . 1 On August 30, 2023, the Company concluded the sale of the previously controlled subsidiary Aesop to L’Oreal for a total consideration of R$12,429,175, after obtaining all relevant regulatory approvals. The total gain earned on the write-off of the subsidiary's assets and liabilities and recognized as discontinued operations net of income tax and social contribution was R$7,377,768, which includes the reclassification of balance sheet conversion gains accumulated and recognized in other comprehensive results of R$115,168. In addition to the gain obtained with the derecognition of assets and liabilities, certain incremental costs involving legal advisors and bank fees in the transaction were incurred and classified as part of discontinued operations. 35 . 2 On December 29, 2023, the Company concluded the sale of the previous subsidiary, The Body Shop, to Aurelius Investment Advisory Limited. The final consideration includes the payment of two fixed installments, one 2028 2025 2026 Based on the information available as of December 31, 2023, no indications were identified that the metrics for receiving the variable consideration would not be met. The total loss incurred in the derecognition of assets and liabilities of the subsidiary, recognized as discontinued operations, net of income tax and social contribution, amounted to R$1,081,340. This includes the reclassification of balance sheet conversion gains accumulated and recognized in other comprehensive income of R$1,622,436 and the impairment loss upon reclassification of the respective operations to assets held for sale, amounting to R$4,007,744. The summary detailing the determination of the loss upon classification as assets held for sale and the subsequent fair value movements are presented below: 2023 Fair value of the previously subsidiary The Body Shop (a) 826,560 Incremental transaction costs on sale (64,288 ) Fair value less selling costs 762,272 Net assets of the previously subsidiary The Body Shop (b) (4,770,016 ) Impairment loss (4,007,744 ) Balance after recognition of loss due to impairment 762,272 Adjustments to the fair value of assets held for sale 91,824 Balances on the date of derecognition 854,096 (a) It reflects the best estimate of the fair value of the operations on the date the criteria for classification as assets held for sale were met, on October 31, 2023. These estimates reflect the consideration agreed upon with the buyer, presented in the table below, reflecting the translation rate from British pounds to Brazilian real on that date. (b) It reflects the carrying amount of the operation reclassified to non-current assets held for sale on the date when the aforementioned criteria were met, on October 31, 2023. In addition to the loss obtained with the derecognition of assets and liabilities, certain costs involving legal advisors and bank fees in the transaction were incurred and classified as part of discontinued operations. 3 5 . 3 Breakdown of discontinued operations The breakdown of results presented in discontinued operations in the income statement for the years is presented below: 2023 2022 2021 Cash Consideration received for the sale to the previously controlled Aesop 12,429,175 - - Net assets of the previously controlled Aesop, derecognized (1,140,751 ) - - Accumulated gains in other comprehensive income from currency translation 115,168 - - Incremental transaction costs on sale (289,686 ) - - Income tax and social contribution (3,736,138 ) - - Net gain on the sale of the previously controlled Aesop 7,377,768 - - Fair value of the consideration receivable from the sale of the previously subsidiary The Body Shop - - Fixed amount receivable upon completion 22,915 - - Fixed amount receivable in 2028 320,153 - - Contingent consideration 486,429 - - Total fair value of the consideration 829,497 - - Impairment loss (4,007,744 ) - - Assets derecognized( 1 (762,272 ) - - Adjustments to the fair value of assets (91,824 ) - - Conversion gains rolled into other comprehensive income 1,622,436 - - Incremental transaction costs on sale (64,288 ) - - Income tax and social contribution 1,392,855 - - Net loss on the sale of the previously controlled The Body Shop (1,081,340 ) - - Net gain on the sale of subsidiaries 6,296,428 - - Loss before taxes from discontinued operations (867,308 ) (570,444 ) 339,984 Income tax and social contribution 127,337 (27,211 ) (249,251 ) Loss from discontinued operations (739,971 ) (597,655 ) 90,733 Total discontinued operations 5,556,457 (597,655 ) 90,733 ( 1 On transaction date Aesop and The Body Shop presents Cash and Cash Equivalent in the amount of R$ 400,585 and R$ 214,387, respectively The results in discontinued operations, which includes the operational results of the former controlled subsidiaries Aesop and The Body Shop for the years ended on December 31, 2023 and 2022 2023 2022 2021 Net revenue 5,578,990 7,125,967 8,421,961 Cost of sales (1,137,127 ) (1,384,258 ) (1,480,222 ) Gross profit 4,441,863 5,741,709 6,941,739 Operating (expenses) income (5,185,984 ) (6,196,273 ) (6,482,868 ) Selling, marketing, and logistics expenses (3,139,196 ) (3,996,851 ) (4,613,032 ) Administrative, R&D, IT and projects expenses (1,432,107 ) (1,688,874 ) (1,741,233 ) Other operating income (expenses), net (a) (614,681 ) (510,548 ) (128,603 ) Operating profit (loss) before financial result (744,121 ) (454,564 ) 458,871 Financial results (123,187 ) (115,880 ) (118,887 ) Net income (loss) before income tax and social contribution (867,308 ) (570,444 ) 339,984 Income tax and social contribution 127,337 (27,211 ) (249,251 ) Net income (loss) for the year (739,971 ) (597,655 ) 90,733 a) In addition to the results of the former subsidiaries Aesop and The Body Shop, the amount includes R$428,684 (R$380,416 in 2023 The net cash flows incurred by the discontinued operations are: 2023 2022 Operational activities (5,992,000 ) 1,185,485 Investment activities 12,287,226 (336,953 ) Financing activities (584,118 ) (1,123,031 ) Net cash generated (consumed) 5,711,108 (274,499 )

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	36 SUBSEQUENTS EVENTS 3 6 . 1 Announcement of former subsidiary The Body Shop entering administration in the UK During January 2024, information became public that under the guidance of its new controllers, the former subsidiary The Body Shop filed for administration in the United Kingdom, covering operations in that country in the request. Receipt of this information led the Company's management to assess whether such event subsequent to the balance sheet date would affect the financial statements. The main receivables potentially impacted and management's considerations are included below: a) Receivable arising from the sale or former subsidiary The Body Shop As disclosed on footnote 5.5 2025 2026 However, in April 2024, when the joint administrators of The Body Shop International issued their proposals for administration, such proposal contained additional information that affect the fair value assessment of the receivable.. The Company has assessed that the information that supported the fair value measurement of such receivables as of December 31, 2023 may no longer be deemed reliable for the purposes of determining the current fair value of the receivable. Therefore, while no adjustment is required to be made on the financial statements for the year ended December 31, 2023, the full balance described on footnote 5.5 2024 2024 With regards to the deferred fixed consideration due from the acquirer, (Aurelius Group) the Company has not identified indications that credit risk of the counterparty would have increased significantly to a point that would require the recognition of expected credit losses as of December 31 2023 Management continues to monitor the evolution of the operations of the former subsidiary The Body Shop to assess whether they affect the fair value of the receivable and give rise to accounting adjustments in the financial statements of future periods. b) Operational receivables held by Avon from The Body Shop On December 31, 2023, the subsidiary Avon had receivables from the former subsidiary The Body Shop arising from the manufacture of products in the total amount of approximately R$57 million. In light of the above mentioned information that became available in 2024 Therefore, while no adjustment is required to be made on the financial statements for the year ended December 31, 2023, the full balance described above, along with the additional receivables that arose in 2024 2024 2024 3 6 . 2 Dividends distribution On March 11, 2024, the Company's Board of Directors approved the distribution of dividends in the total amount of R$979,176, corresponding to the estimated value of R$0.709217 per share, excluding treasury shares. Such dividends include the minimum mandatory dividends of R$293,986, corresponding to 30% of the adjusted net profit for the year (see note no. 23 3 6 . 3 Flooding in the Brazilian State of Rio Grande do Sul During May 2024, the state of Rio Grande do Sul in the south of Brazil was hit by a natural disaster. Significant flooding across the state has resulted in damage to third party property and displacement of populations, among other adverse effects. We are currently supporting our network of representatives and analyzing possible actions that may further assist the population at this time. As of the date of this annual report, we are assessing the potential impacts on the Company’s assets that may have been affected, especially considering the existence of a distribution center in the region, where some of the Company’s products are stored.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Current versus non-current classification	3.1 Current versus non-current classification The Company presents assets and liabilities in the balance sheet based on the classification of current and non-current, according to the expectation for realization and/or expected consumption during the ordinary course of the operating cycle, as defined in CPC 26 2 1 Deferred tax assets and liabilities are classified as non-current assets and liabilities, as disclosed in note no. 3.17
Foreign currency translation	3.2 Foreign currency translation Functional currency The items included in the financial statements of the Company and each of the companies included in the consolidated financial statements are measured using the currency of the main economic environment in which each of the companies operates (“functional currency”). The financial statements are presented in the Company’s functional and presentation currency, the Brazilian Real. 3.2.1 Transactions and balances in a currency other than the functional currency Transactions in foreign currency, that is, any currency other than the functional currency, are translated into the functional currency of the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions. Balance sheet account balances are translated using the exchange rates prevailing on the dates of the reporting period. Gains and losses from exchange rate variation arising from the settlement of such transactions and the translation of monetary assets and monetary liabilities denominated in foreign currency are recognized in the statement of profit or loss as “finance income” and “finance expenses”. 3.2.2 Subsidiaries with different functional currency In preparing the consolidated financial statements, the statement of profit or loss and cash flow statement and all other changes of assets and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions. The balance sheet is translated into Brazilian Reais at the exchange rate prevailing at each reporting date. The effects of exchange rate variations resulting from these translations are presented under the item Other Comprehensive Income (“OCI”) in the statement of comprehensive income in shareholders’ equity. The translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”), Cosmeticos Avon Sociedad Anonima Comercial e Industrial (“Avon Argentina") and Avon Kozmetik Urunleri Sanayi ve Ticaret Anonim Siketi (“Avon Turkey”), which became hyperinflationary economies as of July 1, 2018 for Argentina and June 1, 2022 for Turkey, in which other than the balance sheet, the revenue and expenses are also translated into Reais at the exchange rates prevailing at each reporting date (note no. 3.2.4 3.2.3 Hyperinflationary economy On July 1, 2018 and June 1, 2022, Argentina and Turkey were considered hyperinflationary economies, respectively considering the rise in the official price indices of the respective countries accumulated on those dates (Consumer Price Index, or “IPC” for the Argentina and the Internal Wholesale Price Index, or “IPIM” for Turkey). Accordingly, non-monetary assets and liabilities recorded at historical cost in these subsidiaries were restated based on the respective indices mentioned above, with the effects resulting from changes in general purchasing power being presented in the statement of income. The net effect of the inflation adjustment for the years ended December 31, 2023 and 2022 28 For the purpose of converting the accounting balances of the respective subsidiaries into the presentation currency (reais R$) used in the Company's individual and consolidated financial statements, the following procedures were adopted: ➢ Assets and liabilities were translated at the exchange rate prevailing at the reporting date (0.0059 and 0.02955 Argentine peso for each Brazilian Real and 0.1639 and 0.2786 Turkish lira for each Brazilian Real on December 31, 2023 and 2022 ➢ Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date (the same as indicated above), instead of the average exchange rate of the year, which is used to translate currencies in non- economies. The accumulated inflation for the year ended December 31, 2023 was 211.4% in Argentina and 64.8% in Turkey (94.8% in Argentina and 64.3% in Turkey as of December 31, 2022), as per IPC and IPIM
Consolidation	3.3 Consolidation The following procedures are applied in the preparation of the financial statements: a) Investments in subsidiaries The Company controls an entity when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date when the Company obtains control until the date when the control ceases to exist. Below is a list of the Company’s direct subsidiaries as of December 31, 2023 and 2022 Interest - % 2023 2022 Direct interest: Avon Products, Inc. 100.00 100.00 Natura Cosméticos S.A. 100.00 100.00 Natura &Co International S.à r.l. 100.00 100.00 The activities of the direct subsidiaries are described below: ➢ Avon Products, Inc . (“Avon Products”): a global manufacturer and marketer of beauty and related products, with operations started in 1886 one ➢ Natura S.A. (“ ”): is a privately held corporation, established in accordance with the laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term and the main focus of which is the commercialization of cosmetics and fragrances in general. It also operates through e-commerce and has an expanded network of its own physical stores. The former subsidiaries The Body Shop International Limited (The Body Shop) and Holding Pty Ltd. (Aesop) were fully sold during the year ended December 31, 2023 (see explanatory notes no. 1.1 1.2 35 ➢ Natura &Co International S.à r.l. (“ &Co International”): a company established in Luxembourg on February 14, 2020 with the main purpose of operating as the finance arm of the Company (a “ ”), centralizing the fundraising activities with external entities and providing funding for the other entities of the economic group on behalf of the parent company. Furthermore, the entity has also the purpose of managing and holding stakes in national and foreign companies. As of December 31, 2023 and 2022
Goodwill	3.4 Goodwill Goodwill arising from a business combination is initially measured at cost, with the exceeding aggregate amount of: (i) the consideration transferred, measured at fair value; (ii) the amount of any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s previously held equity interest in the acquiree at the acquisition date; over the net assets acquired (identifiable net assets acquired and assumed liabilities). When this aggregate amount is lower than the net amount of the identifiable assets acquired and the assumed liabilities, a gain on a bargain purchase is immediately recognized in the statement of profit or loss. Subsequently, goodwill is measured at cost less any accumulated impairment losses. For impairment testing purposes, goodwill acquired in a business combination is, from the acquisition date, allocated to each of the group of Cash-Generating Units (“CGU”) that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to those units and annually tested, and whenever circumstances indicate that the carrying amount may present impairment losses.
Cash and cash equivalents	3.5 Cash and cash equivalents Cash and cash equivalents are maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents include cash, demand deposits and short-term investments realizable within 90 days of the original date of the security or considered to be highly liquid granted by the issuer or convertible into a known amount of cash and which are subject to an insignificant risk of changes in value. Instruments that are not eligible for the classification of cash and cash equivalents, due to their liquidity, maturity or even the risk of changes in value, are classified as short-term investments.
Financial instruments	3.6 Financial instruments 3.6.1 Financial assets Initial recognition and measurement Upon initial recognition, a financial asset not measured at fair value through profit or loss, is measured at fair value plus or minus transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability. Subsequently, financial assets are measured at amortized cost, at fair value through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”). The classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial asset and the business model of the Company for the management of these financial assets. The business model of the Company for managing financial assets refers to how the Company manages its financial assets to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are “non-derivative” financial assets held within a business model with the objective to hold financial assets to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are held within a business model with the objective of holding financial assets to collect contractual cash flows and selling them. Subsequent measurement Financial assets at amortized cost Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains or losses are recognized in the statement of profit or loss when the asset is written off, modified, or impaired. The main financial assets of the Company classified as amortized cost include balances of trade accounts receivable, other current assets and non-current assets balances (see note 5.5 Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are presented in the balance sheet at fair value with net changes in fair value recognized in the statement of profit or loss. This category includes derivative instruments and short-term investments which the Company had not irrevocably elected to classify according to the fair value through OCI. The financial assets measured at fair value through profit or loss are investment funds, government securities, restricted cash, treasury bills, investment fund Dynamo Beauty Ventures Ltd. fund (“DBV Fund”), Certificate of Bank Deposits (“CDB”), repurchase operations, derivatives financial and operational instruments and contingent considerations arising from the disposal of the former subsidiary The Body Shop, as presented in note no. 5.5 Derecognition (write-off) of financial instruments A financial asset (or, where applicable, part of a financial asset or part of a group of similar financial assets) is written off when the rights to receive cash flows from the asset have expired, when the Company transfers its rights or risk to receive cash flows from the asset or when the Company has assumed an obligation to pay the full amount of received cash flows, without significant delay, to a third party under an on-lending agreement and either (i) the Company has transferred substantially all risks and benefits of the asset, or (ii) the Company has neither transferred nor retained substantially all risks and benefits of the asset, but transferred the asset control. When the Company transfers its rights to receive cash flows of an asset or executes an on-lending agreement, it assesses whether, and at which extent, it has retained the risks and benefits of ownership. When the Company has neither transferred nor retained substantially all risks and benefits of the asset, nor transferred control over the asset, the Company continues to recognize the asset transferred to the extent of its continued involvement. In this case, the Company also recognizes an associated liability. The transferred assets and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained. Impairment of financial assets The Company recognizes an allowance for expected credit losses (“ECL”) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive, discounted by an approximation of the original effective interest rate. ECLs are recognized in two stages: (i) for credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provisioned for credit losses that result from default events that are possible within the next 12 months 12 For trade accounts receivable, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for losses based on the ECL at each reporting date. The Company has recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment. Further details are disclosed in note no. 4.6 The Company considers a financial asset in default when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. 3.6.2 Financial liabilities Initial recognition and measurement All financial liabilities are recognized initially at fair value and, in the case of borrowing, financing and debentures, net of directly attributable transaction costs. The Company’s main financial liabilities include borrowing in local and foreign currency, financing and debentures (note no. 18 5 19 31 17 22 23 Subsequent measurement For purposes of subsequent measurement, financial liabilities are classified in two categories: (i) financial liabilities at fair value through profit or loss; or (ii) financial liabilities at amortized cost. Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition at fair value through profit or loss. Due to the fair value hedge established to protect against interest rate variability associated with the issuance of real estate receivable certificates (“CRI”), the respective liabilities presented in borrowing, financing and debentures were designated at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the short term. This category also includes derivative instruments entered into by the Company that are not classified as hedging instruments in the hedge relationships defined by CPC 48 9 Gains or losses on liabilities held for trading are recognized in the statement of profit or loss. Financial liabilities designated on initial recognition at fair value through profit or loss are designated on the initial recognition date and only if the criteria of CPC 48 9 Financial liabilities at amortized cost This is the most relevant category for the Company. After initial recognition, interest-bearing borrowings, financing and debentures are subsequently measured (except issuance of the aforementioned real estate receivables certificates) at amortized cost using the effective interest rate method. Gains and losses are recognized in profit or loss when the liabilities are written off as well as through the effective interest rate amortization process. Any difference between raised and settled amounts is recognized in the statement of profit or loss, using the effective interest rate method during the year in which the borrowings, financing and debentures are outstanding. Amortized cost is calculated by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest rate method. The effective interest rate amortization is included as finance expenses in the statement of profit or loss. This category generally applies to trade accounts payable and reverse factoring operations (see note no. 19 18 17 Derecognition Financial liability is written off when the obligation under the liability is discharged, canceled, or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as derecognition of the original liability and recognition of a new liability. The difference in the respective carrying amounts is recognized in the statement of profit or loss. Offsetting of financial instruments Financial assets and financial liabilities are offset, and the net amount is reported in the balance sheet if there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously. The offsetting of financial instruments is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with the financial institution, in which the current account positions of the Company (including overdraft balances) are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions on a net basis. 3.6.3 Derivative financial instruments Derivative financial instruments transactions contracted by the Company consist of swaps and non-deliverable forwards (“NDF”) intended exclusively to hedge against foreign exchange risks related to (i) exchange rate risks associated to balance sheet position, purchase of goods and property, plant and equipment, forecast exports in addition to and foreign-denominated cash flows for capital contributions in foreign subsidiaries; and (ii) variability in interest rates associated with contracted debt. The derivative instruments are measured at fair value, and changes are recognized through profit or loss, except when they are designated as cash flow hedge accounting, in which changes in fair value are recorded in OCI. The fair value of derivative instruments is measured by the treasury department of the Company based on information on each contracted transaction and related market inputs as of the reporting date of the financial statements, such as interest and exchange rates. For the purpose of hedge accounting, hedges are classified as: (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction or the foreign currency risk in an unrecognized firm commitment; and that may affect the result. The Company does not have a hedge At the inception of a hedge relationship, the Company formally designates and documents the hedge relationship to which it wishes to apply hedge accounting, the risk management goal and strategy for hedging. The documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed on an ongoing and future basis to determine that they actually have been highly effective throughout the financial reporting periods for which they were designated. Any imbalance between the hedge index of the object and the hedge instrument that is not in compliance with the hedge purpose is adjusted so that the index returns to the standards established in the protection strategy. Fair value and cash flow hedges that meet all the qualifying criteria for hedge accounting are accounted for as described below. Fair value Hedge It consists in providing protection against variation at fair value of assets or liabilities recognized or firm commitments not recognized, or a component of any such items, that is attributed to a specific risk and that may affect the result. Any gain or loss arising from variations at fair value of the derivative instruments designated as hedge instruments and the hedged assets or liabilities are recognized in the financial result. In the years ending on December 31, 2023 and 2022 5.3 Cash flow hedges It consists in providing a hedge against variation in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast transaction and that may affect statement of profit or loss. The effective portion of changes in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated in the “gains (losses) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly in OCI, in shareholders’ equity, while the ineffective portion of hedge is immediately recognized as finance income (expense). For the years ended December 31, 2023 and 2022 5.3 Discontinuing hedge accounting Hedge accounting is discontinued when the Company terminates the hedge relationship, the hedge instrument matures or is sold, revoked, or executed, or no longer qualifies to hedge accounting. Any gains or losses recognized in OCI and accumulated in shareholders’ equity up to that date remain in shareholders’ equity related to cash flow hedge and are recognized when the forecast transaction is eventually recognized in the statement of profit or loss. If a forecast transaction results in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss. For example, when the non-financial asset is depreciated or sold. On the other hand, if a forecast transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit or loss. For example, when financial income or expense is recognized. When the forecast transaction is no longer expected, cumulative gains or losses and deferred in the statement of changes in shareholders' equity are immediately recognized in the statement of profit or loss. The Company assesses, on a prospective basis, throughout the hedge term, the effectiveness of its derivative instruments, as well as changes in their fair value. The fair values of derivative instruments are disclosed in note no. 5.5
Trade accounts receivable	3.7 Trade accounts receivable Trade accounts receivable correspond to amounts receivable for the sale of goods and services in the ordinary course of the activities of the Company and are recognized to the extent that the consideration, which is unconditional, is due by the customer (that is, only the passage of time is required before payment of the consideration is due) and are measured on initial recognition at cost for the consideration to which the Company expects to be entitled in exchange for the products promised to the client. Subsequently, trade accounts receivables are measured at amortized cost by using the interest rate method and they are subject to an impairment test.
Inventories	3.8 Inventories Inventories are valued at their average cost and the net realizable value, whichever is lower. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale. The Company considers the following items when determining its allowance for inventory losses: discontinued products, products with slow turnover, expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “cost of sales”.
Carbon credits – carbon neutral program	3.9 Carbon credits – carbon neutral program In 2007 This commitment, which presently refers to the operations of all Company and does not reflect a legal obligation to the extent in which the specific regulations still have not been promulgated by the legislative branch. Thus, considering the practices historically applied by the Company and the specificity of the commitments assumed and disclosed to the market and society, this commitment is considered a non-formalized obligation, according to CPC 25 37 The liability is estimated through carbon emission inventories carried out annually and valued based on the best estimate of the cash disbursement that will be required to settle the current obligation at the reporting date, considering the history of similar transactions carried out by the Company for such end. As of December 31, 2023 and 2022 2015 2023 The Company elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market. Thus, the costs incurred will generate carbon credits after completion or maturation of these projects. Such expenses are recorded in the line item “other current assets” (see note 14 Upon effective delivery of the related carbon neutral certificates to the Company, and duly filed, the obligation of being carbon neutral is effectively fulfilled; therefore, the asset balances are offset against those of the liabilities.
Property, plant and equipment	3.10 Property, plant and equipment Property, plant and equipment is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if applicable. Land is not depreciated. Depreciation of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values using the straight-line method over their useful lives and is recognized in the statement of profit or loss. The estimated useful lives of the assets are mentioned in note no. 15 Gains and losses on disposals are calculated by comparing the proceeds from the sale with the carrying residual amount and are recognized in the statement of profit or loss as “other operating income (expenses), net”. Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.
Intangible assets	3.11 Intangible assets Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are reported at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangible assets, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the year in which the expenditure is incurred. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the method for an intangible asset with a finite useful life are reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense regarding intangible assets with finite lives is recognized in the statement of profit or loss in the expense category that is consistent with the function of the intangible assets. Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, and when circumstances indicate that the carrying amount may be impaired, either individually or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether indefinite life continues to be supportable. If not, the useful life is changed from indefinite to finite on a prospective basis. An intangible asset is written off upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon write-offs of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of profit or loss in item “other operating income (expenses), net”. The main classes of intangible assets and useful life are detailed below and described in note no. 16 3.11.1 Software Licenses of software and enterprise management systems acquired are capitalized and amortized according to the useful lives, and maintenance costs are recognized as expenses when incurred. Business management system acquisition and implementation costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will be generated and when the asset is controlled by the Company, taking into consideration its economic and technological viability. Contracts involving hosting and/or processing of information in the cloud (“cloud computing arrangements”) generate intangible assets to the extent that on the contract start date, the Company obtains control of the software. Contracts which only provide the right of access to the supplier's software during the term of the contract are treated as a service contract and, consequently, recognized as an expense in the statement of profit or loss as the service is provided (since the right of receiving access to the supplier's software does not give the Company, at the commencement date of the contract, the power to obtain the future economic benefits arising from the software itself and to restrict third parties' access to those benefits). The amounts incurred on software development recognized as assets are amortized under the straight-line method over its estimated useful life. The expenditures related to software maintenance are recognized in profit or loss of the year when incurred. 3.11.2 Trademarks and patents Separately acquired trademarks and patents are stated at their historical cost. Trademarks and patents acquired in a business combination are recognized at fair value on the date of acquisition. For trademarks and patents with a defined useful life, amortization is calculated using the straight-line method. 3.11.3 Relationship with agents Relationships with agents acquired in business combinations are recognized at fair value on the date of acquisition and amortization is calculated using the straight-line method. 3.11.4 Technologies developed Technologies developed include technology for product development (including formulas, labeling data, manufacturing processes, regulatory approvals, product packaging and designs) arising from business combination, and are recognized at fair value on the date of acquisition and its amortization is calculated using the straight-line method.
Impairment of non-financial assets	3.12 Impairment of non-financial assets The Company reviews, on each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when the annual impairment testing for an asset is required, the Company estimates the asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset or the CGU fair value less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written off to its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their current value using a pre-tax discount rate that reflects the subsidiary’s weighted average cost of capital in which the CGU operates, which reflects the risks specific to the CGU and is derived from its existing business and respective risks. The Company bases its impairment calculation on most recent budgets and forecast calculations, which are prepared separately for each of the Company’s CGU (or groups of cash-generating units with respect to goodwill for future profitability) to which the individual assets are allocated and monitored for the purpose of its recoverability. These budgets and forecast calculations generally cover a period of ten years Impairment losses are recognized in the statement of profit or loss in expense categories consistent with the function of the impaired asset. For non-financial assets, excluding goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such an indication exists, the Company estimates the assets or CGU’s recoverable amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the asset’s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such a reversal is recognized in the statement of profit or loss. Goodwill and other intangible assets with indefinite useful lives are tested for impairment annually as of December 31, and when circumstances indicate that the carrying amount may be impaired. Impairment losses relating to goodwill cannot be reversed in future periods.
Lease liability	3.13 Lease liability The Company reviews, at the beginning of the contract, whether a contract is, or contains, a lease. That is, if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company (as a lessee) applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets. At the commencement date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the strike price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for terminating the lease, if the lease term reflects the Company exercising the option to terminate. Variable lease payments that do not depend on an index or a rate are recognized as expenses (unless they are incurred to produce inventories) in the period in which the event or condition that triggers the payment occurs. In calculating the current value of lease payments, the Company uses its incremental borrowing rate at the lease commencement date because the interest rate that is implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments (i.e., changes to future payments resulting from a change in an index or rate used to determine such lease payments) or a change in the assessment of an option to purchase the underlying asset. The Company's lease liabilities are disclosed in note no. 17 3.13.1 Right-of-use assets Right-of-use assets are recognized at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated using the straight-line method over the shorter of the lease term and the estimated useful lives of the assets, disclosed in note no. 17 The right-of-use assets are also subject to impairment, as disclosed in note no. 3.12 3.13.2 Short-term leases and leases of low-value assets The Company applies the short-term lease recognition exemption to its short-term leases regardless of their nature (that is, those leases that have a lease term of 12 months 3.13.3 Sale and leaseback transaction When an entity transfers an asset to another entity and leases that asset back from the buyer-lessor, the entity (as the seller-lessee) determines whether the transfer of an asset is accounted for as a sale of that asset in accordance with IFRS standards. Whenever the transfer of the asset by the seller-lessee satisfies the requirements to be accounted for as a sale of the asset, the Company, as seller-lessee, measures the right-of-use asset resulting from a sale and leaseback transaction in proportion to the previous carrying value of the asset relating to the right of use retained by the seller-lessee. Therefore, in a sale and leaseback transaction, the seller-lessee recognizes only the amount of any gain or loss related to the rights transferred to the buyer-lessor. If the transfer of the asset does not satisfy the requirements to be accounted for as a sale, the Company continues to recognize the transferred asset and recognizes a financial liability equal to the transfer proceeds. For subsequent measurement, the Company, as seller-lessee, determines “lease payments” or “revised lease payments” in a way that the seller-lessee would not recognize any amount of the gain or loss that relates to the right of use retained. The application of these does not prevent the seller-lessee from recognizing in profits or loss results any gain or loss relating to the partial or full termination of a lease.
Discontinued operations	3.14 D iscontinued operations A group of assets comprising operations intended for disposal qualifies as a discontinued operation disposal group if it is a component of an entity that either has been disposed of, or is classified as held for sale, and: (i) represents a separate major line of business or geographical area of operations; (ii) is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or (iii) is a subsidiary acquired exclusively for the purpose of resale. Discontinued operations are excluded from the results of continuing operations and are presented as a single amount in the statement of profit or loss as profit or loss after taxes in the statement of profit or loss. On December 31, 2023, the discontinued operations refer to the results derived from the derecognition of assets, liabilities, and operations of the former subsidiaries Aesop and The Body Shop, arising from the conclusion of the sale of the entities on August 30, 2023, and December 29, 2023, respectively, and to costs incurred with the resolution of lawsuits associated with the operation that the subsidiary Avon kept in North America, which was sold prior to the acquisition of subsidiary Avon by the Company. The Company presents these effects as part of its discontinued operations since it considers the discontinued operations of the subsidiary Avon as an extension of the Company and for assessing that this presentation reliably represents the essence of the associated transaction.
Trade accounts payables and reverse factoring operations	3.15 Trade accounts payables and reverse factoring operations The Company is part of a reverse factoring operation ( “ supplier finance arrangement ” ) This operation does not change the amounts, nature, and timing of the liability (including previously agreed-upon terms, prices and conditions) and it does not affect the Company with financial charges practiced by the financial institution, on performing a thorough analysis of suppliers by category. There is no guarantee given by the Company. Additionally, the payments made by the Company represent purchases of goods and services, are directly related to invoices from trade accounts payable and do not change the Company’s cash flows. Thus, the Company continues to recognize the liability as a trade accounts payable and these transactions are presented as operating activities in the cash flow statement.
Provisions for tax, civil and labor risks	3.16 Provisions for tax, civil and labor risks Provisions are recognized when the Company has a legal or constructive obligation as a result of past events, and it is probable that an outflow of resources will be required to settle the obligation, and its value can be reliably estimated. Provisions are quantified at the current value of the expected outflow of resources to settle the obligations using the appropriate discount rate according to risks related to the liability. The provisions for tax, civil and labor risks are monetarily adjusted through the end of the year to cover probable losses, based on the nature of the risk and the opinion of the Company’s legal advisors. The monetary adjustments are recorded in finance income (expenses), see note no. 28 Contingent assets are not recognized by the Company and are only disclosed in case of probable receipt of economic benefits. If it is practically certain that economic benefits will be received, the assets and the corresponding gain are recorded in the financial statements of the year corresponding to the change in the estimate. Contingent liability recognized in a business combination is initially measured at its fair value. Subsequently, it is measured at the higher of the amount that would be recognized in accordance with the requirements for provisions above or the amount initially recognized less (when appropriate) cumulative amortization recognized in accordance with the requirements for revenue recognition. The Company has contracts that provide for the payment of success fees arising from tax, civil and labor proceedings in which it is a defendant, and based on its best estimate, calculated, and provisioned the amounts for which it understands that there is an expectation of future disbursement.
Current and deferred income tax and social contribution	3.17 Current and deferred income tax and social contribution Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the tax authorities based on the tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Company operates and generates taxable income. The Company periodically assesses the tax treatment assumed in the determination of taxes on profit with respect to situations in which the applicable tax regulation gives rise to interpretations that may be different and considers whether it is likely that the tax authority would accept the uncertain tax treatment. The Company assesses these taxes balances based on the most probable or expected value, depending on which method is assessed as the one The Company applies the provisions of ICPC 22 23 21 The Company has material uncertain tax positions, and which - in case of any unfavorable outcome under litigation - could result in a material adverse impact to the financial statements. In Brazil, they include the corporate income tax (“IRPJ”) and the social contribution on net income (“CSLL”), which are calculated based on taxable income by applying the 15% rate plus additional of 10% on taxable income exceeding R$ 240 for IRPJ and 9% for CSLL and considers the offset of tax losses, limited to 30% of annual taxable income. Taxable income reflects profit before taxes adjusted by non-taxable and non-deductible items (both temporary and permanent items). Deferred taxes represent tax debits and credits on temporary differences between tax base and accounting base of assets and liabilities on accrued tax losses. Deferred tax assets and liabilities are classified as non-current as required by CPC 32 12 The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered. The estimate of future taxable income requires judgements, estimates and interpretation of tax laws. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted at the reporting date and reflect the uncertainties relating to these taxes, when applicable. Deferred tax assets and liabilities are offset if there is a legal feasible right to offset tax liabilities against tax assets, and if they are related to taxes registered by the same tax authority under the same taxable entity. Thus, for presentation purposes, tax asset and liability balances are disclosed separately.
Employee benefits	3.18 Employee benefits 3.18.1 Short-term benefits The obligations of short-term benefits for employees are recognized as personnel expenses as the corresponding service is rendered. The liability is recognized at the amount of the expected payment if the Company has a legal or non-formalized obligation to pay the amount due to services rendered by the employee in the past and the obligation can be reliably estimated. 3.18.2 Profit sharing program The Company recognizes a liability and an expense for its profit-sharing program based on criteria that considers the profit attributable to its shareholders and which is tied to the achievement of specific operational goals and objectives established and approved in the beginning of each year. 3.18.3 Defined contribution plans Obligations to contribute to defined contribution plans are recognized in the statement of profit or loss as personnel expenses when the related services are rendered by employees. Contributions paid in advance are recognized as an asset to the extent that a cash refund or a reduction in future payments is possible. 3.18.4 Defined benefit plans The Company’s net obligation for defined benefit plans (retirement and post-employment health care) is calculated for each plan based on the estimated amount of the future benefit that beneficiaries will receive in return for services rendered in previous years. This amount is discounted to its current value and is presented net of any plan asset’s fair value. The calculation of the defined benefit plan obligation is carried out annually by an external and independent actuary using the Projected Unit Credit Method. When the calculation results in a potential asset for the Company, the asset to be recognized is limited to the current value of economic benefits available in the form of future reimbursements or reductions in future contributions. To calculate the current value of economic benefits, any applicable minimum cost requirements are considered. The current service cost and accrued interest on the present value of the liability are recognized in the statement of income and the actuarial gains and losses, generated by the remeasurement of the liability due to changes in actuarial assumptions, are recognized in “OCI”. In the event of changes or reductions in the plan, the effects of the cost of past services are recognized in the statement of profit or loss on its occurrence date.
Share-based payments	3.19 Share-based payments The Company’s executive officers are granted the following purchase option plans, settled exclusively with its own shares. i) Stock option plans; ii) Restricted share purchase program; iii) Stock option plan related to the strategy acceleration; and iv) Performance share purchase program. The plans are measured at fair value at the grant date. In determining the fair value, the Company uses an adequate valuation method, details of which are disclosed in note no. 27.1 The cost of transactions settled with equity instruments is recognized, together with a corresponding increase in shareholders’ equity under “additional paid-in capital”, throughout the period in which the service conditions are fulfilled, ending on the date on which the employee is fully vested in the right to the award (vesting date). The cumulative expense recognized for equity instruments transactions settled on each base date up to the vesting date reflects the extent to which the vesting period has transpired and the Company’s best estimate of the number of equity instruments to be vested. The expense or credit of the year is recorded in the statement of profit or loss under “selling or administrative expenses”, depending on the internal department where the eligible employee is allocated. For the stock options plan and the strategy-acceleration program, even after expiration of the term for exercise, the recognized expense is not reversed since the right has been vested in executive officers. When an award of equity instruments settlement is canceled (except when the cancellation occurs due to loss of right over the equity instrument for not fulfilling the grant conditions), it is treated as if it had been acquired on the date of cancellation, and any expense not recognized is registered immediately. This includes any award for which the Company or the counterparty have the option of not fulfilling the non-vesting obligation. All cancellations of transactions settled with equity instruments are treated in the same way. The dilution effect of options granted is reflected as additional share dilution in the calculation of diluted earnings per share.
Dividends and interest on net equity	3.20 Dividends and interest on net equity The proposed payment of dividends and interest on net equity made by the Management that is within the portion equivalent to the minimum mandatory dividend is recorded in the line item “dividends and interest on net equity” in current liabilities, as it is considered a legal obligation provided for by the Company’s bylaws; However, the portion of dividends exceeding minimum mandatory dividends the reporting date but declared and approved by Management after the reporting date, the respective liability is not recognized and the proposed balances are reclassified within lines in shareholders’ equity. For corporate and accounting purposes, interest on net equity is stated as allocation of income directly in shareholders’ equity.
Treasury shares	3.21 Treasury shares The Company’s own equity instruments which are reacquired (treasury shares) are recognized at acquisition cost and deducted from shareholders’ equity. No gain or loss is recognized in the statement of profit or loss regarding the purchase, sale, issue or cancellation of the Company’s own equity instruments. Upon disposal or transfer of treasury shares to beneficiaries of share-based payment plans (settled in shares), the amount of the consideration received is recognized as an increase in shareholders’ equity, and any gain or loss resulting from the transaction is recorded as a capital reserve.
Operating segments	3.22 Operating segments The information per business segment is presented in note 24 The main decision-making body of the Company, which is responsible for defining the allocation of funds and for the performance assessment of the operating segments, is the Board of Directors, which is supported by five thematic advisory committees: The Audit, Risk Management, and Finance Committee, responsible for operationalizing internal and external audit processes, mechanisms, and controls related to risk management, as well as ensuring the coherence of financial policies with strategic guidelines and the business risk profile; The Strategic Committee, responsible for supporting the monitoring and direction of corporate strategy; The Corporate Governance Committee, responsible for overseeing the functioning of our corporate governance system; The Organizational Development and People Committee, responsible for providing support to the Board of Directors in making decisions related to Human Resources, Organizational Development, and Management Systems strategies, policies, and norms; and the Sustainability Committee, responsible for monitoring the Group's and its Business Units' strategies on issues associated with achieving the objectives established in the Commitment to Life, assumed by the Company in 2020
Revenue from contracts with customers	3.23 Revenue from contracts with customers Revenue from contracts with customer is recognized when control of the goods or services is transferred to the customer at an amount that reflects the fair value of the consideration the Company expects to be entitled in exchange for those goods or services. The Company has concluded that it is the principal in its revenue arrangements. The Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price, the effects of variable consideration, existence of a significant financing component, non-cash consideration, and consideration payable to the customer (if any) are considered. The nature and other considerations on the transaction price and the moment in which the performance obligation is fulfilled for each of the main revenue streams are shown below. 3.23.1 Direct sales Revenue from direct sales is generated by sales to the Company’s consultants (our customers) based on the fair value of consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. Revenue from sales is recognized when the performance obligation is fulfilled, i.e., when the promised product is physically delivered, and the Consultant obtains control over the product. 3.23.2 Direct sales – Additional charges and penalties for late payments The Company charges their customers (Consultants) additional charges and penalties for late payments in the settlement of sales receivables. Due to the level of uncertainty in collecting these amounts (variable consideration), the subsidiaries recognize revenue from additional charges and penalties based on the consideration that Company expects to be entitled given its history of collection from customers. 3.23.3 Retail sales The Company, which operates in the retail market, measures sales revenues based on the fair value of the consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. These revenues are recognized when the performance obligation is fulfilled, i.e., when the promised product is physically delivered, and the consumer obtains control over the product. 3.23.4 Other performance obligation 3.23.4.1 Loyalty program (points campaign) The Company offers points campaign (loyalty program), in which customers accumulate points - while buying the Company’s products - to be exchanged (redeemed) for products in the future. Measurement of points is based on their expected cost, plus a margin. The amount allocated to the loyalty program is deferred and the revenue is recognized upon redemption of the points accumulated by consultants for retail and direct sales, or when they expire or are no longer considered redeemable. The loyalty program points are valid for up to approximately five months 3.23.4.2 Program for recognition of Natura and Avon beauty consultants’ performance The Company has performance recognition programs, in which the beauty consultants are awarded based on different indicators, for example, volume of purchases, length of service, among others. The Company believes that this performance recognition program has an added value and hence is considered a commitment to our network. Measurement of performance recognition programs is based on their expected cost, plus a margin. The amount allocated to performance recognition programs is deferred and revenue is recognized when awards are delivered to the Company’s Consultants. 3.23.4.3 Events The Company organizes events to encourage and recognize the best Consultants. The Company believes that these events have added value for the Consultants, in addition to generating in them an expectation to participate in these events. Thus, the Company has determined that these events are a performance obligation. Measurement of events is based on their expected cost, plus a margin. The amount allocated to events is deferred and the revenue is recognized when the event is held. 3.23.4.4 Franchises (courses, training and consulting/outfit and opening) Upon execution of the agreement, the Company charges from franchisees a fixed amount, part of which is allocated to courses, training and consultancy to train and instruct the franchisee to sell “Natura” and “The Body Shop” brand products. In addition, the other part of the charged amounts refers to outfit (specific products to be used at the franchisee store) and inauguration (franchisee’s store opening event). The Company believes that these items represent a material right and, for such, they are considered a performance obligation. Measurement is based on the market value of these items, being initially recognized as deferred revenue. When the franchisee’s store is opened, this deferred revenue is allocated to the statement of profit or loss. 3.23.4.5 Franchises (brand right of use) Upon the execution of the agreement, the Company charges from franchisees a fixed amount, part of which is for the use of the “Natura” brand. The Company believes that this item represents a material right and, for such, it was considered a performance obligation. Measurement is based on residual value, i.e., the remaining value after excluding the market value of courses, training and consultancy services, outfit and inauguration, and the advertising fund. This amount is initially recognized as deferred revenue. This deferred revenue is allocated to statement of profit or loss, on a straight-line basis, over the term of the franchise agreement. 3.23.4.6 Incentives related to “free-of-charge” products and promotional gifts The Company grants incentives related to “free-of-charge” products and promotional gifts for its customers (Natura and Avon consultants and/or end consumers). Since it is considered a material right, the Company recognizes it as a performance obligation. Considering that the delivery of products and the fulfillment of the performance obligation to deliver “free-of-charge” products or promotional gifts occurs at the same time, the Company concluded that an allocation of prices and monitoring these two performance obligations separately are not applicable.
Sales taxes	3.24 Sales taxes Net revenues are recognized net of sales taxes, except (i) when sales taxes incurred on the purchase of goods or services are not recoverable from the tax authorities, in which case the sales tax is recognized as part of the acquisition cost of the asset or expense item, as the case may be; (ii) when the amounts receivable and payable are presented together with the sales taxes amount; and (iii) when the net amount of sales taxes, recoverable or payable, is included as a component of the amounts receivable or payable in the balance sheet. Tax incentives related to taxes on sales for the current year are recognized in the Company's statement of profit or loss for the year and recorded in net sales. 3.24.1 Concept of supplies for calculating credits of PIS and COFINS contributions The Company claims that PIS and COFINS credits are measured and calculated reliably and based on the best interpretation of current legislation and the country’s jurisprudential scenario, whose evolution is permanently assessed by the Company and its legal advisors.
Earnings per share	3.25 Earnings per share The basic earnings per share are calculated by dividing the profit (loss) attributable to the Company’s shareholders by the weighted average number of outstanding common shares, excluding common shares purchased by the Company and held as treasury shares. Diluted earnings per share are calculated by adjusting the weighted average number of outstanding common shares, assuming the conversion of all potential common shares that would cause dilution. The Company has stock options, restricted shares, strategy acceleration and performance shares that would have a dilutive effect on any earnings per share. The Company chose to present the basic and diluted amounts per share resulting from discontinued operations together with the information on earnings per share of continuing operations in note 31
New standards, amendments and interpretations issued but not yet effective	3.26 New standards, amendments and interpretations issued but not yet effective The new and amended standards and interpretations that are issued, but not yet effective, up to the date of issue of the Company’s financial statements are disclosed below, except for those which, in the Management’s assessment, cannot produce any effect on the financial statements. The Company intends to adopt these new and amended standards and interpretations, if applicable, when they become effective. 3.26.1 Amendments to IAS 1 26 1 IASB issued amendments to IAS 1 26 1 twelve months twelve months The amendments are effective for years beginning on or after January 1, 2024. and are not expected to have an impact on the Company's financial statements due to the history of the Company of satisfying covenants, as well as the consistency between the Company's classification policies for current and non-current liabilities and the clarifications established by the amendments." 3.26.2 Amendments to IFRS 16 06 2 sale and leaseback IASB changed the amendments issued for IFRS 16 06 2 15 47 The amendments are effective for years beginning on or after January 1, 2024, and are not expected to have an impact on the Company's financial statements, as there is consistency between the Company's policies for sale and leaseback accounting and the clarifications established by the amendments (including the disclosure of leaseback recognition as disclosed in explanatory note no. 17 3.26.3 Amendments to IFRS 7 7 IASB issued amendments to IFRS 7 7 These additional required disclosures will include: (a) the terms and conditions of the arrangements (for example, extended payment terms and security or guarantees provided); (b) as at the beginning and end of the reporting period: (i) the carrying amounts, and associated line items, of the financial liabilities that are part of a supplier finance arrangement; (ii) the carrying amounts, and associated line items, of the financial liabilities for which suppliers have already received payment from the finance providers; (iii) the range of payment due dates for both the financial liabilities disclosed under (i), as the comparable trade payables that are not part of a supplier finance arrangement; and (c) the type and effect of non-cash changes in the carrying amounts of the financial liabilities. The amendments are applicable for years beginning on or after January 1, 2024, and do not affect the measurement and classification bases for such transactions in the financial statements. The Company will include such disclosures in its financial statements when these changes become effective.
New standards, amendments and interpretations of standards adopted for the first time for the year beginning on January 1, 2022	3.27 New standards, amendments and interpretations of standards adopted for the first time for the year beginning on January 1, 202 3 Standards and changes that came into force as of the years started on or after January 1, 2023, did not have any material impact on the Company’s financial statements. The Company has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. As of January 1, 2023, amendments to CPC 23 8 26 1 1 2 26 1 Additionally, in May 2023 IASB published amendments to IAS 12 2 During 2023 Two 12 Two Based on the Company’s ongoing evaluation of the CBCR-SH rules published by the OECD and expected to be enacted as applied to the results, the Company does not expect that there would be any material significant exposure to incremental income taxes associated with Pillar II legislation. The Company’s analysis is currently indicating that substantially all countries in which the Natura Group operates will satisfy at least one three The Group will continue to assess its exposure to Pillar II as further legislation is implemented for Pillar II as well as the CBCR-SH. Provided that further legislation is aligned with OECD guidance, the Group would not expect any change in our present assessment noted herein.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Polices (Tables)	12 Months Ended
	Dec. 31, 2023
Text Block [Abstract]
Summary of Information About Company Principal Subsidiaries	Interest - % 2023 2022 Direct interest: Avon Products, Inc. 100.00 100.00 Natura Cosméticos S.A. 100.00 100.00 Natura &Co International S.à r.l. 100.00 100.00

FINANCIAL RISK MANAGEMENT (Tabl

FINANCIAL RISK MANAGEMENT (Tables)	12 Months Ended
	Dec. 31, 2023
FINANCIAL RISK MANAGEMENT
Summary of financial derivative positions	Consolidated Fair value Gains (losses) of fair value adjustment Description 2023 2022 2021 2023 2022 2021 Swap agreements: (a) Asset portion: Dollar long position 876,664 6,108,505 6,881,981 19,457 34,867 978,350 Liability portion: Post-fixed CDI Rate: Short position in CDI (824,344 ) (6,874,285 ) (6,348,442 ) - (697,678 ) (823,887 ) Forward contracts and NDF: Liability portion: Post-fixed CDI Rate: Natura Cosméticos (5,878 ) (521 ) (48 ) (2,090 ) (521 ) (48 ) Natura Indústria (28,856 ) (6,633 ) - (28,856 ) (6,633 ) - Natura Mexico (Latam) 320 - - 151 - - The Body Shop - 16,789 (2,554 ) - (1,180 ) 12 Aesop - (1,350 ) - - 90 - Avon Brasil (3,702 ) (1,183 ) - (3,702 ) (1,183 ) - Avon Internacional (43,248 ) (19,203 ) (14,462 ) (28,633 ) (6,925 ) 106 Natura Luxembourg (22,182 ) (18,996 ) (89 ) 180 2,293 (89 ) Total derivative instruments, net: (51,226 ) (796,877 ) 516,386 (43,493 ) (676,870 ) 154,420 a) Swap transactions consist of swapping the exchange rate variation for a correction related to a percentage of the fluctuation of the Certificate of bank deposits (post-fixed CDI), in the case of Brazil
Schedule of changes in net financial derivatives	Consolidated Balance as of December 31, 2021 516,637 Losses from swap and forward derivative contracts for the year (unrealized) (992,813 ) Payment of funds due to settlement of derivative transactions - operational activity 594,225 Receipt of funds due to settlements of derivative instruments - financing activity (118,707 ) Losses in cash flow hedge operations (other comprehensive income) (790,479 ) Other movements (5,740 ) Balance as of December 31, 2022 (796,877 ) Losses from swap and forward derivative contracts for the year (unrealized) (1,791,905 ) Payment of funds due to settlement of derivative transactions - operational activity 1,487,092 Payment of funds due to settlements of derivative instruments - financing activity 310,870 Losses in cash flow hedge operations (other comprehensive income) 746,648 Other movements (7,054 ) Balance as of December 31, 2023 ( 51,226 )
Disclosure Of Net Asset Exposure	Consolidated 2023 2022 Borrowing and financing in foreign currency in Brazil (a) - (5,252,376 ) Trade accounts receivable in foreign currency in Brazil 328,346 521,427 Trade accounts payable in foreign currencies in Brazil (158,500 ) (15,214 ) Fair value of financial derivatives (38,436 ) 6,101,350 Net asset exposure 131,410 1,355,187 a) Excluding transaction costs.
Disclosure Of Net Foreign Exchange Exposure	Consolidated Parity - R$ vs US$ 4.8413 3.6715 2.4477 Scenario Scenario I Scenario II Operation/Instrument Brazilian Real Depreciation 25 Depreciation 50 Assets denominated in US$ Fair value of “financial” derivatives (38,436 ) (29,149 ) (19,432 ) Trade accounts receivable in foreign currency in Brazil 328,346 249,007 166,005 Liabilities denominated in US$ Trade accounts payable in foreign currencies in Brazil (158,500 ) (120,201 ) (80,134 ) Impact on net income and shareholders’ equity 131,410 (31,753 ) (64,971 )
Disclosure of Detailed Information About Cash Flow Hedged Items	Other comprehensive income Hedged item Notional currency Fair value Gain (loss) in the year Gain (loss) in the year Currency swap – US$/R$ - Natura Cosméticos Currency and interest rate BRL (5,878 ) (2,090 ) 763,197 Forward agreements (Avon Industria) Currency BRL (3,702 ) (3,702 ) 5,452 Forward agreements (Natura Dist. Mexico) Currency BRL 320 151 151 Forward agreements (Natura Industria) Currency BRL (21,497 ) (21,497 ) ( 22,637 ) Forward agreements (Natura Holding) Currency BRL 1,731 486 485 Total (29,026 ) (26,652 ) 746,648
Disclosure of changes in cash flow hedge reserve recorded in OCI	Consolidated Cash flow hedge balance as of December 31, 2020 159,077 Change in the fair value of hedge instrument recognized in OCI (210,150 ) Tax effects on fair value of hedge instrument 72,939 Cash flow hedge balance as of December 31, 2021 21,866 Change in the fair value of hedge instrument recognized in OCI (790,479 ) Tax effects on fair value of hedge instrument 270,035 Cash flow hedge balance as of December 31, 2022 (498,578 ) Change in the fair value of hedge instrument recognized in OCI 746,648 Tax effects on fair value of hedge instrument (251,950 ) Cash flow hedge balance as of December 31, 2023 (3,880 )
Disclosure of the net position of derivative instruments designated as fair value hedges consists exclusively of financial derivatives	Protection object Reference currency (Notional) Fair value Fair value Interest Rate BRL 52,319 Total 52,319
Disclosure of Detailed Information About Interest Rate Risks of Transactions	Consolidated Total borrowing, financing and debentures - in local currency (note 19 (6,111,702 ) Operations in foreign currency with derivatives related to CDI (a) 52,319 Short-term investments (notes 6 7 5,661,434 Net exposure (397,949 ) (a) Refers to transactions involving derivatives related to CDI to hedge the borrowing, financing and debentures arrangements raised in foreign currency in Brazil.
Summary of Net Exposure to Interest Rate Risk by Scenario	Description Company Risk Probable scenario Scenario II Scenario III Consolidated Net liability Rate increases (5,683 ) 40,184 86,050
Summary of net working capital	Consolidated 2023 2022 Total current assets 15,987,222 16,121,527 Total current liabilities (10,413,499 ) (13,337,868 ) Total net working capital 5,573,723 2,783,659
Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities	2023 Less than a year One five More than five Total expected contractual cash flow Interest to be accrued Carrying amount Borrowing, financing and debentures 357,568 4,194,476 4,078,504 8,630,548 (2,518,846 ) 6,111,702 Derivatives 140,679 71,134 (160,587 ) 51,226 - 51,226 Lease liability 401,217 912,529 135,207 1,448,953 (298,513 ) 1,150,440 Trade accounts payables, related parties and reverse factoring operations 5,302,478 - - 5,302,478 - 5,302,478 Dividends payable 294,231 - - 294,231 - 294,231 2022 Less than a year One five More than five Total expected contractual cash flow Interest to be accrued Carrying amount Borrowing, financing and debentures 722,146 3,228,866 13,140,599 17,091,611 (3,499,325) 13,592,286 Derivatives 640,257 1,504,007 (1,347,387) 796,877 - 796,877 Lease liability 1,070,253 2,019,723 856,402 3,946,378 (675,641) 3,270,737 Trade accounts payables, related parties and reverse factoring operations 6,375,930 - - 6,375,930 - 6,375,930 Dividends payable 260 - - 260 - 260
Disclosure of carrying amounts and fair values of the Company’s financial instruments	Carrying amount Fair value Consolidated Nota Classification by category Fair value hierarchy 2023 2022 2023 2022 Financial assets Cash and cash equivalent 6 Cash and banks Amortized cost Level 2 2,113,566 2,904,808 2,113,566 2,904,808 Certificate of bank deposits Fair value through profit or loss Level 2 203,561 46,864 203,561 46,864 Repurchase operations Fair value through profit or loss Level 2 1,433,817 1,244,041 1,433,817 1,244,041 3,750,944 4,195,713 3,750,944 4,195,713 Short-term investments 7 Government securities Fair value through profit or loss Level 2 1,272,445 31,415 1,272,445 31,415 Restricted cash Fair value through profit or loss Level 2 30,240 1,481 30,240 1,481 Financial treasury bills Fair value through profit or loss Level 2 392,253 539,450 392,253 539,450 Loan investment fund Fair value through profit or loss Level 2 2,329,118 1,228,093 2,329,118 1,228,093 DBV fund Fair value through profit or loss Level 3 36,698 35,235 36,698 35,235 4,060,754 1,835,674 4,060,754 1,835,674 Trade accounts receivables - related parties 8 32.1 Amortized cost Level 2 3,524,395 3,502,399 3,524,395 3,502,399 Judicial deposits 12 Amortized cost Level 2 408,030 457,550 408,030 457,550 Sublease receivables 14 Amortized cost Level 2 180,440 262,108 180,440 262,108 Receivables from service providers 14 Amortized cost Level 2 109,639 110,214 109,639 110,214 Accounts receivable - sale of subsidiary Amortized cost Fixed consideration 34 Amortized cost Level 2 343,068 - 343,068 - Contingent consideration 34 Fair value through profit or loss Level 3 486,429 - 486,429 - 5,052,001 4,332,271 5,052,001 4,332,271 Financial derivatives (hedge instrument) Fair value through profit or loss Level 2 23,293 - 23,293 - Financial derivative instruments Fair value through profit or loss Level 2 255,157 1,008,365 255,157 1,008,365 278,450 1,008,365 278,450 1,008,365 Financial liabilities Borrowing, financing and debentures 19 Borrowing in local currency Amortized cost Level 2 (6,111,702 ) (8,419,320 ) (6,111,702 ) (8,419,320 ) Foreign currency borrowings Amortized cost Level 2 - (5,172,966 ) - (5,172,966 ) (6,111,702 ) (13,592,286 ) (6,111,702 ) (13,592,286 ) Financial and operating derivative instruments Fair value through profit or loss Level 2 (329,676 ) (1,805,242 ) (329,676 ) (1,805,242 ) Lease liability 18 Amortized cost Level 2 (1,150,440 ) (3,270,737 ) (1,150,440 ) (3,270,737 ) Prepaid insurance Amortized cost Level 2 14,013 - 14,013 - Trade accounts payables, related-parties’ and reverse factoring 20 32.1 Amortized cost Level 2 (5,302,478 ) (6,375,930 ) (5,302,478 ) (6,375,930 ) Insurance payables 23 Amortized cost Level 2 (1,239 ) (69,364 ) (1,239 ) (69,364 ) Dividends payable 24 Amortized cost Level 2 (294,231 ) (260 ) (294,231 ) (260 )

CASH AND CASH EQUIVALENT (Table

CASH AND CASH EQUIVALENT (Tables)	12 Months Ended
	Dec. 31, 2023
CASH AND CASH EQUIVALENT
Schedule of Detailed Information About Cash And Cash Equivalents	Consolidated 2023 2022 Cash and banks 2,113,566 2,904,808 Certificate of bank deposits 203,561 46,864 Repurchase operations (a) 1,433,817 1,244,041 3,750,944 4,195,713 (a) Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”), these investments offer high liquidity with a redemption period of up to 90 2022

SHORT-TERM INVESTMENTS (Tables)

SHORT-TERM INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2023
Short Term Investments [Abstract]
Schedule of Short-Term Investments	Consolidated 2023 2022 Loan investment funds (a) 2,329,118 1,228,093 Treasury bills (b) 392,253 539,450 Government securities (LFT) (c) 1,272,445 31,415 DBV fund 36,698 35,235 Restricted cash 30,240 1,481 4,060,754 1,835,674 Current 4,024,056 1,800,439 Non-current 36,698 35,235 (a) Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the entities of Argentina, Chile, Colombia and Mexico. (b) As of December 31, 2023, investments in treasury bills are remunerated at an average rate of 108.15% of the CDI (109.69% as of December 31, 2022). (c) As of December 31, 2023, investments in Government securities (LFT) are remunerated at an average rate of 100.75% of the CDI (100.02% of the CDI as of December 31, 2022).
Schedule of Detailed Information About Investment Portfolio	Consolidated 2023 2022 Certificate of bank deposits (CDB) 644 2,012 Repurchase operations (cash and cash equivalents) 1,433,487 937,645 Treasury bills 392,253 539,450 Government securities (LFT) 1,272,445 46,071 3,098,829 1,525,178

TRADE ACCOUNTS RECEIVABLE (Tabl

TRADE ACCOUNTS RECEIVABLE (Tables)	12 Months Ended
	Dec. 31, 2023
Statement [Line Items]
Schedule of Detailed Information About Trade Receivables	Consolidated 2023 2022 Trade accounts receivable 3,893,880 3,933,550 (-) Allowance for expected credit losses (369,485 ) (431,151 ) 3,524,395 3,502,399
Schedule of Trade Receivables by Exposure to Doubtful Accounts	Consolidated 2023 2022 Trade accounts receivable Allowance for expected credit losses Trade accounts receivable Allowance for expected credit losses Current 3,150,046 (111,784 ) 2,814,843 (94,148 ) Past due: Up to 30 348,851 (48,397 ) 621,711 (59,764 ) 31 60 89,271 (32,502 ) 142,507 (53,609 ) 61 90 66,496 (31,128 ) 106,124 (48,851 ) 91 180 239,194 (145,656 ) 248,365 (174,779 ) Over 180 22 (18 ) - - 3,893,880 (369,485 ) 3,933,550 (431,151 )
Trade receivables [member]
Statement [Line Items]
Schedule of Allowance For Credit Losses	Consolidated Balance as of December 31, 2020 (432,108 ) Additions, net of reversals (837,822 ) Write-offs (a) 817,446 Translation adjustment (1,497 ) Balance as of December 31, 2021 (453,981 ) Additions, net of reversals (605,995 ) Write-offs (a) 592,857 Translation adjustment 35,968 Balance as of December 31, 2022 (431,151 ) Write-off from sale of subsidiaries 7,107 Additions, net of reversals (605,874 ) Write-offs (a) 634,657 Translation adjustment 25,776 Balance as of December 31, 2023 (369,485 ) (a) Refers to accounts overdue for more than 180

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2023
INVENTORIES
Schedule of Inventories	Consolidated 2023 2022 Finished products 2,390,999 3,634,068 Raw materials and packaging 882,514 1,159,507 Auxiliary materials 224,370 146,409 Products in progress 41,604 68,849 (-) Provision for inventory losses (452,092 ) (491,959 ) 3,087,395 4,516,874
Schedule of Changes In The Allowance For Inventory Losses	Consolidated Balance as of December 31, 2020 (594,071 ) Additions, net of reversals (a) (837,822 ) Write- off (b) 817,446 Translation adjustment (1,497 ) Balance as of December 31, 2021 (615,944 ) Additions, net of reversals (a) (305,705 ) Write- off (b) 366,198 Translation adjustment 63,492 Balance as of December 31, 2022 (491,959 ) Write-off from sale of subsidiaries 63,971 Additions, net of reversals (a) (422,498 ) Write-o ffs (b) 352,519 Translation adjustment 45,875 Balance as of December 31, 2023 (452,092 ) a) This refers to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company. b) It consists of write-offs of products for which there already had an allowance for losses, where the Company has no expectation of sales/realization.

RECOVERABLE TAXES (Tables)

RECOVERABLE TAXES (Tables)	12 Months Ended
	Dec. 31, 2023
RECOVERABLE TAXES
Schedule of Current Tax Assets	Consolidated 2023 2022 ICMS on purchase of go ods (a) 561,224 704,018 Taxes on purchase of goods – foreign subsidiaries 214,699 245,955 ICMS on purchases of property, plant and equipment and purchase of goods 15,912 14,365 PIS and COFINS on purchase of property, plant and equipment and purchase of g oods (b) 620,631 950,307 Withholding PIS, COFINS and CSLL 1,671 1,671 Tax on Manufactured Goods - IPI (c) 127,127 152,686 Other 179,673 199,276 1,720,937 2,268,278 Current 608,530 911,410 Non-current 1,112,407 1,356,868 a) Tax credits related to the tax on the circulation of goods, interstate and inter-municipal transport and communication services (ICMS) were generated mainly by purchases, whose tax rate is higher than the average of sales. The Company expects to realize these credits during the ordinary course of business through offsetting with sales operations in the domestic market. b) The accumulated tax credits of PIS and COFINS basically arise from credits on purchases of raw materials used in the production and from purchase of property, plant and equipment, as well as credits arising out of the exclusion of ICMS from the calculation basis of the PIS/COFINS. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. c) The balance will be used to offset IPI (Taxes over industrialized products) payable in future operations of the Company.

INCOME TAX AND SOCIAL CONTRIB_2

INCOME TAX AND SOCIAL CONTRIBUTION (Tables)	12 Months Ended
	Dec. 31, 2023
INCOME TAX AND SOCIAL CONTRIBUTION
Summary of breakdown of deferred income tax and social contribution – Assets	Consolidated 2023 2022 Tax loss carryforwards 1,778,203 2,465,805 Receivables 141,595 192,260 Inventory 141,650 219,367 Fixed and intangible assets 31,991 160,716 Lease liabilities 262,175 444,444 Accruals, reserves and provision for tax, civil and labor risks (b) 358,108 649,768 Employee benefits 340,807 373,817 Non-functional currency positions, including derivatives and hedge accounting transactions (c) 9,811 307,732 Foreign t ax c redit c arryforwards (a) 10,003 363,493 Other temporary differences 145,151 124,689 Total deferred tax assets 3,219,494 5,302,091 Non-functional currency positions, including derivatives and hedge accounting transactions (c) (16,500 ) - Fixed and intangible assets (213,266 ) (339,627 ) Employee benefits (145,149 ) (132,609 ) Right to use assets (195,814 ) (359,072 ) Contingent consideration (157,966 ) - Fair value of identifiable net assets in business combination (d) (281,436 ) (1,561,946 ) Other temporary differences (336,758 ) (323,736 ) Total deferred tax liabilities (1,346,889 ) (2,716,990 ) Total of deferred income tax and social contribution, net 1,872,605 2,585,101 Deferred income taxes and social contribution assets, net (e) 2,200,695 3,519,515 Deferred income taxes and social contribution liabilities, net (e) (328,090 ) (934,414 ) a) Primarily relates to foreign tax credit in Brazil that had historically been reported as prepaid income taxes rather than deferred tax assets. b) Includes (i) expenses under the accrual basis, reflecting deductible expenses incurred in the year, (ii) deferred revenue, (iii) accrued and unpaid compensation and (iv) other reserves not currently deductible for tax. c) Due to underlying changes in non-functional currencies relative to the Brazilian Real, the balance at 2023 year-end primarily reflects a loss on a hedge instrument that can only be deducted when the hedge instrument is settled; as of 2022 year-end, the balance primarily reflected a gain on a hedge which could be deferred until settlement. d) The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of the subsidiaries Avon, The Body Shop and Aesop. e) Balance presented in the balance sheet including the effects of the jurisdictional offset of deferred tax assets and liabilities of the same nature, originating from the same taxpayer and tax authority.
Summary of changes in deferred asset and liability income tax and social contribution	Consolidated Asset Liability Balance as of December 31, 2021 3,100,515 (994,041 ) Effect on statement of profit or loss 599,136 (1,071 ) Reserve for grant of options and restricted shares 28,750 (1,617 ) Other comprehensive income impact 270,035 - Translation adjustment (478,921 ) 62,315 Balance as of December 31, 2022 3,519,515 (934,414 ) Effect on income statement (894,732 ) (167,668 ) Transfer between deferred income tax and social contribution liabilities and assets (18,502 ) 18,502 Reclass of UTP to Deferred Tax Liability - (46,760 ) Transfer of Prepaid to Deferred Tax 20,213 Discontinued operations (374,090 ) 788,977 Reserve for grant of options and restricted shares (31,772 ) 2,486 Other comprehensive income impact 8,195 - Translation adjustment (28,132 ) 10,787 Balance as of December 31, 2023 2,200,695 (328,090 )
Schedule of tax losses carryforwards for which no deferred tax asset recognised	Item Amount Indefinite Expiration Definite Expiration Net operating loss (a) 9,513,303 8,715,748 797,555 Credits (b) 584,474 - 584,474 Other future deductible Items 2,156,658 2,156,658 Total 12,254,435 10,872,406 1,382,029 a) During , no significant expirations are expected; the majority of expirations are expected to occur in and successive years. b) During 2024 2027 .
Summary of reconciliation of income tax and social contribution	Consolidated 2023 2022 Loss before income tax and social contribution (2,668,347 ) (2,168,618 ) Income tax and social contribution at the rate of 34% 907,238 737,330 Brazil Investment subsidies 427,897 207,608 Share of profit of equity investees - - Effect from differences of tax rates of entities abroad (147,265 ) (103,447 ) Taxation of profits of foreign subsidiaries (a) (49,264 ) 56,126 Unrecognized Deferred income tax ( b ) (642,608 ) (762,362 ) Exercise of purchase options and restricted share plans 52 Non-Deductible donation and contribution (27,136 ) (35,616 ) Interest on Net Equity - - Withholding and Sub-national taxes not recognized (42,763 ) (60,121 ) Goodwill impairment (b) (225,723 ) (70,730 ) Other permanent differences (113,976 ) (61,193 ) Income tax and social contribution benefit (expenses) 86,400 (92,353 ) Income tax and social contribution - current (976,000 ) (690,418 ) Income tax and social contribution - deferred 1,062,400 598,065 Effective tax rate - % 4.3% (4.3% ) a) Certain earnings of foreign subsidiaries may be subjected to income taxation net of applicable credits, if any, by their parent holding companies in addition to the local taxing jurisdictions in which they conduct operations. Within the Natura Group, these types of taxation regimes exist in various jurisdictions including but not limited to Brazil, Australia, United Kingdom, United States. b) During 2022 and 2023 , the Company recognizes an impairment of the g oodwill associated with Avon International CGU. The Avon International g oodwill resulting from its acquisition is non-deductible for income tax purposes.

JUDICIAL DEPOSITS (Tables)

JUDICIAL DEPOSITS (Tables)	12 Months Ended
	Dec. 31, 2023
JUDICIAL DEPOSITS
Summary of detailed information about judicial deposits	Consolidated 2023 2022 Unaccrued tax proc eedings (a) 228,331 274,273 Accrued tax proc eeding (b) 154,077 150,929 Unaccrued civil proceedings 5,462 5,783 Accrued civil proceedings 1,453 1,470 Unaccrued labor proceedings 10,018 11,014 Accrued labor proceedings 8,689 14,081 Total judicial deposits 408,030 457,550 a) The tax proceedings related to these judicial deposits refer mainly to the ICMS-ST. b) The tax proceedings related to these judicial deposits refer, substantially, to the sum of the amounts highlighted in note no. 21 20
Summary of detailed information about changes in judicial deposits	Consolidated Balance as of December 31, 2021 585,284 New deposits 27,479 Redemptions in favor of the Company (67,533 ) Monetary adjustment 35,508 Application in the liquidation of proceedings (121,025 ) Transfers 25 Translation adjustment (2,188 ) Balance as of December 31, 2022 457,550 Consolidated Balance as of December 31, 2022 457,550 New deposits 13,493 Redemptions in favor of the Company (35,227 ) Monetary adjustment 28,460 Application in the liquidation of proceedings (55,494 ) Translation adjustment (752 ) Balance as of December 31, 2023 408,030

NON-CURRENT ASSETS HELD FOR S_2

NON-CURRENT ASSETS HELD FOR SALE (Tables)	12 Months Ended
	Dec. 31, 2023
NON-CURRENT ASSETS HELD FOR SALE
Schedule of the changes in assets classified as held for sale	Consolidated Balance as of December 31, 2021 52,921 Transfers from property, plant and equipment, other assets and liabilities 13,235 Impairment (12,510 ) Sal e (55,034 ) Translation adjustment 1,439 Balance as of December 31, 2022 51 Balance as of December 31, 2022 51 Transfers from the former subsidiary Aeso p (a) 2,492,471 Other transf ers (b) 555,013 Impairment (c) (53,117 ) Write off due to ale (d) (2,988,713 ) Translation adjustment (5,705 ) Balance as of December 31, 2023 - a) These transfers include the assets of the former subsidiary Aesop, and whose sale was assessed as highly probable in the quarter ended March 31, 2023. The sales impacts are presented in note no. 36 b) The other transfers include certain properties of the subsidiary Avon, located in the United States, Chile and Brazil. c) Reflect the recognition of loss due to impairment of properties of the subsidiary Avon, located in the United States, Chile and Brazil, transferred to non-current assets held for sale and being tested for impairment purposes upon transfer and consequent measurement to the lower of fair value less selling costs and previous book value. d) The write-offs due to disposal presented in the movement include the value of the assets of the former subsidiary Aesop. Also among the write-offs are the sale of an asset of the subsidiary Avon in Chile, amounting to R$37,484.

OTHER CURRENT AND NONCURRENT _2

OTHER CURRENT AND NONCURRENT ASSETS (Tables)	12 Months Ended
	Dec. 31, 2023
OTHER CURRENT AND NONCURRENT ASSETS
Summary of detailed information about other assets	Consolidated 2023 2022 Marketing and advertising advances 43,150 43,509 Supplier advances 203,193 290,205 Employee advances 19,297 20,267 Rent advances and guarantee deposit (a) 20,284 160,437 Advance insurance expenses 110,355 124,293 Overfunded pension plan (b) 723,130 694,527 Customs broker advances - Import taxes 43,316 38,398 Sublease receivables (c) 180,440 262,108 Carbon credits 13,970 14,297 Receivables from service providers (d) 109,639 110,214 Other 165,332 257,566 1,632,106 2,015,821 Current 604,427 763,384 Non-current 1,027,679 1,252,437 a) Mainly related to: (i) advances for lease agreements that were not included in the initial measurement of lease liabilities / right-of-use of the former subsidiary Avon, in accordance with the exemptions of IFRS 16 06 2 2022 b) Pension plan arising from the acquisition of subsidiary Avon. The variance in the balance refers to the revision in mortality tables offset by the impact of exchange rate variation due to the appreciation of the real. c) Refers to the sublease receivable from the New York office owned by the subsidiary Avon. d) Refers to receivables mainly arising from damage that occurred with carriers and insurance companies

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2023
PROPERTY, PLANT AND EQUIPMENT
Summary Of Detailed Information About Property, Plant And Equipment	Consolidated Useful life range (in years) 2022 Additions Write-offs Transfers Transfer to asset held for sale Write-off due to sale of subsidiary Translation adjustment 2023 Cost: Vehicles 2 to 5 74,362 9,285 (5,629 ) 11 - - (30,292 ) 47,737 Tooling 3 204,177 72 (135 ) 6,700 - - 212 211,026 Tools and accessories 3 to 20 175,452 13,676 (16,033 ) 4,360 - - 4,275 181,730 Facilities 3 to 60 307,448 984 (1,338 ) 25,016 (166 ) - 7,491 339,435 Machinery and accessories 3 to 15 2,272,136 37,809 (75,340 ) 180,157 (25,065 ) (62,120 ) (127,358 ) 2,200,219 Leasehold improvements 2 to 20 1,128,086 47,444 (93,243 ) 4,514 (696,954 ) (223,379 ) (28,035 ) 138,433 Buildings 14 to 60 1,916,939 15,966 (56,721 ) (2,617 ) (582,033 ) (28,653 ) (132,441 ) 1,130,440 Furniture and fixtures 2 to 25 674,062 57,609 (89,422 ) 672 (93,440 ) (359,311 ) (31,344 ) 158,826 Land - 645,657 30,313 (631 ) - (267,425 ) (4,934 ) (13,106 ) 389,874 IT equipment 3 to 15 627,770 23,286 (108,116 ) 9,268 (52,223 ) (66,626 ) (39,004 ) 394,355 Other assets - 26,230 - (12 ) - - - (758 ) 25,460 Projects in progress - 580,627 376,452 (35,425 ) (318,663 ) (38,743 ) (11,016 ) (54,937 ) 498,295 Total cost 8,632,946 612,896 (482,045 ) (90,582 ) (1,756,049 ) (756,039 ) (445,297 ) 5,715,830 Accumulated depreciation: Vehicles (38,070 ) (5,812 ) 4,912 - (24) - 16,107 (22,887 ) Tooling (179,485 ) (8,920 ) 135 (13 ) - - (117 ) (188,400 ) Tools and accessories (135,440 ) (17,766 ) 15,872 (1,260 ) - - 76,188 (62,406 ) Facilities (201,307 ) (14,395 ) 2,554 (390 ) 166 - 6,033 (207,339 ) Machinery and accessories (1,118,339 ) (203,294 ) 62,508 (126 ) 17,185 37,722 15,722 (1,188,622 ) Leasehold improvements (626,431 ) (65,843 ) 89,857 - 464,551 120,073 23,647 5,854 Buildings (455,402 ) (105,083 ) 27,612 6 301,177 10,480 60,398 (160,812 ) Furniture and fixtures (408,832 ) (79,210 ) 71,758 1,620 62,651 248,773 22,245 (80,995 ) IT equipment (475,668 ) (64,163 ) 105,080 14 31,284 44,521 (13,775 ) (372,707 ) Other assets (27,822 ) (549 ) - - - - 48,429 20,058 Total depreciation (3,666,796 ) (565,035 ) 380,288 (149 ) 876,990 461,569 254,877 (2,258,256 ) Net total 4,966,150 47,861 (101,757 ) (90,731 ) (879,059 ) (294,470 ) (190,420 ) 3,457,574 Consolidated Useful life range (in years) 2021 Additions Write-offs Impairment Transfers Translation adjustment 2022 Cost: Vehicles 2 to 5 38,902 8 (6,559 ) - 49,285 (7,274 ) 74,362 Tooling 3 191,840 - (2,310 ) - 14,976 (329 ) 204,177 Tools and accessories 3 to 20 110,998 17,261 (8,177 ) - (43,369 ) 98,739 175,452 Facilities 3 to 60 303,452 181 (564 ) - 13,147 (8,768 ) 307,448 Machinery and accessories 3 to 15 1,959,943 23,188 (63,473 ) - 520,561 (168,083 ) 2,272,136 Leasehold improvements 2 to 20 1,128,504 68,980 (54,148 ) (1,665 ) 106,151 (119,736 ) 1,128,086 Buildings 14 to 60 1,982,245 7,174 (19,104 ) - 120,512 (173,888 ) 1,916,939 Furniture and fixtures 2 to 25 660,126 71,960 (41,095 ) (7,629 ) 53,632 (62,932 ) 674,062 Land - 628,373 - - - 10,043 7,241 645,657 IT equipment 3 to 15 634,580 26,602 (34,279 ) (191 ) 84,452 (83,394 ) 627,770 Other assets - 31,636 - (4,227 ) - - (1,179 ) 26,230 Projects in progress - 561,488 495,771 (1,739 ) - (429,391 ) (45,502 ) 580,627 Total cost 8,232,087 711,125 (235,675 ) (9,485 ) 499,999 (565,105 ) 8,632,946 Accumulated depreciation: Vehicles (9,457 ) (6,057 ) 5,508 - (40,920 ) 12,856 (38,070 ) Tooling (174,164 ) (7,841 ) 2,310 - - 210 (179,485 ) Tools and accessories (65,740 ) (16,385 ) 1,823 - 46,967 (102,105 ) (135,440 ) Facilities (183,420 ) (17,051 ) 192 - (8,804 ) 7,776 (201,307 ) Machinery and accessories (728,408 ) (172,480 ) 56,142 - (397,740 ) 124,147 (1,118,339 ) Leasehold improvements (602,622 ) (133,533 ) 50,379 - (12,257 ) 71,602 (626,431 ) Buildings (298,327 ) (103,822 ) 14,111 - (136,601 ) 69,237 (455,402 ) Furniture and fixtures (369,610 ) (90,731 ) 31,606 - (18,576 ) 38,479 (408,832 ) IT equipment (392,095 ) (119,870 ) 36,065 - (71,041 ) 71,273 (475,668 ) Other assets (30,836 ) (2,287 ) 3,868 - - 1,433 (27,822 ) Total depreciation (2,854,679 ) (670,057 ) 202,004 - (638,972 ) 294,908 (3,666,796 ) Net total 5,377,408 41,068 (33,671 ) (9,485 ) (138,973 ) (270,197 ) 4,966,150

INTANGIBLES (Tables)

INTANGIBLES (Tables)	12 Months Ended
	Dec. 31, 2023
INTANGIBLES
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill	Consolidated Useful life range (in years) 2022 Additions Write-offs Impairment Transfers Transfer to asset held for sale Write-off due to sale of subsidiary Translation adjustment 2023 Cost: Software 2.5 to 10 2,949,813 391,102 (621,831 ) - 96,351 (96,956 ) (469,184 ) (150,242 ) 2,099,053 Trademarks and patents (defined useful life) 20 to 25 813,204 - - - - (139,869 ) (4,443 ) (49,005 ) 619,887 Trademarks and patents (indefinite useful life) - 4,818,030 - - - - - (2,503,964 ) 36,281 2,350,347 Goodwill Avon (a) - 12,307,865 - - (663,892 ) - - - (390,514 ) 11,253,459 Goodwill Emeis Brazil Pty Ltd. (b) - 124,315 - - - - (124,315 ) - - - Goodwill The Body Shop (c) - 1,645,527 - - - - - (1,701,981 ) 56,454 - Goodwill acquisition of The Body Shop stores - 1,456 - - - - - (1,456 ) - - Goodwill aquisition of Singu - - 52,049 - - - - - - 52,049 Relationship with retail clients 10 2,583 - (2,856 ) - - (2,255 ) (4,021 ) 6,752 203 Key money (indefinite useful life) (d) - 22,313 - (14,601 ) - - - (7,719 ) 7 - Key money (defined useful life) (e) 3 to 18 7,828 1,329 (3,519 ) - - - (5,279 ) (359 ) - Relationship with franchisees and sub franchisees and sales representative (f) 14 to 15 2,676,563 - - - - - (686,701 ) (57,787 ) 1,932,075 Technology developed (by acquired subsidiary) - 1,457,039 - - - - - - (105,109 ) 1,351,930 Other intangible assets and intangible under development - 133,403 3,779 (18,995 ) - (8,115 ) (9,797 ) (83,397 ) (10,149 ) 6,729 Total cost 26,959,939 448,259 (661,802 ) (663,892 ) 88,236 (373,192 ) (5,468,145 ) (663,671 ) 19,665,732 Accumulated amortization: Software (1,720,169 ) (439,031 ) 584,109 - 1,875 75,818 387,808 96,495 (1,013,094 ) Trademarks and patents (169,620 ) (31,901 ) - - - 45,298 12,127 18,919 (125,177 ) Key money (10,103 ) - - - - - 10,103 - - Relationship with retail clients (2,968 ) (1,668 ) 2,719 - - 2,255 - (540 ) (202 ) Relationship with franchisees and sub franchisees (918,994 ) (260,104 ) - - - - 279,726 30,248 (869,124 ) Technology developed (874,225 ) (278,969 ) - - - - - 71,649 (1,081,545 ) Other intangible assets (2,890 ) (4,136 ) 16,757 - 619 9,797 - (26,871 ) (6,724 ) Total accrued amortization (3,698,969 ) (1,015,809 ) 603,585 - 2,495 133,168 689,764 189,900 (3,095,866 ) Net total 23,260,970 (567,550 ) (58,217 ) (663,892 ) 90,731 (240,024 ) (4,778,381 ) (473,771 ) 16,569,866 Consolidated Useful life range (in years) 2021 Additions Write-offs Impairment Transfers Translation adjustment 2022 Cost: Software 2.5 to 10 2,492,616 155,044 (43,333 ) (21,381 ) 640,903 (274,036 ) 2,949,813 Trademarks and patents (defined useful life) 20 to 25 889,834 - - - - (76,630 ) 813,204 Trademarks and patents (indefinite useful life) - 5,888,623 - (43 ) - - (1,070,550 ) 4,818,030 Goodwill Avon (a) - 13,381,191 - - (282,921 ) - (790,405 ) 12,307,865 Goodwill Emeis Brazil Pty Ltd. (b) - 143,180 - - - - (18,865 ) 124,315 Goodwill The Body Shop (c) - 2,063,672 - - (2,599 ) - (415,546 ) 1,645,527 Goodwill acquisition of The Body Shop stores - 1,456 - - - - - 1,456 Relationship with retail clients 10 2,880 - - - - (297 ) 2,583 Key money (indefinite useful life) (d) - 24,985 268 (152 ) (623 ) - (2,165 ) 22,313 Key money (defined useful life) (e) 3 to 18 14,363 - (3,618 ) (940 ) - (1,977 ) 7,828 Relationship with franchisees and sub franchisees and sales representative (f) 14 to 15 2,990,558 - - - - (313,995 ) 2,676,563 Technology developed (by acquired subsidiary) - 1,580,808 - - - - (123,769 ) 1,457,039 Other intangible assets and intangible under development - 277,776 207,911 (21 ) - (336,346 ) (15,917 ) 133,403 Total cost 29,751,942 363,223 (47,167 ) (308,464 ) 304,557 (3,104,152 ) 26,959,939 Accumulated amortization: Software (1,369,767 ) (417,253 ) 42,462 - (179,645 ) 204,034 (1,720,169 ) Trademarks and patents (143,186 ) (36,791 ) - - - 10,357 (169,620 ) Key money (16,517 ) - 4,505 - - 1,909 (10,103 ) Relationship with retail clients (3,218 ) (42 ) - - - 292 (2,968 ) Relationship with franchisees and sub franchisees (729,049 ) (264,320 ) - - - 74,375 (918,994 ) Technology developed (632,326 ) (272,297 ) - - - 30,398 (874,225 ) Other intangible assets (296 ) (3,228 ) - - (48 ) 682 (2,890 ) Total accrued amortization (2,894,359 ) (993,931 ) 46,967 - (179,693 ) 322,047 (3,698,969 ) Net total 26,857,583 (630,708 ) (200 ) (308,464 ) 124,864 (2,782,105 ) 23,260,970 a) Goodwill related to the acquisition of subsidiary Avon. It does not have defined useful life and it is subject to annual impairment tests. b) Goodwill related to the acquisition of subsidiary Holdings Pty Ltd. acquisition. It does not have defined useful life and it is subject to annual impairment tests. c) Goodwill related to the acquisition of subsidiary The Body Shop, classified as future economic benefits. It does not have defined useful life and it is subject to annual impairment tests. d) Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. e) Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. f) The balance refers to identifiable intangible assets from relationship with the subsidiary The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years.
Disclosure Of Information For Cash-generating Units	Groups of CGUs Trademarks and patents Goodwill Total 2023 2022 2023 2022 2023 2022 Natura &Co Latam - - 9,527,619 9,765,077 9,527,619 9,765,077 Avon International 2,350,347 2,396,290 1,777,889 2,542,788 4,128,236 4,939,078 TBS International - 2,421,740 - 1,645,527 - 4,067,267 Aesop International (*) - - - 124,315 - 124,315 Total 2,350,347 4,818,030 11,305,508 14,077,707 13,655,855 18,895,737 (*) The trademarks and patents recognized as part of the acquisition of Aesop were assessed as having a determined useful life and, therefore, are not presented in the table above as of December 31, 2022.
Disclosure Of Detailed Information About Assumptions Used To Calculate The Fair Value Less Cost To Sell	Avon International Natura &C o Latam Impairment estimate (value in use) Discounted cash flow based on financial budgets approved by the Board of Directors for a period of three years and complemented for a discretionary period of ten years estimated by Management, with a terminal value projected for the end of the period. The ten-year period was considered for better aligning and smoothing the effects projected between the discretionary period and the effects calculated in perpetuity. Operating margin Operating margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next ten years. These margins are increased over the budget period to improve the expected efficiency. Estimated cost Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share. Revenue growth rates Growth rates are initially based on published industry research and adjusted by the expected performance for each CGUs group (which, considering the level of goodwill monitoring by the Company, reflects the operating segments), given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by governance leadership bodies (including the Board of Directors). Perpetuity growth rate (*) Constant growth of 4.66% Constant growth of 6.48 Discount rate Discount rates represent the risk assessment in the current market, specific to each group of CGUs, taking into account the value of overtime and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. Such cash flows were discounted at the discount rate calculated before tax on the currency with the one (*) The rates are based on published market analyzes and projections regarding the reporting segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable. Such rates are also calculated in a currency consistent with those used for the projects and the discount rates.
Disclosure of information for impairment loss recognised or reversed for individual asset or cash-generating unit [text block]	Significant assumption affected by possible deterioration 1 Reduction of 1 Reduction of 1 Additional impairment that would be recognized in profit or loss for the year 762,709 401,389 651,156 Total impairment that would be recognized in profit or loss for the year 1,426,604 1,065,284 1,315,051

RIGHT OF USE AND LEASE LIABIL_2

RIGHT OF USE AND LEASE LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2023
RIGHT OF USE AND LEASE LIABILITIES
Schedule of Quantitative Information About Right-Of-Use Assets	a) Right of use asset Consolidated Useful life range (in years) (a) 2022 Additions Write-offs Transfer to asset held for sale Write-off due to sale of subsidiary Translation adjustments 2023 Cost: Vehicles 3 164,661 73,708 (68,871 ) - (1,883 ) (8,446 ) 159,169 Machinery and equipment 3 to 10 31,216 19,850 (2,155 ) - (7,515 ) (3,515 ) 37,881 Buildings 3 to 10 1,570,088 224,800 (80,185 ) - (160,049 ) (79,839 ) 1,500,669 IT equipment 10 29,052 3,891 (6,299 ) - (1,702 ) 146 25,088 Retail stores 3 to 10 3,361,432 344,870 (299,934 ) (1,388,973 ) (1,790,631 ) (79,770 ) 146,994 Software 3 to 4 13,527 5,566 - - - 37 19,130 Tools and accessories 3 498 - (415 ) - (76 ) (7 ) - Total cost 5,170,474 672,685 (457,859 ) (1,388,973 ) (1,961,856 ) (171,394 ) 1,888,931 Depreciation value: Vehicles (105,457 ) (45,378 ) 66,122 - 1,109 7,117 (76,487 ) Machinery and equipment (13,787 ) (11,535 ) 1,996 - 6,120 3,762 (13,444 ) Buildings (556,655 ) (235,874 ) 61,748 - 54,968 48,061 (627,752 ) IT equipment (23,957 ) (5,645 ) 6,299 - 1,028 3,672 (18,603 ) Retail stores (1,525,308 ) (390,499 ) 235,125 563,908 994,062 31,908 (90,804 ) Software (3,121 ) (5,772 ) - - - (61 ) (8,954 ) Tools and accessories (302 ) (132 ) 300 - - (1,944 ) (2,078 ) Total accrued depreciation (2,228,587 ) (694,835 ) 371,590 563,908 1,057,287 92,515 (838,122 ) Net total 2,941,887 (22,150 ) (86,269 ) (825,065 ) (904,569 ) (78,879 ) 1,050,809 Consolidated Useful life in Years (a) 2021 Additions Write-offs Impairment Transfers (c) Translation adjustment 2022 Cost: Vehicles 3 168,062 38,241 (25,734 ) - - (15,908 ) 164,661 Machinery and equipment 3 a 10 33,629 13,455 (11,166 ) - - (4,702 ) 31,216 Buildings 3 a 10 1,543,018 296,161 (185,967 ) - (35,484 ) (47,640 ) 1,570,088 IT equipment 10 31,803 2,618 (4,151 ) - - (1,218 ) 29,052 Retail stores 3 a 10 3,417,595 712,979 (373,830 ) (30,785 ) 36,401 (400,928 ) 3,361,432 Software - 13,527 - - - - 13,527 Tools and accessories 3 1,053 - (394 ) - - (161 ) 498 Total cost 5,195,160 1,076,981 (601,242 ) (30,785 ) 917 (470,557 ) 5,170,474 Depreciation value: Vehicles (91,509 ) (46,287 ) 24,354 - - 7,985 (105,457 ) Machinery and equipment (17,133 ) (9,986 ) 11,166 - - 2,166 (13,787 ) Buildings (507,045 ) (249,796 ) 137,349 - 31,917 30,920 (556,655 ) IT equipment (24,410 ) (6,608 ) 4,345 - - 2,716 (23,957 ) Retail stores (1,458,512 ) (611,862 ) 367,247 - (31,960 ) 209,779 (1,525,308 ) Software - (3,121 ) - - - - (3,121 ) Tools and accessories (582 ) (206 ) 394 - - 92 (302 ) Total accrued depreciation (2,099,191 ) (927,866 ) 544,855 - (43 ) 253,658 (2,228,587 ) Net total 3,095,969 149,115 (56,387 ) (30,785 ) 874 (216,899 ) 2,941,887
Schedule Of Detailed Information About Cash Outflow Related To Leases	Consolidated 2023 2022 Amounts recognized in the statement of income and losses: Financial expense on lease 110,356 112,456 Amortization of right of use 287,568 302,144 Appropriation in the result of variable lease installments not included in the measurement of lease liabilities 7,382 1,855 Sublease revenue (17,210 ) (20,724 ) Short-term lease expenses and low-value assets 6,444 21,556 Benefits granted by lessor related to Covid- 19 (111 ) (1,366 ) Adjustment to recoverable value of right-of-use assets - impairment 1,321 - Amounts recognized in the financing activities in the cash flow statement: Lease payments (principal) 309,328 277,086 Amounts recognized in the operating activities in the cash flow statement: Lease payments (interest) 100,442 113,655 Variable lease payments, not included in the measurement of lease liabilities 7,382 1,855 Short-term and low-value assets lease payments 1,906 6,510
Schedule Of Lease Obligation	Consolidated 2023 2022 Current 298,600 878,448 Non-current 851,840 2,392,289 Total 1,150,440 3,270,737
Schedule Of Changes In The Balance Of Lease Obligation	Consolidated Balance as of December 31, 2021 3,547,863 New agreements and modifications 1,065,794 Payments (principal amount) (953,048 ) Payments (interest) (199,769 ) Appropriation of financial charges 200,246 Write-off (a) (19,763 ) Translation adjustment (370,585 ) Balance as of December 31, 2022 3,270,737 Transfer to held for sale (891,098 ) New agreements and modifications 779,049 Payments (principal amount) (828,538 ) Payments (interest) (183,409 ) Appropriation of financial charges 187,410 Write-offs (a) (43,877 ) Write-off due to sale of subsidiary (b) (1,025,898 ) Translation adjustment (113,936 ) Balance as of December 31, 2023 1,150,440 a) Mainly related to termination of agreements related to lease of stores. b) Refers to the write-off of lease liabilities associated with the sale of the former subsidiaries Aesop and The Body Shop.
Schedule of lease rates applied, according to the lease terms based on maturity.	Contractual payments - consolidated Maturity Average discount rate 2023 2024 2025 2026 2027 Onwards 2028 2023 2024 5.5% to 16.3% 25,982 135,841 - - - - 2025 2027 5.4% to 18.7% 102,094 107,651 85,311 74,275 19,394 - 2028 2030 7.3% to 20.5% 8,119 9,092 10,200 11,450 12,850 12,442 2031 2036 7.7% to 21.9% 3,465 10,513 10,728 10,980 11,259 41,990 Total 139,660 263,097 106,239 96,705 43,503 54,432 Projected inflation 1 4% 3% 3% 3% 3% 3 % 1 Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3
Schedule of maturities of the lease liabilities	Consolidated 2023 2022 Less than 1 401,217 1,070,253 From 1 5 912,529 2,019,723 More than 5 s 135,207 856,402 Total expected cashflows 1,448,953 3,946,378 Interests to incur (298,513 ) (675,641 ) Total 1,150,440 3,270,737

BORROWING, FINANCING AND DEBE_2

BORROWING, FINANCING AND DEBENTURES (Tables)	12 Months Ended
	Dec. 31, 2023
BORROWING, FINANCING AND DEBENTURES
Schedule Of Detailed Information About Borrowing	Ref. Consolidated 2023 2022 Local currency Financing Agency for Studies and Projects - 3,546 16,979 Debentures A 1,962,188 1,913,204 Business notes B 517,534 519,044 Working capital – Avon operation 1,832 113,664 Working capital - C - 1,304,425 Notes – Avon D 129,535 1,421,272 Notes – Lux E, F 3,497,067 3,130,732 Total in local currency 6,111,702 8,419,320 Foreign currency: Notes F - 5,172,966 Total in foreign currency - 5,172,966 Grand total 6,111,702 13,592,286 Current 163,844 331,151 Non-current 5,947,858 13,261,135 Debentures Current 68,189 77,601 Non-current 1,852,699 1,835,603
Schedule Of Additional Information About Borrowings	Ref. Currency Maturity Charges Effective interest rate Guarantees A Brazilian Real July 2027 to September 2032 CDI + 1.65%; CDI + 0.8%; IPCA + 6.8% and IPCA + 6.9% with bi-annual payments CDI+1.65%, CDI+0.8%, CDI+1.34% e CDI+1.60% Guarantee of Natura &Co Holding S.A. B Brazilian Real September 2025 CDI interest + 1.55% with bi-annual payments CDI+1.55% Guarantee of Natura &Co Holding S.A. C US Dollar November 2025 SOFR + 2.47% p.a. with bi-annual payments SOFR + 2.47% p.a. Guarantee of Natura &Co Holding S.A. and Natura Cosmeticos S.A. D US Dollar March 2043 Interest of 8.45% of p.a. with bi-annual payments 8.45% p.a None E US Dollar April 2029 Interest of 6.00% p.a. with bi-annual payments 6.125% p.a Guarantee of Natura &Co Holding S.A. and Natura Cosmeticos S.A. F US Dollar May 2028 Interest of 4.125% p.a. with bi-annual payments 4.125% Guarantee of Natura &Co Holding S.A.
Schedule Of Changes In Balances Of Borrowing	Consolidated Balance as of December 31, 2021 12,716,832 New borrowing and financing (a) 8,557,507 Repayment ( b ) (6,826,628 ) Appropriation of financial charges, net of costs of new borrowing and financing 762,703 Financial charges payment (808,976 ) Exchange rate variation (394,389 ) Translation effects (OCI) (414,763 ) Balance as of December 31, 2022 13,592,286 New borrowing and financing (c) 1,494,101 Repayment (d) (8,057,650 ) Gain on Borrowing and financing prepayment (206,228 ) Appropriation of financial charges, net of costs of new borrowing and financing (e) 839,580 Financial charges payment (842,719 ) Exchange rate variation (322,049 ) Translation effects (OCI) (385,619 ) Balance as of December 31, 2023 6,111,702 a) Funding carried out in the year ended December 31, 2022 basically refers to: (i) use of a revolving credit line in the principal amount of up to US$ million by the subsidiary &Co Luxembourg; (ii) issuance of debt securities by the subsidiary &Co Luxembourg maturing on April 19, 2029 in the total principal amount of US$ million (approximately R$ million), subject to interest of % per year, which are guaranteed by &Co Holding and the subsidiary S.A. (iii) issuance of the 11 th series of debentures in the amount of R$ million maturing in 2025 and issuance of the 12 th series of debentures in the amount of R$ million, maturing between 2025 and 2032 by the subsidiary S.A. (iv) issuance of commercial notes by the subsidiary in the amount of R$ million maturing in 2025 and (v) new credit line in the total principal amount of US$ million by the subsidiary &Co Luxembourg. b) The repayments carried out in the year ended December 31, 2022 mainly refer to (i) early redemption of debt securities of the subsidiary Avon; (ii) the early redemption of the 9 th and 10 th series of debentures issued by the subsidiary (iii) the early redemption of the credit line in the amount of £ million from the former indirect subsidiary The Body Shop and (iv) the refinancing of the credit line credit under Resolution No. 4131 / 62 of the subsidiary . c) The movement that occurred in 2023 is mainly due to the revolving credit line obtained by the subsidiary &Co Luxembourg during the year, which was fully settled during the third quarter with resources from the sale of the former subsidiary Aesop. d) The movement in amortizations in 2023 is substantially due to the debt rebalancing process initiated in the third quarter, where the Company carried out and settled (i) an offer to the holders of securities representing Avon's debt to repurchase approximately % of securities issued for R$ (comprising R$ of principal, R$ of premium and R$ of accrued interest); and (ii) offer to holders of debt securities of &Co Luxembourg (maturing in 2028 and 2029 ) to repurchase approximately % of the securities issued for R$ (comprising R$ of principal, R$ premium and R$ accrued interest). Other amortizations in the period also include the payment of working capital debt amounts at &Co Luxembourg of R$ (of which R$ refer to the settlement of the open position in the credit line revolving loan and R$ of working capital debt (“Club Loan”), in abovementioned item c). e) Amounts are net of funding costs in the total amount of R$ 15,361.
Schedule Of Maturity Analysis For Noncurrent Borrowings	Consolidated 2023 2022 2025 101,577 1,763,902 2026 - 11,497,233 2027 5,846,281 - Total 5,947,858 13,261,135
Schedule of main features of the debentures	Debentures of the 12 Title Contractual fee Maturity Total Amount Number of Debentures 1 100% DI + 0.8% 09/14/2027 R$ 255,889 255,889 2 IPCA + 6.8% 09/14/2029 R$ 487,214 487,214 3 IPCA + 6.9% 09/14/2032 R$ 306,897 306,897
Schedule of detailed information about Notes - Avon	Notes - Avon Main US$ Main R$ Annual percentage interest rate Maturity Unguaranteed 21,609 104,613 8.45% March 15, 2043

TRADE ACCOUNTS PAYABLE AND RE_2

TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2023
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS	Consolidated 2023 2022 Domestic trade accounts payable 4,058,832 4,644,534 Foreign trade accounts payable (a) 588,685 877,496 Subtotal 4,647,517 5,522,030 Reverse factoring operations (b) 654,961 853,900 Total 5,302,478 6,375,930 a) Refers to imports mainly denominated in US dollars, Euros and British pounds. b) The Company has contracts signed with first-line financial institutions, mainly Banco S.A. to directly structure a reverse factoring operation with the Company’s main suppliers. Further details on these operations are included in note no. 3.15

TAX LIABILITIES (Tables)

TAX LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2023
TAX LIABILITIES
Schedule of detailed information about tax liabilities	Consolidated 2023 2022 ICMS (ordinary) (a) 216,882 180,708 ICMS-ST provision (b) 63,722 60,945 Taxes on invoicing abroad 150,706 346,407 Withholding tax 118,133 138,293 Other taxes payable - foreign subsidiaries 102,537 147,056 Income tax 23,084 18,170 PIS and COFINS payable (c) 60,678 140 INSS and service tax (ISS) payable 5,603 31,895 Other 20,609 21,869 Total 761,954 945,483 Current 634,760 828,125 Non-current 127,194 117,358 a) Refers to ICMS on the Company's sales of goods in Brazil. b) The Company has discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company, and in some cases, the amounts are deposited in court, as mentioned in note no. 12 c) Refers to the value of PIS and COFINS levied on interest on equity received from the subsidiary S.A.

PROVISION FOR TAX, CIVIL AND _2

PROVISION FOR TAX, CIVIL AND LABOR RISKS (Tables)	12 Months Ended
	Dec. 31, 2023
PROVISION FOR TAX, CIVIL AND LABOR RISKS
Schedule of tax, civil and labor provision and contingent liabilities	Consolidated Tax Civil Labor Contingent liabilities (business combination) (3) Total 2023 ( 4 2022 2023 2022 2023 2022 2023 ( 2 2022 2023 2022 Balance at the beginning of the years 187,052 181,694 557,675 305,690 186,118 233,472 406,428 597,585 1,337,273 1,318,441 Additions 42,055 78,410 446,554 425,398 122,846 91,694 4,204 - 615,659 595,502 Reversal (2) (18,136 ) (45,902 ) (10,172 ) (12,791 ) (57,530 ) (51,649 ) (29,971 ) (196,925 ) (115,809 ) (307,267 ) Payments / utilization of judicial deposits (1) (53,143 ) (31,354 ) (357,633 ) (162,953 ) (47,512 ) (67,424 ) - - (458,288 ) (261,731 ) Inflation adjustment 12,852 36,155 29,439 16,477 5,884 5,093 24,836 21,555 73,011 79,280 Exchange rate variation (OCI) (3,958 ) (31,951 ) (38,836 ) (14,146 ) (21,799 ) (25,068 ) (19,516 ) (15,787 ) (84,109 ) (86,952 ) Disposal of The Body Shop - - (445 ) - (700 ) - - - (1,145 ) - Balance at the end of the years 166,722 187,052 626,582 557,675 187,307 186,118 385,981 406,428 1,366,592 1,337,273 Current 491,301 463,655 Non-current 875,291 873,618 (1) Tax payments refer mainly to the completion of the administrative procedure with the State of Amazonas for the effective settlement of tax amnesties, using judicial deposits. (2) Reversals of contingent liabilities (business combination) with Avon refer mainly to the change in estimates for tax, civil and labor lawsuits. (3) The business combination amounts as of December 31, 2023, arising from the business combination with Avon are segregated between tax (R$ ) and labor (R$ ) lawsuits. (4) In December 2023, the subsidiary recognized a provision for estimated costs in relation to litigation involving discussion about the collection of ICMS Tax Rate Differential (“DIFAL”) with several states in Brazil, in the amount of R$ . The recognition of the provision occurs as a result of an unfavorable decision to the taxpayer in judgment at the Federal Supreme Court (STF), leading to a change in the prognosis from loss to probable.
Schedule of contingent liabilities	Consolidated 2023 2022 Tax 10,375,764 8,480,614 Civil 246,500 161,859 Labor 169,463 164,462 Total contingent liabilities 10,791,727 8,806,935

OTHER LIABILITIES (Table)

OTHER LIABILITIES (Table)	12 Months Ended
	Dec. 31, 2023
Disclosure of defined benefit plans [line items]
Schedule of Detailed Information about Other Liabilities [Table Text Block]	Consolidated 2023 2022 Pension and post-employment health care plans (a) 515,901 463,948 Deferred revenue from performance obligations with customers (b) 131,113 313,204 Provision for incentives to consultants 153,692 217,349 Provision for operating expenses (marketing / technology, etc.) (c) 482,287 604,064 Provision for store renovation - 116,137 Crer Para Ver (d) 47,571 87,420 Provision for restructuring (e) 113,440 175,809 Insurance payables 84,032 69,364 Other liabilities (f) 87,518 203,331 Total 1,657,012 2,250,626 Current 970,479 1,499,060 Non-current 686,533 751,566 a) As of December 31, 2023, there is R$253,606 (R$282,295 as of December 31, 2022) referring to pension plans, and R$567 referring to post-employment plans (R$28,456 as of December 31, 2022) of subsidiary Avon International, and R$209,288 (R$129,697 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary and R$52,441 (R$51,956 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary &Co International. b) Refers to the deferral of revenue from performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct sales consultants, of which R$88,017 (R$190,790 as of December 31, 2022) is referring to subsidiary Avon, R$31,089 (R$93,761 as of December 31, 2022) referring to the consolidated subsidiary and R$12,007 (R$28,653 as of December 31, 2022) referring to subsidiary &Co International. c) Refers to the Company's operating provisions arising mainly from expenses with the provision of technology, marketing, and advertising services. d) Contribution of the social program to the development of the quality of education. e) Provision for costs directly related to the integration plan and changes in the organizational structure of the subsidiary Avon and Group corporate structure review. f) Refers to miscellaneous provisions such as indemnities and non-current contractual obligations.
Avon [member]
Disclosure of defined benefit plans [line items]
Schedule of detailed information about movements of actuarial liabilities	Pension plan 2023 2022 Balance at the beginning of the year 334,251 445,804 Cost of services – current 21,871 19,707 Interest cost – recognized in the statement of profit or loss 21,542 15,568 Administrative costs 4,046 2,698 Company contributions (6,004 ) (4,299 ) Benefits paid (30,896 ) (22,262 ) Actuarial loss in OCI (a) (2,096 ) (254,913 ) Reclassifications 832 24,956 Other 7,082 88,474 Translation adjustment (26,266 ) 18,518 Balance at end of year 324,362 334,251 (a) The actuarial loss recorded throughout 2022 19
Schedule of significant actuarial assumptions for the determination of the actuarial liability	2023 2022 Discount rate 1.20 % to 11.60 % 1.30 % to 12.00 % Rate of compensation increase 2.15 % to 5.50 % 2.55 % to 7.40 %
Schedule of fair values of each major class of plan assets	Consolidated 2023 2022 Cash and cash equivalent 46,957 7,330 Equity instruments of other entities 486,511 520,799 Government bonds 1,481,317 1,013,584 Corporate bonds 1,219,908 1,317,122 Real estate 8,714 10,957 Other (525,722 ) (121,574 ) Total 2,717,685 2,748,218
Natura Cosmticos SA [Member]
Disclosure of defined benefit plans [line items]
Schedule of detailed information about movements of actuarial liabilities	Consolidated 2023 2022 Balance at the beginning of the year 129,697 124,649 Cost of the current service of subsidiary Natura Cosmeticos 983 812 Cost of interest 13,314 11,078 Expenses paid (4,021 ) (3,398 ) Actuarial gains in OCI 51,566 (3,444 ) Balance as of the end of the year 191,539 129,697
Schedule of significant actuarial assumptions for the determination of the actuarial liability	2023 2022 Discount rate 9.69% 10.43% Initial growth rate of medical cost 4.25% 4.25% Inflation rate 4.00% 4.00% Final growth rate of medical cost 8.42% 8.42% Growth rate of medical costs due to aging - costs Per age range 1.25% a 4.75% a.a. Per age range 1.25% a 4.75% a.a. Growth rate of medical costs by aging - contributions 0.00% 0.00% Percentage of adherence to the plan in retirement Bradesco Plan 58.00% / Unimed Plan 85.00% Bradesco Plan 58.00% / Unimed Plan 85.00% Schedule of disabled mortality Mercer Disability Mercer Disability Schedule of mortality AT-2000 AT-2000 Schedule of turnover Proportional calculation at the time of service Proportional calculation at the time of service
Schedule of detailed information about sensitivity analysis for actuarial assumptions	Rate Chance PVO Discount rate 9.69% 1% increase 229,052 Discount rate 9.69% 1% decrease 173,673 Rate of compensation 8.42% 1% increase 174,202 Rate of compensation 8.42% 1% decrease 227,843

SHAREHOLDER'S EQUITY (Table)

SHAREHOLDER'S EQUITY (Table)	12 Months Ended
	Dec. 31, 2023
SHAREHOLDER'S EQUITY
Schedule of Composition of Share Capital	Number of shares R$ (in thousands) Average price per share - R$ Balance as of December 31, 2020 316,701 11,667 38.04 Used (754,719) (34,438) 45.63 Acquired 5,337,558 174,113 32.62 Balance as of December 31, 2021 4,899,540 151,342 30.89 Used (377,585 ) (9,282 ) 24.58 Acquired 5,391,900 120,300 22.31 Balance as of December 31, 2022 9,913,855 262,360 26.46 Used (3,709,807 ) (98,124 ) 26.45 Balance as of December 31, 2023 6,204,048 164,236 26.47

INFORMATION ON SEGMENTS (Tables

INFORMATION ON SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2023
INFORMATION ON SEGMENTS
Summary of operating segment	2023 Reconciliation to net income for the year Net Revenue Performance assessed by the company Depreciation and amortization Discontinued operations (1) Financial results Income tax Net income (loss) for the year Natura &Co Latam 20,440,834 2,239,663 (921,510 ) 6,286,298 (2,249,167 ) 624,892 5,980,176 Avon Internationa 1 6,286,771 (493,462 ) (665,753 ) (434,852 ) (855,283 ) (320,889 ) (2,770,239 ) The Body Shop 1 - - - (302,529 ) - - (302,529 ) Aesop 1 - - - (3,576 ) - - (3,576 ) Corporate expenses 9,672 (313,055 ) (731 ) 11,116 590,951 (217,603 ) 70,678 Consolidated 26,737,277 1,433,146 (1,587,994 ) 5,556,457 (2,513,499 ) 86,400 2,974,510 (1) The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023. 3 2022 Reconciliation to net loss for the year Net Revenue Performance assessed by the company Depreciation and amortization Discontinued operations Financial results Income tax Net loss for the year Natura&CoLatam 22,027,337 1,912,651 (912,412 ) - (1,412,369 ) 98,712 (313,418 ) Avon International 1 7,195,984 (74,655 ) (683,845 ) (380,416 ) (665,653 ) (200,474 ) (2,005,043 ) The Body Shop 2 - - - (349,448 ) - - (349,448 ) Aesop 2 - - - 132,677 - - 132,677 Corporative expenses 335 (615,103 ) (10,273 ) (468 ) 293,041 9,409 (323,394 ) Consolidated 29,223,656 1,222,893 (1,606,530 ) (597,655 ) (1,784,981 ) (92,353 ) (2,858,626 ) 2021 Reconciliation to net loss for the year Net Revenue Performance assessed by the company Depreciation and amortization Discontinued operations Financial results Income tax Net loss for the year Natura &Co Latam 22,413,401 2,595,653 (871,973 ) - (700,181 ) 165,137 1,188,636 Avon International 1 9,329,325 272,655 (830,931 ) (98,550 ) (473,195 ) 210,705 (919,316 ) The Body Shop 2 - - - (4,900 ) - - (4,900 ) Aesop 2 - - - 194,183 - - 194,183 Corporative expenses - ( 604,594) - - 265,286 921,394 582,086 Consolidated 31,742,726 2,263,714 (1,702,904 ) 90,733 (908,090 ) 1,297,236 1,040,689
Summary of operating segments of assets and liabilities	2023 2022 Non-current assets Total assets Current liabilities Non-current liabilities Non-current assets Total assets Current liabilities Non-current liabilities Natura &Co Latam 18,240,916 23,253,227 6,914,476 4,324,263 18,256,204 29,762,132 8,363,130 10,164,706 Avon International 1 8,008,108 10,608,234 2,792,255 977,003 11,197,014 14,259,571 1,894,856 1,838,328 The Body Shop 2 - - - - 6,565,913 7,928,270 1,292,903 1,669,625 Aesop 2 - - - - 1,621,126 2,735,417 731,018 776,512 Corporate expenses 510,769 8,885,554 706,768 3,911,785 923,606 - 1,055,961 4,547,167 Consolidated 26,759,793 42,747,015 10,413,499 9,213,051 38,563,863 54,685,390 13,337,868 18,996,338 1 The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment. 2 The balances are at zero 2023
Summary of revenue and assets by geographical area wise	Net revenue Non-current asset 2023 2022 2021 2023 2022 Asia 1,326,431 1,555,054 1,758,912 572,168 1,284,783 North America 3,919,414 4,472,169 4,931,608 3,956,986 6,261,545 Mexico 3,284,608 3,570,990 3,079,033 3,883,804 3,631,768 Other 634,806 901,180 1,052,575 73,182 2,629,777 South America 16,481,018 17,513,597 17,476,158 14,015,695 14,508,816 Brazil 12,004,994 11,280,690 10,521,780 10,933,917 12,656,298 Argentina 1,711,783 3,003,214 2,973,638 261,155 694,172 Other 2,764,241 3,229,693 3,980,740 2,820,623 1,158,346 Europe, Middle East and Africa (EMEA) 5,010,413 5,682,836 7,445,713 8,214,944 15,271,251 United Kingdom 257,944 577,544 896,945 5,132,107 10,894,799 Other 4,752,469 5,105,292 6,548,768 3,082,837 4,376,452 Oceania - - 130,335 - 1,237,468 Consolidated 26,737,277 29,223,656 31,742,726 26,759,793 38,563,863

REVENUE (Tables)

REVENUE (Tables)	12 Months Ended
	Dec. 31, 2023
REVENUE
Summary of revenue by Sales Channels Wise	Consolidated Gross revenue: 2023 2022 2021 Direct Selling 31,399,069 34,011,306 36,297,680 Retail 549,749 431,848 1,367,517 Online 1,461,888 1,737,356 1,491,696 Other sales 1,307,844 1,705,890 1,641,032 Subtotal 34,718,550 37,886,400 40,797,925 Returns and cancellations (442,676 ) (588,579 ) (590,911 ) Commercial discounts and rebates (11,610 ) (29 ) (1,771 ) Taxes on sales (7,526,987 ) (8,074,136 ) (8,462,517 ) Subtotal (7,981,273 ) (8,662,744 ) (9,055,199 ) Total net revenue 26,737,277 29,223,656 31,742,726

OPERATING EXPENSES AND COST O_2

OPERATING EXPENSES AND COST OF SALES (Tables)	12 Months Ended
	Dec. 31, 2023
OPERATING EXPENSES AND COST OF SALES
Summary of operating income (expenses) and cost of sales classified by function and nature	Consolidated Classified by function 2023 2022 2021 Cost of sales 9,675,435 11,770,762 12,531,303 Selling, marketing and logistics expenses 11,015,940 11,558,866 12,386,193 Administrative, R&D, IT and project expenses 4,225,027 5,023,626 5,217,633 Total 24,916,402 28,353,254 30,135,129 Classified by nature Cost of sales 9,675,435 11,770,762 12,531,303 Raw material/packaging material/resale 8,541,488 10,587,972 10,703,627 Employee benefits expense (note 28 516,046 565,431 554,999 Depreciation and amortization 170,288 168,713 246,091 Other 447,613 448,646 1,026,586 Selling, marketing and logistics expenses 11,015,940 11,558,866 12,386,193 Logistics costs 1,523,083 1,941,593 2,161,844 Personnel expenses (note 28 2,804,788 2,734,895 3,101,951 Marketing, sales force and other selling expenses 6,224,588 6,357,494 6,371,933 Depreciation and amortization 463,481 484,614 745,419 Impairment - 40,270 5,046 Administrative, R&D, IT and project expenses 4,225,027 5,023,626 5,217,633 Innovation expenses 161,477 262,646 210,170 Personnel expenses (note 28 1,754,650 2,073,680 2,008,106 Restructuring expenses 730 125,804 - Other administrative expenses 1,354,083 1,619,949 2,030,979 Depreciation and amortization 954,087 941,547 968,378 Total 24,916,402 28,353,254 30,135,129

EMPLOYEE BENEFITS (Tables)

EMPLOYEE BENEFITS (Tables)	12 Months Ended
	Dec. 31, 2023
EMPLOYEE BENEFITS
Summary of Employee Benefit Expense	Consolidated 2023 2022 2021 Payroll, profit sharing and bonuses 3,553,374 3,848,557 3,975,494 Pension Plan 100,498 90,392 106,303 Share-based payments, net of charges 126,987 90,796 183,815 Health care, food and other benefits 579,116 704,449 661,445 Charges, taxes and social contributions 473,382 588,538 534,375 INSS 242,127 51,274 203,624 Total 5,075,484 5,374,006 5,665,056
Summary of Number and Weighted Average Number of Shares	Stock option plan and Strategy Acceleration Plan Weighted average strike price per option – R$ Options (thousands) Balance as of December 31, 2021 21.05 20,137 Granted 16.45 1,710 Changes from options to restricted shares 48.98 (1,100 ) Expired/Cancelled 27.22 (861 ) Exercised 11.98 (226 ) Balance as of December 31, 2022 18.92 19,660 Granted 16.45 30 Expired/Cancelled 22.92 (758 ) Exercised 13.02 (568 ) TBS Awards – equity to cash settlement conversion 21.43 (1,334 ) Balance as of December 31, 2023 18.74 17,030 Restricted shares (thousands) Performance shares (thousands) Balance as of December 31, 2021 5,494 8,045 Granted 2,359 6,485 Changes from options to restricted shares 1,100 - Expired/Cancelled (442 ) (1,902 ) Released (2,453 ) (573 ) Balance as of December 31, 2022 6,058 12,055 Granted 3,966 8,736 Expired/Cancelled (360 ) (2,921 ) Stock adjustment based on acquisition performance - (990 ) Released (3,033 ) (2,686 ) Adjustments related to vesting in the sale of Aesop - (964 ) Awards related to the sale of Aesop (182 ) (875 ) Adjustments related to the acquisition of rights in the sale of TBS (18 ) (1,476 ) TBS Awards – equity to cash settlement conversion (129 ) (383 ) Balance as of December 31, 2023 6,302 10,496
Summary of Terms and Conditions of Share-based Payment Arrangement	As of December 31, 2023 – Stock options Grant date Conditions for acquisition of right as of the grant date Strike Price (R$) Fair value at grant date (R$) Existing shares (thousands) Maximum remaining contractual life (years) Exercisable options (thousands) March 16,2015 2 to 4 years of service 12.71 7.16 to 7.43 85 0.2 85 July 11, 2016 (acceleration strategy) 4 to 5 years of service 11.28 6.84 to 6.89 1,540 0.5 1,540 March 10, 2017 2 to 4 years of service 12.46 6.65 to 6.68 350 1.2 350 March 10, 2017 (acceleration strategy) 4 to 5 years of service 12.46 6.87 to 6.89 1,890 1.5 1,890 March 12, 2018 2 to 4 years of service 16.83 7.96 to 8.21 1,501 2.2 1,501 March 12, 2018 (acceleration strategy) 3 to 5 years of service 12.04 to 16.83 8.21 to 9.67 3,800 2.2 3,800 April 12, 2019 2 to 4 years of service 23.41 11.71 to 11.82 1,421 3.2 1,421 April 12, 2019 (acceleration strategy) 4 to 5 years of service 23.41 11.51 to 11.71 1,900 3.2 950 December 17, 2021 3 to 4 years of service 27.28 13.85 to 18.16 3,703 8.0 - September 14, 2022 3 to 4 years of service 16.45 8.39 to 10.32 840 8.7 600 17,030 12,137 As of December 31, 202 3 – Restricted shares Grant date Conditions for acquisition of right as of the grant date Existing shares (thousands) Fair value at grant date (R$) Maximum remaining contractual life (years) March 31, 2021 1 to 3 years of service 737 48.13 0.3 April 14, 2022 1 to 3 years of service 1,138 24.91 to 24.99 1.3 March 31, 2021 (as modified in September 2022)* 4 to 5 years of service 1,100 7.41 to 24.77 2.3 May 5, 2023 1 to 3 years of service 3,327 11.2 2.3 6,302 *The original grant of March 31, 2021 was stock options, but became a restricted share award as a result of the September 2022 amendment. As of December 31, 2023 – Performed shares Grant date Conditions for acquisition of right as of the grant date Existing shares (thousands) Fair value at grant date (R$) Maximum remaining contractual life (years) March 31, 2021 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards 1,859 46.57 to 50.98 0.3 to 1.3 April 14, 2022 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards. 3,545 18.66 a 24.99 1.3 to 2.3 May 5, 2023 Achievement of performance conditions, 3 years of service 5,092 11.20 a 11.55 2.3 a 3.3 10,496
Summary of Measurement Inputs for Fair Value of Shares	Assumptions B 3 ADRs Share price (also used as strike price on Finnerty) R$ 11.21 USD 4.49 Strike price R$ 0.01 USD 0.00403 Expected volatility 48.64% to 57.70% 55.20% to 63.11% Expected term 1 to 3 years 1 to 3 years Expected dividend yield 0.00% 0.00% Risk-free interest rate 11.69% to 12.93% 3.68% to 4.82%

FINANCIAL RESULTS__ (Tables)

FINANCIAL RESULTS (Tables)	12 Months Ended
	Dec. 31, 2023
FINANCIAL RESULTS
Summary of net of financial expense based on the nature of the related transactions	Consolidated 2023 2022 2021 Finance expesnes (debt interest) (868,614 ) (721,083 ) (610,913 ) Financial short-term investments and others income 977,203 535,587 251,542 Exchange variations on financial activities, net 322,049 323,496 (287,329 ) Losses with derivatives on exchange rate variations on financial activities, net (342,005 ) (383,178 ) 257,964 Losses on derivatives on interest payments and other financial activities, net (1,449,900 ) (553,253 ) 71,616 Monetary adjustment of provision for tax, civil and labor risks, and tax liabilities (73,011 ) (79,280 ) (25,731 ) Leases interest expenses (110,356 ) (112,456 ) (116,381 ) Other finance expenses (522,748 ) (327,588 ) (380,152 ) Hyperinflationary economy adjustment (117,553 ) (187,612 ) (26,528 ) Other gains (losses) from exchange rate variation on operating activities (328,564 ) (279,614 ) (42,178 ) Financial results (2,513,499 ) (1,784,981 ) (908,090 )

OTHER OPERATING EXPENSES, NET (

OTHER OPERATING EXPENSES, NET (Tables)	12 Months Ended
	Dec. 31, 2023
OTHER OPERATING EXPENSES, NET
Summary of detailed information about other operating expense, net	Consolidated 2023 2022 2021 Other operating income, net Result on write-off of property, plant and equipment - (8,443 ) - Tax credits (a) 195,780 71,720 215,085 Tax benefit from amnesty program (b) - 126,272 82,140 Reversal for impairment provision - - - Revenue with sale of the customer portfolio 16,471 11,874 16,113 Royalty income (c) - 119,438 - Other operating income 23,924 (25,359 ) 30,214 Total other operating income 236,175 295,502 343,552 Other operating expenses, net Result on write-off of property, plant and equipment (32,704 ) 5,273 ( 9,122 ) Crer para Ver (d) (20,115 ) (54,062 ) (47,523 ) Goodwill Impairment (663,892 ) (282,921 ) - Provision for losses on fixed assets. intangible assets and leases (22,040 ) (34,198 ) - Expenses with sale of customer portfolio (8,168 ) - - Transformation and integration plan (e) (769,404 ) (423,232 ) ( 511,048 ) Restructuring expenses (f) (52,641 ) (50,903 ) ( 3,079 ) Increased provision for tax, labor and civil contingencies (32,383 ) - - Tax benefit for joining the amnesty program - (23,803 ) - Other operating expenses (4,677 ) (80,848 ) 19,789 Total other operating expenses (1,606,024 ) (944,694 ) ( 550,983 ) Other operating expenses, net (1,369,849 ) (649,192 ) ( 207,431 ) a) Refers to tax credits from PIS and COFINS. b) Refers to tax benefits in Brazil arising from the adhesion to state tax amnesty programs by the subsidiaries Natura Cosmeticos S.A. and Avon Cosmeticos Ltda. c) Refers to revenue from royalties received by subsidiary Avon from its representative in Japan, after a legal dispute. d) Refers to appropriation of operating resultsobtained on the sales of the non-cosmetic product line called "Crer Para Ver" to the Natura Institute, specifically earmarked for social projects aimed at developing the quality of education. e) Expenses related to the execution of the integration plan between the Natura and Avon brands, which is mainly supported by operational and logistical workflows, structure reorganization, credit and collection review and commercial model optimizations. f) Refers to expenses related to the closure of the operations of the subsidiary The Body Shop in Russia, the main expenses being related to employee remuneration and fines for terminating the store rental contract.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2023
EARNINGS PER SHARE
Summary of Basic Earnings Per Share	Consolidated 2023 2022 2021 Profit (loss) attributable to the Company’s controlling shareholders 2,973,731 (2,859,629 ) 1,047,960 Weighted average of the number of issued common shares 1,385,675,623 1,381,594,182 1,377,932,809 Weighted average treasury shares (7,806,697 ) (9,613,311 ) ( 788,866 ) Weighted average of the number of outstanding common shares issued, net of treasured shares 1,377,868,926 1,371,980,871 1,377,143,943 Basic gain (loss) earnings per share - R$ 2.1582 (2.0843 ) 0.7610
Summary of Diluted Earnings Per Share	Consolidated 2023 2021 Profit attributable to the Company’s controlling shareholders 2,973,731 1,047,960 Weighted average of the number of issued common shares issued, net of treasured shares 1,377,868,926 1,377,143,943 Adjustment for stock options and restricted shares 6,401,920 19,531,951 Weighted average of the number of ordinary shares for diluted earnings calculation 1,384,270,846 1,396,675,894 Diluted earnings per share – R$ 2.1482 0.7503
Summary of basic earnings (loss) per share for the results of discontinued operations	Consolidated 2023 2022 2021 Profit (loss) attributable to the Company’s controlling shareholders 5,556,457 (597,655 ) 90,733 Weighted average of the number of issued common shares 1,385,675,623 1,381,594,182 1,377,932,809 Adjustment for stock options and restricted shares (7,806,697 ) (9,613,311 ) (788,866 ) Weighted average number of common shares issued, net of treasured shares 1,377,868,926 1,371,980,871 1,377,143,943 Basic profit (loss) per share – R$ 4.0326 (0.4365 ) 0.0659
Summary of diluted earnings per share for the results of discontinued operations	Consolidated 2023 2021 Profit attributable to the Company’s controlling shareholders 5,556,457 90,733 Weighted average of the number of issued common shares issued, net of treasured shares 1,377,868,926 1,377,143,943 Weighted average number of treasury shares 6,401,920 19,531,951 Weighted average number of common shares considered to diluted earnings per share 1,384,270,846 1,396,675,894 Diluted earnings per share - R$ 4.0139 0.0650

TRANSACTIONS WITH RELATED PAR_2

TRANSACTIONS WITH RELATED PARTIES (Tables)	12 Months Ended
	Dec. 31, 2023
TRANSACTIONS WITH RELATED PARTIES
Summary of Total Compensation of the Company's Key Management Personnel	2023 2022 2021 Compensation Compensation Compensation Fixed Variable Total Fixed Variable Total Fixed Variable Total Board of Directors 8,212 11,660 19,872 13,252 146,603 159,855 15,043 72,187 87,230 Executive Directors 27,991 200,529 228,520 34,403 50,423 84,826 51,576 71,162 122,738 36,203 212,189 248,392 47,655 197,026 244,681 66,619 143,349 209,968

COMMITMENTS (Tables)

COMMITMENTS (Tables)	12 Months Ended
	Dec. 31, 2023
COMMITMENTS
Summary of Contractual Commitments	Consolidated 2023 2022 Less than one 273,548 614,075 One five 486,961 659,626 Above five 799 49,331 Total 761,308 1,323,032

INSURANCE (Tables)

INSURANCE (Tables)	12 Months Ended
	Dec. 31, 2023
INSURANCE
Summary of Types of Insurance Coverage	Item Type of coverage Amount insured 2023 2022 Industrial complex and administrative sites Any damages to buildings, facilities, inventories, and machinery and equipment 4,694,455 4,924,868 Vehicles Fire, theft and collision for the vehicles insured by the Company 24,907 221,523 Loss of profits No loss of profits due to material damages to facilities buildings and production machinery and equipment - 2,056,000 Transport Damages to products in transit 81,328 97,308 Civil liability Protection against error or complaints in the exercise of professional activity that affect third parties 886,720 1,991,888 Environmental liability Protection against environmental accidents that may result in environmental lawsuits 30,000 30,000

ADDITIONAL INFORMATION RELATI_2

ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS (Tables)	12 Months Ended
	Dec. 31, 2023
Summary of Additional Information On Transactions Related To Cash Flow Statement	Consolidated 2023 2022 2021 Non-cash items Hedge accounting, net of tax effects 494,698 (520,444 ) (137,211 ) Dividends declared and not yet paid 294,231 - 180,772 Net effect of acquisition of property, plant and equipment and intangible assets not yet paid 27,900 28,472 172,104 Application of judicial deposits in the settlement of legal proceedings 55,494 121,025 -

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2023
Disclosure of analysis of single amount of discontinued operations [abstract]
Summary detailing the determination of the loss upon classification as assets held for sale and the subsequent fair value movements	2023 Fair value of the previously subsidiary The Body Shop (a) 826,560 Incremental transaction costs on sale (64,288 ) Fair value less selling costs 762,272 Net assets of the previously subsidiary The Body Shop (b) (4,770,016 ) Impairment loss (4,007,744 ) Balance after recognition of loss due to impairment 762,272 Adjustments to the fair value of assets held for sale 91,824 Balances on the date of derecognition 854,096 (a) It reflects the best estimate of the fair value of the operations on the date the criteria for classification as assets held for sale were met, on October 31, 2023. These estimates reflect the consideration agreed upon with the buyer, presented in the table below, reflecting the translation rate from British pounds to Brazilian real on that date. (b) It reflects the carrying amount of the operation reclassified to non-current assets held for sale on the date when the aforementioned criteria were met, on October 31, 2023.
Schedule of breakdown of results presented in discontinued operations in the income statement	2023 2022 2021 Cash Consideration received for the sale to the previously controlled Aesop 12,429,175 - - Net assets of the previously controlled Aesop, derecognized (1,140,751 ) - - Accumulated gains in other comprehensive income from currency translation 115,168 - - Incremental transaction costs on sale (289,686 ) - - Income tax and social contribution (3,736,138 ) - - Net gain on the sale of the previously controlled Aesop 7,377,768 - - Fair value of the consideration receivable from the sale of the previously subsidiary The Body Shop - - Fixed amount receivable upon completion 22,915 - - Fixed amount receivable in 2028 320,153 - - Contingent consideration 486,429 - - Total fair value of the consideration 829,497 - - Impairment loss (4,007,744 ) - - Assets derecognized( 1 (762,272 ) - - Adjustments to the fair value of assets (91,824 ) - - Conversion gains rolled into other comprehensive income 1,622,436 - - Incremental transaction costs on sale (64,288 ) - - Income tax and social contribution 1,392,855 - - Net loss on the sale of the previously controlled The Body Shop (1,081,340 ) - - Net gain on the sale of subsidiaries 6,296,428 - - Loss before taxes from discontinued operations (867,308 ) (570,444 ) 339,984 Income tax and social contribution 127,337 (27,211 ) (249,251 ) Loss from discontinued operations (739,971 ) (597,655 ) 90,733 Total discontinued operations 5,556,457 (597,655 ) 90,733 ( 1 On transaction date Aesop and The Body Shop presents Cash and Cash Equivalent in the amount of R$ 400,585 and R$ 214,387, respectively
Schedule of results in discontinued operations	2023 2022 2021 Net revenue 5,578,990 7,125,967 8,421,961 Cost of sales (1,137,127 ) (1,384,258 ) (1,480,222 ) Gross profit 4,441,863 5,741,709 6,941,739 Operating (expenses) income (5,185,984 ) (6,196,273 ) (6,482,868 ) Selling, marketing, and logistics expenses (3,139,196 ) (3,996,851 ) (4,613,032 ) Administrative, R&D, IT and projects expenses (1,432,107 ) (1,688,874 ) (1,741,233 ) Other operating income (expenses), net (a) (614,681 ) (510,548 ) (128,603 ) Operating profit (loss) before financial result (744,121 ) (454,564 ) 458,871 Financial results (123,187 ) (115,880 ) (118,887 ) Net income (loss) before income tax and social contribution (867,308 ) (570,444 ) 339,984 Income tax and social contribution 127,337 (27,211 ) (249,251 ) Net income (loss) for the year (739,971 ) (597,655 ) 90,733
Schedule of net cash flows incurred by the discontinued operations	2023 2022 Operational activities (5,992,000 ) 1,185,485 Investment activities 12,287,226 (336,953 ) Financing activities (584,118 ) (1,123,031 ) Net cash generated (consumed) 5,711,108 (274,499 )

GENERAL INFORMATION - Additiona

GENERAL INFORMATION - Additional Information (Detail) R$ in Thousands			12 Months Ended
	Dec. 29, 2023 BRL (R$)	Aug. 30, 2023 BRL (R$)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2022 BRL (R$)	Dec. 31, 2021 BRL (R$)	Dec. 29, 2029 BRL (R$)	Dec. 29, 2028 BRL (R$)	Jan. 02, 2024 BRL (R$)	Dec. 29, 2023 GBP (£) Installments	Dec. 29, 2023 BRL (R$) Installments
Discontinued operations [member]
General Information [Line Items]
Net gain (loss) on the sale of subsidiaries			R$ 6296428
Natura Brazil Pty Ltd. (Aesop) [Member] | Discontinued operations [member]
General Information [Line Items]
Disposal date fair value of total consideration received			12,429,175
Net gain (loss) on the sale of subsidiaries			7,377,768
Accumulated gains in other comprehensive income from currency translation			115,168
The Body Shop [member] | Discontinued operations [member]
General Information [Line Items]
Disposal date fair value of total consideration received			829,497
Net gain (loss) on the sale of subsidiaries			(1,081,340)
Accumulated gains in other comprehensive income from currency translation			1,622,436
Impairment loss of recoverable amount of net assets held for sale			4,007,744
Fixed amount receivable upon completion			22,915
Fixed amount receivable in fourth year after completion of business disposal			320,153
Contingent consideration			486,429
L’Oréal Group [Member] | Natura Brazil Pty Ltd. (Aesop) [Member]
General Information [Line Items]
Disposal date fair value of total consideration received		R$ 12429175
Net gain (loss) on the sale of subsidiaries		7,377,768
Accumulated gains in other comprehensive income from currency translation		115,168
Write-off of goodwill		124,315
L’Oréal Group [Member] | Natura Brazil Pty Ltd. (Aesop) [Member] | Discontinued operations [member]
General Information [Line Items]
Disposal date fair value of total consideration received		12,429,175
Net gain (loss) on the sale of subsidiaries		7,377,768
Accumulated gains in other comprehensive income from currency translation		R$ 115168
Aurelius Investment Advisory Limited (“Aurelius”) [Member] | The Body Shop [member]
General Information [Line Items]
Disposal date fair value of total consideration received										R$ 829496
Accumulated gains in other comprehensive income from currency translation	R$ 1622436
Write-off of goodwill	4,007,744
Impairment loss of recoverable amount of net assets held for sale	4,007,744
Fixed amount receivable upon completion								R$ 22915
Fixed amount receivable in fourth year after completion of business disposal						R$ 320153
Number of variable installments of contingent consideration ('earn-out')							2
Contingent consideration							R$ 486429
Aurelius Investment Advisory Limited (“Aurelius”) [Member] | The Body Shop [member] | Discontinued operations [member]
General Information [Line Items]
Net gain (loss) on the sale of subsidiaries	R$ 1081340		1,081,340
Accumulated gains in other comprehensive income from currency translation			1,622,436
Impairment loss of recoverable amount of net assets held for sale			R$ 4007744
Number of variable installments of contingent consideration ('earn-out') | Installments									2	2
Contingent consideration | £									£ 90,000

SUMMARY OF MATERIAL ACCOUNTIN_2

SUMMARY OF MATERIAL ACCOUNTING POLICIES - Summary of Information About Company Principal Subsidiaries (Detail)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Avon Products, Inc
Disclosure of Significant Accounting Polices [Line Items]
Direct interest	100%	100%
Natura Cosmeticos S.A. [member]
Disclosure of Significant Accounting Polices [Line Items]
Direct interest	100%	100%
Natura &Co International S.à r.l.
Disclosure of Significant Accounting Polices [Line Items]
Direct interest	100%	100%

SUMMARY OF MATERIAL ACCOUNTIN_3

SUMMARY OF MATERIAL ACCOUNTING POLICIES - Additional Information (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)	Dec. 31, 2022	Dec. 31, 2023 ARS ($)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2023 TRY (₺)	May 31, 2023	Dec. 31, 2022 ARS ($)	Dec. 31, 2022 TRY (₺)
Disclosure of Significant Accounting Polices [Line Items]
Closing foreign exchange rate			0.0059		0.1639		0.02955	0.2786
Number of stages for expected credit losses (“ECL”) are recognized	2
Maximum period of default events that are possible for credit losses	12 months
Number of categories of financial liabilities	2
Number of subsidiaries directly or indirectly controlled that have significant interests held by non-controlling shareholders	0	0
Investment holding period	90 days
Period covered by budgets and forecast calculations	10 years
Impairment loss of non-financial assets, excluding goodwill	R$ 0
Period of lease term of short-term leases	12 months
Applicable tax rate	4.30%	(4.30%)
Tax loss carryforward on taxable income | %	30%
Maximum period of loyalty program points	5 months
Number of periodic cycles of loyalty program points	6
Number of performance obligations of supply contracts	2
Number of thematic advisory committees	5
Period of right to avoid liquidation of a liability	12 months
Period to understand the risk that the liabilities will be advanced	12 months
Global minimum effective tax rate						15%
Corporate income tax ("IRPJ")
Disclosure of Significant Accounting Polices [Line Items]
Applicable tax rate	15%
Additional applicable tax rate	10%
Income Taxable				R$ 240
Social contribution on net income ("CSLL")
Disclosure of Significant Accounting Polices [Line Items]
Applicable tax rate	9%
Argentina
Disclosure of Significant Accounting Polices [Line Items]
Rates of inflation	211.40%	94.80%
Turkey
Disclosure of Significant Accounting Polices [Line Items]
Rates of inflation	64.80%	64.30%

CRITICAL ACCOUNTING ESTIMATES_2

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS - Additional Information (Details) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of Accounting Judgements and Estimates [Line Items]
Tax losses carried forward	R$ 12254435	R$ 12735337
Term for budgeted cash flow	3 years
Discretionary period	10 years

FINANCIAL RISK MANAGEMENT - Sum

FINANCIAL RISK MANAGEMENT - Summary of Derivative Positions (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of fair value measurement of liabilities [line items]
Total financial derivative instruments		R$ 278450	R$ 1008365
Total net derivative financial instruments		(51,226)	(796,877)	R$ 516386
Total net derivative financial instruments		(43,493)	(676,870)	154,420
Natura Cosmeticos S.A. [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(5,878)	(521)	(48)
Gain (Loss) on Derivative Financial Liabilities		(2,090)	(521)	(48)
Natura Industria [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(28,856)	(6,633)
Gain (Loss) on Derivative Financial Liabilities		(28,856)	(6,633)
Natura Mexico (Latam) [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		320
Gain (Loss) on Derivative Financial Liabilities		151
The Body Shop [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities			16,789	(2,554)
Gain (Loss) on Derivative Financial Liabilities			(1,180)	12
Aesop [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities			(1,350)
Gain (Loss) on Derivative Financial Liabilities			90
Avon Brasil [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(3,702)	(1,183)
Gain (Loss) on Derivative Financial Liabilities		(3,702)	(1,183)
Avon Internacional [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(43,248)	(19,203)	(14,462)
Gain (Loss) on Derivative Financial Liabilities		(28,633)	(6,925)	106
Natura and Co Luxembourg Holdings Sarl [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(22,182)	(18,996)	(89)
Gain (Loss) on Derivative Financial Liabilities		180	2,293	(89)
Short Position CDI Floating Rate Swap Contract One [Member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(824,344)	(6,874,285)	(6,348,442)
Gain (Loss) on Derivative Financial Liabilities			(697,678)	(823,887)
Long Position US Dollar Swap Contract One [Member]
Disclosure of fair value measurement of liabilities [line items]
Total financial derivative instruments	[1]	876,664	6,108,505	6,881,981
Gain (Loss) on Derivative Financial Assets	[1]	R$ 19457	R$ 34867	R$ 978350
[1]Swap transactions consist of swapping the exchange rate variation for a correction related to a percentage of the fluctuation of the Certificate of bank deposits (post-fixed CDI), in the case of Brazil

FINANCIAL RISK MANAGEMENT - Sch

FINANCIAL RISK MANAGEMENT - Schedule of changes in net financial derivatives (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
FINANCIAL RISK MANAGEMENT
Losses in cash flow hedge operations (other comprehensive income)	R$ 746648	R$ 790479	R$ 210150
Balance at end of period	52,319
Derivatives [member]
FINANCIAL RISK MANAGEMENT
Balance at beginning of period	(796,877)	516,637
Losses from swap and forward derivative contracts for the year (unrealized)	(1,791,905)	(992,813)
Payment of funds due to settlements of derivative instruments - financing activity	310,870
Losses in cash flow hedge operations (other comprehensive income)	746,648	(790,479)
Payment of funds due to settlement of derivative transactions - operational activity	1,487,092	594,225
Receipt of funds due to settlements of derivative instruments - financing activity		(118,707)
Other movements	(7,054)	(5,740)
Balance at end of period	R$ 51226	R$ 796877	R$ 516637

FINANCIAL RISK MANAGEMENT - S_2

FINANCIAL RISK MANAGEMENT - Summary of Net Asset Exposure (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
FINANCIAL RISK MANAGEMENT
Borrowing and financing in foreign currency in Brazil	[1]		R$ 5252376
Trade accounts receivable in foreign currency in Brazil		328,346	521,427
Trade accounts payable in foreign currencies in Brazil		(158,500)	(15,214)
Fair value of financial derivatives		(38,436)	6,101,350
Net asset exposure		R$ 131410	R$ 1355187
[1]Excluding transaction costs.

FINANCIAL RISK MANAGEMENT - Dis

FINANCIAL RISK MANAGEMENT - Disclosure Of Net Foreign Exchange Exposure (Detail)		12 Months Ended
		Dec. 31, 2023 BRL (R$)	Dec. 31, 2023 ARS ($)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2023 TRY (₺)	Dec. 31, 2022 ARS ($)	Dec. 31, 2022 BRL (R$)	Dec. 31, 2022 TRY (₺)
Disclosure of financial assets [line items]
Closing foreign exchange rate			0.0059		0.1639	0.02955		0.2786
Fair value of “financial” derivatives				R$ 38436000			R$ 6101350000
Trade accounts receivable in foreign currency in Brazil				328,346,000			521,427,000
Borrowing and financing in foreign currency in Brazil	[1]						(5,252,376,000)
Trade accounts payable in foreign currencies in Brazil				(158,500,000)			R$ 15214000
Scenario - Real (4.8413 Parity - R$ vs US$) | USD
Disclosure of financial assets [line items]
Fair value of “financial” derivatives				(38,436,000)
Trade accounts receivable in foreign currency in Brazil				328,346,000
Trade accounts payable in foreign currencies in Brazil				R$ 158500000
Impact on net income and shareholders’ equity		R$ 131410000
Scenario - Real (4.8413 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of financial assets [line items]
Closing foreign exchange rate				4.8413
Scenario I - Depreciation 25% (3.6715 Parity - R$ vs US$) | USD
Disclosure of financial assets [line items]
Fair value of “financial” derivatives				R$ 29149000
Trade accounts receivable in foreign currency in Brazil				249,007,000
Trade accounts payable in foreign currencies in Brazil				R$ 120201000
Impact on net income and shareholders’ equity		R$ 31753000
Scenario I - Depreciation 25% (3.6715 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of financial assets [line items]
Closing foreign exchange rate				3.6715
Foreign exchange rate, percentage of decrease		25%
Scenario II - Depreciation 50% (2.4477 Parity - R$ vs US$) | USD
Disclosure of financial assets [line items]
Fair value of “financial” derivatives				R$ 19432000
Trade accounts receivable in foreign currency in Brazil				166,005,000
Trade accounts payable in foreign currencies in Brazil				R$ 80134000
Impact on net income and shareholders’ equity		R$ 64971000
Scenario II - Depreciation 50% (2.4477 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of financial assets [line items]
Closing foreign exchange rate				2.4477
Foreign exchange rate, percentage of decrease		50%
[1]Excluding transaction costs.

FINANCIAL RISK MANAGEMENT - D_2

FINANCIAL RISK MANAGEMENT - Disclosure of Detailed Information About Cash Flow Hedged Items (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of financial assets [line items]
Fair value	R$ 29026
Accumulated contract gain (loss)	(26,652)
Gain (loss) in the period	R$ 746648	R$ 790479	R$ 210150
Currency swap – US$/R$ - Natura Cosméticos [Member]
Disclosure of financial assets [line items]
Hedged item	Currency and interest rate
Notional currency	BRL
Fair value	R$ 5878
Accumulated contract gain (loss)	(2,090)
Gain (loss) in the period	R$ 763197
Forward agreements (Avon Industria)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 3702
Accumulated contract gain (loss)	(3,702)
Gain (loss) in the period	R$ 5452
Forward agreements (Natura Dist. Mexico)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 320
Accumulated contract gain (loss)	151
Gain (loss) in the period	R$ 151
Forward agreements (Natura Industria)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 21497
Accumulated contract gain (loss)	(21,497)
Gain (loss) in the period	R$ 22637
Forward agreements (Natura Holding)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 1731
Accumulated contract gain (loss)	486
Gain (loss) in the period	R$ 485

FINANCIAL RISK MANAGEMENT - D_3

FINANCIAL RISK MANAGEMENT - Disclosure of Detailed Information About Cash Flow Hedged Reserve Booked Under Other Comprehensive Income (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
FINANCIAL RISK MANAGEMENT
Cash flow hedge beginning of balance	R$ 498578	R$ 21866	R$ 159077
Change in the fair value of hedge instrument recognized in OCI	746,648	(790,479)	(210,150)
Tax effects on fair value of hedge instrument	(251,950)	270,035	72,939
Cash flow hedge end of balance	R$ 3880	R$ 498578	R$ 21866

FINANCIAL RISK MANAGEMENT - D_4

FINANCIAL RISK MANAGEMENT - Disclosure of the net position of derivative instruments designated as fair value hedges consists exclusively of financial derivatives (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)
FINANCIAL RISK MANAGEMENT
Fair value	R$ 52319
Fair value hedges [member]
FINANCIAL RISK MANAGEMENT
Protection object	Interest Rate
Reference currency (Notional)	BRL
Fair value	R$ 52319

FINANCIAL RISK MANAGEMENT - D_5

FINANCIAL RISK MANAGEMENT - Disclosure of Detailed Information About Interest Rate Risks of Transactions (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)
FINANCIAL RISK MANAGEMENT
Total borrowing, financing and debentures - in local currency	R$ 6111702
Operations in foreign currency with derivatives related to CDI	52,319	[1]
Short-term investments	5,661,434
Net exposure	R$ 397949
[1]Refers to transactions involving derivatives related to CDI to hedge the borrowing, financing and debentures arrangements raised in foreign currency in Brazil.

FINANCIAL RISK MANAGEMENT - S_3

FINANCIAL RISK MANAGEMENT - Summary of Net Exposure to Interest Rate Risk by Scenario (Detail) - Interest rate risk [member] R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)
Disclosure of risk management strategy related to hedge accounting [line items]
Risk	Rate increases
Probable scenario [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	R$ 5683
Scenario Two [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	40,184
Scenario Three [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	R$ 86050

FINANCIAL RISK MANAGEMENT - S_4

FINANCIAL RISK MANAGEMENT - Summary of Working Capital Calculation (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022
FINANCIAL RISK MANAGEMENT
Total current assets	R$ 15987222	R$ 16121527
Total current liabilities	(10,413,499)	(13,337,868)
Total net working capital	R$ 5573723	R$ 2783659

FINANCIAL RISK MANAGEMENT - D_6

FINANCIAL RISK MANAGEMENT - Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	R$ 8630548	R$ 17091611
Derivatives	51,226	796,877
Lease liability	1,448,953	3,946,378
Trade accounts payables, related parties and reverse factoring operations	5,302,478	6,375,930
Dividends payable	294,231	260
Borrowings, financing and debentures, Interest to be accrued	(2,518,846)	(3,499,325)
Lease liability, interest to be accrued	(298,513)	(675,641)
Borrowings, financing and debentures, Carrying amount	6,111,702	13,592,286	R$ 12716832
Derivatives, Carrying amount	51,226	796,877
Lease liability, Carrying amount	1,150,440	3,270,737	R$ 3547863
Trade accounts payables, related parties and reverse factoring operations, Carrying amount	5,302,478	6,375,930
Dividends payable	294,231	260
Less than one year [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	357,568	722,146
Derivatives	140,679	640,257
Lease liability	401,217	1,070,253
Trade accounts payables, related parties and reverse factoring operations	5,302,478	6,375,930
Dividends payable	294,231	260
One to five years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	4,194,476	3,228,866
Derivatives	71,134	1,504,007
Lease liability	912,529	2,019,723
Trade accounts payables, related parties and reverse factoring operations
Dividends payable
Over five years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	4,078,504	13,140,599
Derivatives	(160,587)	(1,347,387)
Lease liability	135,207	856,402
Trade accounts payables, related parties and reverse factoring operations
Dividends payable

FINANCIAL RISK MANAGEMENT - D_7

FINANCIAL RISK MANAGEMENT - Disclosure Of Carrying Amounts And Fair Values Of The Company's Financial Instruments (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about financial instruments [line items]
Cash and banks		R$ 2113566	R$ 2904808
Certificate of bank deposits		203,561	46,864
Repurchase operations	[1]	1,433,817	1,244,041
Total cash and cash equivalent		3,750,944	4,195,713	R$ 4007257	R$ 5821672
Government securities	[2]	1,272,445	31,415
Restricted cash		30,240	1,481
Financial treasury bills	[3]	392,253	539,450
Loan investment funds	[4]	2,329,118	1,228,093
DBV fund		36,698	35,235
Total short-term investments		4,060,754	1,835,674
Trade receivables		3,524,395	3,502,399
Receivables from service providers	[5]	109,639	110,214
Total receivables		5,052,001	4,332,271
Total financial derivative instruments		278,450	1,008,365
Total borrowing, financing and debentures		(6,111,702)	(13,592,286)
Lease liability		(1,150,440)	(3,270,737)	R$ 3547863
Trade accounts payables, related-parties' and reverse factoring operations		(5,302,478)	(6,375,930)
Dividends payable		(294,231)	(260)
Financial liabilities at amortised cost, category [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Prepaid insurance		14,013
Financial liabilities at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Financial and operating derivatives		(329,676)	(1,805,242)
Financial Liabilities - Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Borrowing in local currency		(6,111,702)	(8,419,320)
Foreign currency borrowings			(5,172,966)
Lease liability		(1,150,440)	(3,270,737)
Trade accounts payables, related-parties' and reverse factoring operations		(5,302,478)	(6,375,930)
Insurance payable		(1,239)	(69,364)
Dividends payable		(294,231)	(260)
Financial assets at amortised cost, class [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Cash and banks		2,113,566	2,904,808
Foreign currency borrowings
Financial assets at fair value through profit or loss, category [member] | Level 1 [member]
Disclosure of detailed information about financial instruments [line items]
Receivables from service providers			110,214
Financial assets at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Certificate of bank deposits		203,561	46,864
Repurchase operations		1,433,817	1,244,041
Government securities		1,272,445	31,415
Restricted cash		30,240	1,481
Financial treasury bills		392,253	539,450
Loan investment funds		2,329,118	1,228,093
Trade receivables		3,524,395	3,502,399
Judicial deposits		408,030	457,550
Sublease receivables		180,440	262,108
Receivables from service providers		109,639
Fixed consideration		343,068
Financial derivatives (hedge instrument)		23,293
Financial derivative instruments		255,157	1,008,365
Financial assets at fair value through profit or loss, category [member] | Level 3 [member]
Disclosure of detailed information about financial instruments [line items]
DBV fund		36,698	35,235
Contingent consideration		486,429
Fair value [member]
Disclosure of detailed information about financial instruments [line items]
Total cash and cash equivalent		3,750,944	4,195,713
Total short-term investments		4,060,754	1,835,674
Total receivables		5,052,001	4,332,271
Total financial derivative instruments		278,450	1,008,365
Total borrowing, financing and debentures		(6,111,702)	(13,592,286)
Fair value [member] | Financial liabilities at amortised cost, category [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Prepaid insurance		14,013
Fair value [member] | Financial liabilities at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Financial and operating derivatives		(329,676)	(1,805,242)
Fair value [member] | Financial Liabilities - Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Borrowing in local currency		(6,111,702)	(8,419,320)
Foreign currency borrowings			(5,172,966)
Lease liability		(1,150,440)	(3,270,737)
Trade accounts payables, related-parties' and reverse factoring operations		(5,302,478)	(6,375,930)
Insurance payable		(1,239)	(69,364)
Dividends payable		(294,231)	(260)
Fair value [member] | Financial assets at amortised cost, class [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Cash and banks		2,113,566	2,904,808
Foreign currency borrowings
Fair value [member] | Financial assets at fair value through profit or loss, category [member] | Level 1 [member]
Disclosure of detailed information about financial instruments [line items]
Receivables from service providers		109,639	110,214
Fair value [member] | Financial assets at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure of detailed information about financial instruments [line items]
Certificate of bank deposits		203,561	46,864
Repurchase operations		1,433,817	1,244,041
Government securities		1,272,445	31,415
Restricted cash		30,240	1,481
Financial treasury bills		392,253	539,450
Loan investment funds		2,329,118	1,228,093
Trade receivables		3,524,395	3,502,399
Judicial deposits		408,030	457,550
Sublease receivables		180,440	262,108
Fixed consideration		343,068
Financial derivatives (hedge instrument)		23,293
Financial derivative instruments		255,157	1,008,365
Fair value [member] | Financial assets at fair value through profit or loss, category [member] | Level 3 [member]
Disclosure of detailed information about financial instruments [line items]
DBV fund		36,698	35,235
Contingent consideration		R$ 486429
[1]Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”), these investments offer high liquidity with a redemption period of up to 90 2022 As of December 31, 2023, investments in Government securities (LFT) are remunerated at an average rate of 100.75% of the CDI (100.02% of the CDI as of December 31, 2022). As of December 31, 2023, investments in treasury bills are remunerated at an average rate of 108.15% of the CDI (109.69% as of December 31, 2022). Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the entities of Argentina, Chile, Colombia and Mexico.

FINANCIAL RISK MANAGEMENT - Add

FINANCIAL RISK MANAGEMENT - Additional Information (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2023 BRL (R$)	Dec. 31, 2023	Dec. 31, 2023 ARS ($)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2023 TRY (₺)	Dec. 31, 2022 ARS ($)	Dec. 31, 2022 TRY (₺)	May 04, 2021
Disclosure of detailed information about financial instruments [line items]
Closing foreign exchange rate			0.0059		0.1639	0.02955	0.2786
Percentage of borrowings linked to CDI rate		99.40%
Borrowings interest rate		11.30%
Scenario I - Depreciation 25% (3.6715 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of detailed information about financial instruments [line items]
Period of future currency rates are considered in sensitivity analysis		90 days
Closing foreign exchange rate				3.6715
Foreign exchange rate, percentage of decrease		25%
Scenario II - Depreciation 50% (2.4477 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of detailed information about financial instruments [line items]
Closing foreign exchange rate				2.4477
Foreign exchange rate, percentage of decrease		50%
Scenario Two [Member]
Disclosure of detailed information about financial instruments [line items]
Percentage of reasonably possible increase in unobservable input, liabilities		25%
Borrowings interest rate		14.13%
Scenario Three [Member]
Disclosure of detailed information about financial instruments [line items]
Percentage of reasonably possible increase in unobservable input, liabilities		50%
Borrowings interest rate		16.95%
Probable scenario [Member]
Disclosure of detailed information about financial instruments [line items]
Period of future interest rates are considered in sensitivity analysis		90 days
Probable scenario [Member] | Brazilian real per US dollar
Disclosure of detailed information about financial instruments [line items]
Closing foreign exchange rate				4.8953
Foreign currency risk [member]
Disclosure of detailed information about financial instruments [line items]
Average Period of Commitments for Foreign Currency of Receivables and Payables		12 months
Derivatives liability position	R$ 1380405000
Natura Cosmeticos S.A. [member] | ESG debt securities (“Notes ESG”) [Member]
Disclosure of detailed information about financial instruments [line items]
Borrowings interest rate								4.125%
Natura Cosmeticos S.A. [member] | Foreign currency risk [member]
Disclosure of detailed information about financial instruments [line items]
Derecognition of financial liability	4,958,286,000
Losses arising from derecognition of financial liabilities, before tax	R$ 700810000

FINANCIAL RISK MANAGEMENT - A_2

FINANCIAL RISK MANAGEMENT - Additional Information (Details - Textuals 1) R$ in Thousands, $ in Thousands		12 Months Ended
	May 04, 2021 BRL (R$)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2023 GBP (£)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2022 BRL (R$)	May 04, 2021 USD ($)
Disclosure of detailed information about financial instruments [line items]
Borrowings interest rate			11.30%	11.30%
Percentage of reasonably possible increase (decrease) in unobservable input, investment assets		1%
Percentage of Discount Applied in Unobservable Input Investment Assets		15.30%
Increase (decrease) in the fair value of the investment due to 1% increase (decrease) in the applied discount (16.7%) | R$				R$ 394	R$ 402
Cash flow hedges [member]
Disclosure of detailed information about financial instruments [line items]
Hedge ratio		1:1
Fair value hedges [member]
Disclosure of detailed information about financial instruments [line items]
Hedge ratio		1:1
Aurelius Investment Advisory Limited (“Aurelius”) [Member] | The Body Shop [member]
Disclosure of detailed information about financial instruments [line items]
Contingent consideration receivable from business divestments, First instalment in 2025 | £			£ 30,000
Contingent consideration receivable from business divestments, Second instalment in 2026 | £			£ 60,000
Percentage of increase (reduction) in the applied discount rate, consideration receivables			1%	1%
Percentage of discount rate, contingent consideration receivables			4.50%	4.50%
increase (reduction) in the fair value of the credit receivable | R$		R$ 13456
Percentage of increase (decrease) in probability-adjusted EBITDA, consideration receivables			25%	25%
Natura Cosmticos SA [Member] | ESG debt securities (“Notes ESG”) [Member]
Disclosure of detailed information about financial instruments [line items]
Borrowings interest rate	4.125%					4.125%
Borrowings, maturity	May 3, 2028
Notional Amount	R$ 5600000					$ 1,000,000
Minimum target percentage of reduction in greenhouse gas emissions		13%
Minimum target percentage of usage of recycled plastic in packaging		25%
Period before target date for lack of report issued by an external verifier attesting to fulfilment of environment goals		30 days
Description of estimated interest rate increase for non-compliance for fulfilment of environment goals		65-basic

CASH AND CASH EQUIVALENT - Summ

CASH AND CASH EQUIVALENT - Summary of Detailed Information About Cash And Cash Equivalents (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
CASH AND CASH EQUIVALENT
Cash and banks		R$ 2113566	R$ 2904808
Certificate of bank deposits		203,561	46,864
Repurchase operations	[1]	1,433,817	1,244,041
Total cash and cash equivalent		R$ 3750944	R$ 4195713	R$ 4007257	R$ 5821672
[1]Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”), these investments offer high liquidity with a redemption period of up to 90 2022

CASH AND CASH EQUIVALENT - Su_2

CASH AND CASH EQUIVALENT - Summary of Detailed Information About Cash And Cash Equivalents (Parenthetical) (Detail)	Dec. 31, 2023	Dec. 31, 2022
CASH AND CASH EQUIVALENT
Average repurchase operations remuneration rate	100%	100%

SHORT-TERM INVESTMENTS - Summar

SHORT-TERM INVESTMENTS - Summary of Short-Term Investments (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Short Term Investments [Abstract]
Loan investment funds	[1]	R$ 2329118	R$ 1228093
Treasury bills	[2]	392,253	539,450
Government securities (LFT)	[3]	1,272,445	31,415
DBV fund		36,698	35,235
Restricted cash		30,240	1,481
Total short-term investments		4,060,754	1,835,674
Current		4,024,056	1,800,439
Non-current		R$ 36698	R$ 35235
[1] Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the entities of Argentina, Chile, Colombia and Mexico. As of December 31, 2023, investments in treasury bills are remunerated at an average rate of 108.15% of the CDI (109.69% as of December 31, 2022). As of December 31, 2023, investments in Government securities (LFT) are remunerated at an average rate of 100.75% of the CDI (100.02% of the CDI as of December 31, 2022).

SHORT-TERM INVESTMENTS - Summ_2

SHORT-TERM INVESTMENTS - Summary of Short-Term Investments (Parenthetical) (Detail)	Dec. 31, 2023	Dec. 31, 2022
Treasury Bills [Member]
Disclosure of short-term investments
Average rate of remuneration for shor-term investments	108.15%	109.69%
Government securities (LFT) [Member]
Disclosure of short-term investments
Average rate of remuneration for shor-term investments	100.75%	100.02%

SHORT-TERM INVESTMENTS - Summ_3

SHORT-TERM INVESTMENTS - Summary of Detailed Information About Investment Portfolio (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Short Term Investments [Abstract]
Certificate of bank deposits (CDB)		R$ 644	R$ 2012
Repurchase operations (cash and cash equivalents)		1,433,487	937,645
Treasury bills	[1]	392,253	539,450
Government securities (LFT)		1,272,445	46,071
Exclusive Investment Fund Portfolio		R$ 3098829	R$ 1525178
[1] As of December 31, 2023, investments in treasury bills are remunerated at an average rate of 108.15% of the CDI (109.69% as of December 31, 2022).

TRADE ACCOUNTS RECEIVABLE - Sum

TRADE ACCOUNTS RECEIVABLE - Summary of Detailed Information About Trade Receivables (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Trade receivables	R$ 3893880	R$ 3933550
(-) Allowance for expected credit losses	(369,485)	(431,151)
Trade Receivables, Net	R$ 3524395	R$ 3502399

TRADE ACCOUNTS RECEIVABLE - S_2

TRADE ACCOUNTS RECEIVABLE - Summary of Trade Receivables by Exposure to Doubtful Accounts (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disclosure of financial assets [line items]
Trade receivables	R$ 3893880	R$ 3933550
Allowance for expected credit losses	(369,485)	(431,151)
Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	3,893,880	3,933,550
Allowance for expected credit losses	(369,485)	(431,151)	R$ 453981	R$ 432108
Current [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	3,150,046	2,814,843
Allowance for expected credit losses	(111,784)	(94,148)
Up to 30 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	348,851	621,711
Allowance for expected credit losses	(48,397)	(59,764)
31 to 60 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	89,271	142,507
Allowance for expected credit losses	(32,502)	(53,609)
61 to 90 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	66,496	106,124
Allowance for expected credit losses	(31,128)	(48,851)
91 to 180 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	239,194	248,365
Allowance for expected credit losses	(145,656)	(174,779)
Over 180 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	22
Allowance for expected credit losses	R$ 18

TRADE ACCOUNTS RECEIVABLE - S_3

TRADE ACCOUNTS RECEIVABLE - Summary of Allowance For Credit Losses (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of financial assets [line items]
Beginning Balance		R$ 431151
Ending balance		(369,485)	R$ 431151
Trade Receivables [member]
Disclosure of financial assets [line items]
Beginning Balance		(431,151)	(453,981)	R$ 432108
Write-off from sale of subsidiaries		7,107
Additions, net of reversals		(605,874)	(605,995)	(837,822)
Write-offs	[1]	634,657	592,857	817,446
Translation adjustment		25,776	35,968	(1,497)
Ending balance		R$ 369485	R$ 431151	R$ 453981
[1]Refers to accounts overdue for more than 180

INVENTORIES - Summary of Invent

INVENTORIES - Summary of Inventories (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
INVENTORIES
Finished products	R$ 2390999	R$ 3634068
Raw materials and packaging	882,514	1,159,507
Auxiliary materials	224,370	146,409
Products in progress	41,604	68,849
(-) Provision for inventory losses	(452,092)	(491,959)	R$ 615944	R$ 594071
Current Inventories	R$ 3087395	R$ 4516874

INVENTORIES - Summary of Change

INVENTORIES - Summary of Changes In The Provision For Inventory Losses (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
INVENTORIES
Beginning balance		R$ 491959	R$ 615944	R$ 594071
Write-off from sale of subsidiaries		63,971
Additions, net of reversals	[1]	(422,498)	(305,705)	(837,822)
Write-offs	[2]	352,519	366,198	817,446
Translation adjustment		45,875	63,492	(1,497)
Ending balance		R$ 452092	R$ 491959	R$ 615944
[1]This refers to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company.[2] It consists of write-offs of products for which there already had an allowance for losses, where the Company has no expectation of sales/realization.

RECOVERABLE TAXES - Summary of

RECOVERABLE TAXES - Summary of Current Tax Assets (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
RECOVERABLE TAXES
ICMS on purchase of goods	[1]	R$ 561224	R$ 704018
Taxes on purchase of goods – foreign subsidiaries		214,699	245,955
ICMS on purchases of property, plant and equipment and purchase of goods		15,912	14,365
PIS and COFINS on purchase of property, plant and equipment and purchase of goods	[2]	620,631	950,307
Withholding PIS, COFINS and CSLL		1,671	1,671
Tax on Manufactured Goods - IPI	[3]	127,127	152,686
Other		179,673	199,276
Total		1,720,937	2,268,278
Current		608,530	911,410
Non-current		R$ 1112407	R$ 1356868
[1] Tax credits related to the tax on the circulation of goods, interstate and inter-municipal transport and communication services (ICMS) were generated mainly by purchases, whose tax rate is higher than the average of sales. The Company expects to realize these credits during the ordinary course of business through offsetting with sales operations in the domestic market. The accumulated tax credits of PIS and COFINS basically arise from credits on purchases of raw materials used in the production and from purchase of property, plant and equipment, as well as credits arising out of the exclusion of ICMS from the calculation basis of the PIS/COFINS. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. The balance will be used to offset IPI (Taxes over industrialized products) payable in future operations of the Company.

INCOME TAX AND SOCIAL CONTRIB_3

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of Breakdown of Deferred Income Tax And Social Contribution Assets (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
INCOME TAX AND SOCIAL CONTRIBUTION
Tax loss carryforwards		R$ 1778203		R$ 2465805
Receivables		141,595		192,260
Inventory		141,650		219,367
Fixed and Intangible Assets		31,991		160,716
Lease liabilities		262,175		444,444
Accruals, reserves and provision for tax, civil and labor risks	[1]	358,108		649,768
Employee benefits		340,807		373,817
Non-functional currency positions, including derivatives and hedge accounting transactions (d)	[2]	9,811		307,732
Foreign Tax Credit Carryforwards (b)	[3]	10,003		363,493
Other temporary differences		145,151		124,689
Total Deferred Tax Assets		3,219,494		5,302,091
Non-functional currency positions, including derivatives and hedge accounting transactions	[2]	(16,500)
Fixed and intangible assets		(213,266)		(339,627)
Employee benefits		(145,149)		(132,609)
Right to use assets		(195,814)		(359,072)
Contingent consideration		(157,966)
Fair value of identifiable net assets in business combination	[4]	(281,436)		(1,561,946)
Other temporary differences		(336,758)		(323,736)
Total Deferred Tax Liabilities		(1,346,889)		(2,716,990)
Total of Deferred income tax and social contribution, net		1,872,605		2,585,101
Deferred income taxes and social contribution assets, net		2,200,695	[5]	3,519,515	[5]	R$ 3100515
Deferred income taxes and social contribution liabilities, net		R$ 328090	[5]	R$ 934414	[5]	R$ 994041
[1] Includes (i) expenses under the accrual basis, reflecting deductible expenses incurred in the year, (ii) deferred revenue, (iii) accrued and unpaid compensation and (iv) other reserves not currently deductible for tax. Due to underlying changes in non-functional currencies relative to the Brazilian Real, the balance at 2023 year-end primarily reflects a loss on a hedge instrument that can only be deducted when the hedge instrument is settled; as of 2022 year-end, the balance primarily reflected a gain on a hedge which could be deferred until settlement. Primarily relates to foreign tax credit in Brazil that had historically been reported as prepaid income taxes rather than deferred tax assets. The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of the subsidiaries Avon, The Body Shop and Aesop. Balance presented in the balance sheet including the effects of the jurisdictional offset of deferred tax assets and liabilities of the same nature, originating from the same taxpayer and tax authority.

INCOME TAX AND SOCIAL CONTRIB_4

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of changes In Deferred Asset And Liability Income Tax And Social Contribution (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Begining balance, asset		R$ 3519515	[1]	R$ 3100515
Beginning balance, liability		(934,414)	[1]	(994,041)
Ending balance, asset	[1]	2,200,695		3,519,515
Ending balance, liability	[1]	(328,090)		(934,414)
Effect on statement of profit or loss [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(894,732)		599,136
Increase decrease in deferred tax liability		(167,668)		(1,071)
Transfer between deferred income tax and social contribution [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(18,502)
Increase decrease in deferred tax liability		18,502
Reclass of UTP to Deferred Tax Liability
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset
Increase decrease in deferred tax liability				(46,760)
Transfer of Prepaid to Deferred Tax
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		20,213
Discontinued operations
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(374,090)
Increase decrease in deferred tax liability		788,977
Reserve for grant of options and restricted shares [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(31,772)		28,750
Increase decrease in deferred tax liability		2,486		(1,617)
Translation adjustment [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(28,132)		(478,921)
Increase decrease in deferred tax liability		10,787		62,315
OCI impact
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		R$ 8195		270,035
Increase decrease in deferred tax liability
[1] Balance presented in the balance sheet including the effects of the jurisdictional offset of deferred tax assets and liabilities of the same nature, originating from the same taxpayer and tax authority.

INCOME TAX AND SOCIAL CONTRIB_5

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of tax losses carryforwards for which no deferred tax asset recognised (Detail) R$ in Thousands	Dec. 31, 2023 BRL (R$)
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	R$ 9513303	[1]
Credits (b)	584,474	[2]
Other future deductible Items	2,156,658
Total	12,254,435
Net Operating Loss, expected expirations during 2023	0
Credits, expected expirations during 2022
Indefinite Expiration Period [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	8,715,748	[1]
Credits (b)		[2]
Other future deductible Items	2,156,658
Total	10,872,406
Definite Expiration Period
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	797,555	[1]
Credits (b)	584,474	[2]
Total	R$ 1382029
[1] During , no significant expirations are expected; the majority of expirations are expected to occur in and successive years. During 2024 2027 .

INCOME TAX AND SOCIAL CONTRIB_6

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of Reconciliation of Income Tax And Social Contribution (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
INCOME TAX AND SOCIAL CONTRIBUTION
Loss before income tax and social contribution		R$ 2668347	R$ 2168618
Income tax and social contribution at the rate of 34%		907,238	737,330
Brazil Investment subsidies		427,897	207,608
Share of profit of equity investees
Effect from differences of tax rates of entities abroad		(147,265)	(103,447)
Taxation of profits of foreign subsidiaries	[1]	(49,264)	56,126
Unrecognized Deferred income tax	[2]	(642,608)	(762,362)
Exercise of purchase options and restricted share plans			52
Non-Deductible donation and contribution		(27,136)	(35,616)
Interest on Net Equity
Withholding and Sub-national taxes		(42,763)	(60,121)
Goodwill impairment	[2]	(225,723)	(70,730)
Other permanent differences		(113,976)	(61,193)
Income tax and social contribution benefit (expenses)		86,400	(92,353)	R$ 1297237
Income tax and social contribution - current		(976,000)	(690,418)
Income tax and social contribution - deferred		R$ 1062400	R$ 598065
Income tax and social contribution, applicable tax rate		34%
Applicable tax rate		4.30%	(4.30%)
[1] Certain earnings of foreign subsidiaries may be subjected to income taxation net of applicable credits, if any, by their parent holding companies in addition to the local taxing jurisdictions in which they conduct operations. Within the Natura Group, these types of taxation regimes exist in various jurisdictions including but not limited to Brazil, Australia, United Kingdom, United States. During 2022 and 2023 , the Company recognizes an impairment of the g oodwill associated with Avon International CGU. The Avon International g oodwill resulting from its acquisition is non-deductible for income tax purposes.

INCOME TAX AND SOCIAL CONTRIB_7

INCOME TAX AND SOCIAL CONTRIBUTION - Additional Information (Details) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	4.30%		(4.30%)
Deferred income tax asset on tax losses	R$ 12254435
Tax loss carryforwards	1,778,203		R$ 2465805
Net deferred tax asset	2,200,695	[1]	3,519,515	[1]	R$ 3100515
Net deferred tax liability	R$ 1346889		2,716,990
Pre-tax profit (loss) from discontinued operations			428,684		339,984
Income tax expense from the results of discontinued operations					249,251
Income tax and social contribution, applicable tax rate	34%
Discontinued operations [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Pre-tax profit (loss) from discontinued operations	R$ 867308		(570,444)		339,984
Income tax expense from the results of discontinued operations	R$ 127337		27,211		R$ 249251
Discontinued operations [member] | Aesop and The Body Shop [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	28.50%
Pre-tax profit (loss) from discontinued operations	R$ 7772		(380)
Income tax expense from the results of discontinued operations	R$ 2214		0
Percentage of difference between the effective tax rate and the statutory tax rate	5.50%
Income tax and social contribution, applicable tax rate	34%
Avon Mexico [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Tax loss carryforwards	R$ 376000		R$ 293000
Operational entities [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Tax loss carryforwards	R$ 1550000
[1] Balance presented in the balance sheet including the effects of the jurisdictional offset of deferred tax assets and liabilities of the same nature, originating from the same taxpayer and tax authority.

JUDICIAL DEPOSITS - Summary of

JUDICIAL DEPOSITS - Summary of Detailed Information About Judicial Deposits (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement [Line Items]
Judicial deposits		R$ 408030	R$ 457550	R$ 585284
Unaccrued tax proceedings [Member]
Statement [Line Items]
Judicial deposits	[1]	228,331	274,273
Accrued tax proceedings [Member]
Statement [Line Items]
Judicial deposits	[2]	154,077	150,929
Unaccrued civil proceedings [Member]
Statement [Line Items]
Judicial deposits		5,462	5,783
Accrued civil proceedings [Member]
Statement [Line Items]
Judicial deposits		1,453	1,470
Unaccrued labor proceedings [Member]
Statement [Line Items]
Judicial deposits		10,018	11,014
Accrued labor proceedings [Member]
Statement [Line Items]
Judicial deposits		R$ 8689	R$ 14081
[1] The tax proceedings related to these judicial deposits refer mainly to the ICMS-ST. The tax proceedings related to these judicial deposits refer, substantially, to the sum of the amounts highlighted in note no. 21 20

JUDICIAL DEPOSITS - Summary o_2

JUDICIAL DEPOSITS - Summary of Detailed Information About Changes In Judicial Deposits (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
JUDICIAL DEPOSITS
Deposits - Beggining balance	R$ 457550	R$ 585284
New deposits	13,493	27,479
Redemptions in favor of the Company	(35,227)	(67,533)
Monetary adjustment	28,460	35,508
Application in the liquidation of proceedings	(55,494)	(121,025)
Transfers		25
Translation adjustment	(752)	(2,188)
Deposits - Ending balance	R$ 408030	R$ 457550

NON-CURRENT ASSETS HELD FOR S_3

NON-CURRENT ASSETS HELD FOR SALE (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
NON-CURRENT ASSETS HELD FOR SALE
Balance at the beginning of the year		R$ 51		R$ 52921
Transfers from property, plant and equipment, other assets and liabilities				13,235
Transfers from the former subsidiary Aesop	[1]	2,492,471
Other transfers	[2]	555,013
Impairment		(53,117)	[3]	(12,510)
Sale				(55,034)
Write off due to Sale	[4]	(2,988,713)
Translation adjustment		(5,705)		1,439
Balance as of the end of the year				R$ 51
[1] These transfers include the assets of the former subsidiary Aesop, and whose sale was assessed as highly probable in the quarter ended March 31, 2023. The sales impacts are presented in note no. 36 The other transfers include certain properties of the subsidiary Avon, located in the United States, Chile and Brazil. Reflect the recognition of loss due to impairment of properties of the subsidiary Avon, located in the United States, Chile and Brazil, transferred to non-current assets held for sale and being tested for impairment purposes upon transfer and consequent measurement to the lower of fair value less selling costs and previous book value. The write-offs due to disposal presented in the movement include the value of the assets of the former subsidiary Aesop. Also among the write-offs are the sale of an asset of the subsidiary Avon in Chile, amounting to R$37,484.

NON-CURRENT ASSETS HELD FOR S_4

NON-CURRENT ASSETS HELD FOR SALE - Additional Information (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of analysis of single amount of discontinued operations [line items]
Sale		R$ 55034
Avon [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Sale	R$ 37484

OTHER CURRENT AND NONCURRENT _3

OTHER CURRENT AND NONCURRENT ASSETS (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
OTHER CURRENT AND NONCURRENT ASSETS
Marketing and advertising advances		R$ 43150	R$ 43509
Supplier advances		203,193	290,205
Employee advances		19,297	20,267
Rent advances and guarantee deposit	[1]	20,284	160,437
Advance insurance expenses		110,355	124,293
Overfunded pension plan	[2]	723,130	694,527
Customs broker advances - Import taxes		43,316	38,398
Sublease receivables	[3]	180,440	262,108
Carbon credits		13,970	14,297
Receivables from service providers	[4]	109,639	110,214
Other		165,332	257,566
Total		1,632,106	2,015,821
Current		604,427	763,384
Non-current		R$ 1027679	R$ 1252437
[1] Mainly related to: (i) advances for lease agreements that were not included in the initial measurement of lease liabilities / right-of-use of the former subsidiary Avon, in accordance with the exemptions of IFRS 16 06 2 2022 Pension plan arising from the acquisition of subsidiary Avon. The variance in the balance refers to the revision in mortality tables offset by the impact of exchange rate variation due to the appreciation of the real. Refers to the sublease receivable from the New York office owned by the subsidiary Avon.

PROPERTY, PLANT AND EQUIPMENT -

PROPERTY, PLANT AND EQUIPMENT - Summary Of Detailed Information About Property, Plant And Equipment (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 4966150	R$ 5377408
Additions	47,861	41,068
Write-offs	(101,757)	(33,671)
Impairment		(9,485)
Transfers	(90,731)	(138,973)
Transfer to asset held for sale	(879,059)
Write-off due to sale of subsidiary	(294,470)
Translation adjustment	(190,420)	(270,197)
Property, Plant And Equipment, Ending	3,457,574	4,966,150
Gross carrying amount [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	8,632,946	8,232,087
Additions	612,896	711,125
Write-offs	(482,045)	(235,675)
Impairment		(9,485)
Transfers	(90,582)	499,999
Transfer to asset held for sale	(1,756,049)
Write-off due to sale of subsidiary	(756,039)
Translation adjustment	(445,297)	(565,105)
Property, Plant And Equipment, Ending	5,715,830	8,632,946
Gross carrying amount [member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	74,362	38,902
Additions	9,285	8
Write-offs	(5,629)	(6,559)
Impairment
Transfers	11	49,285
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	(30,292)	(7,274)
Property, Plant And Equipment, Ending	R$ 47737	R$ 74362
Gross carrying amount [member] | Vehicles [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	2 years	2 years
Gross carrying amount [member] | Vehicles [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	5 years	5 years
Gross carrying amount [member] | Tooling [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	3 years	3 years
Property, Plant And Equipment, Beginning	R$ 204177	R$ 191840
Additions	72
Write-offs	(135)	(2,310)
Impairment
Transfers	6,700	14,976
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	212	(329)
Property, Plant And Equipment, Ending	211,026	204,177
Gross carrying amount [member] | Tools and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	175,452	110,998
Additions	13,676	17,261
Write-offs	(16,033)	(8,177)
Impairment
Transfers	4,360	(43,369)
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	4,275	98,739
Property, Plant And Equipment, Ending	R$ 181730	R$ 175452
Gross carrying amount [member] | Tools and accessories [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	3 years	3 years
Gross carrying amount [member] | Tools and accessories [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	20 years	20 years
Gross carrying amount [member] | Facilities [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 307448	R$ 303452
Additions	984	181
Write-offs	(1,338)	(564)
Impairment
Transfers	25,016	13,147
Transfer to asset held for sale	(166)
Write-off due to sale of subsidiary
Translation adjustment	7,491	(8,768)
Property, Plant And Equipment, Ending	R$ 339435	R$ 307448
Gross carrying amount [member] | Facilities [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	3 years	3 years
Gross carrying amount [member] | Facilities [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	60 years	60 years
Gross carrying amount [member] | Machinery and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 2272136	R$ 1959943
Additions	37,809	23,188
Write-offs	(75,340)	(63,473)
Impairment
Transfers	180,157	520,561
Transfer to asset held for sale	(25,065)
Write-off due to sale of subsidiary	(62,120)
Translation adjustment	(127,358)	(168,083)
Property, Plant And Equipment, Ending	R$ 2200219	R$ 2272136
Gross carrying amount [member] | Machinery and accessories [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	3 years	3 years
Gross carrying amount [member] | Machinery and accessories [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	15 years	15 years
Gross carrying amount [member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 1128086	R$ 1128504
Additions	47,444	68,980
Write-offs	(93,243)	(54,148)
Impairment		(1,665)
Transfers	4,514	106,151
Transfer to asset held for sale	(696,954)
Write-off due to sale of subsidiary	(223,379)
Translation adjustment	(28,035)	(119,736)
Property, Plant And Equipment, Ending	R$ 138433	R$ 1128086
Gross carrying amount [member] | Leasehold improvements [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	2 years	2 years
Gross carrying amount [member] | Leasehold improvements [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	20 years	20 years
Gross carrying amount [member] | Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 1916939	R$ 1982245
Additions	15,966	7,174
Write-offs	(56,721)	(19,104)
Impairment
Transfers	(2,617)	120,512
Transfer to asset held for sale	(582,033)
Write-off due to sale of subsidiary	(28,653)
Translation adjustment	(132,441)	(173,888)
Property, Plant And Equipment, Ending	R$ 1130440	R$ 1916939
Gross carrying amount [member] | Buildings [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	14 years	14 years
Gross carrying amount [member] | Buildings [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	60 years	60 years
Gross carrying amount [member] | Furniture and fixtures [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 674062	R$ 660126
Additions	57,609	71,960
Write-offs	(89,422)	(41,095)
Impairment		(7,629)
Transfers	672	53,632
Transfer to asset held for sale	(93,440)
Write-off due to sale of subsidiary	(359,311)
Translation adjustment	(31,344)	(62,932)
Property, Plant And Equipment, Ending	R$ 158826	R$ 674062
Gross carrying amount [member] | Furniture and fixtures [Member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	2 years	2 years
Gross carrying amount [member] | Furniture and fixtures [Member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	25 years	25 years
Gross carrying amount [member] | Land [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 645657	R$ 628373
Additions	30,313
Write-offs	(631)
Impairment
Transfers		10,043
Transfer to asset held for sale	(267,425)
Write-off due to sale of subsidiary	(4,934)
Translation adjustment	(13,106)	7,241
Property, Plant And Equipment, Ending	389,874	645,657
Gross carrying amount [member] | IT equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	627,770	634,580
Additions	23,286	26,602
Write-offs	(108,116)	(34,279)
Impairment		(191)
Transfers	9,268	84,452
Transfer to asset held for sale	(52,223)
Write-off due to sale of subsidiary	(66,626)
Translation adjustment	(39,004)	(83,394)
Property, Plant And Equipment, Ending	R$ 394355	R$ 627770
Gross carrying amount [member] | IT equipment [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	3 years	3 years
Gross carrying amount [member] | IT equipment [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life range (in years)	15 years	15 years
Gross carrying amount [member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 26230	R$ 31636
Additions
Write-offs	(12)	(4,227)
Impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	(758)	(1,179)
Property, Plant And Equipment, Ending	25,460	26,230
Gross carrying amount [member] | Projects in progress [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	580,627	561,488
Additions	376,452	495,771
Write-offs	(35,425)	(1,739)
Impairment
Transfers	(318,663)	(429,391)
Transfer to asset held for sale	(38,743)
Write-off due to sale of subsidiary	(11,016)
Translation adjustment	(54,937)	(45,502)
Property, Plant And Equipment, Ending	498,295	580,627
Accumulated depreciation, amortisation and impairment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(3,666,796)	(2,854,679)
Additions in depreciation	(565,035)	(670,057)
Write-offs	380,288	202,004
Impairment
Transfers	(149)	(638,972)
Transfer to asset held for sale	876,990
Write-off due to sale of subsidiary	461,569
Translation adjustment	254,877	294,908
Property, Plant And Equipment, Ending	(2,258,256)	(3,666,796)
Accumulated depreciation, amortisation and impairment [member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(38,070)	(9,457)
Additions in depreciation	(5,812)	(6,057)
Write-offs	4,912	5,508
Impairment
Transfers		(40,920)
Write-off due to sale of subsidiary
Translation adjustment	16,107	12,856
Property, Plant And Equipment, Ending	(22,887)	(38,070)
Accumulated depreciation, amortisation and impairment [member] | Tooling [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(179,485)	(174,164)
Additions in depreciation	(8,920)	(7,841)
Write-offs	135	2,310
Impairment
Transfers	(13)
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	(117)	210
Property, Plant And Equipment, Ending	(188,400)	(179,485)
Accumulated depreciation, amortisation and impairment [member] | Tools and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(135,440)	(65,740)
Additions in depreciation	(17,766)	(16,385)
Write-offs	15,872	1,823
Impairment
Transfers	(1,260)	46,967
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	76,188	(102,105)
Property, Plant And Equipment, Ending	(62,406)	(135,440)
Accumulated depreciation, amortisation and impairment [member] | Facilities [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(201,307)	(183,420)
Additions in depreciation	(14,395)	(17,051)
Write-offs	2,554	192
Impairment
Transfers	(390)	(8,804)
Transfer to asset held for sale	166
Write-off due to sale of subsidiary
Translation adjustment	6,033	7,776
Property, Plant And Equipment, Ending	(207,339)	(201,307)
Accumulated depreciation, amortisation and impairment [member] | Machinery and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(1,118,339)	(728,408)
Additions in depreciation	(203,294)	(172,480)
Write-offs	62,508	56,142
Impairment
Transfers	(126)	(397,740)
Transfer to asset held for sale	17,185
Write-off due to sale of subsidiary	37,722
Translation adjustment	15,722	124,147
Property, Plant And Equipment, Ending	(1,188,622)	(1,118,339)
Accumulated depreciation, amortisation and impairment [member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(626,431)	(602,622)
Additions in depreciation	(65,843)	(133,533)
Write-offs	89,857	50,379
Impairment
Transfers		(12,257)
Transfer to asset held for sale	464,551
Write-off due to sale of subsidiary	120,073
Translation adjustment	23,647	71,602
Property, Plant And Equipment, Ending		(626,431)
Accumulated depreciation, amortisation and impairment [member] | Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(455,402)	(298,327)
Additions in depreciation	(105,083)	(103,822)
Write-offs	27,612	14,111
Impairment
Transfers	6	(136,601)
Transfer to asset held for sale	301,177
Write-off due to sale of subsidiary	10,480
Translation adjustment	60,398	69,237
Property, Plant And Equipment, Ending	(160,812)	(455,402)
Accumulated depreciation, amortisation and impairment [member] | Furniture and fixtures [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(408,832)	(369,610)
Additions in depreciation	(79,210)	(90,731)
Write-offs	71,758	31,606
Impairment
Transfers	1,620	(18,576)
Transfer to asset held for sale	62,651
Write-off due to sale of subsidiary	248,773
Translation adjustment	22,245	38,479
Property, Plant And Equipment, Ending	(80,995)	(408,832)
Accumulated depreciation, amortisation and impairment [member] | IT equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(475,668)	(392,095)
Additions in depreciation	(64,163)	(119,870)
Write-offs	105,080	36,065
Impairment
Transfers	14	(71,041)
Transfer to asset held for sale	31,284
Write-off due to sale of subsidiary	44,521
Translation adjustment	(13,775)	71,273
Property, Plant And Equipment, Ending	(372,707)	(475,668)
Accumulated depreciation, amortisation and impairment [member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(27,822)	(30,836)
Additions in depreciation	(549)	(2,287)
Write-offs		3,868
Impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment	48,429	1,433
Property, Plant And Equipment, Ending		R$ 27822
Capital Appreciation [Member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Transfer to asset held for sale	(24)
Capital Appreciation [Member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Ending	5,854
Capital Appreciation [Member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Ending	R$ 20058

INTANGIBLES - Disclosure Of Rec

INTANGIBLES - Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 23260970	R$ 26857583
Additions		567,550	630,708
Write-offs		(58,217)	(200)
(Impairment) reversal of impairment		(663,892)	(308,464)
Transfers		90,731	124,864
Transfer to asset held for sale		(240,024)
Write-off due to sale of subsidiary		(4,778,381)
Translation adjustment		(473,771)	(2,782,105)
Intangible assets and goodwill, Ending		16,569,866	23,260,970
Gross carrying amount [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		26,959,939	29,751,942
Additions		448,259	363,223
Write-offs		(661,802)	(47,167)
(Impairment) reversal of impairment		(663,892)	(308,464)
Transfers		88,236	304,557
Transfer to asset held for sale		(373,192)
Write-off due to sale of subsidiary		(5,468,145)
Translation adjustment		(663,671)	(3,104,152)
Intangible assets and goodwill, Ending		19,665,732	26,959,939
Gross carrying amount [member] | Software [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		2,949,813	2,492,616
Additions		391,102	155,044
Write-offs		(621,831)	(43,333)
(Impairment) reversal of impairment			(21,381)
Transfers		96,351	640,903
Transfer to asset held for sale		(96,956)
Write-off due to sale of subsidiary		(469,184)
Translation adjustment		(150,242)	(274,036)
Intangible assets and goodwill, Ending		R$ 2099053	R$ 2949813
Gross carrying amount [member] | Software [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		2 years 6 months	2 years 6 months
Gross carrying amount [member] | Software [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years	10 years
Gross carrying amount [member] | Trademarks and patents Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 813204	R$ 889834
Additions
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale		(139,869)
Write-off due to sale of subsidiary		(4,443)
Translation adjustment		(49,005)	(76,630)
Intangible assets and goodwill, Ending		R$ 619887	R$ 813204
Gross carrying amount [member] | Trademarks and patents Finite [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		20 years	20 years
Gross carrying amount [member] | Trademarks and patents Finite [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		25 years	25 years
Gross carrying amount [member] | Trademarks and patents Indefinite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 4818030	R$ 5888623
Additions
Write-offs			(43)
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary		(2,503,964)
Translation adjustment		36,281	(1,070,550)
Intangible assets and goodwill, Ending		2,350,347	4,818,030
Gross carrying amount [member] | Goodwill Avon [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[1]	12,307,865	13,381,191
Additions	[1]
Write-offs	[1]
(Impairment) reversal of impairment	[1]	(663,892)	(282,921)
Transfers	[1]
Transfer to asset held for sale	[1]
Write-off due to sale of subsidiary	[1]
Translation adjustment	[1]	(390,514)	(790,405)
Intangible assets and goodwill, Ending	[1]	11,253,459	12,307,865
Gross carrying amount [member] | Goodwill Emeis Brazil Pty Ltd [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[2]	124,315	143,180
Additions	[2]
Write-offs	[2]
(Impairment) reversal of impairment	[2]
Transfers	[2]
Transfer to asset held for sale	[2]	(124,315)
Write-off due to sale of subsidiary	[2]
Translation adjustment	[2]		(18,865)
Intangible assets and goodwill, Ending	[2]		124,315
Gross carrying amount [member] | Goodwill The Body Shop International Limited [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[3]	1,645,527	2,063,672
Additions	[3]
Write-offs	[3]
(Impairment) reversal of impairment	[3]		(2,599)
Transfers	[3]
Transfer to asset held for sale	[3]
Write-off due to sale of subsidiary	[3]	(1,701,981)
Translation adjustment	[3]	56,454	(415,546)
Intangible assets and goodwill, Ending	[3]		1,645,527
Gross carrying amount [member] | Goodwill acquisition of The Body Shop stores [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		1,456	1,456
Additions
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary		(1,456)
Translation adjustment
Intangible assets and goodwill, Ending			1,456
Gross carrying amount [member] | Goodwill aquisition of Singu [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning
Additions		52,049
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment
Intangible assets and goodwill, Ending		R$ 52049
Gross carrying amount [member] | Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years	10 years
Intangible assets and goodwill, Beginning		R$ 2583	R$ 2880
Additions
Write-offs		(2,856)
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale		(2,255)
Write-off due to sale of subsidiary		(4,021)
Translation adjustment		6,752	(297)
Intangible assets and goodwill, Ending		203	2,583
Gross carrying amount [member] | Key Money Indefinite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[4]	22,313	24,985
Additions	[4]		268
Write-offs	[4]	(14,601)	(152)
(Impairment) reversal of impairment	[4]		(623)
Transfers	[4]
Transfer to asset held for sale	[4]
Write-off due to sale of subsidiary	[4]	(7,719)
Translation adjustment	[4]	7	(2,165)
Intangible assets and goodwill, Ending	[4]		22,313
Gross carrying amount [member] | Key Money Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[5]	7,828	14,363
Additions	[5]	1,329
Write-offs	[5]	(3,519)	(3,618)
(Impairment) reversal of impairment	[5]		(940)
Transfers	[5]
Transfer to asset held for sale	[5]
Write-off due to sale of subsidiary	[5]	(5,279)
Translation adjustment	[5]	(359)	(1,977)
Intangible assets and goodwill, Ending	[5]		R$ 7828
Gross carrying amount [member] | Key Money Finite [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[5]	3 years	3 years
Gross carrying amount [member] | Key Money Finite [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[5]	18 years	18 years
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[6]	R$ 2676563	R$ 2990558
Additions	[6]
Write-offs	[6]
(Impairment) reversal of impairment	[6]
Transfers	[6]
Transfer to asset held for sale	[6]
Write-off due to sale of subsidiary	[6]	(686,701)
Translation adjustment	[6]	(57,787)	(313,995)
Intangible assets and goodwill, Ending	[6]	R$ 1932075	R$ 2676563
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[6]	14 years	14 years
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[6]	15 years	15 years
Gross carrying amount [member] | Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 1457039	R$ 1580808
Additions
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment		(105,109)	(123,769)
Intangible assets and goodwill, Ending		1,351,930	1,457,039
Gross carrying amount [member] | Other intangible assets [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		133,403	277,776
Additions		3,779	207,911
Write-offs		(18,995)	(21)
(Impairment) reversal of impairment
Transfers		(8,115)	(336,346)
Transfer to asset held for sale		(9,797)
Write-off due to sale of subsidiary		(83,397)
Translation adjustment		(10,149)	(15,917)
Intangible assets and goodwill, Ending		6,729	133,403
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(3,698,969)	(2,894,359)
Amortization additions		(1,015,809)	(993,931)
Write-offs		603,585	46,967
(Impairment) reversal of impairment
Transfers		2,495	(179,693)
Transfer to asset held for sale		133,168
Write-off due to sale of subsidiary		689,764
Translation adjustment		189,900	322,047
Intangible assets and goodwill, Ending		(3,095,866)	(3,698,969)
Accumulated depreciation, amortisation and impairment [member] | Software [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(1,720,169)	(1,369,767)
Amortization additions		(439,031)	(417,253)
Write-offs		584,109	42,462
(Impairment) reversal of impairment
Transfers		1,875	(179,645)
Transfer to asset held for sale		75,818
Write-off due to sale of subsidiary		387,808
Translation adjustment		96,495	204,034
Intangible assets and goodwill, Ending		(1,013,094)	(1,720,169)
Accumulated depreciation, amortisation and impairment [member] | Trademarks and patents Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(169,620)	(143,186)
Amortization additions		(31,901)	(36,791)
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale		45,298
Write-off due to sale of subsidiary		12,127
Translation adjustment		18,919	10,357
Intangible assets and goodwill, Ending		(125,177)	(169,620)
Accumulated depreciation, amortisation and impairment [member] | Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(2,968)	(3,218)
Amortization additions		(1,668)	(42)
Write-offs		2,719
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale		2,255
Write-off due to sale of subsidiary
Translation adjustment		(540)	292
Intangible assets and goodwill, Ending		(202)	(2,968)
Accumulated depreciation, amortisation and impairment [member] | Key Money Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(10,103)	(16,517)
Amortization additions
Write-offs			4,505
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary		10,103
Translation adjustment			1,909
Intangible assets and goodwill, Ending			(10,103)
Accumulated depreciation, amortisation and impairment [member] | Relationship with franchisees and sub franchisees [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(918,994)	(729,049)
Amortization additions		(260,104)	(264,320)
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary		279,726
Translation adjustment		30,248	74,375
Intangible assets and goodwill, Ending		(869,124)	(918,994)
Accumulated depreciation, amortisation and impairment [member] | Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(874,225)	(632,326)
Amortization additions		(278,969)	(272,297)
Write-offs
(Impairment) reversal of impairment
Transfers
Transfer to asset held for sale
Write-off due to sale of subsidiary
Translation adjustment		71,649	30,398
Intangible assets and goodwill, Ending		(1,081,545)	(874,225)
Accumulated depreciation, amortisation and impairment [member] | Other intangible assets [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(2,890)	(296)
Amortization additions		(4,136)	(3,228)
Write-offs		16,757
(Impairment) reversal of impairment
Transfers		619	(48)
Transfer to asset held for sale		9,797
Write-off due to sale of subsidiary
Translation adjustment		(26,871)	682
Intangible assets and goodwill, Ending		R$ 6724	R$ 2890
[1] Goodwill related to the acquisition of subsidiary Avon. It does not have defined useful life and it is subject to annual impairment tests. Goodwill related to the acquisition of subsidiary Holdings Pty Ltd. acquisition. It does not have defined useful life and it is subject to annual impairment tests. Goodwill related to the acquisition of subsidiary The Body Shop, classified as future economic benefits. It does not have defined useful life and it is subject to annual impairment tests. Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. The balance refers to identifiable intangible assets from relationship with the subsidiary The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years.

INTANGIBLES - Disclosure Of Inf

INTANGIBLES - Disclosure Of Information For Cash-generating Units (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of information for cash-generating units [line items]
Total		R$ 16569866	R$ 23260970	R$ 26857583
Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents		2,350,347	4,818,030
Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill		11,305,508	14,077,707
Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total		13,655,855	18,895,737
Natura and Co Latam [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents
Natura and Co Latam [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill		9,527,619	9,765,077
Natura and Co Latam [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total		9,527,619	9,765,077
Avon International [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents		2,350,347	2,396,290
Avon International [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill		1,777,889	2,542,788
Avon International [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total		4,128,236	4,939,078
TBS International [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents			2,421,740
TBS International [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill			1,645,527
TBS International [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total			4,067,267
Aesop [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	[1]
Aesop [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	[1]		124,315
Aesop [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total	[1]		R$ 124315
[1]The trademarks and patents recognized as part of the acquisition of Aesop were assessed as having a determined useful life and, therefore, are not presented in the table above as of December 31, 2022.

INTANGIBLES - Disclosure Of Det

INTANGIBLES - Disclosure Of Detailed Information About Assumptions Used To Calculate The Fair Value Less Cost To Sell (Detail)	12 Months Ended
	Dec. 31, 2023
Avon International [member]
Disclosure of information for cash-generating units [line items]
Impairment estimate (value in use)	Discounted cash flow based on financial budgets approved by the Board of Directors for a period of three years and complemented for a discretionary period of ten years estimated by Management, with a terminal value projected for the end of the period. The ten-year period was considered for better aligning and smoothing the effects projected between the discretionary period and the effects calculated in perpetuity.
Operating margin	Operating margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next ten years. These margins are increased over the budget period to improve the expected efficiency.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Revenue Growth rates	Growth rates are initially based on published industry research and adjusted by the expected performance for each CGUs group (which, considering the level of goodwill monitoring by the Company, reflects the operating segments), given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by governance leadership bodies (including the Board of Directors).
Perpetuity growth rate	4.66%	[1]
Discount rate	13.87%
Natura and Co Latam [member]
Disclosure of information for cash-generating units [line items]
Impairment estimate (value in use)	Discounted cash flow based on financial budgets approved by the Board of Directors for a period of three years and complemented for a discretionary period of ten years estimated by Management, with a terminal value projected for the end of the period. The ten-year period was considered for better aligning and smoothing the effects projected between the discretionary period and the effects calculated in perpetuity.
Operating margin	Operating margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next ten years. These margins are increased over the budget period to improve the expected efficiency.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Revenue Growth rates	Growth rates are initially based on published industry research and adjusted by the expected performance for each CGUs group (which, considering the level of goodwill monitoring by the Company, reflects the operating segments), given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by governance leadership bodies (including the Board of Directors).
Perpetuity growth rate	6.48%	[1]
Discount rate	17.74%
[1]The rates are based on published market analyzes and projections regarding the reporting segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable. Such rates are also calculated in a currency consistent with those used for the projects and the discount rates.

INTANGIBLES - Schedule of Signi

INTANGIBLES - Schedule of Significant assumption affected by possible deterioration (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)
1 p.p. increase in the discount rate
INTANGIBLE ASSETS
Additional impairment that would be recognized in profit or loss for the year	R$ 762709
Total impairment that would be recognized in profit or loss for the year	1,426,604
Reduction of 1 p.p. in the growth rate in perpetuity
INTANGIBLE ASSETS
Additional impairment that would be recognized in profit or loss for the year	401,389
Total impairment that would be recognized in profit or loss for the year	1,065,284
Reduction of 1 p.p. in operating margins
INTANGIBLE ASSETS
Additional impairment that would be recognized in profit or loss for the year	651,156
Total impairment that would be recognized in profit or loss for the year	R$ 1315051

INTANGIBLES - Additional inform

INTANGIBLES - Additional information (Detail) - BRL (R$)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of detailed information about intangible assets [line items]
Goodwill Impairment	R$ 663892000	R$ 282921000
Avon International [member]
Disclosure of detailed information about intangible assets [line items]
Goodwill Impairment	663,892,000	R$ 282921000
Recoverable amount of cash-generating unit	R$ 6511243
Discount rate	13.87%

RIGHT OF USE AND LEASE LIABIL_3

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Quantitative Information About Right-of-Use Assets (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	R$ 2941887	R$ 3095969
Additions	22,150	149,115
Write-offs	(86,269)	(56,387)
Impairment		(30,785)
Transfer to asset held for sale	(825,065)
Write-off due to sale of subsidiary	(904,569)
Transfers		874
Translation adjustments	(78,879)	(216,899)
Right of use, Ending	1,050,809	2,941,887
Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	5,170,474	5,195,160
Additions	672,685	1,076,981
Write-offs	(457,859)	(601,242)
Impairment		(30,785)
Transfer to asset held for sale	(1,388,973)
Write-off due to sale of subsidiary	(1,961,856)
Transfers		917
Translation adjustments	(171,394)	(470,557)
Right of use, Ending	1,888,931	5,170,474
Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	(2,228,587)	(2,099,191)
Depreciation Additions	(694,835)	(927,866)
Write-offs	371,590	544,855
Impairment
Transfer to asset held for sale	563,908
Write-off due to sale of subsidiary	1,057,287
Transfers		(43)
Translation adjustments	92,515	253,658
Right of use, Ending	R$ 838122	R$ 2228587
Vehicles [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	3 years	3 years
Right of use, Beginning	R$ 164661	R$ 168062
Additions	73,708	38,241
Write-offs	(68,871)	(25,734)
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	(1,883)
Transfers
Translation adjustments	(8,446)	(15,908)
Right of use, Ending	159,169	164,661
Vehicles [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	(105,457)	(91,509)
Depreciation Additions	(45,378)	(46,287)
Write-offs	66,122	24,354
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	1,109
Transfers
Translation adjustments	7,117	7,985
Right of use, Ending	(76,487)	(105,457)
Machinery and equipment [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	31,216	33,629
Additions	19,850	13,455
Write-offs	(2,155)	(11,166)
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	(7,515)
Transfers
Translation adjustments	(3,515)	(4,702)
Right of use, Ending	R$ 37881	R$ 31216
Machinery and equipment [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	3 years	3 years
Machinery and equipment [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	10 years	10 years
Machinery and equipment [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	R$ 13787	R$ 17133
Depreciation Additions	(11,535)	(9,986)
Write-offs	1,996	11,166
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	6,120
Transfers
Translation adjustments	3,762	2,166
Right of use, Ending	(13,444)	(13,787)
Buildings [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	1,570,088	1,543,018
Additions	224,800	296,161
Write-offs	(80,185)	(185,967)
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	(160,049)
Transfers		(35,484)
Translation adjustments	(79,839)	(47,640)
Right of use, Ending	R$ 1500669	R$ 1570088
Buildings [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	3 years	3 years
Buildings [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	10 years	10 years
Buildings [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	R$ 556655	R$ 507045
Depreciation Additions	(235,874)	(249,796)
Write-offs	61,748	137,349
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	54,968
Transfers		31,917
Translation adjustments	48,061	30,920
Right of use, Ending	R$ 627752	R$ 556655
IT equipment [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	10 years	10 years
Right of use, Beginning	R$ 29052	R$ 31803
Additions	3,891	2,618
Write-offs	(6,299)	(4,151)
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	(1,702)
Transfers
Translation adjustments	146	(1,218)
Right of use, Ending	25,088	29,052
IT equipment [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	(23,957)	(24,410)
Depreciation Additions	(5,645)	(6,608)
Write-offs	6,299	4,345
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	1,028
Transfers
Translation adjustments	3,672	2,716
Right of use, Ending	(18,603)	(23,957)
Retail stores [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	3,361,432	3,417,595
Additions	344,870	712,979
Write-offs	(299,934)	(373,830)
Impairment		(30,785)
Transfer to asset held for sale	(1,388,973)
Write-off due to sale of subsidiary	(1,790,631)
Transfers		36,401
Translation adjustments	(79,770)	(400,928)
Right of use, Ending	R$ 146994	R$ 3361432
Retail stores [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	3 years	3 years
Retail stores [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	10 years	10 years
Retail stores [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	R$ 1525308	R$ 1458512
Depreciation Additions	(390,499)	(611,862)
Write-offs	235,125	367,247
Impairment
Transfer to asset held for sale	563,908
Write-off due to sale of subsidiary	994,062
Transfers		(31,960)
Translation adjustments	31,908	209,779
Right of use, Ending	(90,804)	(1,525,308)
Software [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	13,527
Additions	5,566	13,527
Write-offs
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary
Transfers
Translation adjustments	37
Right of use, Ending	R$ 19130	13,527
Software [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	3 years
Software [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	4 years
Software [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	R$ 3121
Depreciation Additions	(5,772)	(3,121)
Write-offs
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary
Transfers
Translation adjustments	(61)
Right of use, Ending	R$ 8954	R$ 3121
Tools and accessories [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life range (in years)	3 years	3 years
Right of use, Beginning	R$ 498	R$ 1053
Additions
Write-offs	(415)	(394)
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary	(76)
Transfers
Translation adjustments	(7)	(161)
Right of use, Ending		498
Tools and accessories [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning	(302)	(582)
Depreciation Additions	(132)	(206)
Write-offs	300	394
Impairment
Transfer to asset held for sale
Write-off due to sale of subsidiary
Transfers
Translation adjustments	(1,944)	92
Right of use, Ending	R$ 2078	R$ 302

RIGHT OF USE AND LEASE LIABIL_4

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Detailed information about cash outflow related to leases (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Amounts recognized in the statement of income and losses
Financial expense on lease	R$ 110356	R$ 112456	R$ 116381
Amortization of right of use	287,568	302,144
Appropriation in the result of variable lease installments not included in the measurement of lease liabilities	7,382	1,855
Sublease revenue	(17,210)	(20,724)
Short-term lease expenses and low-value assets	6,444	21,556
Benefits granted by lessor related to Covid-19	(111)	(1,366)
Adjustment to recoverable value of right-of-use assets - impairment	1,321
Amounts recognized in the financing activities in the cash flow statement
Lease payments (principal)	309,328	277,086
Amounts recognized in the operating activities in the cash flow statement:
Lease payments (interest)	100,442	113,655
Variable lease payments, not included in the measurement of lease liabilities	7,382	1,855
Short-term and low-value assets lease payments	R$ 1906	R$ 6510

RIGHT OF USE AND LEASE LIABIL_5

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Lease Obligation (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
RIGHT OF USE AND LEASE LIABILITIES
Current	R$ 298600	R$ 878448
Non-current	851,840	2,392,289
Total	R$ 1150440	R$ 3270737	R$ 3547863

RIGHT OF USE AND LEASE LIABIL_6

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Changes In The Balance of Lease Obligations (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
RIGHT OF USE AND LEASE LIABILITIES
Beginning balance		R$ 3270737	R$ 3547863
Transfer to held for sale		(891,098)
New agreements and modifications		779,049	1,065,794
Payments (principal amount)		(828,538)	(953,048)
Payments (interest)		(183,409)	(199,769)
Appropriation of financial charges		187,410	200,246
Write-offs		(43,877)	(19,763)	[1]
Write-off due to sale of subsidiary	[2]	(1,025,898)
Translation adjustment		(113,936)	(370,585)
Ending balance		R$ 1150440	R$ 3270737
[1] Mainly related to termination of agreements related to lease of stores. Refers to the write-off of lease liabilities associated with the sale of the former subsidiaries Aesop and The Body Shop.

RIGHT OF USE AND LEASE LIABIL_7

RIGHT OF USE AND LEASE LIABILITIES - Schedule of rates applied, according to the lease terms (Detail) R$ in Thousands	Dec. 31, 2023 BRL (R$)
1 year [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 139660
Lease terms, Estimated inflation rate	4%	[1]
2 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 263097
Lease terms, Estimated inflation rate	3%	[1]
3 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 106239
Lease terms, Estimated inflation rate	3%	[1]
4 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 96705
Lease terms, Estimated inflation rate	3%	[1]
5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 43503
Lease terms, Estimated inflation rate	3%	[1]
Over five years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 54432
Lease terms, Estimated inflation rate	3%	[1]
Average discount rate 5.5% to 16.3% [member] | Bottom of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	5.50%
Average discount rate 5.5% to 16.3% [member] | Top of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	16.30%
Average discount rate 5.5% to 16.3% [member] | 1 year [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 25982
Average discount rate 5.5% to 16.3% [member] | 2 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	135,841
Average discount rate 5.5% to 16.3% [member] | 3 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation
Average discount rate 5.5% to 16.3% [member] | 4 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation
Average discount rate 5.5% to 16.3% [member] | 5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation
Average discount rate 5.5% to 16.3% [member] | Over five years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation
Average discount rate 5.4% to 18.7% [member] | Bottom of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	5.40%
Average discount rate 5.4% to 18.7% [member] | Top of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	18.70%
Average discount rate 5.4% to 18.7% [member] | 1 year [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 102094
Average discount rate 5.4% to 18.7% [member] | 2 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	107,651
Average discount rate 5.4% to 18.7% [member] | 3 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	85,311
Average discount rate 5.4% to 18.7% [member] | 4 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	74,275
Average discount rate 5.4% to 18.7% [member] | 5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	19,394
Average discount rate 5.4% to 18.7% [member] | Over five years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation
Average discount rate 7.3% to 20.5% [member] | Bottom of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	7.30%
Average discount rate 7.3% to 20.5% [member] | Top of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	20.50%
Average discount rate 7.3% to 20.5% [member] | 1 year [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 8119
Average discount rate 7.3% to 20.5% [member] | 2 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	9,092
Average discount rate 7.3% to 20.5% [member] | 3 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	10,200
Average discount rate 7.3% to 20.5% [member] | 4 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	11,450
Average discount rate 7.3% to 20.5% [member] | 5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	12,850
Average discount rate 7.3% to 20.5% [member] | Over five years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 12442
Average discount rate 7.7% to 21.9% [member] | Bottom of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	7.70%
Average discount rate 7.7% to 21.9% [member] | Top of range [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Lease terms, average discount rate	21.90%
Average discount rate 7.7% to 21.9% [member] | 1 year [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 3465
Average discount rate 7.7% to 21.9% [member] | 2 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	10,513
Average discount rate 7.7% to 21.9% [member] | 3 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	10,728
Average discount rate 7.7% to 21.9% [member] | 4 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	10,980
Average discount rate 7.7% to 21.9% [member] | 5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	11,259
Average discount rate 7.7% to 21.9% [member] | Over five years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Estimated future lease payment flows indexed to inflation	R$ 41990
[1]Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3

RIGHT OF USE AND LEASE LIABIL_8

RIGHT OF USE AND LEASE LIABILITIES - Schedule of maturities of the lease liabilities (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Total expected cashflows	R$ 1448953	R$ 3946378
Interests to incur	(298,513)	(675,641)
Total	1,150,440	3,270,737	R$ 3547863
1 year [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Total expected cashflows	401,217	1,070,253
From 1 to 5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Total expected cashflows	912,529	2,019,723
More than 5 years [member]
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Total expected cashflows	R$ 135207	R$ 856402

RIGHT OF USE AND LEASE LIABIL_9

RIGHT OF USE AND LEASE LIABILITIES - Additional information (Detail) - Interlagos Manufacturing Unit [member] - Natura Cosmticos SA [Member] R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)
Disclosure of Right of Use Assets and Lease Liabilities [Line Items]
Sale and Leaseback Transactions, Consideration received	R$ 272000
Sale Leaseback Transactions, Right of use recognized	R$ 62197
Sale Leaseback Transactions, Lease Term	3 years
Sale and Leaseback Transactions, impairment loss	R$ 14150

BORROWING, FINANCING AND DEBE_3

BORROWING, FINANCING AND DEBENTURES - Schedule Of Detailed Information About Borrowings (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
BORROWING, FINANCING AND DEBENTURES
Borrowings	R$ 6111702	R$ 13592286	R$ 12716832
Current	163,844	331,151
Non-current	5,947,858	13,261,135
Debentures Current	68,189	77,601
Debentures Non-current	1,852,699	1,835,603
Local Currency
BORROWING, FINANCING AND DEBENTURES
Borrowings	6,111,702	8,419,320
Local Currency | Financing Agency for Studies and Projects FINEP [Member]
BORROWING, FINANCING AND DEBENTURES
Borrowings	3,546	16,979
Local Currency | Debentures [Member]
BORROWING, FINANCING AND DEBENTURES
Borrowings	1,962,188	1,913,204
Local Currency | Business notes [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings	517,534	519,044
Local Currency | Notes - Avon [Member]
BORROWING, FINANCING AND DEBENTURES
Borrowings	129,535	1,421,272
Local Currency | Notes - Lux [Member]
BORROWING, FINANCING AND DEBENTURES
Borrowings	3,497,067	3,130,732
Local Currency | Operations Avon [Member] | Working capital loan [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings	1,832	113,664
Local Currency | Natura &Co Luxemburgo operation | Working capital loan [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings		1,304,425
Foreign Currency
BORROWING, FINANCING AND DEBENTURES
Borrowings		5,172,966
Foreign Currency | Notes [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings		R$ 5172966

BORROWING, FINANCING AND DEBE_4

BORROWING, FINANCING AND DEBENTURES - Schedule Of Detailed Information About Borrowings Charges (Detail)	12 Months Ended
	Dec. 31, 2023
Debentures [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, original currency	Brazilian Real
Borrowings, maturity	July 2027 to September 2032
Description of borrowing charges	CDI + 1.65%; CDI + 0.8%; IPCA + 6.8% and IPCA + 6.9% with bi-annual payments
Description of effective interest rate for borrowings	CDI+1.65%, CDI+0.8%, CDI+1.34% e CDI+1.60%
Description of guarantees provided for borrowings	Guarantee of Natura &Co Holding S.A.
Business notes [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, original currency	Brazilian Real
Borrowings, maturity	September 2025
Description of borrowing charges	CDI interest + 1.55% with bi-annual payments
Description of effective interest rate for borrowings	CDI+1.55%
Description of guarantees provided for borrowings	Guarantee of Natura &Co Holding S.A.
Working capital loan [member] | USD | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Borrowings, original currency	US Dollar
Borrowings, maturity	November 2025
Description of borrowing charges	SOFR + 2.47% p.a. with bi-annual payments
Description of effective interest rate for borrowings	SOFR + 2.47% p.a.
Description of guarantees provided for borrowings	Guarantee of Natura &Co Holding S.A. and Natura Cosmeticos S.A.
Notes - Avon [Member] | USD
BORROWING, FINANCING AND DEBENTURES
Borrowings, original currency	US Dollar
Borrowings, maturity	March 2043
Description of borrowing charges	Interest of 8.45% of p.a. with bi-annual payments
Description of effective interest rate for borrowings	8.45% p.a
Description of guarantees provided for borrowings	None
Notes - Lux [Member] | USD
BORROWING, FINANCING AND DEBENTURES
Borrowings, original currency	US Dollar
Borrowings, maturity	April 2029
Description of borrowing charges	Interest of 6.00% p.a. with bi-annual payments
Description of effective interest rate for borrowings	6.125% p.a
Description of guarantees provided for borrowings	Guarantee of Natura &Co Holding S.A. and Natura Cosmeticos S.A.
Notes [member] | USD
BORROWING, FINANCING AND DEBENTURES
Borrowings, original currency	US Dollar
Borrowings, maturity	May 2028
Description of borrowing charges	Interest of 4.125% p.a. with bi-annual payments
Description of effective interest rate for borrowings	4.125%
Description of guarantees provided for borrowings	Guarantee of Natura &Co Holding S.A

BORROWING, FINANCING AND DEBE_5

BORROWING, FINANCING AND DEBENTURES - Schedule of detailed information about borrowings (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate	11.30%
Debentures maturity on July 21, 2027 [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, Interest rate basis	CDI
Borrowings, adjustment to interest rate basis	1.65%
Borrowings, effective interest rate basis	CDI
Borrowings, adjustment to effective interest rate basis	1.65%
Debentures maturity on September 14, 2027 [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, Interest rate basis	CDI
Borrowings, adjustment to interest rate basis	0.80%
Borrowings, effective interest rate basis	CDI
Borrowings, adjustment to effective interest rate basis	0.80%
Debentures maturity on September 14, 2029 [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, Interest rate basis	IPCA
Borrowings, adjustment to interest rate basis	6.80%
Borrowings, effective interest rate basis	CDI
Borrowings, adjustment to effective interest rate basis	1.34%
Debentures maturity on September 14, 2032 [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, Interest rate basis	IPCA
Borrowings, adjustment to interest rate basis	6.90%
Borrowings, effective interest rate basis	CDI
Borrowings, adjustment to effective interest rate basis	1.60%
Business notes [member] | BRL
BORROWING, FINANCING AND DEBENTURES
Borrowings, Interest rate basis	CDI
Borrowings, adjustment to interest rate basis	1.55%
Borrowings, effective interest rate basis	CDI
Borrowings, adjustment to effective interest rate basis	1.55%
Working capital loan [member] | USD | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Borrowings, Interest rate basis	SOFR
Borrowings, adjustment to interest rate basis	2.47%
Borrowings, effective interest rate basis	SOFR
Borrowings, adjustment to effective interest rate basis	2.47%
Notes - Avon [Member] | USD
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate	8.45%
Borrowings effective interest rate	8.45%
Notes - Lux [Member] | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate		6%
Notes - Lux [Member] | USD
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate	6%
Borrowings effective interest rate	6.125%
Notes [member] | USD
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate	4.125%
Borrowings, adjustment to effective interest rate basis	4.125%

BORROWING, FINANCING AND DEBE_6

BORROWING, FINANCING AND DEBENTURES - Schedule Of Changes In Balances Of Borrowings (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
BORROWING, FINANCING AND DEBENTURES
Balance at beginning	R$ 13592286		R$ 12716832
New borrowing and financing	1,494,101	[1]	8,557,507	[2]	R$ 5683509
Repayment	(8,057,650)	[3]	(6,826,628)	[4]
Gain on Borrowing and financing prepayment	(206,228)
Appropriation of financial charges, net of costs of new borrowing and financing	839,580	[5]	762,703
Financial charges payment	(842,719)		(808,976)
Exchange rate variation	(322,049)		(394,389)
Translation effects (OCI)	(385,619)		(414,763)
Balance at ending	R$ 6111702		R$ 13592286		R$ 12716832
[1] The movement that occurred in 2023 is mainly due to the revolving credit line obtained by the subsidiary &Co Luxembourg during the year, which was fully settled during the third quarter with resources from the sale of the former subsidiary Aesop. Funding carried out in the year ended December 31, 2022 basically refers to: (i) use of a revolving credit line in the principal amount of up to US$ million by the subsidiary &Co Luxembourg; (ii) issuance of debt securities by the subsidiary &Co Luxembourg maturing on April 19, 2029 in the total principal amount of US$ million (approximately R$ million), subject to interest of % per year, which are guaranteed by &Co Holding and the subsidiary S.A. (iii) issuance of the 11 th series of debentures in the amount of R$ million maturing in 2025 and issuance of the 12 th series of debentures in the amount of R$ million, maturing between 2025 and 2032 by the subsidiary S.A. (iv) issuance of commercial notes by the subsidiary in the amount of R$ million maturing in 2025 and (v) new credit line in the total principal amount of US$ million by the subsidiary &Co Luxembourg. The movement in amortizations in 2023 is substantially due to the debt rebalancing process initiated in the third quarter, where the Company carried out and settled (i) an offer to the holders of securities representing Avon's debt to repurchase approximately % of securities issued for R$ (comprising R$ of principal, R$ of premium and R$ of accrued interest); and (ii) offer to holders of debt securities of &Co Luxembourg (maturing in 2028 and 2029 ) to repurchase approximately % of the securities issued for R$ (comprising R$ of principal, R$ premium and R$ accrued interest). Other amortizations in the period also include the payment of working capital debt amounts at &Co Luxembourg of R$ (of which R$ refer to the settlement of the open position in the credit line revolving loan and R$ of working capital debt (“Club Loan”), in abovementioned item c). The repayments carried out in the year ended December 31, 2022 mainly refer to (i) early redemption of debt securities of the subsidiary Avon; (ii) the early redemption of the 9 th and 10 th series of debentures issued by the subsidiary (iii) the early redemption of the credit line in the amount of £ million from the former indirect subsidiary The Body Shop and (iv) the refinancing of the credit line credit under Resolution No. 4131 / 62 of the subsidiary .

BORROWING, FINANCING AND DEBE_7

BORROWING, FINANCING AND DEBENTURES - Schedule Of Changes In Balances Of Borrowings (Parenthetical) (Detail) R$ in Thousands, £ in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023 BRL (R$)		Dec. 31, 2022 GBP (£)	Dec. 31, 2022 BRL (R$)		Dec. 31, 2021 BRL (R$)	Dec. 31, 2022 USD ($)	Jul. 25, 2022 BRL (R$)
BORROWING, FINANCING AND DEBENTURES
Repayment	R$ 8057650	[1]		R$ 6826628	[2]
Annual percentage interest rate	11.30%
New borrowing and financing	R$ 1494101	[3]		8,557,507	[4]	R$ 5683509
Accrued interest of debt securities issued	2,518,846			3,499,325
Net of funding costs	15,361
Line of Credit facility | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Principal amount of borrowings obtained				250,000
Line of Credit facility | Operations The Body Shop [Member]
BORROWING, FINANCING AND DEBENTURES
Repayment | £			£ (70)
Revolving credit facility [Member] | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Repayment	1,283,025
Line of credit facility, maximum borrowing capacity | $							$ 625
Notes - Avon [Member]
BORROWING, FINANCING AND DEBENTURES
Principal amount of borrowings obtained	R$ 934742
Percentage of repurchase of securities issued	90%
Debt securities repurchase amount	R$ 1156743
Premium amount of borrowings obtained	193,086
Accrued interest of debt securities issued	28,915
Notes - Lux [Member]
BORROWING, FINANCING AND DEBENTURES
Principal amount of borrowings obtained	R$ 4049329
Percentage of repurchase of securities issued	55%
Debt securities repurchase amount	R$ 4142906
Premium amount of borrowings obtained	5,800
Accrued interest of debt securities issued	87,778
Notes - Lux [Member] | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Principal amount of borrowings obtained				R$ 2809000			$ 600
Annual percentage interest rate				6%			6%
Working capital loan [member] | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Repayment	2,402,790
Working capital debt [member] | Natura &Co Luxemburgo operation
BORROWING, FINANCING AND DEBENTURES
Repayment	R$ 1119764
Debentures, Series 11 [Member]
BORROWING, FINANCING AND DEBENTURES
Principal amount of borrowings obtained								R$ 826030
Debentures, Series 11 [Member] | Natura Cosmticos SA [Member]
BORROWING, FINANCING AND DEBENTURES
New borrowing and financing				R$ 826000
Debentures, Series 12 [Member] | Natura Cosmticos SA [Member]
BORROWING, FINANCING AND DEBENTURES
Repayment				1,050,000
Commercial notes [Member] | Natura Cosmticos SA [Member]
BORROWING, FINANCING AND DEBENTURES
Repayment				R$ 500
[1] The movement in amortizations in 2023 is substantially due to the debt rebalancing process initiated in the third quarter, where the Company carried out and settled (i) an offer to the holders of securities representing Avon's debt to repurchase approximately % of securities issued for R$ (comprising R$ of principal, R$ of premium and R$ of accrued interest); and (ii) offer to holders of debt securities of &Co Luxembourg (maturing in 2028 and 2029 ) to repurchase approximately % of the securities issued for R$ (comprising R$ of principal, R$ premium and R$ accrued interest). Other amortizations in the period also include the payment of working capital debt amounts at &Co Luxembourg of R$ (of which R$ refer to the settlement of the open position in the credit line revolving loan and R$ of working capital debt (“Club Loan”), in abovementioned item c). The repayments carried out in the year ended December 31, 2022 mainly refer to (i) early redemption of debt securities of the subsidiary Avon; (ii) the early redemption of the 9 th and 10 th series of debentures issued by the subsidiary (iii) the early redemption of the credit line in the amount of £ million from the former indirect subsidiary The Body Shop and (iv) the refinancing of the credit line credit under Resolution No. 4131 / 62 of the subsidiary . The movement that occurred in 2023 is mainly due to the revolving credit line obtained by the subsidiary &Co Luxembourg during the year, which was fully settled during the third quarter with resources from the sale of the former subsidiary Aesop. Funding carried out in the year ended December 31, 2022 basically refers to: (i) use of a revolving credit line in the principal amount of up to US$ million by the subsidiary &Co Luxembourg; (ii) issuance of debt securities by the subsidiary &Co Luxembourg maturing on April 19, 2029 in the total principal amount of US$ million (approximately R$ million), subject to interest of % per year, which are guaranteed by &Co Holding and the subsidiary S.A. (iii) issuance of the 11 th series of debentures in the amount of R$ million maturing in 2025 and issuance of the 12 th series of debentures in the amount of R$ million, maturing between 2025 and 2032 by the subsidiary S.A. (iv) issuance of commercial notes by the subsidiary in the amount of R$ million maturing in 2025 and (v) new credit line in the total principal amount of US$ million by the subsidiary &Co Luxembourg.

BORROWING, FINANCING AND DEBE_8

BORROWING, FINANCING AND DEBENTURES - Schedule of maturity analysis for non-current borrowings (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022
BORROWING, FINANCING AND DEBENTURES
Borrowings, financing and debentures	R$ 5947858	R$ 13261135
2025 [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings, financing and debentures	101,577	1,763,902
2026 [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings, financing and debentures		11,497,233
2027 onwards [member]
BORROWING, FINANCING AND DEBENTURES
Borrowings, financing and debentures	R$ 5846281

BORROWING, FINANCING AND DEBE_9

BORROWING, FINANCING AND DEBENTURES - Schedule of main features of the debentures (Detail) - Debentures, Series 12 [Member] R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$) Debenture
1st series [member]
BORROWING, FINANCING AND DEBENTURES
Contractual fee	100% DI + 0.8%
Maturity	09/14/2027
Notional amount | R$	R$ 255889
Number Of Debentures Issued | Debenture	255,889
Borrowings, Interest rate basis	100% DI
Borrowings, adjustment to interest rate basis	0.80%
2nd series [member]
BORROWING, FINANCING AND DEBENTURES
Contractual fee	IPCA + 6.8%
Maturity	09/14/2029
Notional amount | R$	R$ 487214
Number Of Debentures Issued | Debenture	487,214
Borrowings, Interest rate basis	IPCA
Borrowings, adjustment to interest rate basis	6.80%
3rd series [member]
BORROWING, FINANCING AND DEBENTURES
Contractual fee	IPCA + 6.9%
Maturity	09/14/2032
Notional amount | R$	R$ 306897
Number Of Debentures Issued | Debenture	306,897
Borrowings, Interest rate basis	IPCA
Borrowings, adjustment to interest rate basis	6.90%

BORROWING, FINANCING AND DEB_10

BORROWING, FINANCING AND DEBENTURES - Schedule Of detailed information about Notes - Avon (Details) R$ in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$)	Dec. 31, 2023 USD ($)
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate	11.30%	11.30%
Notes 8.45% Due March 15, 2043 [Member] | Unsecured Debt [Member]
BORROWING, FINANCING AND DEBENTURES
Main	R$ 104613	$ 21,609
Annual percentage interest rate	8.45%	8.45%
Maturity	March 15, 2043

BORROWING, FINANCING AND DEB_11

BORROWING, FINANCING AND DEBENTURES - Additional Information (Detail) $ in Thousands				12 Months Ended
	Dec. 06, 2022 BRL (R$)	Jul. 25, 2022 BRL (R$) Debenture	May 04, 2021 BRL (R$)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2022 BRL (R$)	Aug. 31, 2023 BRL (R$)	Sep. 19, 2022 BRL (R$)	May 04, 2021 USD ($)
BORROWING, FINANCING AND DEBENTURES
Annual percentage interest rate				11.30%
Unsecured Debentures [Member]
BORROWING, FINANCING AND DEBENTURES
Debt Issuance Cost				R$ 27072000	R$ 32059000
Interest Costs				4,987,000	7,704,000
Debentures, Series 11 [Member]
BORROWING, FINANCING AND DEBENTURES
Notional Amount		R$ 826030000
Number Of Debentures Issued | Debenture		826,030
Borrowings Adjustment To Interest Rate Basis		1.65%
Borrowings Interest Rate Basis		100% of the accrued variation of the daily average rates for Interfinancial Deposits (DI)
Nominal Unit Value		R$ 1000000
Unsecured Debentures Due September 21, 2022 [Member] | Tranche Three [Member]
BORROWING, FINANCING AND DEBENTURES
Repayments Of Debentures				162,800,000
Unsecured Debentures Due August 26, 2024 [Member] | Tranche One [Member]
BORROWING, FINANCING AND DEBENTURES
Repayments Of Debentures				145,830,000
Unsecured Debentures Due August 26, 2024 [Member] | Tranche Two [Member]
BORROWING, FINANCING AND DEBENTURES
Repayments Of Debentures				19,210,000
Unsecured Debentures Due August 26, 2024 [Member] | Tranche Three [Member]
BORROWING, FINANCING AND DEBENTURES
Repayments Of Debentures				295,280,000
Unsecured Debentures Due August 26, 2024 [Member] | Tranche Four [Member]
BORROWING, FINANCING AND DEBENTURES
Repayments Of Debentures				202,910,000
Unsecured Debentures Due August 26, 2024 [Member] | Natura Cosmticos SA [Member]
BORROWING, FINANCING AND DEBENTURES
Repayments Of Debentures	R$ 913220000
ESG debt securities (“Notes ESG”) [Member] | Natura Cosmticos SA [Member]
BORROWING, FINANCING AND DEBENTURES
Notional Amount			R$ 5600000000					$ 1,000,000
Borrowings Maturity			May 3, 2028
Debt Issuance Cost				R$ 0
Deferred Notes Issuance Costs						R$ 79410000
Annual percentage interest rate			4.125%					4.125%
Target Percentage Of Reduction In Greenhouse Gas Emission				13%
Target Percentage Of Recycledplastic Use In Packaging				25%
Commercial notes [Member] | Natura Cosmticos SA [Member]
BORROWING, FINANCING AND DEBENTURES
Notional Amount							R$ 500000000
Debt Issuance Cost				R$ 801000	1,266,000
Interest Costs				R$ 465000	R$ 126000

TRADE ACCOUNTS PAYABLE AND RE_3

TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS (Details) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS.
Trade and other payables		R$ 4647517	R$ 5522030
Reverse factoring operations	[1]	654,961	853,900
Trade payables		5,302,478	6,375,930
Domestic trade accounts payable [Member]
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS.
Trade and other payables		4,058,832	4,644,534
Foreign trade accounts payable [Member]
TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS.
Trade and other payables	[2]	R$ 588685	R$ 877496
[1] The Company has contracts signed with first-line financial institutions, mainly Banco S.A. to directly structure a reverse factoring operation with the Company’s main suppliers. Further details on these operations are included in note no. 3.15 Refers to imports mainly denominated in US dollars, Euros and British pounds.

TAX LIABILITIES - Schedule of d

TAX LIABILITIES - Schedule of detailed information about tax liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Dislosure Of Tax Liabilities [Line Items]
ICMS (ordinary)	[1]	R$ 216882	R$ 180708
ICMS-ST provision	[2]	63,722	60,945
Taxes on invoicing abroad		150,706	346,407
Withholding tax		118,133	138,293
Other taxes payable - foreign subsidiaries		102,537	147,056
Income tax		23,084	18,170
PIS and COFINS payable	[3]	60,678	140
INSS and service tax (ISS) payable		5,603	31,895
Other		20,609	21,869
Total		761,954	945,483
Current		634,760	828,125
Non-current		R$ 127194	R$ 117358
[1] Refers to ICMS on the Company's sales of goods in Brazil. The Company has discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company, and in some cases, the amounts are deposited in court, as mentioned in note no. 12 Refers to the value of PIS and COFINS levied on interest on equity received from the subsidiary S.A.

PROVISION FOR TAX, CIVIL AND _3

PROVISION FOR TAX, CIVIL AND LABOR RISKS - Schedule of detailed information about other provisions (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year				R$ 1337273		R$ 1318441
Additions		R$ 615659		595,502
Reversals	[1]	(115,809)		(307,267)
Payments	[2]	(458,288)		(261,731)
Inflation adjustment		73,011		79,280
Exchange rate variation (OCI)		(84,109)		(86,952)
Disposal of The Body Shop		(1,145)
Balance as of the end of the year		1,366,592		1,337,273
Current		491,301		463,655
Non-current		875,291		873,618
Contingent liabilities (business combination)
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year	[3]			406,428	[1]	597,585
Additions	[3]	4,204	[1]
Reversals	[1],[3]	(29,971)		(196,925)
Payments	[2],[3]		[1]
Inflation adjustment	[3]	24,836	[1]	21,555
Exchange rate variation (OCI)	[3]	(19,516)	[1]	(15,787)
Disposal of The Body Shop	[3]		[1]
Balance as of the end of the year	[3]	385,981	[1]	406,428
Tax
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year				187,052	[4]	181,694
Additions		42,055	[4]	78,410
Reversals	[1]	(18,136)	[4]	(45,902)
Payments	[2]	(53,143)	[4]	(31,354)
Inflation adjustment		12,852	[4]	36,155
Exchange rate variation (OCI)		(3,958)	[4]	(31,951)
Disposal of The Body Shop			[4]
Balance as of the end of the year		166,722	[4]	187,052
Tax | Contingent liabilities (business combination)
Tax, civil and labor provision and contingent liabilities
Balance as of the end of the year		381,447
Civil
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year				557,675		305,690
Additions		446,554		425,398
Reversals	[1]	(10,172)		(12,791)
Payments	[2]	(357,633)		(162,953)
Inflation adjustment		29,439		16,477
Exchange rate variation (OCI)		(38,836)		(14,146)
Disposal of The Body Shop		(445)
Balance as of the end of the year		626,582		557,675
Labour
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year				186,118		R$ 233472
Additions		122,846		91,694
Reversals	[1]	(57,530)		(51,649)
Payments	[2]	(47,512)		(67,424)
Inflation adjustment		5,884		5,093
Exchange rate variation (OCI)		(21,799)		(25,068)
Disposal of The Body Shop		(700)
Balance as of the end of the year		187,307		R$ 186118
Labour | Contingent liabilities (business combination)
Tax, civil and labor provision and contingent liabilities
Balance as of the end of the year		R$ 4533
[1] Reversals of contingent liabilities (business combination) with Avon refer mainly to the change in estimates for tax, civil and labor lawsuits. Tax payments refer mainly to the completion of the administrative procedure with the State of Amazonas for the effective settlement of tax amnesties, using judicial deposits. The business combination amounts as of December 31, 2023, arising from the business combination with Avon are segregated between tax (R$ ) and labor (R$ ) lawsuits. In December 2023, the subsidiary recognized a provision for estimated costs in relation to litigation involving discussion about the collection of ICMS Tax Rate Differential (“DIFAL”) with several states in Brazil, in the amount of R$ . The recognition of the provision occurs as a result of an unfavorable decision to the taxpayer in judgment at the Federal Supreme Court (STF), leading to a change in the prognosis from loss to probable.

PROVISION FOR TAX, CIVIL AND _4

PROVISION FOR TAX, CIVIL AND LABOR RISKS - Schedule of contingencies assessed as possible risk of loss (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	R$ 10791727	R$ 8806935
Tax [member]
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	10,375,764	8,480,614
Civil [member]
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	246,500	161,859
Labor [member]
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	R$ 169463	R$ 164462

PROVISION FOR TAX, CIVIL AND _5

PROVISION FOR TAX, CIVIL AND LABOR RISKS - Contingent liabilities additional information (Detail 2) R$ in Thousands, $ in Millions		12 Months Ended
		Dec. 31, 2023 BRL (R$)		Dec. 31, 2022 BRL (R$)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 BRL (R$)
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		R$ 10791727		R$ 8806935
Provisions		1,366,592		1,337,273
Additional impact on the provision		615,659		595,502
Reversals of provisions	[1]	115,809		307,267
Royalty income	[2]			119,438
Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		10,375,764		8,480,614
Civil, commercial and other lawsuits [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		246,500		161,859
Labor [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		169,463		164,462
Related to Decree nº 8.393/2015 [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		2,456,695		2,218,971
Related to Collection of ICMS and ICMS-ST [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		1,640,391		1,374,933
Related to Collection of ICMS and ICMS-ST [member] | Tax Contingency [member] | Natura Cosmticos SA [Member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		22,472
Related to IRPJ and CSLL tax debts [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		1,598,213		1,509,890
Related to collection of ICMS-ST by Finance Department of the São Paulo Federal State [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		682,263		633,671
IPI tax debts for disagreeing with the tax classification [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		2,199,853		719,920
Infraction notices relating to tax classification of some products | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss		1,245,438
Contingent liabilities (business combination)
Disclosure of contingent liabilities [line items]
Provisions	[3]	385,981	[1]	406,428
Additional impact on the provision	[3]	4,204	[1]
Reversals of provisions	[1],[3]	R$ 29971		196,925
Avon Products Inc [Member]
Disclosure of contingent liabilities [line items]
Settlement amount | $					$ 29.3
Avon Products Inc [Member] | Civil, commercial and other lawsuits [member]
Disclosure of contingent liabilities [line items]
Number of pending individual cases		372
Number of new proceedings filed		234
Number of cases dismissed, settled or otherwise resolved		90
Labour
Disclosure of contingent liabilities [line items]
Provisions		R$ 187307		186,118
Additional impact on the provision		122,846		91,694
Reversals of provisions	[1]	57,530		51,649
Labour | Contingent liabilities (business combination)
Disclosure of contingent liabilities [line items]
Provisions		4,533
Civil
Disclosure of contingent liabilities [line items]
Provisions		626,582		557,675
Additional impact on the provision		446,554		425,398
Reversals of provisions	[1]	10,172		12,791
Civil | Avon Products Inc [Member]
Disclosure of contingent liabilities [line items]
Compensatory damages | $					36
Punitive damages | $					$ 10.3
Tax
Disclosure of contingent liabilities [line items]
Provisions		166,722	[4]	187,052
Additional impact on the provision		42,055	[4]	78,410
Reversals of provisions	[1]	18,136	[4]	R$ 45902
Tax | Contingent liabilities (business combination)
Disclosure of contingent liabilities [line items]
Provisions		R$ 381447
[1] Reversals of contingent liabilities (business combination) with Avon refer mainly to the change in estimates for tax, civil and labor lawsuits. Refers to revenue from royalties received by subsidiary Avon from its representative in Japan, after a legal dispute. The business combination amounts as of December 31, 2023, arising from the business combination with Avon are segregated between tax (R$ ) and labor (R$ ) lawsuits. In December 2023, the subsidiary recognized a provision for estimated costs in relation to litigation involving discussion about the collection of ICMS Tax Rate Differential (“DIFAL”) with several states in Brazil, in the amount of R$ . The recognition of the provision occurs as a result of an unfavorable decision to the taxpayer in judgment at the Federal Supreme Court (STF), leading to a change in the prognosis from loss to probable.

OTHER LIABILITIES - Schedule of

OTHER LIABILITIES - Schedule of detailed information about other liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
OTHER LIABILITIES
Pension and post-employment health care plans	[1]	R$ 515901	R$ 463948
Deferred revenue from performance obligations with customers	[2]	131,113	313,204
Provision for incentives to consultants		153,692	217,349
Provision for operating expenses (marketing / technology, etc.)	[3]	482,287	604,064
Provision for store renovation			116,137
Crer Para Ver	[4]	47,571	87,420
Provision for restructuring	[5]	113,440	175,809
Insurance payables		84,032	69,364
Other liabilities	[6]	87,518	203,331
Total		1,657,012	2,250,626
Current		970,479	1,499,060
Non-current		R$ 686533	R$ 751566
[1] As of December 31, 2023, there is R$253,606 (R$282,295 as of December 31, 2022) referring to pension plans, and R$567 referring to post-employment plans (R$28,456 as of December 31, 2022) of subsidiary Avon International, and R$209,288 (R$129,697 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary and R$52,441 (R$51,956 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary &Co International. Refers to the deferral of revenue from performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct sales consultants, of which R$88,017 (R$190,790 as of December 31, 2022) is referring to subsidiary Avon, R$31,089 (R$93,761 as of December 31, 2022) referring to the consolidated subsidiary and R$12,007 (R$28,653 as of December 31, 2022) referring to subsidiary &Co International. Refers to the Company's operating provisions arising mainly from expenses with the provision of technology, marketing, and advertising services. Contribution of the social program to the development of the quality of education. Provision for costs directly related to the integration plan and changes in the organizational structure of the subsidiary Avon and Group corporate structure review.

OTHER LIABILITIES - Schedule _2

OTHER LIABILITIES - Schedule of change in actuarial liabilities (Detail) - Avon [member] - Pension Plan [member] - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year		R$ 334251	R$ 445804
Cost of services - current		21,871	19,707
Interest cost - recognized in the statement of profit or loss		21,542	15,568
Administrative costs		4,046	2,698
Company contributions		(6,004)	(4,299)
Benefits paid		(30,896)	(22,262)
Actuarial loss in OCI	[1]	(2,096)	(254,913)
Reclassifications		832	24,956
Other		7,082	88,474
Translation adjustment		(26,266)	18,518
Balance as of the end of the year		R$ 324362	R$ 334251
[1]The actuarial loss recorded throughout 2022 19

OTHER LIABILITIES - Schedule _3

OTHER LIABILITIES - Schedule of significant actuarial assumptions for the determination of the actuarial liability (Details) - Avon [member] - Pension Plan [member]	Dec. 31, 2023	Dec. 31, 2022
Bottom of range [member]
Disclosure of defined benefit plans [line items]
Discount rate	1.20%	1.30%
Rate of compensation increase	2.15%	2.55%
Top of range [member]
Disclosure of defined benefit plans [line items]
Discount rate	11.60%	12%
Rate of compensation increase	5.50%	7.40%

OTHER LIABILITIES - Schedule _4

OTHER LIABILITIES - Schedule of fair values of each major class of plan assets (Details) - Avon [member] - Pension Plan [member] - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Disclosure of defined benefit plans [line items]
Cash and cash equivalent	R$ 46957	R$ 7330
Equity instruments of other entities	486,511	520,799
Government bonds	1,481,317	1,013,584
Corporate bonds	1,219,908	1,317,122
Real estate	8,714	10,957
Other	(525,722)	(121,574)
Total	R$ 2717685	R$ 2748218

OTHER LIABILITIES - Schedule _5

OTHER LIABILITIES - Schedule of detailed information about actuarial liabilities computation (Detail) - Natura Cosmticos SA [Member]	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of defined benefit plans [line items]
Discount rate	9.69%	10.43%
Initial growth rate of medical cost	4.25%	4.25%
Inflation rate	4%	4%
Final growth rate of medical cost	8.42%	8.42%
Growth rate of medical costs by aging - contributions	0%	0%
Schedule of disabled mortality	Mercer Disability	Mercer Disability
Schedule of mortality	AT-2000	AT-2000
Schedule of turnover	Proportional calculation at the time of service	Proportional calculation at the time of service
Bottom of range [member]
Disclosure of defined benefit plans [line items]
Growth rate of medical costs due to aging - costs	1.25%	1.25%
Top of range [member]
Disclosure of defined benefit plans [line items]
Growth rate of medical costs due to aging - costs	4.75%	4.75%
Bradesco Plan [Member] | Bottom of range [member]
Disclosure of defined benefit plans [line items]
Percentage of adherence to the plan in retirement	58%	58%
Unimed Plan [Member] | Top of range [member]
Disclosure of defined benefit plans [line items]
Percentage of adherence to the plan in retirement	85%	85%

OTHER LIABILITIES - Schedule _6

OTHER LIABILITIES - Schedule of detailed information about sensitivity analysis for actuarial assumptions (Detail) - Natura Cosmticos SA [Member] R$ in Thousands	Dec. 31, 2023 BRL (R$)
Discount rate [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	9.69%
Percentage of reasonably possible increase in actuarial assumption	1%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 229052
Decreased Actuarial Assumption Percentage	9.69%
Percentage of reasonably possible decrease in actuarial assumption	1%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 173673
Rate of compensation
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	8.42%
Percentage of reasonably possible increase in actuarial assumption	1%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 174202
Decreased Actuarial Assumption Percentage	8.42%
Percentage of reasonably possible decrease in actuarial assumption	1%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 227843

OTHER LIABILITIES - Schedule _7

OTHER LIABILITIES - Schedule of detailed information about movements of actuarial liabilities (Detail) - Natura Cosmticos SA [Member] - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year	R$ 129697	R$ 124649
Cost of the current service of subsidiary Natura Cosméticos	983	812
Cost of interest	13,314	11,078
Expenses paid	(4,021)	(3,398)
Actuarial loss in OCI	51,566	(3,444)
Balance as of the end of the year	R$ 191539	R$ 129697

OTHER LIABILITIES - Additional

OTHER LIABILITIES - Additional Information (Detail) R$ in Thousands		12 Months Ended
		Dec. 31, 2023 BRL (R$) Employees	Dec. 31, 2022 BRL (R$) Employees
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans	[1]	R$ 515901	R$ 463948
Deferred revenue from performance obligations with customers	[2]	131,113	313,204
Pension Plan [member] | Avon International [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		253,606	282,295
Post-retirement benefits [member] | Avon International [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		567	28,456
Avon [member]
Disclosure Of Other Liabilities [Line Items]
Deferred revenue from performance obligations with customers		88,017	190,790
Natura Cosmticos SA [Member]
Disclosure Of Other Liabilities [Line Items]
Deferred revenue from performance obligations with customers		R$ 31089	R$ 93761
Weighted average of life expectancy after retirement		21 years 10 months 24 days	20 years
Number of active employees | Employees		842	866
Number of retired and dependent employees. | Employees		614	406
Discount rate		9.69%	10.43%
Actuarial gains in other comprehensive income		R$ 51566
Natura Cosmticos SA [Member] | Post-retirement benefits [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		209,288	R$ 129697
Natura &Co International S.à r.l.
Disclosure Of Other Liabilities [Line Items]
Deferred revenue from performance obligations with customers		12,007	28,653
Natura &Co International S.à r.l. | Post-retirement benefits [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		R$ 52441	R$ 51956
[1] As of December 31, 2023, there is R$253,606 (R$282,295 as of December 31, 2022) referring to pension plans, and R$567 referring to post-employment plans (R$28,456 as of December 31, 2022) of subsidiary Avon International, and R$209,288 (R$129,697 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary and R$52,441 (R$51,956 as of December 31, 2022) referring to post-employment healthcare plans of the subsidiary &Co International. Refers to the deferral of revenue from performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct sales consultants, of which R$88,017 (R$190,790 as of December 31, 2022) is referring to subsidiary Avon, R$31,089 (R$93,761 as of December 31, 2022) referring to the consolidated subsidiary and R$12,007 (R$28,653 as of December 31, 2022) referring to subsidiary &Co International.

SHAREHOLDER'S EQUITY - Schedule

SHAREHOLDER'S EQUITY - Schedule of changes in treasury shares (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of classes of share capital [line items]
Balance at beginning of period	R$ 262360
Balance at end of period	164,236	R$ 262360
Treasury shares [member]
Disclosure of classes of share capital [line items]
Balance at beginning of period	R$ 262360	R$ 151342	R$ 11667
Initial share capital (in shares)	9,913,855	4,899,540	316,701
Average price per share, outstanding at beginning of period	R$ 26.46	R$ 30.89	R$ 38.04
Used	R$ 98124	R$ 9282	R$ 34438
Used (in shares)	(3,709,807)	(377,585)	(754,719)
Average price per share, issued	R$ 26.45	R$ 24.58	R$ 45.63
Share repurchase		R$ 120300	R$ 174113
Acquisition (in shares)	0	5,391,900	5,337,558
Average price per share, purchased		R$ 22.31	R$ 32.62
Balance at end of period	R$ 164236	R$ 262360	R$ 151342
Total shares capital subscribed and paid-up (in shares)	6,204,048	9,913,855	4,899,540
Average price per share, outstanding at end of period	R$ 26.47	R$ 26.46	R$ 30.89

SHAREHOLDER'S EQUITY - Addition

SHAREHOLDER'S EQUITY - Additional Information (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of classes of share capital [line items]
Issued capital	R$ 12484515	R$ 12484424
Dividend Rate	30%
Nominal common shares	1,386,848,066	1,383,206,405
Dividends declared and not yet distributed	R$ 293986		R$ 180772
Dividends declared and not yet distributed, per share	R$ 0.2129
Capital reserve [member]
Disclosure of classes of share capital [line items]
Constitution of profit retention reserve	R$ 11175041	R$ 10540885
Increase (decrease) in equity			R$ 650196
Movement of stock option plans and restricted shares	R$ 634156	247,048
Other comprehensive income [member]
Disclosure of classes of share capital [line items]
Reclassification of grant reserve - Natura Cosméticos		R$ 193261

INFORMATION ON SEGMENTS (Detail

INFORMATION ON SEGMENTS (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
INFORMATION ON SEGMENTS
Net revenue		R$ 26737277		R$ 29223656		R$ 31742726
Performance assessed by the company		1,433,146		1,222,893		2,263,714
Depreciation and amortization		(1,587,994)		(1,606,530)		(1,702,904)
Discontinued operations		5,556,457	[1]	(597,655)		90,733
Financial results		(2,513,499)		(1,784,981)		(908,090)
Income tax		86,400		(92,353)		1,297,236
Net income (loss)		2,974,510		(2,858,626)		1,040,689
Natura &Co LATAM
INFORMATION ON SEGMENTS
Net revenue		20,440,834		22,027,337		22,413,401
Performance assessed by the company		2,239,663		1,912,651		2,595,653
Depreciation and amortization		(921,510)		(912,412)		(871,973)
Discontinued operations		6,286,298	[1]
Financial results		(2,249,167)		(1,412,369)		(700,181)
Income tax		624,892		98,712		165,137
Net income (loss)		5,980,176		(313,418)		1,188,636
Avon International [member]
INFORMATION ON SEGMENTS
Net revenue	[2]	6,286,771		7,195,984		9,329,325
Performance assessed by the company	[2]	(493,462)		(74,655)		272,655
Depreciation and amortization	[2]	(665,753)		(683,845)		(830,931)
Discontinued operations	[2]	(434,852)	[1]	(380,416)		(98,550)
Financial results	[2]	(855,283)		(665,653)		(473,195)
Income tax	[2]	(320,889)		(200,474)		210,705
Net income (loss)	[2]	(2,770,239)		(2,005,043)		(919,316)
The Body Shop [member]
INFORMATION ON SEGMENTS
Net revenue			[2]		[3]		[3]
Performance assessed by the company			[2]		[3]		[3]
Depreciation and amortization			[2]		[3]		[3]
Discontinued operations		(302,529)	[1],[2]	(349,448)	[3]	(4,900)	[3]
Financial results			[2]		[3]		[3]
Income tax			[2]		[3]		[3]
Net income (loss)		(302,529)	[2]	(349,448)	[3]	(4,900)	[3]
Aesop [Member]
INFORMATION ON SEGMENTS
Net revenue			[2]		[3]		[3]
Performance assessed by the company			[2]		[3]		[3]
Depreciation and amortization			[2]		[3]		[3]
Discontinued operations		(3,576)	[1],[2]	132,677	[3]	194,183	[3]
Financial results			[2]		[3]		[3]
Income tax			[2]		[3]		[3]
Net income (loss)		(3,576)	[2]	132,677	[3]	194,183	[3]
Corporate expenses [Member]
INFORMATION ON SEGMENTS
Net revenue		9,672		335
Performance assessed by the company		(313,055)		(615,103)		(604,594)
Depreciation and amortization		(731)		(10,273)
Discontinued operations		11,116	[1]	(468)
Financial results		590,951		293,041		265,286
Income tax		(217,603)		9,409		921,394
Net income (loss)		R$ 70678		R$ 323394		R$ 582086
[1]The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023..[2]The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment.[3]The balances are at zero 2023

INFORMATION ON SEGMENTS - Summa

INFORMATION ON SEGMENTS - Summary of operating segments of assets and liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Disclosure of operating segments [line items]
Non-current assets		R$ 26759793	R$ 38563863
Total assets		42,747,015	54,685,390
Current liabilities		10,413,499	13,337,868
Non-current liabilities		9,213,051	18,996,338
Natura &Co Latam [Member]
Disclosure of operating segments [line items]
Non-current assets		18,240,916	18,256,204
Total assets		23,253,227	29,762,132
Current liabilities		6,914,476	8,363,130
Non-current liabilities		4,324,263	10,164,706
Avon International [member]
Disclosure of operating segments [line items]
Non-current assets	[1]	8,008,108	11,197,014
Total assets	[1]	10,608,234	14,259,571
Current liabilities	[1]	2,792,255	1,894,856
Non-current liabilities	[1]	977,003	1,838,328
The Body Shop [Member]
Disclosure of operating segments [line items]
Non-current assets	[2]		6,565,913
Total assets	[2]		7,928,270
Current liabilities	[2]		1,292,903
Non-current liabilities	[2]		1,669,625
Aesop [Member]
Disclosure of operating segments [line items]
Non-current assets	[2]		1,621,126
Total assets	[2]		2,735,417
Current liabilities	[2]		731,018
Non-current liabilities	[2]		776,512
Corporate expenses [Member]
Disclosure of operating segments [line items]
Non-current assets		510,769	923,606
Total assets		8,885,554
Current liabilities		706,768	1,055,961
Non-current liabilities		R$ 3911785	R$ 4547167
[1]The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment.[2]The balances are at zero 2023

INFORMATION ON SEGMENTS - Sum_2

INFORMATION ON SEGMENTS - Summary of revenue and assets by geographical area wise (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	R$ 26737277	R$ 29223656	R$ 31742726
Non-current assets	26,759,793	38,563,863
Asia [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	1,326,431	1,555,054	1,758,912
Non-current assets	572,168	1,284,783
North America [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	3,919,414	4,472,169	4,931,608
Non-current assets	3,956,986	6,261,545
Mexico [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	3,284,608	3,570,990	3,079,033
Non-current assets	3,883,804	3,631,768
Other [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	634,806	901,180	1,052,575
Non-current assets	73,182	2,629,777
South America [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	16,481,018	17,513,597	17,476,158
Non-current assets	14,015,695	14,508,816
Brazil [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	12,004,994	11,280,690	10,521,780
Non-current assets	10,933,917	12,656,298
Argentina
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	1,711,783	3,003,214	2,973,638
Non-current assets	261,155	694,172
Other [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	2,764,241	3,229,693	3,980,740
Non-current assets	2,820,623	1,158,346
Europe, Middle East and Africa (EMEA) [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	5,010,413	5,682,836	7,445,713
Non-current assets	8,214,944	15,271,251
United Kingdom [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	257,944	577,544	896,945
Non-current assets	5,132,107	10,894,799
Other [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS	4,752,469	5,105,292	6,548,768
Non-current assets	3,082,837	4,376,452
Oceania [Member]
Revenue:
NET REVENUE FROM CONTINUING OPERATIONS			R$ 130335
Non-current assets		R$ 1237468

INFORMATION ON SEGMENTS - Addit

INFORMATION ON SEGMENTS - Additional Information (Detail) - Customer	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Major Customer [Member] | Foreign countries [member]
Disclosure of operating segments [line items]
Number of major customers	0
Benchmark for major customer	10%
Natura &Co LATAM
Disclosure of operating segments [line items]
Percentage of entity's revenue	76.50%	75.40%
Avon International [member]
Disclosure of operating segments [line items]
Percentage of entity's revenue	23.50%	24.60%

REVENUE - Summary of revenue by

REVENUE - Summary of revenue by Sales Channels Wise (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue:
Gross revenue	R$ 34718550	R$ 37886400	R$ 40797925
Returns and cancellations	(442,676)	(588,579)	(590,911)
Commercial discounts and rebates	(11,610)	(29)	(1,771)
Taxes on sales	(7,526,987)	(8,074,136)	(8,462,517)
Subtotal	(7,981,273)	(8,662,744)	(9,055,199)
Total net revenue	26,737,277	29,223,656	31,742,726
Direct Selling [member]
Revenue:
Gross revenue	31,399,069	34,011,306	36,297,680
Retail [member]
Revenue:
Gross revenue	549,749	431,848	1,367,517
Online [member]
Revenue:
Gross revenue	1,461,888	1,737,356	1,491,696
Other sales [member]
Revenue:
Gross revenue	R$ 1307844	R$ 1705890	R$ 1641032

OPERATING EXPENSES AND COST O_3

OPERATING EXPENSES AND COST OF SALES - Summary of operating expenses and cost of sales classified by function and nature (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Classified by function
Cost of sales		R$ 9675435	R$ 11770762	R$ 12531303
Selling, marketing and logistics expenses		11,015,940	11,558,866	12,386,193
Administrative, R&D, IT, and project expenses		4,225,027	5,023,626	5,217,633
Total		24,916,402	28,353,254	30,135,129
Classified by nature
Employee benefits expense (note 28)		5,075,484	5,374,006	5,665,056
Restructuring expenses	[1]	52,641	50,903	3,079
Depreciation and amortization		1,587,994	1,606,530	1,702,904
Impairment		(663,892)	(308,464)
Total		24,916,402	28,353,254	30,135,129
Cost of sales [member]
Classified by nature
Raw material/packaging material/resale		8,541,488	10,587,972	10,703,627
Employee benefits expense (note 28)		516,046	565,431	554,999
Depreciation and amortization		170,288	168,713	246,091
Other		447,613	448,646	1,026,586
Selling, marketing and logistics expenses [member]
Classified by nature
Logistics costs		1,523,083	1,941,593	2,161,844
Employee benefits expense (note 28)		2,804,788	2,734,895	3,101,951
Marketing, sales force and other selling expenses		6,224,588	6,357,494	6,371,933
Depreciation and amortization		463,481	484,614	745,419
Impairment			40,270	5,046
Administrative, R&D, IT and project expenses [member]
Classified by nature
Innovation expenses		161,477	262,646	210,170
Employee benefits expense (note 28)		1,754,650	2,073,680	2,008,106
Restructuring expenses		730	125,804
Other administrative expenses		1,354,083	1,619,949	2,030,979
Depreciation and amortization		R$ 954087	R$ 941547	R$ 968378
[1] Refers to expenses related to the closure of the operations of the subsidiary The Body Shop in Russia, the main expenses being related to employee remuneration and fines for terminating the store rental contract.

EMPLOYEE BENEFITS - Summary of

EMPLOYEE BENEFITS - Summary of Employee Benefit Expense (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
EMPLOYEE BENEFITS
Payroll, profit sharing and bonuses	R$ 3553374	R$ 3848557	R$ 3975494
Pension Plan	100,498	90,392	106,303
Share-based payments and charges on restricted shares	126,987	90,796	183,815
Health care, food and other benefits	579,116	704,449	661,445
Charges, taxes and social contributions	473,382	588,538	534,375
INSS	242,127	51,274	203,624
Total	R$ 5075484	R$ 5374006	R$ 5665056

EMPLOYEE BENEFITS - Summary o_2

EMPLOYEE BENEFITS - Summary of Number and Weighted Average Number of Shares (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2023 shares R$ / shares	Dec. 31, 2022 shares R$ / shares
Disclosure of Employee Benefits [Line Items]
Weighted average strike price per option, Changes from options to restricted shares | R$ / shares		R$ 48.98
Stock option plan and Strategy Acceleration Plan [Member]
Disclosure of Employee Benefits [Line Items]
Weighted average strike price per option, Balance | R$ / shares	R$ 18.92	21.05
Weighted average strike price per option, Granted | R$ / shares	16.45	16.45
Weighted average strike price per option, Expired / Cancelled | R$ / shares	22.92	27.22
Weighted average exercise price per option, Exercised | R$ / shares	13.02	11.98
Weighted average strike price per option, TBS Awards - equity to cash settlement conversion | R$ / shares	21.43
Weighted average strike price per option, Balance | R$ / shares	R$ 18.74	R$ 18.92
Options, Balance	19,660	20,137
Options, Granted	30	1,710
Options, Changes from options to restricted shares		(1,100)
Options, Exercised	(568)	(226)
Options, Expired / Cancelled	(758)	(861)
Options, TBS Awards - equity to cash settlement conversion	(1,334)
Options, Balance	17,030	19,660
Shares, Balance	17,030
Restricted Stocks [Member]
Disclosure of Employee Benefits [Line Items]
Shares, Balance	6,058	5,494
Shares, Granted	3,966	2,359
Shares, Changes from options to restricted shares		1,100
Shares, Expired/Canceled	(360)	(442)
Shares, Stock adjustment based on acquisition performance
Shares, Released	(3,033)	(2,453)
Shares, Adjustments related to vesting in the sale of Aesop
Shares, Awards related to the sale of Aesop	(182)
Shares, Adjustments related to the acquisition of rights in the sale of TBS	(18)
Shares, TBS Awards - equity to cash settlement conversion	(129)
Shares, Balance	6,302	6,058
Performance Shares [Member]
Disclosure of Employee Benefits [Line Items]
Shares, Balance	12,055	8,045
Shares, Granted	8,736	6,485
Shares, Changes from options to restricted shares
Shares, Expired/Canceled	(2,921)	(1,902)
Shares, Stock adjustment based on acquisition performance	(990)
Shares, Released	(2,686)	(573)
Shares, Adjustments related to vesting in the sale of Aesop	(964)
Shares, Awards related to the sale of Aesop	(875)
Shares, Adjustments related to the acquisition of rights in the sale of TBS	(1,476)
Shares, TBS Awards - equity to cash settlement conversion	(383)
Shares, Balance	10,496	12,055

EMPLOYEE BENEFITS - Summary o_3

EMPLOYEE BENEFITS - Summary of Terms and Conditions of Share-based Payment Arrangement (Detail) shares in Thousands		12 Months Ended
		Dec. 31, 2023 shares R$ / shares	Dec. 31, 2022 shares	Dec. 31, 2021 shares
Stock Options [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing shares | shares		17,030
Existing options | shares		17,030	19,660	20,137
Exercisable options | shares		12,137
Stock Options [Member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 16,2015
Conditions for acquisition of right as of the grant date		2 to 4 years of service
Strike price		R$ 12.71
Existing shares | shares		85
Maximum remaining contractual life (years)		2 months 12 days
Exercisable options | shares		85
Stock Options [Member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		July 11, 2016 (acceleration strategy)
Conditions for acquisition of right as of the grant date		4 to 5 years of service
Strike price		R$ 11.28
Existing shares | shares		1,540
Maximum remaining contractual life (years)		6 months
Exercisable options | shares		1,540
Stock Options [Member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 10, 2017
Conditions for acquisition of right as of the grant date		2 to 4 years of service
Strike price		R$ 12.46
Existing shares | shares		350
Maximum remaining contractual life (years)		1 year 2 months 12 days
Exercisable options | shares		350
Stock Options [Member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 10, 2017 (acceleration strategy)
Conditions for acquisition of right as of the grant date		4 to 5 years of service
Strike price		R$ 12.46
Existing shares | shares		1,890
Maximum remaining contractual life (years)		1 year 6 months
Exercisable options | shares		1,890
Stock Options [Member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 12, 2018
Conditions for acquisition of right as of the grant date		2 to 4 years of service
Strike price		R$ 16.83
Existing shares | shares		1,501
Maximum remaining contractual life (years)		2 years 2 months 12 days
Exercisable options | shares		1,501
Stock Options [Member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 12, 2018 (acceleration strategy)
Conditions for acquisition of right as of the grant date		3 to 5 years of service
Existing shares | shares		3,800
Maximum remaining contractual life (years)		2 years 2 months 12 days
Exercisable options | shares		3,800
Stock Options [Member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		April 12, 2019
Conditions for acquisition of right as of the grant date		2 to 4 years of service
Strike price		R$ 23.41
Existing shares | shares		1,421
Maximum remaining contractual life (years)		3 years 2 months 12 days
Exercisable options | shares		1,421
Stock Options [Member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		April 12, 2019 (acceleration strategy)
Conditions for acquisition of right as of the grant date		4 to 5 years of service
Strike price		R$ 23.41
Existing shares | shares		1,900
Maximum remaining contractual life (years)		3 years 2 months 12 days
Exercisable options | shares		950
Stock Options [Member] | December 17, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		December 17, 2021
Conditions for acquisition of right as of the grant date		3 to 4 years of service
Strike price		R$ 27.28
Existing shares | shares		3,703
Maximum remaining contractual life (years)		8 years
Exercisable options | shares
Stock Options [Member] | September 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		September 14, 2022
Conditions for acquisition of right as of the grant date		3 to 4 years of service
Strike price		R$ 16.45
Existing shares | shares		840
Maximum remaining contractual life (years)		8 years 8 months 12 days
Exercisable options | shares		600
Stock Options [Member] | Bottom of range [member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 7.16
Stock Options [Member] | Bottom of range [member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		6.84
Stock Options [Member] | Bottom of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		6.65
Stock Options [Member] | Bottom of range [member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		6.87
Stock Options [Member] | Bottom of range [member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		7.96
Stock Options [Member] | Bottom of range [member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Strike price		12.04
Fair value at grant date		8.21
Stock Options [Member] | Bottom of range [member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		11.71
Stock Options [Member] | Bottom of range [member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		11.51
Stock Options [Member] | Bottom of range [member] | December 17, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		13.85
Stock Options [Member] | Bottom of range [member] | September 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		8.39
Stock Options [Member] | Top of range [member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		7.43
Stock Options [Member] | Top of range [member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		6.89
Stock Options [Member] | Top of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		6.68
Stock Options [Member] | Top of range [member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		6.89
Stock Options [Member] | Top of range [member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		8.21
Stock Options [Member] | Top of range [member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Strike price		16.83
Fair value at grant date		9.67
Stock Options [Member] | Top of range [member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		11.82
Stock Options [Member] | Top of range [member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		11.71
Stock Options [Member] | Top of range [member] | December 17, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		18.16
Stock Options [Member] | Top of range [member] | September 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 10.32
Restricted Stocks [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing shares | shares		6,302	6,058	5,494
Restricted Stocks [Member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 31, 2021
Conditions for acquisition of right as of the grant date		1 to 3 years of service
Existing shares | shares		737
Fair value at grant date		R$ 48.13
Maximum remaining contractual life (years)		3 months 18 days
Restricted Stocks [Member] | April 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		April 14, 2022
Conditions for acquisition of right as of the grant date		1 to 3 years of service
Existing shares | shares		1,138
Maximum remaining contractual life (years)		1 year 3 months 18 days
Restricted Stocks [Member] | March 31, 2021 (as modified in September 2022)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	[1]	March 31, 2021 (as modified in September 2022)
Conditions for acquisition of right as of the grant date		4 to 5 years of service
Existing shares	[1]	1,100
Maximum remaining contractual life (years)	[1]	2 years 3 months 18 days
Restricted Stocks [Member] | May 05, 2023 [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		May 5, 2023
Conditions for acquisition of right as of the grant date		1 to 3 years of service
Existing shares | shares		3,327
Fair value at grant date		R$ 11.2
Maximum remaining contractual life (years)		2 years 3 months 18 days
Restricted Stocks [Member] | Bottom of range [member] | April 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 24.91
Restricted Stocks [Member] | Bottom of range [member] | March 31, 2021 (as modified in September 2022)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date	[1]	7.41
Restricted Stocks [Member] | Top of range [member] | April 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		24.99
Restricted Stocks [Member] | Top of range [member] | March 31, 2021 (as modified in September 2022)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date	[1]	R$ 24.77
Performance Shares [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing shares | shares		10,496	12,055	8,045
Performance Shares [Member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		March 31, 2021
Conditions for acquisition of right as of the grant date		Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards
Existing shares | shares		1,859
Performance Shares [Member] | April 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		April 14, 2022
Conditions for acquisition of right as of the grant date		Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards
Existing shares | shares		3,545
Performance Shares [Member] | May 05, 2023 [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date		May 5, 2023
Conditions for acquisition of right as of the grant date		Achievement of performance conditions, 3 years of service
Existing shares | shares		5,092
Performance Shares [Member] | Bottom of range [member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 46.57
Maximum remaining contractual life (years)		3 months 18 days
Performance Shares [Member] | Bottom of range [member] | April 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 18.66
Maximum remaining contractual life (years)		1 year 3 months 18 days
Performance Shares [Member] | Bottom of range [member] | May 05, 2023 [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 11.2
Maximum remaining contractual life (years)		2 years 3 months 18 days
Performance Shares [Member] | Top of range [member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 50.98
Maximum remaining contractual life (years)		1 year 3 months 18 days
Performance Shares [Member] | Top of range [member] | April 14, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 24.99
Maximum remaining contractual life (years)		2 years 3 months 18 days
Performance Shares [Member] | Top of range [member] | May 05, 2023 [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value at grant date		R$ 11.55
Maximum remaining contractual life (years)		3 years 3 months 18 days
[1] *The original grant of March 31, 2021 was stock options, but became a restricted share award as a result of the September 2022 amendment.

EMPLOYEE BENEFITS - Summary o_4

EMPLOYEE BENEFITS - Summary of Measurement Inputs for Fair Value of Shares (Detail) - 12 months ended Dec. 31, 2023	yr $ / shares	yr R$ / shares
B3 shares
Disclosure Of Measurement Inputs For Fair Value Of Shares [line items]
Share price (also used as strike price on Finnerty) | R$ / shares		R$ 11.21
Strike price | R$ / shares		R$ 0.01
Expected dividend yield	0%	0%
B3 shares | Bottom of range [member]
Disclosure Of Measurement Inputs For Fair Value Of Shares [line items]
Expected volatility	48.64%	48.64%
Expected term	1	1
Risk-free interest rate	11.69%	11.69%
B3 shares | Top of range [member]
Disclosure Of Measurement Inputs For Fair Value Of Shares [line items]
Expected volatility	57.70%	57.70%
Expected term	3	3
Risk-free interest rate	12.93%	12.93%
ADRs
Disclosure Of Measurement Inputs For Fair Value Of Shares [line items]
Share price (also used as strike price on Finnerty) | $ / shares	$ 4.49
Strike price | $ / shares	$ 0.00403
Expected dividend yield	0%	0%
ADRs | Bottom of range [member]
Disclosure Of Measurement Inputs For Fair Value Of Shares [line items]
Expected volatility	55.20%	55.20%
Expected term	1	1
Risk-free interest rate	3.68%	3.68%
ADRs | Top of range [member]
Disclosure Of Measurement Inputs For Fair Value Of Shares [line items]
Expected volatility	63.11%	63.11%
Expected term	3	3
Risk-free interest rate	4.82%	4.82%

EMPLOYEE BENEFITS - Additional

EMPLOYEE BENEFITS - Additional Information (Detail) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023 BRL (R$) Installments R$ / shares	Dec. 31, 2022 BRL (R$) R$ / shares	Dec. 31, 2021 BRL (R$)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based compensation expense, net of social charges	R$ 126987	R$ 123931	R$ 228133
Share Price | R$ / shares	R$ 16.89	R$ 11.61
Parent company
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based compensation expense, net of social charges	R$ 13304	R$ 8249	R$ 74734
Matching Awards [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Stock split, conversion ratio	1
Number of instalments | Installments	3
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period	3 years

EMPLOYEE BENEFITS - Avon Produc

EMPLOYEE BENEFITS - Avon Products Inc. plans - Additional Information (Detail) - Avon Products, Inc - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]
Threshold period of contribution to meet indefinite beneficiary criteria in medical plan	10 years
Period of benefit for each year of fixed contribution in medical plan	1 year
Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Period of contribution to meet definite beneficiary criteria in medical plan	10 years
UNITED KINGDOM
Disclosure of terms and conditions of share-based payment arrangement [line items]
Matching contributions made by entity	R$ 28080	R$ 33915
Personal Savings Account Plan (PSA) | UNITED STATES
Disclosure of terms and conditions of share-based payment arrangement [line items]
Matching contributions made by entity	R$ 3873	R$ 4174
Maximum Percentage of Eligible Compensation by Eligible Participants	25%
Personal Savings Account Plan (PSA) | UNITED STATES | Bottom of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for fifty cents	4%
Personal Savings Account Plan (PSA) | UNITED STATES | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for dollar	3%
Percentage of eligible compensation for each dollar contributed for fifty cents	6%
Retirement Savings Account ("RSA") | UNITED STATES | Bottom of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for fifty cents	3%
Retirement Savings Account ("RSA") | UNITED STATES | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for fifty cents	6%
Restricted Stock Unit RSU [Member] | UNITED STATES
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period	3 years
Performance Restricted Stock Units (PRSU) | Bottom of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for employer contributions	5%
Performance Restricted Stock Units (PRSU) | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for employer contributions	10%

FINANCIAL RESULTS__ - Summary o

FINANCIAL RESULTS - Summary of net of financial expense based on the nature of the related transactions (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
FINANCIAL RESULTS
Finance expesnes (debt interest)	R$ 868614	R$ 721083	R$ 610913
Financial short-term investments and others income	977,203	535,587	251,542
Exchange variations on financial activities, net	322,049	323,496	(287,329)
Gains (losses) with derivatives on exchange rate variations on financial activities, net	(342,005)	(383,178)	257,964
Gains (losses) on derivatives on interest payments and other financial activities, net	(1,449,900)	(553,253)	71,616
Monetary adjustment of provision for tax, civil and labor risks and tax liabilities	(73,011)	(79,280)	(25,731)
Leases interest expenses	(110,356)	(112,456)	(116,381)
Other finance expenses	(522,748)	(327,588)	(380,152)
Hyperinflationary economy adjustment	(117,553)	(187,612)	(26,528)
Other gains (losses) from exchange rate variation on operating activities	(328,564)	(279,614)	(42,178)
Financial results	R$ 2513499	R$ 1784981	R$ 908090

OTHER OPERATING EXPENSES, NET_2

OTHER OPERATING EXPENSES, NET (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Others operating income, net
Result on write-off of property, plant and equipment			R$ 8443
Tax credits	[1]	195,780	71,720	215,085
Tax benefit from amnesty program	[2]		126,272	82,140
Reversal for impairment provision
Revenue from the sale of the customer portfolio		16,471	11,874	16,113
Royalty income	[3]		119,438
Miscellaneous Other Operating Income Expense		23,924	(25,359)	30,214
Total Other operating income		236,175	295,502	343,552
Other operating expenses, net
Result on write-off of property, plant and equipment		(32,704)	5,273	(9,122)
Crer para Ver	[4]	(20,115)	(54,062)	(47,523)
Goodwill Impairment		(663,892)	(282,921)
Provision for losses on fixed assets, intangible assets and leases		(22,040)	(34,198)
Expenses with sale of customer portfolio		(8,168)
Transformation and integration plan	[5]	(769,404)	(423,232)	(511,048)
Restructuring expenses	[6]	(52,641)	(50,903)	(3,079)
Increased provision for tax, labor and civil contingencies		(32,383)
Tax benefit for joining the amnesty program			(23,803)
Other operating expenses		(4,677)	(80,848)
Other operating income				19,789
Total other operating expenses		(1,606,024)	(944,694)	(550,983)
Other operating expenses, net		R$ 1369849	R$ 649192	R$ 207431
[1] Refers to tax credits from PIS and COFINS. Refers to tax benefits in Brazil arising from the adhesion to state tax amnesty programs by the subsidiaries Natura Cosmeticos S.A. and Avon Cosmeticos Ltda. Refers to revenue from royalties received by subsidiary Avon from its representative in Japan, after a legal dispute. Refers to appropriation of operating resultsobtained on the sales of the non-cosmetic product line called "Crer Para Ver" to the Natura Institute, specifically earmarked for social projects aimed at developing the quality of education. Expenses related to the execution of the integration plan between the Natura and Avon brands, which is mainly supported by operational and logistical workflows, structure reorganization, credit and collection review and commercial model optimizations. Refers to expenses related to the closure of the operations of the subsidiary The Body Shop in Russia, the main expenses being related to employee remuneration and fines for terminating the store rental contract.

EARNINGS PER SHARE - Summary of

EARNINGS PER SHARE - Summary of Basic Earnings Per Share (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
EARNINGS PER SHARE
Profit (loss) attributable to the Company’s controlling shareholders	R$ 2973731	R$ 2859629	R$ 1047960
Weighted average of the number of issued common shares	1,385,675,623	1,381,594,182	1,377,932,809
Weighted average treasury shares	(7,806,697)	(9,613,311)	(788,866)
Weighted average number of common shares issued, net of treasured shares	1,377,868,926	1,371,980,871	1,377,143,943
Basic gain (loss) earnings per share - R$	R$ 2.1582	R$ 2.0843	R$ 0.761

EARNINGS PER SHARE - Summary _2

EARNINGS PER SHARE - Summary of Diluted Earnings Per Share (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
EARNINGS PER SHARE
Profit attributable to the Company’s controlling shareholders	R$ 2973731	R$ 2859629	R$ 1047960
Weighted average of the number of issued common shares issued, net of treasured shares	1,377,868,926	1,371,980,871	1,377,143,943
Adjustment for stock options and restricted shares	6,401,920		19,531,951
Weighted average of the number of ordinary shares for diluted earnings calculation	1,384,270,846		1,396,675,894
Diluted earnings per share - R$	R$ 2.1482	R$ 2.0843	R$ 0.7503

EARNINGS PER SHARE - Summary _3

EARNINGS PER SHARE - Summary of basic earnings (loss) per share for the results of discontinued operations (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
EARNINGS PER SHARE
Profit (loss) attributable to the Company’s controlling shareholders	R$ 5556457	[1]	R$ 597655	R$ 90733
Weighted average of the number of issued common shares	1,385,675,623		1,381,594,182	1,377,932,809
Adjustment for stock options and restricted shares	(7,806,697)		(9,613,311)	(788,866)
Weighted average number of common shares issued, net of treasured shares	1,377,868,926		1,371,980,871	1,377,143,943
Basic profit (loss) per share - R$	R$ 4.0326		R$ 0.4365	R$ 0.0659
[1]The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023..

EARNINGS PER SHARE - Summary _4

EARNINGS PER SHARE - Summary of diluted earnings (loss) per share for the results of discontinued operations (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
EARNINGS PER SHARE
Profit attributable to the Company’s controlling shareholders	R$ 5556457	[1]	R$ 597655	R$ 90733
Weighted average of the number of issued common shares issued, net of treasured shares	1,377,868,926		1,371,980,871	1,377,143,943
Weighted average number of treasury shares	6,401,920			19,531,951
Weighted average of the number of ordinary shares for diluted earnings calculation	1,384,270,846			1,396,675,894
Diluted earnings per share - R$	R$ 4.0139			R$ 0.065
[1]The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023..

TRANSACTIONS WITH RELATED PAR_3

TRANSACTIONS WITH RELATED PARTIES - Additional Information (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Instituto Natura [Member]
Disclosure of transactions between related parties [line items]
Donations associated with sale	R$ 49800	R$ 55000
Right-of-use assets [member] | Buildings [member] | Bresco IX [Member]
Disclosure of transactions between related parties [line items]
Purchases of property and other assets related party transaction		47,445
Lease paid		8,786
Right-of-use assets [member] | Buildings [member] | Bresco Logística Fundo de Investimento Imobiliário [Member]
Disclosure of transactions between related parties [line items]
Purchases of property and other assets related party transaction	3,634	4,996
Lease paid	2,258	2,152
Fundo de Investimento Essencial [Member] | Instituto Natura [Member]
Disclosure of transactions between related parties [line items]
Investments	6,994	6,805
Indústria e Comércio de Cosméticos Natura Ltda [member] | Right-of-use assets [member] | Buildings [member] | Bres Itupeva Empreendimentos Imobiliários Ltda. [Member]
Disclosure of transactions between related parties [line items]
Purchases of property and other assets related party transaction	52,742	63,665
Lease paid	R$ 16549	R$ 15680

TRANSACTIONS WITH RELATED PAR_4

TRANSACTIONS WITH RELATED PARTIES - Summary of Total Compensation of the Company's Key Management Personnel (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of transactions between related parties [line items]
Fixed	R$ 36203	R$ 47655	R$ 66619
Variable	212,189	197,026	143,349
Total	248,392	244,681	209,968
Board of Directors [Member]
Disclosure of transactions between related parties [line items]
Fixed	8,212	13,252	15,043
Variable	11,660	146,603	72,187
Total	19,872	159,855	87,230
Executive Board [Member]
Disclosure of transactions between related parties [line items]
Fixed	27,991	34,403	51,576
Variable	200,529	50,423	71,162
Total	R$ 228520	R$ 84826	R$ 122738

COMMITMENTS - Summary of Contra

COMMITMENTS - Summary of Contractual Commitments (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Contractual commitments disclosure [line items]
Total	R$ 761308	R$ 1323032
Less than one year [member]
Contractual commitments disclosure [line items]
Total	273,548	614,075
One to five years [member]
Contractual commitments disclosure [line items]
Total	486,961	659,626
Over five years [member]
Contractual commitments disclosure [line items]
Total	R$ 799	R$ 49331

INSURANCE - Summary of Types of

INSURANCE - Summary of Types of Insurance Coverage (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Industrial complex and administrative sites [member]
INSURANCE
Type of coverage	Any damages to buildings, facilities, inventories, and machinery and equipment
Amount insured	R$ 4694455	R$ 4924868
Vehicles [member]
INSURANCE
Type of coverage	Fire, theft and collision for the vehicles insured by the Company
Amount insured	R$ 24907	221,523
Loss of profits [member]
INSURANCE
Type of coverage	No loss of profits due to material damages to facilities buildings and production machinery and equipment
Amount insured		2,056,000
Transport [member]
INSURANCE
Type of coverage	Damages to products in transit
Amount insured	R$ 81328	97,308
Civil liability [member]
INSURANCE
Type of coverage	Protection against error or complaints in the exercise of professional activity that affect third parties
Amount insured	R$ 886720	1,991,888
Environmental liability [member]
INSURANCE
Type of coverage	Protection against environmental accidents that may result in environmental lawsuits
Amount insured	R$ 30000	R$ 30000

ADDITIONAL INFORMATION RELATI_3

ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS - Summary of additional information on transactions related to the cash flow statement (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Non-cash items
Hedge accounting, net of tax effects	R$ 494698	R$ 520444	R$ 137211
Dividends declared and not yet paid	294,231		180,772
Net effect of acquisition of property, plant and equipment and intangible assets not yet paid	27,900	28,472	172,104
Application of judicial deposits in the settlement of legal proceedings	R$ 55494	R$ 121025

DISCONTINUED OPERATIONS - Summa

DISCONTINUED OPERATIONS - Summary detailing the determination of the loss upon classification as assets held for sale and the subsequent fair value movements (Detail) - Discontinued operations [member] - The Body Shop [member] - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of analysis of single amount of discontinued operations [line items]
Fair value of the previously subsidiary	[1]	R$ 826560
Incremental transaction costs on sale		(64,288)
Fair value less selling costs		762,272
Net assets of the previously subsidiary	[2]	(4,770,016)
Impairment loss		(4,007,744)
Balance after recognition of loss due to impairment	[3]	762,272
Adjustments to the fair value of assets held for sale		91,824
Balances on the date of derecognition		R$ 854096
[1] It reflects the best estimate of the fair value of the operations on the date the criteria for classification as assets held for sale were met, on October 31, 2023. These estimates reflect the consideration agreed upon with the buyer, presented in the table below, reflecting the translation rate from British pounds to Brazilian real on that date. It reflects the carrying amount of the operation reclassified to non-current assets held for sale on the date when the aforementioned criteria were met, on October 31, 2023.

DISCONTINUED OPERATIONS - Sched

DISCONTINUED OPERATIONS - Schedule of breakdown of results presented in discontinued operations in the income statement (Detail) - BRL (R$) R$ in Thousands		3 Months Ended	12 Months Ended
		Jun. 30, 2022	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
Disclosure of analysis of single amount of discontinued operations [line items]
Loss before taxes from discontinued operations					R$ 428684	R$ 339984
Income tax and social contribution						(249,251)
Loss from discontinued operations						90,733
Total discontinued operations			R$ 5556457	[1]	(597,655)	90,733
Discontinued operations [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net gain (loss) on the sale of subsidiaries			6,296,428
Loss before taxes from discontinued operations			(867,308)		(570,444)	339,984
Income tax and social contribution			127,337		(27,211)	(249,251)
Loss from discontinued operations			(739,971)		(597,655)	90,733
Total discontinued operations		R$ 597655	5,556,457			90,733
Discontinued operations [member] | Natura Brazil Pty Ltd. (Aesop) [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Cash Consideration received for the sale to the previously controlled subsidiaries			12,429,175
Net assets of the previously controlled subsidiary, derecognized			(1,140,751)
Accumulated gains in other comprehensive income from currency translation			115,168
Incremental transaction costs on sale			(289,686)
Income tax and social contribution			(3,736,138)
Net gain (loss) on the sale of subsidiaries			7,377,768
Discontinued operations [member] | The Body Shop [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Cash Consideration received for the sale to the previously controlled subsidiaries			829,497
Net assets of the previously controlled subsidiary, derecognized	[2]		(762,272)
Accumulated gains in other comprehensive income from currency translation			1,622,436
Incremental transaction costs on sale			(64,288)
Income tax and social contribution			1,392,855
Net gain (loss) on the sale of subsidiaries			(1,081,340)
Fixed amount receivable upon completion			22,915
Fixed amount receivable in 2028			320,153
Contingent consideration			486,429
Impairment loss			(4,007,744)
Adjustments to the fair value of assets			R$ 91824
[1]The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023..[2]On transaction date Aesop and The Body Shop presents Cash and Cash Equivalent in the amount of R$ 400,585 and R$ 214,387, respectively

DISCONTINUED OPERATIONS - Sch_2

DISCONTINUED OPERATIONS - Schedule of results in discontinued operations (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of analysis of single amount of discontinued operations [line items]
Net revenue	R$ 26737277	R$ 29223656	R$ 31742726
Cost of Sales	(9,675,435)	(11,770,762)	(12,531,303)
GROSS PROFIT	17,061,842	17,452,894	19,211,423
Selling, marketing and logistics expenses	(11,015,940)	(11,558,866)	(12,386,193)
Administrative, R&D, IT and project expenses	(4,225,027)	(5,023,626)	(5,217,633)
Other operating income (expenses), net	(1,369,849)	(649,192)	(207,431)
OPERATING PROFIT (LOSS) BEFORE FINANCIAL RESULT	(154,848)	(383,637)	560,809
Financial results	(2,513,499)	(1,784,981)	(908,090)
Net income (loss) before income tax and social contribution		428,684	339,984
Income tax and social contribution			(249,251)
Net income (loss) for the year			90,733
Discontinued operations [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net revenue	5,578,990	7,125,967	8,421,961
Cost of Sales	(1,137,127)	(1,384,258)	(1,480,222)
GROSS PROFIT	4,441,863	5,741,709	6,941,739
Operating (expenses) income	(5,185,984)	(6,196,273)	(6,482,868)
Selling, marketing and logistics expenses	(3,139,196)	(3,996,851)	(4,613,032)
Administrative, R&D, IT and project expenses	(1,432,107)	(1,688,874)	(1,741,233)
Other operating income (expenses), net	(614,681)	(510,548)	(128,603)
OPERATING PROFIT (LOSS) BEFORE FINANCIAL RESULT	(744,121)	(454,564)	458,871
Financial results	(123,187)	(115,880)	(118,887)
Net income (loss) before income tax and social contribution	(867,308)	(570,444)	339,984
Income tax and social contribution	127,337	(27,211)	(249,251)
Net income (loss) for the year	R$ 739971	R$ 597655	R$ 90733

DISCONTINUED OPERATIONS - Sch_3

DISCONTINUED OPERATIONS - Schedule of net cash flows incurred by the discontinued operations (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disclosure of analysis of single amount of discontinued operations [abstract]
Operational activities	R$ 5992000	R$ 1185485	R$ 1260662
Investment activities	12,287,226	(336,953)	(493,208)
Financing activities	(584,118)	(1,123,031)	R$ 212108
Net cash generated (consumed)	R$ 5711108	R$ 274499

DISCONTINUED OPERATIONS - Addit

DISCONTINUED OPERATIONS - Additional Information (Detail) R$ in Thousands			12 Months Ended
	Dec. 29, 2023 BRL (R$)	Aug. 30, 2023 BRL (R$)	Dec. 31, 2023 BRL (R$)	Dec. 31, 2022 BRL (R$)	Dec. 31, 2021 BRL (R$)	Dec. 29, 2028 BRL (R$)	Dec. 29, 2023 GBP (£) Installments	Dec. 29, 2023 BRL (R$) Installments
Disclosure of analysis of single amount of discontinued operations [line items]
Pre-tax profit (loss) from discontinued operations				R$ 428684	R$ 339984
Natura Brazil Pty Ltd. (Aesop) [Member] | L’Oréal Group [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disposal date fair value of total consideration received		R$ 12429175
Net gain (loss) on the sale of subsidiaries		7,377,768
Accumulated gains in other comprehensive income from currency translation		115,168
The Body Shop [member] | Aurelius Investment Advisory Limited (“Aurelius”) [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disposal date fair value of total consideration received								R$ 829496
Accumulated gains in other comprehensive income from currency translation	R$ 1622436
Number of variable installments of contingent consideration ('earn-out')						2
Contingent consideration						R$ 486429
Impairment loss of recoverable amount of net assets held for sale	4,007,744
Discontinued operations [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Net gain (loss) on the sale of subsidiaries			R$ 6296428
Pre-tax profit (loss) from discontinued operations			(867,308)	(570,444)	339,984
Discontinued operations [member] | Natura Brazil Pty Ltd. (Aesop) [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disposal date fair value of total consideration received			12,429,175
Net gain (loss) on the sale of subsidiaries			7,377,768
Accumulated gains in other comprehensive income from currency translation			115,168
Discontinued operations [member] | Natura Brazil Pty Ltd. (Aesop) [Member] | L’Oréal Group [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Cash and Cash Equivalents of discontinued operations			400,585
Disposal date fair value of total consideration received		12,429,175
Net gain (loss) on the sale of subsidiaries		7,377,768
Accumulated gains in other comprehensive income from currency translation		R$ 115168
Discontinued operations [member] | The Body Shop [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Disposal date fair value of total consideration received			829,497
Net gain (loss) on the sale of subsidiaries			(1,081,340)
Accumulated gains in other comprehensive income from currency translation			1,622,436
Contingent consideration			486,429
Impairment loss of recoverable amount of net assets held for sale			4,007,744
Discontinued operations [member] | The Body Shop [member] | Aurelius Investment Advisory Limited (“Aurelius”) [Member]
Disclosure of analysis of single amount of discontinued operations [line items]
Cash and Cash Equivalents of discontinued operations			214,387
Net gain (loss) on the sale of subsidiaries	R$ 1081340		1,081,340
Accumulated gains in other comprehensive income from currency translation			1,622,436
Number of fixed installments in business divestment | Installments							2	2
Fixed amount receivable from business disposal in business divestment | £							£ 80,000
Number of variable installments of contingent consideration ('earn-out') | Installments							2	2
Contingent consideration | £							£ 90,000
Impairment loss of recoverable amount of net assets held for sale			4,007,744
Discontinued operations [member] | Avon [member]
Disclosure of analysis of single amount of discontinued operations [line items]
Pre-tax profit (loss) from discontinued operations			R$ 380416

SUBSEQUENT EVENTS - Additional

SUBSEQUENT EVENTS - Additional Information (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	Mar. 11, 2024	Dec. 31, 2023
Avon Products, Inc | The Body Shop [member]
Subsequent Event
Amounts receivable, related party transactions		R$ 57000
Distribution of dividends [member]
Subsequent Event
Dividends proposed or declared before financial statements authorised for issue	R$ 979176
Dividends proposed or declared before financial statements authorised for issue (in brazilian real per share)	R$ 0.709217
Minimum mandatory dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners	R$ 293986
Minimum mandatory dividends as percentage of the adjusted net profit (as a percent)	30%

SUBSEQUENTS EVENTS - Summary of

SUBSEQUENTS EVENTS - Summary of Business Combinations (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
	Apr. 30, 2024	Dec. 31, 2023	[1]	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2024
Disclosure of non-adjusting events after reporting period [line items]
PROFIT (LOSS) FROM DISCONTINUED OPERATIONS		R$ 5556457		R$ 597655	R$ 90733
The Body Shop [member]
Disclosure of non-adjusting events after reporting period [line items]
Maximum exposure to credit risk of financial assets designated as measured at fair value through profit or loss						R$ 92000
Major business combination [member] | The Body Shop [member]
Disclosure of non-adjusting events after reporting period [line items]
PROFIT (LOSS) FROM DISCONTINUED OPERATIONS	R$ 320000
[1]The Natura &Co amounts are refers to gain from the TBS and Aesop sale occurred in 2023..